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Recent approaches to cancer therapy have centered on developing small molecule inhibitors for signaling
pathways deranged in common cancers; these compounds are sometimes referred to as tumor
antibiotics. One promising target for tumor antibiotics is Hsp90, a heat shock protein that plays a central
role in promoting the functionality and stability of a group of proteins associated with cancer called client
proteins. Hsp90 inhibitors have been receiving extensive research attention, with geldanamycin,
tanespimycin, and their derivatives at the forefront. This report describes a novel, cost-effective,
commercial scale process design for the production of tanespimycin. The proposed production facility is
designed to deliver 1,084 kg/year through 55 batches, requiring operation of 293 days/year. Detailed
economic analysis suggest the recuperation of funds after an initial investment into the
biopharmaceutical plant and Phase III trials, which suggest that further investment in this process design
would be highly profitable.
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Dear Advisors:
Enclosed is a detailed analysis of the economic and process design for the production of
tanespimycin, a cancer therapeutic abandoned by Bristol-Myers Squibb after successful Phase II
clinical trials. The current process as outlined in a 2003 patent was scaled up so as to meet the
production goal of 1000 kg/year calculated from market analysis, which would allow for
treatment of 112,000 patients per year. As such, it is recommended that two 50,000 L
bioreactors staggered by 5 days operate for approximately 295 days/year in order to meet the
production needs of geldanamycin, the precursor compound to our desired product.
This report details the equipment and units necessary for our proposed process, provides a
thorough market analysis meant to simulate realistic capture of the breast cancer market, and
describes a financial analysis that outlines a competitive pricing for tanespimycin which allows
for greater capture of the prospective market and recoup of funds invested in phase III clinical
trials and biopharamaceutical facility production. The plant will require an initial investment of
the phase III clinical trial of an estimated $2 billion, as well as a total capital investment of $387
million. The internal rate of return (IRR) is 33% and the net present value of about $3.2 billion,
assuming the plant operates for 14 years and the drug can be sold at a price of $2,136,752 per kg
of tanespimycin, or $20,000 per treatment.
After careful consideration, we submit this report for review with strong recommendations to
build the facility to produce tanespimycin, pending its success in Phase III trials to treat breast
cancer under a method of treatment in conjunction with the current drug Herceptin.
Sincerely,
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1.0 Abstract
Recent approaches to cancer therapy have centered on developing small molecule inhibitors for
signaling pathways deranged in common cancers; these compounds are sometimes referred to as tumor
antibiotics. One promising target for tumor antibiotics is Hsp90, a heat shock protein that plays a central
role in promoting the functionality and stability of a group of proteins associated with cancer called client
proteins. Hsp90 inhibitors have been receiving extensive research attention, with geldanamycin,
tanespimycin, and their derivatives at the forefront.
This report describes a novel, cost-effective, commercial scale process design for the production
of tanespimycin. The proposed production facility is designed to deliver 1,084 kg/year through 55
batches, requiring operation of 293 days/year. Detailed economic analysis suggest the recuperation of
funds after an initial investment into the biopharmaceutical plant and Phase III trials, which suggest that
further investment in this process design would be highly profitable.

Keywords: tanespimycin, 17-AAG, geldanamycin, breast cancer, drug production
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2.0 Introduction
2.1 Project Background
The pharmaceutical industry is driven financially by the number of lucrative drugs in each
company’s pipeline. As technologies grow and develop over time, advancements can be made that allow
for new drugs to come to fruition. However, each of these new drugs must undergo a series of expensive
and time consuming FDA regulated clinical trials before being sold as a good in the marketplace. The vast
majority of drugs in the pipeline will fail in these trials; therefore, companies must be selective in
choosing which drugs to pursue and which to abandon. Sometimes the expected return on investment
projected by the company drives the discontinuation of a pipeline drug; other times it can be a change in a
company’s focus. Because the ebb and flow of drug markets is so transient, a useful thought experiment
involves returning to ideas that were once halted and revisiting whether a once-abandoned drug has the
potential to become profitable to a company.
Tanespimycin was a cancer therapeutic abandoned by Bristol-Myers Squibb (BMS) in 2010 for
reasons that will not be disclosed but are not due to lack of efficacy or
high levels of toxicity in patients. After successful Phase I and II
trials, the company decided to halt its production before finishing
Phase III trials. The drug, also known as 17-N-allylamino-17demethoxygeldanamycin, or 17-AAG, had been particularly
promising as a treatment for breast cancer, multiple myelomas, and
childhood leukemias.
The precursor to tanespimycin is geldanamycin, which was first isolated as a fermentation
product of the organism Streptomyces hygroscopicus, a general class of benzoquinone ansamycins. In the
1980s, research suggested that this molecule could act as a tyrosine kinase inhibitor through heat shock
protein 90 (HSP90) chaperone function; however, clinical trials were never performed due to the toxicity
of this molecule (NCI). More recently, several derivatives of geldanamycin have been investigated as
alternatives to the parent compound with lower toxicity and greater chemical stability.
7

HSP90s are important for the folding, activation, and assembly of many proteins and specifically
those involved in signal transduction, cell cycle control, and transcriptional regulation (from 2009 17AAG patent), however, most heat shock proteins (HSPs) are
molecular chaperones. Proper protein synthesis and folding is
supported in vivo by molecular chaperones (Powers, 2007). These
molecular chaperone facilitate the correct folding of nascent
polypeptides, prevent non-specific interactions, and repair damage
proteins (J.C. Young, 2004). Research suggests that HSPs have an
important role in the pathology of cancer (Whitesell, 2005). This
protein has been shown to aid other proteins found in tumor growth, which is why it has recently become
to target of many cancer drugs, including tanespimycin. At the time of this publication, however, no
HSP90 inhibitors have made it successfully through clinical trials and FDA recognition.
Although tanespimycin was not further pursued by Bristol-Myers Squibb at the beginning of the
decade, the recent expiry of the original patent in 2014 has prompted a deeper investigation into the
profitability of this drug, along with the potential for generic production in the future. As members of the
company, we have been tasked with reevaluating the financials to decide if this drug is a potential
moneymaker for BMS and if it could be competitive in today’s market. BMS recently completed a new
biologics production facility in Devens, Massachusetts, which offers over 60 acres of usable real estate
for the large scale production of tanespimycin. As such, it will be assumed that as a group internal to
Bristol-Myers Squibb, common-use equipment will be readily available to those on the production team.
This equipment would include, but is not limited to, a waste neutralization system, industrial autoclaves,
biosafety cabinets, a water purification system and WFI still, a steam generator, and any quality assurance
equipment and testing necessary to ensure the purity of the product.
The installation of this facility is necessarily contingent upon the success of the Phase III trials for
tanespimycin. A contract manufacturing organization will be used to produce the small amount of 17AAG necessary for the trials. After FDA acceptance, the plant in Massachusetts will then be completed.
8

The financial analysis of this project assumes Phase III success for tanespimycin. However, many
proposed drugs in pharmaceutical pipelines fail in Phase III. In fact, roughly 62% of drugs fail to yield
results that are statistically significant. With this in mind, our analysis will shift to show the expected
value of the return on investment is still lucrative enough to move forward with the production of the
plant.
The plant itself and design process for tanespimycin was based off a 2009 patent from Conforma,
but the parent geldanamycin will be produced using the language from a 2003 patent application from
Upjohn Pharmaceuticals, which was acquired by Pfizer. In both cases, the process was scaled so as to
meet the needs defined in the market analysis so as to minimize disposal costs and increase the efficiency
of the process.
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2.2 Project Charter
Project Name: Cost Effective, Commercial Scale Production of Tanespimycin
Project Leaders: Rocky Diegmiller, Alexanra Dreyfuss, Shira Redlich, Melissa Schantz
Specific Goal: To design a biologics plant and process to produce tanespimycin in bulk from its
precursor geldanamycin, isolated from Streptomyces hygroscopicus cells.
Project Scope:
In Scope:


Manufacturing process for tanespimycin from geldanamycin parent compound



Post-manufacturing purification steps of geldanamycin from final fermentation to reactor for
allylamine addition to become 17-AAG



Meet current health and safety and health regulations for biologics



Adherence to good manufacturing practices (GMP)

Out of Scope:


Clinical Trials (assumed to have passed Phase I and II)



Packaging and distribution of drug



Cell line development

Deliverables: Business opportunity assessment


What is the market for tanespimycin and breast cancer treatments in general?
Technical feasibility assessment



Is it technically feasible to manufacture tanespimycin on a large scale using scale up from a
baseline process following a patent?
Manufacturing capability assessment



Can this facility be built and the process utilized without significant capital investment?



Will this process satisfy FDA regulations?

Time Line: Facility and process design along with economic analysis within four months
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3.0 Market and Competitive Analysis
The antitumor effect of tanespimycin has been demonstrated in a variety of Phase II clinical trials.
Specifically, tanespimycin has been used to successfully treat patients suffering from renal tumors due to
Von Hippel Lindau disease, pediatric acute lymphoblastic leukemia, and HER2-positive breast cancer.
Focus should be placed on the largest target population due to the expense of a Phase III clinical trial that
can conservatively be estimated to cost $2 billion dollars.
Dr. Diamond from the University of Pennsylvania, an expert in biotechnology, states that, if only
considering the costs of treating the patients, a Phase III trial will cost $200 million to $500 million. The
$2 billion dollar estimate includes the cost of failed trials suspecting that one drug may get approved for
$500 million, but three others will fail at $500 million thus yielding the $2 billion dollar figure per drug.
Also the $2 billion figure accounts for the opportunity cost of committing $1 billion dollars for 10 years,
which could otherwise be invested for 5 percent for 10 years.
As seen in Figure 3.1, HER2-positive breast cancer patients represent the majority of potential
beneficiaries of tanespimycin treatment; therefore, this will be the target patient population for this
production.

Figure 3.1 Representation of each patient population in the United States and in Europe.
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The 2011 clinical trial detailing tanespimycin treatment for HER2-positive patients used a
combination therapy with Herceptin, a humanized monoclonal antibody that blocks HER2 function. In
order to define a production goal, limitations of the population of HER2-positive patients must be
defined. The patient population is first narrowed to the percentage that already uses Herceptin in
treatment. With further consideration that only a subset of these patients will respond positively and that
not all Herceptin users will additionally choose to use tanespimycin, the target population is further
limited to 6 percent of the total HER2-positive patients.
Following the dosing of the successful Phase II clinical trial, patients will receive weekly
treatments of tanespimycin at 450 mg/m2. The average treatment duration was three months thus yielding
13 weeks of therapy. With the average woman having a surface area of 1.6m2, 9.36 grams of
tanespimycin are needed for one treatment. Using the narrowed target population, a production goal of
approximately 1109 kg of tanespimycin per annum is achieved. Due to the limitations of the equipment
yields, the process proposed maximally yields 1084 kg per year. To account for bad batches and potential
equipment failure, only 95 percent of the maximal yield will be sold for treatment and accounted for in
projected sales.
Medical News Today, estimated that in 2012 the average cost of a full course of Herceptin
treatment costs about $70,000 according to various medical sources. Because tanespimycin will be used
in conjunction to this drug the price will not be directly competitive, for combination treatment would
then be twice as expensive as using Herceptin alone. Instead tanespimycin will be priced at XXX per
treatment to account for the hesitancy to use a new method of treatment as well as the added expense of
combination therapy. This price and level of production will yield annual sales totaling XXX.
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4.0 Preliminary Process Synthesis
The overarching goal of this project is to design the most economically efficient process for the
production of tanespimycin. To do so, it was first determined that the commercial price of geldanamycin
(precursor to tanespimycin) of $383 million / 1.2 kg was indefensibly high (NCI, 2013). This motivated
the undertaking of our own production of geldanamycin.
Figure 4.1 outlines a ‘Decision Map’ depicting the alternative flow sheets considered, and the
process by which the final design for both geldanamycin and tanespimycin production was reached.

Figure 4.1 ‘Decision Map’ documenting the alternative flow sheets considered in reaching the final design for geldanamycin and
tanespimycin production.

4.0.1 Geldanamycin Patent Design
The design displayed in Figure 4.2 was used as a starting point for geldanamycin production
design (Pharmacia & Upjohn Company, 2004). The process consists of three fermentation steps with
~25x scale-up between each, followed by several downstream isolation and purification steps: rotary
13

vacuum filtration to remove biomass, cellulose-based filtration to remove media, extraction to remove the
cellulose-based filter media, distillation to concentrate the geldanamycin solution, crystallization, and
recrystallization. The process produces 3.375 kg geldanamycin / batch with a 45% yield resulting from

loss of product in downstream processing.
Figure 4.2 Base design of geldanamycin production, modeled after Pharmacia & Upjohn Company’s 2003 design.

4.0.2 Initial Production Goal
The initial process goal was to produce 100-200 kg tanespimycin / year. Since conversion of
geldanamycin to tanespimycin is achieved with >85 % yield (Conforma Therapeutics Corporation, 2009),
the original design was adjusted and tailored to produce ~200 kg geldanamycin / year. Two designs for
the upstream process were considered, with downstream processing remaining the same albeit equipment
sizing adjustments.
For the first design, it was determined that the cycle time of the described process was 15 days - 3
days for each of the first two fermentations, 8 days for the final fermentation, and 1 day for downstream
14

processing. Assuming operation of the plant for ~300 days / year, three fermentation trains running in
parallel would yield (300/15)*3.375*3 = 202.5 kg geldanamycin / year.
Alternatively, by identifying the bottleneck of the process as the large fermenter with a total
fermentation time of 8 days, we investigated the result of staggering two fermentation trains by 4 days.
The total output from this design, again assuming 300 days of operation, was estimated as (1+
285/4)*3.375 = 240 kg geldanamycin / year. Thus, this design was pursued.

4.0.3 Revised Production Goal & Scale-Up
Upon further analysis of the potential market, it became desirable to increase production to 1000
kg tanespimycin/ year, or ~1100 kg geldanamycin / year. (Refer to Chapter 3 for in-detail discussion of
market analysis.) Two alternatives for scale up were proposed. The difference in each design was in the
upstream geldanamycin production process, so only this portion of the process is shown in Figures 4.3
and 4.4.
Five-Fold Replication. The block block diagram for the five-fold replication of the base process
design is displayed in Figure 4.3 Sizing of fermenters and storage tanks remain identical to that in the
original process design, and each pair of fermenters remains staggered by 4 days. The total amount of
geldanamycin produced / year is estimated as (240 kg geldanamycin / year * 5) = 1200 kg/year.

15

Figure 4.3 Upstream design replicated 5 times to achieve ~1000 kg geldanamycin / year. Vessel volumes shown in red. Pairs of
fermentation trains staggered by 4 days. All FERM blocks feed into one storage tank for subsequent downstream processing.
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Six-Fold Volume Scale-Up. The block diagram for the six-fold enlargement design is displayed in
Figure 4.4. The most notable change in this design is the increased fermentation time of the 50,000 L
fermenter from 8 days to 10 days. Thus, the two fermentation trains are staggered by five days, not four,
with each fermenter giving 21.9 kg geldanamycin / batch. The total amount of geldanamycin produced /

year is then (~55 batches*21.9) = 1205 kg/year..
Figure 4.4 Block Diagram of six-fold volume scale up design for >1000 kg geldanamycin production/year.

The purchase cost of two 50,000 L fermenters (estimated by scaling up the price of two 8,000 L
fermenters by 10^.6) as compared to the purchase cost of an additional eight 8,000 L fermenters would
clearly require less investment. Additionally, when considering maintenance requirements, number of
employees, and number of pumps for two larger or ten smaller fermenters, it is clear that a fewer number
of large fermenters would have an overall lower cost. Thus, the six-fold volume scale up of the base
design fermenters was pursued.

4.0.4 Tanespimycin Base Design & Scale-up.
Following the determination of a process design for geldanamycin, the design of a process on the
appropriate scale for the conversion of geldanamycin to tanespimycin was needed. Conforma
Therapeutics Corporation’s bench-scale design was used as a basis, and two options for scale up were
considered.
Reactor Volume Increase. This design, depicted in Figure 4.5, involves the scaling up of reactor
volume to ~1000 L, accommodating the increased geldanamycin produced. However, this adjustment was
not feasible because the reaction of geldanamycin with allylamine to produce tanespimycin would have
17

taken at least 90 days; allylamine must be added dropwise over an extended period of time (Conforma
Therapeutics Corporation, 2009). In order to keep the reaction time under 5 days (duration of bottleneck
step / 2 fermentation trains), another design was sought.

Figure 4.5 Reactor volume scale up to accommodate increase in geldanamycin being produced. Design not feasible due to the
impractical duration of time needed to conduct the reaction on such a large scale.

Reactor Number Increase. To avoid the impractical reaction time resulting from reactor volume
increase, reactor number increase was investigated. It was desirable to keep the reaction time under 5
days, as anything above 5 days would result in less batches/year and lower production rate. It was
determined that 18 reactors were required to process the amount of geldanamycin produced/batch in the
process designed above, with a reaction time of under 5 days. Calculations for this result are shown in
Appendix A.

Figure 4.6 Reactor number increase to accommodate increase in geldanamycin production, while maintaining a reaction time of
<5 days.
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4.0.5 Final Design
The final process for the production of tanespimycin is a combination of the diagrams discussed
above, and is shown in Figure 4.6. A detailed description can be found in Chapter 7. Additionally,
deviations from patents and innovations are discussed in that chapter.

19

Figure 4.6 Block diagram of final process design for tanespimycin production
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5.0 Assembly of Database
The database of chemical used throughout the process can be found in Appendix E as MSDS
sheets. As such, it is worth noting that the only chemicals that have been deemed hazardous in this
production process are that of methylene chloride and isooctane. Methylene chloride is a known
carcinogen, which ensures that extra caution is taken when handling. Additionally, exposure to isooctane
can cause damage to the central nervous system, as well as to the eye and stomach if contacted. Prices for
all of the chemicals in the database are given in Table 5.1

Table 5.1 Principle Chemical Purchase Costs.

Component

Price($/Kg)

Source

Glucose Monohydrate

47.83

Millipore

Yeast Extract

192.02

Fisher BioReagents

Peptone Extract

194.99

Fisher BioReagents

Ampule (10 mg/mL)

354.24

ATCC

PEG (1.128 g/mL)

69.925

MP Biomedicals

Soyflour

9.48

MP Biomedicals

Corn Starch

22.35

Fisher Scientific

Ammonium Sulfate

33.14

Millipore

Calcium Carbonate

63.12

Fisher Chemical

Cobalt Chloride Dihydrate

650.63

MP Biomedicals

Ferrous Sulfate Heptahydrate

225.28

Millipore

Alpha Amylase

540.80

MP Biomedicals

Soybean Oil

165.57

MP Biomedicals

Polyalkylene Glycol

116.51

Sigma Aldrich

Filter Aid

16.98

Fisher Scientific
21

Cellulose-based Filter Media

16.98

Fisher Scientific

Methylene Chloride

37.25

Fisher Scientific

Isooctane

233.35

Fisher Scientific

THF

83.52

Fisher Scientific

Allylamine

251.64

Fisher Scientific

6.0 Process Flow Diagram & Material Balance
This chapter presents the proposed process flow diagram for tanespimycin production. The
complete process flow diagram is shown in Figure 6.1. The overall component material balance is
displayed in Table 1. Material flow rates, temperature, and pressure are also presented for each stream in
Table 2. The ensuing sections of this chapter subdivide the process into three parts: upstream
geldanamycin production, downstream geldanamycin production, and tanespimycin production, with
respective flow diagrams and material balances on each piece of equipment presented. Material balances
calculations were performed by scaling up patent specifications when applicable. All other calculations,
including biomass production and flow rates for continuous processing steps are shown in Appendix A.
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Figure 6.1 The complete process flow diagram of tanespimycin production.
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Table 6.1 Overall Component Balances (kg/batch). Outlines inputs, outputs, and changes in mass.

Component

Input

Output

Produced

Consumed/Lost/Discarded

Out-In

Glucose Monohydrate

14.021

0.000

0.000

14.021

0.000

Yeast Extract

3.505

0.000

0.000

3.505

0.000

Peptone Extract

14.021

0.000

0.000

14.021

0.000

Cells

0.173

0.000

371.966

371.966

0.000

PEG

2.343

0.000

0.000

2.343

0.000

Geldanamycin

0.000

0.000

48.685

48.685

0.000

Soyflour

1217.137

0.000

0.000

1217.137

0.000

Corn Starch

2839.987

0.000

0.000

2839.987

0.000

Ammonium Sulfate

81.142

0.000

0.000

81.142

0.000

Calcium Carbonate

243.427

0.000

0.000

243.427

0.000

Cobalt Chloride Dihydrate

0.325

0.000

0.000

0.325

0.000

Ferrous Sulfate Heptahydrate

3.651

0.000

0.000

3.651

0.000

Alpha Amylase

1.623

0.000

0.000

1.623

0.000

Soybean Oil

0.001

0.000

0.000

0.001

0.000

Polyalkyleneglycol

5.193

0.000

0.000

5.193

0.000

Water Shots

5842.259

0.000

0.000

5842.259

0.000

Methylene Chloride

3464.650

0.000

0.000

3464.650

0.000

Isooctane

1725.000

0.000

0.000

1725.000

0.000

THF

627.232

0.000

0.000

627.232

0.000

Allyl Amine

34.685

0.000

0.000

34.685

0.000

H20

204.475

0.040

0.000

204.435

0.000

Tanespimycin

0.000

19.717

21.742

2.025

0.000

* Filter Aid

1352.912

0.000

0.000

1352.912

0.000

* Cellulose-based Filter Media

1352.912

0.000

0.000

1352.912

0.000
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Table 6.2 Material Flow Rates, Temperatures, and Pressures of each stream.

Stream Summary

S1

S2

S3

S4

S5

S6

S7

Media

1.17

1.17

0.00

0.00

0.58

31.54

0.58

Ampule (10 mg/mL)

0.00

0.00

0.17

0.17

0.00

0.00

0.00

Biomass

0.00

0.00

0.00

0.00

0.76

0.00

0.76

Geldanamycin

0.00

0.00

0.00

0.00

0.00

0.00

0.00

Water Shots

0.00

0.00

0.00

0.00

0.00

0.00

0.00

Total Mass (kg/batch)

1.17

1.17

0.17

0.17

1.34

31.54

1.34

Stream Summary

S8

S9

S10

S11

S12

S13

S14

S15

Media

31.54

29.52

4392.49

29.52

4392.49

4242.165

4242.165

4242.165

Ampule (10 mg/mL)

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

Biomass

0.00

3.37

0.00

3.37

0.00

372.139

372.139

372.139

Geldanamycin

0.00

0.00

0.00

0.00

0.00

48.69

48.69

48.69

Water Shots

0.00

0.00

5842.26

0.00

5842.26

5604.65

5604.65

5604.65

Total Mass (kg/batch)

31.54

32.90

10234.75

32.90

10234.75

10267.64

10267.64

10267.64

Component (kg/batch)

Component (kg/batch)

25

Stream Summary

S16

S17

S18

S19

S20

S21

S22

Fermentation Media

0.00

9846.81

9846.81

7877.45

1969.36

1969.36

1969.36

Biomass

372.14

0.00

0.00

0.00

0.00

0.00

0.00

Geldanamycin

9.74

38.95

38.95

3.90

35.05

35.05

10.52

Filter Aid

1352.91

0.00

0.00

0.00

0.00

0.00

0.00

Cellulose-based Filter Media

0.00

0.00

0.00

0.00

1352.91

1352.91

1352.91

Methylene Chloride

0.00

0.00

0.00

0.00

0.00

0.00

6.65

Isooctane

0.00

0.00

0.00

0.00

0.00

0.00

0.00

Total Mass (kg/batch)

1734.79

9885.77

9885.77

7881.35

3357.33

3357.33

3339.44

Stream Summary

S23

S24

S25

S26

S27

S28

S29

S30

Fermentation Media

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

Biomass

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

Geldanamycin

24.54

0.00

24.54

2.45

22.08

22.08

0.18

21.91

Filter Aid

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

Cellulose-based Filter Media

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

Methylene Chloride

3458.00

133.00

3325.00

3291.75

33.25

33.25

33.25

0.00

Isooctane

0.00

0.00

0.00

1707.75

17.25

17.25

17.25

0.00

Total Mass (kg/batch)

3388.24

133.00

3349.54

5001.95

72.58

72.58

50.68

21.91

Component (kg/batch)

Component (kg/batch)
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Stream Summary

S31

S32

S33

S34

S35

S36

S37

Geldanamycin

21.91

1.10

0.00

1.10

1.10

1.10

0.00

THF

627.23

627.23

608.14

18.82

18.82

18.82

0.00

Allyl Amine in THF (1 mol/mL)

34.69

32.01

0.00

32.01

32.01

32.01

0.00

Tanespimycin

0.00

21.74

0.00

21.74

21.74

2.03

19.72

WFI

0.00

0.00

0.00

0.00

0.00

204.44

0.04

Total Mass (kg/batch)

683.83

682.07

608.14

73.66

73.66

258.38

19.76

Component (kg/batch)
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6.1 Upstream Geldanamycin
6.1.1 Process Flow Diagram
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6.1.2 Vessel Material Balances
Vessel names are obtained from the flowsheet in Figure 6.1 All mass values are presented in
kg/batch and represent values for one fermentation train. Additionally, temperatures in vessels are
included when notable deviations from room temperature are required. Temperature specifications
are also addressed in Chapter 7.

1st-SEED.
Component

Input

Output /Ferm Train

Produced

Consumed/Lost

Out - In

Glucose Monohydrate

1.039

0.519

0.000

0.000

0.000

Yeast Extract

0.260

0.130

0.000

0.000

0.000

Peptone Extract

1.039

0.519

0.000

0.000

0.000

52EF-1 , 52EF-1.
Masses represent the input and output of all 52 erlenmeyer flasks combined.
Temperature = 28 °C
Component

Input

Output

Produced

Consumed/Lost

Out - In

1° Seed Medium

1.168

0.578

0.000

0.591

0.000

Ampule (10 mg/mL)

0.173

0.764

0.591

0.000

0.000

2NDSEED1 , 2NDSEED2.
Temperature = 28 °C
Component

Input

Output

Produced

Consumed/Lost

Out - In

1° Seed Medium

0.578

0.531

0.000

0.047

0.000

Cells

0.764

3.373

2.609

0.000

0.000

Glucose Monohydrate

12.983

11.929

0.000

1.054

0.000

Yeast Extract

3.246

2.982

0.000

0.264

0.000

Peptone Extract

12.983

11.929

0.000

1.054

0.000

PEG (1.128 g/mL)

2.343

2.153

0.000

0.190

0.000
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FERM1 , FERM2.
Temperature = 28 °C
Component

Input

Output

Produced

Consumed/Lost

Out - In

1° , 2° Seed Medium

29.523

28.322

0.000

1.201

0.000

Biomass

3.373

372.139

368.766

0.000

0.000

Geldanamycin

0.000

48.685

48.685

0.000

0.000

Soy flour

1217.137

1167.636

0.000

49.501

0.000

Corn Starch

2839.987

2791.994

0.000

47.993

0.000

Ammonium Sulfate

81.142

79.771

0.000

1.371

0.000

Calcium Carbonate

243.427

239.314

0.000

4.114

0.000

Cobalt Chloride Dihydrate

0.325

0.319

0.000

0.006

0.000

Ferrous Sulfate Heptahydrate

3.651

3.589

0.000

0.062

0.000

Alpha Amylase

1.623

1.595

0.000

0.028

0.000

Soybean Oil

0.00060

0.001

0.000

0.000

0.000

Polyalkylene glycol

5.193

5.105

0.000

0.088

0.000

Water Shots

5842.259

5742.902

0.000

99.357

0.000
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6.2 Downstream Geldanamycin
6.2.1 Process Flow Diagram
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6.2.2 Material Balances by Vessel
Downstream processing consists of both batch and continuous processes. Batch step material
balances are presented in kg/batch, while continuous steps material balances are presented in kg/hr.
Continuous steps are denoted with a ‘*’. Additionally, temperatures in vessels are included when
notable deviations from room temperature are required.

ROTV-FLT.*
Component

Input

Discarded

Kept

Fermentation Media

2874.442

0.000

2874.442

Biomass

106.325

106.325

0.000

Geldanamycin

13.910

2.782

11.128

Filter Aid

386.546

386.546

0.000

CLL-FLT.
Component

Input

Discarded

Kept

Fermentation Media

10060.548

8048.439

2012.110

Geldanamycin

38.948

3.895

35.054

Cellulose-based Filter Media

1352.912

0.000

1352.912

EXTRCTION.*
Component

Input

Discarded

Kept

Fermentation Media

1006.055

1006.055

0.000

Geldanamycin

17.527

5.258

12.269

Methylene Chloride

1732.325

3.325

1729.000

Cellulose-based Filter Media

676.456

676.456

0.000
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DISTILL.*
Component

Input

Discarded

Kept

Geldanamycin

3.505

0.000

3.505

Methylene Chloride

494.000

19.000

475.000

CRYST.*
Temperature = 35-40°C
Component

Input

Discarded

Kept

Geldanamycin

3.505

0.350

3.155

Methylene Chloride

475.000

470.250

4.750

Isooctane

246.429

243.964

2.464

ROSENMUND.
Component

Input

Discarded

Kept

Geldanamycin

22.084

0.176

21.908

Methylene Chloride

33.250

33.250

0.000

Isooctane

17.250

17.250

0.000
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6.3 Tanespimycin Production
6.3.1 Process Flow Diagram
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6.3.2 Material Balances by Vessel
Conversion of geldanamycin to tanespimycin consists of both batch and continuous
processing. Batch step material balances are presented in kg / batch, while continuous steps material
balances are presented in kg/hr. Continuous steps are denoted with a ‘*.

REACTOR.
Masses are for all 18 reactors combined.
Temperature = ~45-50°C, slightly below THF boiling point of 66°C
Component

Input

Output

Produced

Consumed/Lost

Out - In

Geldanamycin

21.908

1.095

0.000

20.813

0.000

THF

627.232

627.232

0.000

0.000

0.000

Allyl Amine in THF

34.685

32.005

0.000

2.680

0.000

Tanespimycin

0.000

21.742

21.742

0.000

0.000

ROT-EVAP.*
Component

Input

Discarded

Kept

Geldanamycin

0.548

0.000

0.548

THF

313.616

304.208

9.408

Allyl Amine

16.002

0.000

16.002

Tanespimycin

10.871

0.000

10.871

Component

Input

Discarded

Kept

Geldanamycin

1.095

1.095

0.000

THF

18.817

18.817

0.000

Allyl Amine

32.005

32.005

0.000

Tanespimycin

21.742

2.025

19.717

WFI

204.475

204.435

0.040

FLTR-DRY.
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7.0 Process Description
7.0.1 Process Overview
The tanespimycin production process is designed to run for 293 days/year. One batch will
give 21.91 kg geldanamycin (45% yield), and then 19.7 kg tanespimycin (90% yield). The longest
step in the process is the 10-day duration of the 50,000 L fermentor (cleaning time included). Thus,
two identical fermentation processes will run staggered by 5 days. Every 5 days after the first 23 days
(total process time = 15.75 day geldanamycin upstream + 2.25 days geldanamycin downstream + 5
days tanespimycin) 21.91 kg geldanamycin will be produced. The total mass of tanespimycin
produced/year will then be 1084 kg. (55 batches/year) Accounting for bad batches, the total amount
of usable tanespimycin produced/year, can be estimated according to Morphotek as approximately
95% of overall mass, or 1030 kg tanespimycin/year.
Important process parameters are: cycle time of 23 days, batch time of 5 days, and bottleneck
of 50,000 L fermentation lasting 10 days. A Gantt Chart can be found in Chapter 7.

7.0.2 Employee Requirement
For the upstream and downstream geldanamycin process, a total of 13 employees per shift are
required: 1 employee for fifty-two 2 L fermentors of both trains who will have a break every 5 days to
monitor downstream, 1 employee for secondary fermentor of both trains who will have a break every 5
days to monitor downstream, 1 employee on each of the 50,000 L bioreactors at all times, and 1 employee
at each of the downstream processes (ROTV-FLT, BIOINACT, CLL-FLT, NEUTRLZ1, EXTRCTON,
DISTILL, CRYST, ROSEMUND, and 34-DRUMS) . For the tanespimycin production process, 11
employees per shift are required: 9 total employees for the 18 reactors, 1 employee for downstream, and 1
employee for maintenance. Assuming four 8-hour shifts/day, full time salary is required for 96
employees. Each employee will be paid $47,000/year (Bureau of Labor Statistics, 2014), for a total
employee cost of $4,512,000/year.
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7.0.3 Piping and Flow Rates
Flow rate of material between vessels throughout the entire tanespimycin production process
occurs in pipes approximately 3” in diameter, corresponding to a flow rate of 400 LPM. Since many
steps in the process involve solid-bearing liquids, all pipes will maintain at least a 5 ft/sec velocity to
prevent the solids from settling out in the pipeline and provide sufficient turbulent conditions to keep
the solids in suspension. At the end of every slurry transfer, the pipes will be flushed with clear liquid
to sweep out all solids.

7.0.4 Gantt Chart Scheduling
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Figure 7.1. Block diagram of tanespimycin production.
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7.1 Geldanamycin Upstream Process
Upstream processing consists of three fermentation steps, each at 28°C and successive 25x scaleup. The fermentation is expected to produce 48.684 kg geldanamycin/batch requiring subsequent isolation
and purification.
Input materials include serum-free media and the natural organism Streptomyces hygroscopicus
in a 10 mg/mL solution stored at -80°C. This process treats the organism’s doubling time as 1.4 days with
a yield coefficient of 0.13. Literature reports of 1.4-2 day doubling time and a yield coefficient of 0.1708
show that these parameters in this process are on the conservative side, potentially allowing for even
greater yields (Subhasish Dutta, 2013).
The ensuing description gives numbers for operation of one of the two fermentation trains, as
each operates in alternating 5 day periods. Additionally, page references to descriptions of each piece of
equipment in Chapter 9 are bracketed at the end of each equipment/step subsection.

7.1.1 Primary Seed Media Preparation
Primary media preparation consists of mixing glucose monohydrate, yeast extract, and peptone
extract for a total volume of (52x2) L in a (65x2) L vessel every 10 days, starting on day 5 of operation. 1
L of the media will be dispensed into fifty-two 2 L erlenmeyer flasks, which will then be autoclaved for
45 minutes and subsequently cooled for approximately 30 minutes. Each erlenmeyer flask will be sealed
with a membrane cap by DURANO.

7.1.2 Inoculation
Following cooling, each flask will be inoculated with 1 L of an ampule culture (10 mg/mL, 1.4
day doubling time) of Streptomyces hygroscopicus variety geldanus variety nova (NRRL 3602). The
culture should be previously cultured in primary seed medium, mixed with 15% glycerol, and stored at 80°C. Each of the fifty-two 2 L flasks will then be incubated for 3 days at 28°C on a rotary shaker, after
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which the flasks’ contents will be transferred along with secondary seed medium to an 1750 L fermenter.
Cleaning time for the fifty-two 2 L erlenmeyer flasks is approximately 4 hours.

7.1.3 Secondary Seed Preparation
Secondary seed media preparation consists of mixing glucose monohydrate, yeast extract,
peptone extract, and PEG for a total volume of (1300x2) L in a (1600x2) L tank every 10 days starting on
day 8 of operation.

7.1.4 Secondary Fermenter
Half of the secondary media storage vessel content along with all material from the fifty two 2 L
erlenmeyer flasks will be transferred to an 1750 L fermenter. The reactor is maintained at 28°C without
pH control, at 7 psi backpressure, 200 SLM, and 250 rpm. Incubation will occur for 3 days before all
material is transferred to the final 50,000 L fermenter. Cleaning time is approximately 4 hours.

7.1.5 Fermentation Media Preparation
The fermentation media consists of mixing soy flour, corn starch, ammonium sulfate, calcium
carbonate, cobalt chloride dihydrate, ferrous sulfate heptahydrate, alpha amylase, soybean oil for a total
volume of (32,500x2) in an 82,000 L tank every 10 days starting on day 11. Polyalkylene Glycol is
added to help minimize foam before transfer to a 50,0000 L fermentor.

7.1.6 Fermentation
Half of the secondary media storage vessel content along with all material from the secondary
fermenter will be transferred to a 50,000 L fermenter. The fermentation is maintained at 28°C and the pH
is controlled between 6.25 and 7.75. The back pressure is maintained between 7 and 20 psi with stirring
between 180-220 rpm, and aeration between 1000-5000 SLM. The fermentation will run for 9.75 days,
and receive 1460 L water shots on days 6, 7, 8, and 9.. At harvest, the entire contents of the fermenter
tank are pushed to a 50,000 L storage tank for cooling, and then isolation. Cleaning time for the fermenter
will be 6 hours.
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7.1.7 Storage/Cooling
The resulting product from the 50,000 L fermenter will be transferred to a 50,000 L storage tank
which will cool the material to 5°C over a 3 hour period.

7.2 Geldanamycin Downstream Process
The isolation and purification of a fermentation product is essential to any commercial process.
Since the chemical nature of a fermentation broth is complex, and extremely high purity is required for a
pharmaceutical product intended for patients as tanespimycin is, recovery and purification requires many
processing steps. (Shuler & Kargi, 2002) In this design, isolation and purification of tanespimycin are a
combination of batch and continuous processes, in contrast to the original patent in which all steps were
batch. Continuous processing was employed when possible to exploit: lack of vessel size restrictions, less
costly and time consuming cleaning/rinsing cycle, no time loss filling and emptying tanks, and less
manual operation (Miteco, 2015). Storage tanks are used when a switch from batch to continuous or vice
versa is required.

7.2.1 Rotary Vacuum Filtration: Biomass Removal
The rotary vacuum filter is operates through a revolving drum; each revolution of the drum
consists of cake formation, cake washing (if needed), dewatering or drying, and cake discharge. As the
drum rotates under vacuum, a thin layer of cells will adhere to the drum. A vacuum maintained in the
drum will provide the driving force for liquid flow (Shuler & Kargi, 2002, pg 332).
A mixture of diatomaceous earth produced by Eagle-Picher Industries in Reno, NV and
diatomaceous earth produced by Celite Corporation in Lompac, CA filter aids (1/1) will coat the rotary
vacuum filter drum, in an amount of 4 kg filter aid/100 L of fermentation medium. The fermentation
medium will be filtered continuously over a period of 3.5 hours. The solid cake that forms, comprised of
biomass and filter aid, will be scraped off the vacuum filtration unit as the drum rotates and discarded into
a biowaste tank containing water where they will mix to create a liquid that can be pumped to the
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facility’s built-in biowaste inactivation system. The filtrate containing the geldanamycin product will be
transferred to a 50,000 L storage vessel (STORAGE2/V102) to aid the switch from continuous to batch
processing, and cooled to 5°C in approximately 3 hours. [,]

7.2.2 Cellulose-Based Filtration: Crude Crystals Isolation
The filtrate obtained from rotary vacuum filtration/storage vessel will be contacted with
cellulose-based filter media of type 10A produced by Cuno Incorporated, Meriden, CT in a batchprocessing step that will take approximately 5 hours. The clarified filtrate obtained will be discarded into
an 11,355 L neutralization tank. Crude geldanamycin crystals along with cellulose-based filter media will
be subsequently transferred to a 8500 L storage tank (XTRSTRG1/V-105) to avoid the need to stop the
process if the extractor in the next step, whose contents often emulsify, needs to be adjusted. Material will
be transferred to the storage tank with a pump, as enough liquid fermentation media will be present and
flow at >5 ft/sec which will keep the solids flowing.

7.2.3 Extraction with Methylene Chloride
The crude geldanamycin crystals and cellulose-based filter media will be contacted with
methylene chloride in a 10,000 L extractor to extract the filter media continuously. The extractor will
have two stages which operate in reverse flow. Each of the two phases will be fed into the respective
opposite stage with a metering pump and run through the system due to the conveyance effect of the
stirrers. The overflow phases will be collected in two receivers.
The methylene chloride will be recycled through the filter elements for 2 hours. In contrast to many
liquid liquid extractions in which multiple steps are used to maximize product recovery, only one step
will be used in this solid-liquid extraction. The filter media will be discarded into several 55 gallon drums
that will be removed by a contracted waste management company. Geldanamycin will be obtained
dissolved in an unsaturated solution of methylene chloride.

44

7.2.4 Concentration with Distillation
Excess methylene chloride will be removed with continuous distillation lasting approximately 7
hours. Continuous distillation technology used will be provided by Armfield, Inc. and suitable for at least
500 L of material. The product obtained from this process will still be liquid methylene chloride with
dissolved geldanamycin, but at a higher, still unsaturated, concentration which will allow for better
crystallization of product in the next step. Evaporated methylene chloride will be transferred to 55 gallon
drums that will be removed by a contracted waste management company. (BP Geldanamycin = 783.86
°C, BP Methylene Chloride = 39.6 °C)

7.2.5 Crystallization
The dissolved geldanamycin is continuously crystallized by mixing with isooctane over 7 hours,
maintaining a temperature of 35-40°C. (MP Geldanamycin = 255°C, MP Isooctane = 107.32 °C)
Methylene chloride and isooctane will be transferred to 55 gallon drums that will be removed by a
contracted waste management company. The crystal slurry will be transferred with a conveyer to a 65 L
storage tank (STORAGE3/V-101) and then cooled to 5°C (3 hours) once all product from the
crystallization is processed.

7.2.6. Rosenmund Filter/Drying
Instead of tray drying as specified by the original patent (Gillespie, 2004), this design will use a
Rosenmund Nutsche filter to dry the crystals and purify the geldanamycin to increase efficiency in
washing and drying, allow for quick turn around, and enable visual and physical inspection of product.
The Rosenmund unit will have an internal agitator which will go in one direction to "plow up" the crystals
for washing and drying and reverse to discharge the crystals through a side chute.
The batch washing and drying of the geldanamycin crystal cake will take 14 hours. Methylene
chloride and isooctane will be discarded into 55 gallon drums that will be removed by a contracted waste
management company. The geldanamycin crystals will be collected in drums and dumped or conveyed
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(with a Schutte-Koerting solids ejector or a pneumatic unit from DeDietrich) into each of the next 18
reactors.

7.3 Tanespimycin Production
The goal of the last part of the process is to convert isolated and purified geldanamycin to
tanespimycin, which will then be isolated and purified. The process consists of a reaction taking place
simultaneously in 18 reactors, which then feed into one train of two isolation/purification steps, the first
being continuous and the second being batch. A storage tank aids the switch.

7.3.1 Reaction Conversion of Geldanamycin to Tanespimycin
The purified and dried geldanamycin will be transferred in equal amounts to 18 identical stainless
steel 60 L reactors along with THF (solvent). Allyl amine dissolved in THF will be added over a period of
4.5 days - the entire reaction time. ~95% of the geldanamycin will react to give tanespimycin and reaction
completion will be verified with a TLC column. The entire reactors content will be pushed to isolation.

7.3.2 Rotary Evaporation
A rotary evaporator suitable for 750 L of liquid will be used to continuously remove solvent over
a period of 2 hours. The liquid to be processed in the rotary evaporator is fed directly into the rotary flask
by a feed pipe conducted through the condenser part. Evaporation takes place in the externally heated
rotary flask, and the rotational movement of the piston ensures a good intermixing of the medium, thus
providing regular temperature distribution (De Dietrich, 2014). The THF will be discarded into a 1040.9L
neutralization tank before passing through the facility’s built-in neutralization system. The rest of the
reactor contents will be transferred to a 100 L storage tank (STORAGE4 / V-102) to aid the switch from
continuous to batch before Rosenmund drying.

7.3.3 Rosenmund: Filter/Drying
Instead of tray drying, as specified by the original patent (Gillespie, 2004), this design will use a
Rosenmund Nutsche filter to dry the crystals and purify the geldanamycin to increase efficiency in
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washing and drying, allow for quick turn around, and enable visual and physical inspection of product.
The Rosenmund here will have a filtration area of 5.6 sq. ft., and a 32” diameter suitable for ~250 L of
material.
Filtering/drying will remove any unreacted geldanamycin and allylamine, and the rest of the THF
in a batch-wise manner for approximately 10 hours. Discarded material will be transferred to the same
1040.9L neutralization tank before passing through the facility’s built-in neutralization system. H20 will
be added to aid precipitation and crystallization of the tanespimycin. The Rosenmund will be positioned
above the the nitrogen blanket for direct discharge into that next vessel for storage of the final product.
Tanespimycin will be obtained as a solid at 99.99% purity.

47

8.0 Utility Requirements
The primary requirements of the plant are electricity, steam, and process water. Of these,
electricity is most expensive, making up 96.5% of the total utility cost per year. These calculations are
based off a $0.08 per kWh rate from NSTAR, a Massachusetts energy provider. Of the electricityrequiring processes, the HVAC process consumes 36.3% of the total energy required. The other major
energy consumers are the distillation column (37.3%) and the production bioreactors (9.75% for both).
The table shown in the next section shows the exact amounts of energy listed for each energy-consuming
portion of the plant.
Steam and process water are the other two main contributors to the utility costs. The plant will
need roughly 40,000 lb of steam and 230,000 gal of cooling water per year. The steam will be used in the
steam-in-place setup, while the cooling water will be used in the upstream process to offset the heat
released by the growing organisms in the fermentor. The larger heat duty needed for downstreams
process will be covered by roughly 120,000 kg of propylene glycol per year, which has a much lower
freezing point. At a rate of $0.543 per 1000 L from the Aquarion Water Company in Massachusetts,
water will cost less than $500 per year.
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Table 8.1: Utility Costs Per Unit Equipment

Electricity Costs ($/kWh)

Amount (kWh/batch)

Cost ($/batch)

Cost/yr ($)

UPSTREAM
52-2L, EF (2)

2.67

$0.21

$11.73

2ND-SEED (2)

193.75

$15.50

$852.50

FERMENTR (2)

4276.62

$342.13

$18,817.13

$357.84

$19,681.36

Total
DOWNSTREAM
ROTV-FLT

143.80

$11.50

$632.72

CLL-FLT

3.97

$0.32

$17.47

EXTRCTON

18.50

$1.48

$81.40

DISTILL

16349.00

$1,307.92

$71,935.60

CRYST

110.00

$8.80

$484.00

ROSEMUND

30.00

$2.40

$132.00

$1,332.42

$73,283.19

Total
TANESPIMYCIN PROD
ROT-EVAP

143.80

$11.50

$632.72

FLTR-DRY

30.00

$2.40

$132.00

$13.90

$764.72

Total
OTHER
HVAC

15927.30

$1,274.18

$70,080.12

Incubators

49.92

$3.99

$219.65

CIP/SIP

163.97

$13.12

$721.46

Water Treatment

734.09

$58.73

$3,230.00

WFI

2391.59

$191.33

$10,523.00

Waste Neutralization

1145.20

$91.62

$5,038.88

Clean Steam

938.48

$75.08

$4,129.31

Cooling Systems

1345.24

$107.62

$5,919.07

Total

$1,815.66

$99,861.48

GRAND TOTAL

$3,161.99

$173,909.39
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Figure 8.1 Percent of Total Utility Cost

Figure 8.2: Percent of Total Energy Requirement by Section of Process
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9.0 Equipment List and Unit Descriptions
9.1 Equipment List
Equipment Description

Process Unit

Vendor

Geldanamycin Upstream Process Equipment
Primary Seed Media Prep Tank
(130L)

1ST-SEED/V-102

Sharpsville
Container

Secondary Seed Media Prep
Tank (3250L)

2ND-TRG/V-103

Sharpsville
Container

Fermentation Media Prep Tank
(81,150L)

FERM-STR/V-104

Sharpsville
Container

2L Erlenmeyer Flasks (104)

52EF-1 SFR-104 &
52EF-2 SFR-101

DURAN

1750 L Secondary Fermentor

2ND-SEED1/SFR-105 & 2NDSEED2/SFR-103

ABEC

50000L Fermentor

FERM1-FR-102 & FERM2/FR-101

ABEC

Media Filters (6)

S-1, S-2, S-8, S-6, S-12, S-10

Sartorius Stedim
Biotech

Upstream Pumps (8)

S-8, S-6, S-12, S-10, S-14, S-13, S-11, S-9

Watson-Marlow

50000L Surge Tank

STORAGE`1/V-101

Sharpsville
Container

Geldanamycin Downstream Process Equipment
RotaryVacuum Filter

ROTV-FLT/RVF-102

Komline-Sanderson

Storage Tank (50,000L)

STORAGE2/V-102

Sharpsville
Container

Cellulose-based filter

CLL-FLT/CL-101

Ertel Alsop

Storage Tank

XTRSTRG1/V-105

Sharpsville
Container

Extraction Unit

(EXTRCTON/V-103)

Sulzer Chemtech

Distillation Unit

DISTILL/V-104

Amfield, Inc.

Crystallization Unit

CRYST/CR-101

Conair Group

Storage Tank (65L)

STORAGE3/V-101

Sharpsville
Container

Rosenmund Filter

ROSENMUND/GBX-101

De Dietrich Process
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Systems
Downstream Pumps (14)

S-15, S-16, S-17, S-18, S-20, S-21, S-22, S-23, S-24, S25, S-26, S-27, S-28, S-29

Watson-Marlow

Storage Tubs

DRUM/V-101

Sharpsville
Container

Tanespimycin Production
60L Reactor (18)

REACTOR/PFR-101

ABEC

Rotarry Evaporator

ROT-EVAP/RVF-101

De Dietrich Process
Systems

Storage

STORAGE4/V-102

Sharpsville
Container

Rosenmund Filter

FLTR-DRY/GVX-101

De Dietrich Process
Systems

Pumps (14)

S-32 (x10), S-33, S-34, S-35, S-36

Watson-Marlow

Additional Equipment
Biosafety Cabinet

Assumed in existing BMS facility

Thermo Scientific

Cell Bank

Assumed in existing BMS facility

LabRepCo

Air Generator

Assumed in existing BMS facility

BMS

Clean Steam Generator

Assumed in existing BMS facility

BMS

CIP Skids

Assumed in existing BMS facility

SaniMatic

Filter Integrity Tester

Assumed in existing BMS facility

Millipore

WFI Still

Assumed in existing BMS facility

Paul Mueller Co.

Biowaste Inactivation and
Neutralization Tanks

BIOINACT/LD-101
NEUTRLZ1/LD-101 & NEUTRALZ2/LD-102

Sharpsville
Container, Zurn

Biowaste Inactivation System

Assumed in existing BMS facility

BMS

Waste Neutralization System

Assumed in existing BMS facility

BMS

Methylene Chloride Drumming

34-DRUMS/LD-103

Clean Harbors

Quality Control Laboratory

Assumed in existing BMS facility

BMS

Portable Pumps on Cart (7)

n/a

Watson-Marlow

Final Packaging

Assumed in existing BMS facility

BMS
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9.2 Equipment Selection
Equipment units were selected based on the maximum efficiency of the process with advice from
industrial consultants as well as specific vendors. Units were chosen to optimize careful preservation of
the product as well as maximum yield while complying with GMP regulations.

9.3 Common Units
9.3.1 Pumps
A peristaltic pump is used to transfer fluid from throughout the process. The pump can be
purchased from Watson Marlow and is the 825 Peristaltic Pump. In both the stirred tank and fluidized
bioreactor processes, the power of the pump ranges from 1.5-5.0 hp. The pumps operate at room
temperature and a 50 psi (3.5 bar) pressure drop with maximum flow rate of 33.3 L/min. The pump will
be sterilized and are purchased from Watson Marlow for the cost of $13,000 per pump. Watson Marlow
Bioprene sterile tubing is used to transfer the fluid through the variety of processes. There are a total of 8
pumps in the upstream processing (S-8, S-6, S-12, S-10, S-14, S-13, S-11, S-9), 14 pumps in the
downstream processing (S-15, S-16, S-17, S-18, S-20, S-21, S-22, S-23, S-24, S-25, S-26, S-27, S-28, S29) , 14 pumps in the final processing for 17-AAG (S-32 (x10), S-33, S-34, S-35, S-36), and 7 spare
pumps accounted for. The resulting prices for pumping for upstream, downstream, final processing, and
spares respectively are $104000, $182000, $182000, and $91000.

9.3.2 Media Sterilization Filters
The 0.2 micron filter is used to purify the media by removing any impurities and toxins before
introduction to the bioreactors. The filter is 30 inches in size and the filtration area is 1.8m2 (18ft2 ). The
membrane filter material is Polyethersulfone (PES) and operates at room temperature with a max
differential pressure of 0.5 bar. The filters require a type of housing for security that requires a one-time
purchase from Sartorius Stedim Biotech for the cost of $2,000. The filters are disposable and replaced
after every batch. They are purchased from Sartorious Stedim Biotech under the model name Sartopore 2
for the cost of $700/unit. The filters are disposable, but SIP is required for the housing unit.
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9.4 Upstream Equipment
9.4.1 Primary Seed Media Preparation Tank (1ST-SEED/V-102)
The Primary Seed Media tank (130L) is used to mix the primary seed media composed of
Glucose Monohydrate, Yeast Extract, and Peptone Extract. This tank is required to ensure proper mixing
of the media before it is fed through a sterile filter and added to the Initial Ampule in 2 L flasks (52EF-1
SFR-104 & 52EF-2 SFR-101). The tank is made from stainless steel 316 with a volume of 130L and
working capacity of 80%. It is elecro-polished and equipment with an agitator with hydrofoil impellers
and a dimple style jacket . For sterilization, CIP and SIP are used each time the tank is fully emptied
(every 2 batches). The tank operates at room temperature and 1 bar. The tank is fabricated by Sharpsville
Container and has a purchase cost of $19,765.

9.4.2 Secondary Seed Media Preparation Tank (2ND-TRG/V-103)
The Secondary Seed Media tank (3250L) is used to mix the primary seed media composed of
Glucose Monohydrate, Yeast Extract, Peptone Extract, and PEG/L. This tank is required to ensure proper
mixing of the media before it is fed through a sterile filter and added along with the primary flask broth to
each Secondary Seed Fermentor (2ND-SEED1/SFR-105 & 2NDSEED2/SFR-103). The tank is made
from stainless steel 316 with a volume of 3250L and working capacity of 80%. It is elecro-polished and
equipment with an agitator with hydrofoil impellers and a dimple style jacket. For sterilization, CIP and
SIP are used each time the tank is fully emptied (every 2 batches). The tank operates at room temperature
and 1 bar. The tank is fabricated by Sharpsville Container and has a purchase cost of $51,995.

9.4.3 Fermentation Media Preparation Tank (FERM-STR/V-104)
The Fermentation Media tank (81,150L) is used to mix the primary seed media composed of
Glucose Monohydrate, Yeast Extract, and PEG/L. This tank is required to ensure proper mixing of the
media before it is fed through a sterile filter and added to each Fermentor (FERM1-FR-102 &
FERM2/FR-101). The tank is made from stainless steel 316 with a volume of 50,000L and working
capacity of 80%. It is elecro-polished and equipment with an agitator with hydrofoil impellers and a
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dimple style jacket. For sterilization, CIP and SIP are used each time the tank is fully emptied (every 2
batches). The tank operates at room temperature and 1 bar. The tank is fabricated by Sharpsville
Container and has a purchase cost of $302,765.

9.4.4 Erlenmeyer Flasks (52 x 2) (52EF-1 SFR-104 & 52EF-2 SFR-101)
The Erlenmeyer Flasks are used to grow the Initial Ampule of bacteria. This flask is required to
ensure proper growth of the bacteria in primary media before it is added to the Secondary Fermentor
(2ND-SEED1/SFR-105 & 2NDSEED2/SFR-103). Each flask will be inoculated with 1L of primary seed
media and 0.3L of ampule. The glass flasks have an easy-to-read scale and large labelling field for easy
marking in fired-on, highly durable, white ceramic. The flasks will also have membrane caps, as they
allow for a more definable and reproducible gas exchange than a cotton cap. For sterilization, the flasks
will be autoclaved, as the membrane cap allows pressure equalization and tight sealing, greatly reducing
the risk of contamination. After inoculation, the flasks will be incubated for 3 days at 28℃ on a rotary
shaker. The tank is fabricated by DURANO and has a purchase cost of about $40 per flask.

9.4.5 Secondary Fermentor (2ND-SEED1/SFR-105 & 2NDSEED2/SFR-103)
The Seed Fermentor (1750L) is used to grow the Primary Seed to Flask bacteria/media mixture.
This fermentor is required to ensure proper growth of the bacteria before it is added to the production
fermentor (FERM1-FR-102 & FERM2/FR-101). The unit is made of stainless steel and finished by
electro-polishing. The pH, temperature, and oxygen levels are controlled with PID controls. The tank has
a volume of 1750L and a working volume of 1366L. The tank is fabricated by ABEC and has a purchase
cost of $925,848.50 each, which is $1,851,697 for 2 fermentors.

9.4.6 Production Fermentor (FERM1-FR-102 & FERM2/FR-101)
The Production Fermentor is used to grow the Seed to Fermentor bacteria/media mixture. This
fermentor is required to ensure proper growth of the bacteria and production of geldanamycin for
purification. The unit is made of stainless steel and finished by electro-polishing. The pH, temperature,
and oxygen levels are controlled with PID controls. The tank has a volume of 50,000L and a working
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volume of 39664.9L. The tank is fabricated by ABEC and has a purchase cost of $8,461,649.5 each,
which amounts to $16,923,299 for 2 fermentors.

9.4.7 Surge Tank (STORAGE 1/V-101)
The outputs from both production fermentors (staggered) are stored into the 50,000L surge tank
before downstream processing and isolation. The surge tank will keep at 5℃ to ensure the stability of the
product as well as the bacteria still present in the solution. It is elecro-polished and equipment with an
agitator with hydrofoil impellers and a dimple style jacket. The tank is fabricated by Sharpsville
Container and has a purchase cost of $501431.

9.5 Downstream Equipment
The specific vessels utilized for downstream processing were chosen to optimize efficiency as
well as specificity of the separation process. In this design, isolation and purification of tanespimycin are
a combination of batch and continuous processes.

9.5.2 Rotary Drum Vacuum Filtration Unit (ROTV-FLT/RVF-102)
The Rotary Vacuum Filtration unit is used to separate unwanted solids from the geldanamycin
product. This process is required to eliminate extraneous biological wastes in order to isolate the desired
drug. The unit is fabricated by Komline-Sanderson and has a purchase cost of $150,000. The rotary
vacuum filter will have a filtering area of 200 sq. ft., corresponding to a K-S drum filter diameter of 8 ft.
The Komline-Sanderson Rotary Drum Vacuum Filter specifically provides continuous liquid/solid
separation with minimal operator attention and low maintenance and will be specifically designed for this
process.

9.5.3 Storage Tank (50,000L) (STORAGE2/V-102)
The 50,000L jacketed storage tank will store the the filtrate containing the geldanamycin product
from the rotary drum vacuum filtration unit. This unit will aid the switch from continuous to batch
processing and will cooled to 5°C to ensure the stability of its contents. The tank is made of electro56

polished 316L stainless steel and is equipment with an agitator with hydrofoil impellers and a dimple
style jacket. The tank is fabricated by Sharpsville Container and has a purchase cost of $501,431.

9.5.4 Cellulose-Based Filtratio (CLL-FLT/CL-101)
This Clarifier is used to separate solid geldanamycin from liquid filtrate. This process is required
to purify the geldanamycin for entrance into the Extraction vessel. The unit is fabricated by Ertel Alsop
and has a purchase cost of $500,000.

9.5.5 Storage Tank (8500L) (XTRSTRG1/V-105)
The 8500L jacketed storage tank will store the the filtrate containing the output from the cellulose
filtration unit before further downstream processing. This unit will avoid the need to stop the process if
the extractor in the next step needs to be adjusted to emulsification. The tank is made of electro-polished
316L stainless steel and is equipment with an agitator with hydrofoil impellers and a dimple style jacket.
The tank is fabricated by Sharpsville Container and has a purchase cost of $100,000.

9.5.6 Extraction Vessel (EXTRCTON/V-103)
This Extraction vessel (10,000L) is used to dissolve geldanamycin into dichloromethane. This
process is required to amass the crude geldanamycin for further purification. The glass unit provided by
De Dietrich will ensure inertness and allow for observation of the mixing and separation process, enabling
their easy optimization. The unit is fabricated by Sulzer Chemtech and has a purchase cost of $500,000.

9.5.7 Distillation Vessel (DISTILL/V-104)
This Distillation Column used to condense the dissolved geldanamycin in methylene chloride.
This continuous process is required to allow for higher yield upon crystallization in the Crystallizer
(CRYST/CR-101). The unit is suitable for 500L of material and is made out of stainless steel. The unit is
fabricated by Armfield, Inc. and the specific model used is UOP3CC with a purchase cost of $500,000.
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9.5.8 Crystallizer (CRYST/CR-101)
This Crystallizer is used to precipitate and isolate the geldanamycin product. The unit is
fabricated by Conair Group. The specific unit chosen for this process is the CR135 made of PET with a
purchase cost of $500,000.

9.5.9 Storage Tank (65L) (STORAGE3/V-101)
The 65L jacketed storage tank will store the crystal slurry from the crystallizer (CRYST/CR-101).
The tank is made of electro-polished 316L stainless steel and is equipment with an agitator with hydrofoil
impellers and a dimple style jacket. The tank is fabricated by Sharpsville Container and has a purchase
cost of $15,000.

9.5.10 Rosenmund Filter Dryer (ROSENMUND/GBX-101)
This Rosenmund Filter Dryer used to dry 22kg of geldanamycin product. Rosenmund filters
demonstrate high efficiency in washing and isolate pharmaceuticals. A few upgraded features of this
system include side discharge including a side discharge valve for pressure-tight closure after each
product discharge to insure no contamination. In addition, this vessel contains a three-blade agitator for
efficient agitation and discharge. The total discharge system with the gas knife allows for product
discharge without manual intervention, therefore increasing efficiency and reliability. The equipment also
allows for efficient CIP/WIP and SIP cleaning. The application of specialised spray systems and
sterilisation methods validation of the vessel preparation process. The vessel has a filtration area of 0.16
sq ft and a 18’’ diameter for about 50L of material. The unit is fabricated by De Dietrich and has a
purchase cost of 500,000.

9.5.11 Tubs for geldanamycin product (DRUM/V-101)
The geldanamycin crystals from the Rosenmund Filter will be collected in drums and manually
deposited into each of the 18 reactors.
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9.6 Tanespimycin Production Equipment
9.6.1 Reactor (REACTOR/PFR-101)
18 60L reactors will be used for the reaction of geldanamycin and allyl amine to produce 17AAG. The unit is fabricated by Biomashin, Inc and has a purchase cost of $24,000 per reactor, which
amounts to $432,000 for all eighteen reactors. Biomashin’s pharmaceutical-grade reactor complies with
the highest requirements in accordance with GMP and accompanied by validation documentation IQ, OQ,
FAT, SAT inclusively. The reactor is made of stainless steel AISI 316L with surfaces in contact with the
product Ra 1.6÷0.4um. The vessel is insulated with PU-foam covered with fully welded insulation
cladding. The piece of equipment also includes safety armature and electro-sensors for the control of the
process.

9.6.2 Rotary Evaporator (ROT-EVAP/RVF-101)
The rotary evaporator continuously removes remaining solvent to further purify 17-AAG. The
unit is specifically named the QVF Rotary Evaporator has a working volume of 750L and is made of
borosilicate 3.3 glass and PTFE, offering the following benefits: 1) proper observability of all process 2)
total chemical resistance against nearly all mediums 3) careful evaporation. In addition, the QVC Rotary
Evaporator features robust driving of the rotary flask by a PTFE-lined steel sleeve shaft. This unit is
fabricated by De Dietrich Process Systems, Inc and has a purchase cost of $500,000.

9.6.3 Storage Tank (100L) (STORAGE4/V-102)
The 100L jacketed storage tank will store the product from the Rotary Evaporator (ROTEVAP/RVF-101) to aid the switch from continuous to batch prior to final isolation through Rosenmund
drying. The tank is made of electro-polished 316L stainless steel and is equipment with an agitator with
hydrofoil impellers and a dimple style jacket. The tank is fabricated by Sharpsville Container and has a
purchase cost of $12,000.
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9.6.4 Rosenmund Filter (FLTR-DRY/GBX-101)
This Rosenmund Filter Dryer used to recrystallize the geldanamycin final product. Rosenmund
filters demonstrate high efficiency in washing and isolate pharmaceuticals. A few upgraded features of
this system include side discharge including a side discharge valve for pressure-tight closure after each
product discharge to insure no contamination. In addition, this vessel contains a three-blade agitator for
efficient agitation and discharge. The total discharge system with the gas knife allows for product
discharge without manual intervention, therefore increasing efficiency and reliability. The equipment also
allows for efficient CIP/WIP and SIP cleaning and the application of specialized spray systems and
sterilization methods as a method of validation of the vessel preparation process. This specific vessel has
a filtration area of 5.6 sq ft and a 32” diameter, suitable for about 250L of material. The unit is fabricated
by De Dietrich and has a purchase cost of $500,000.

9.7 Additional Equipment
9.7.1 Biosafety Cabinet
Biosafety cabinets are required to provide a sterile environment to prepare ampule and inoculate
the primary seed medium. Five biosafety cabinets will be needed in order to prepare ampule at a
concentration of 10mg/mL. 104 2L flasks containing 1L primary seed medium will then be inoculated
with 0.3 of this ampule. These biosafety cabinets are standard issue manufactured by Thermo
ScientificTM. These cabinets can be assumed to be preexisting within the BMS facility and thus incur no
additional cost.

9.7.2 Cell Bank
The bacteria will initially be purchased from ATCC for a one-time cost of $354. Cells will then
be grown to a final cell density of 1x108 cells/mL and then placed in 2 ml vials. These vials will be placed
stored in a liquid nitrogen cryogenic sample storage vessel in order to create a cell bank. This freezer can
be obtained from LabRepCo for $2,070.
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9.7.3 Air Generator (HVAC Equipment)
Purified air will be the source of oxygen throughout the process and will be provided by an
HVAC system. The system will supply clean air to fermenters, clean rooms, and other process equipment
with oxygen requirements. The air generator can be assumed to be preexisting within the BMS facility
and thus incur no additional cost.

9.7.4 Clean Steam Generator
The clean steam generator is used to produce steam from WFI for SIP procedures. The clean
steam generator can be assumed to be preexisting within the BMS facility therefore the cost of this system
is just its utilities, which are accounted for in annual expenses.

9.7.5 CIP Skids
Clean-In-Place (CIP) is a technique used to clean equipment. A CIP skid is portable and contains
the necessary equipment and cleaning solution in order for proper cleaning. In order to clean all the unit
operations and storage tanks, fifteen CIP skids will be needed for this process. These skids can be
assumed to be preexisting within the BMS facility and thus incur no additional cost.

9.7.6 Filter Integrity Tester
Disposable filters are used throughout this process; however, due to quality standards, they must
be tested before each use to ensure they are not clogged, torn, or unusable. This testing will also prevent
loss of product. This tester can be obtained from Millipore, although it can be assumed to be preexisting
within the BMS facility and thus incur no additional cost.

9.7.7 WFI Still
A WFI still is used to purify water for use with cell culture. WFI water is used to both ensure the
sterility of the product and to prevent and eliminate cross-contamination issues. The still can be obtained
by the Paul Mueller Co. although the still can be assumed to be preexisting within the BMS facility and
thus incur no additional cost.
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9.7.8 Biowaste and Neutralization Tanks
Two different types of tanks will be used to collect the waste generated by the process. If waste
contains live culture it must be sent to a biowaste tank. All other waste, with the exception of that
containing methylene chloride, is sent to neutralization tanks. The only bioactive waste in this process is
the biomass disposed of after the rotary vacuum filtration. The biomass will be mixed with water in a
biowaste tank
All waste containing bioactive matter must be treated properly before disposal. The biomass that
is removed after rotary vacuum filtration contains live bacterial culture and is therefore transported to the
biowaste tank where it is mixed with water to create a liquid that can be pumped to the biowaste
inactivation system. This tank must be 1,000L to sufficiently hold the approximately 60kg of biomass
produced per batch and necessary water for mixing. This tank can be bought from Sharpsville Container
for $125,000.
All other waste, excluding that containing methylene chloride, is pumped directly to
neutralization tanks. 8,150L of waste is produced from the cellulose-based filtration and an additional
920L from the reaction process. A 3,000 gallon (11,355L) and 275 gallon (1040.9L) neutralization tanks
can be purchased from Zurn for $90,000 and $18,000 respectively.

9.7.9 Biowaste Inactivation System
This system kills any live mass remaining in the biowaste tank. This system includes the CIP and
SIP washes. The system heats the waste to 80C for one minute to inactivate living cell cultures. This
system can be assumed to be preexisting within the BMS facility and thus incur no additional cost.

9.7.10 Waste Neutralization System
The system operates by adjusting the waste to a pH to 7.0. This allows the waste to be sent to the
sewer. This system can be assumed to be preexisting within the BMS facility and thus incur no additional
cost.
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9.7.11 Methylene Chloride Drumming
Methylene chloride is a health hazard and therefore must be removed by a specialty waste
company. The waste streams from the extraction, distillation, and crystallization/drying processes all
contain methylene chloride. This waste can be sent to fill 55 gallon drums. Clean Harbors a specialty
waste disposal company can then safely dispose of these drums for $290 per drum. There is an additional
$30 transport cost per drum and a diesel surcharge price of 11.5% of the total invoice. Empty drums can
also be delivered by Clean Harbors for $30 a drum. A total of 34 drums are filled for each batch.

9.7.12 Quality Control Lab
A quality control lab will be needed to test the all factors involved in production. Samples will be
taken throughout the process in order to test for a specific set of quality assurance criteria. This lab can be
assumed to be preexisting within the BMS facility and thus incur no additional cost.

9.7.13 Portable Pump on Cart
In preparation for pump malfunction, 7 extra replacement pumps will be stored on portable carts.
These pumps will be that same 825 Peristaltic pumps used in the process costing $13,000 per pump and
can be acquired from Watson Marlow.

9.7.14 Final Packaging
The final product from this process will not be ready for direct administration, for it is not
separated in the proper dosing increments nor placed in final packaging. The tanespimycin must be
packaged and shipped to doctors or hospitals where it will be administered to patients intravenously.
BMS has an internal department that can finalize the packaging requirements for this drug. An estimated
$10 will be spent to package and ship each treatment of tanespimycin yielding an additional $1.1 million
expense for this process. The packaging must be non-reactive, clean, and sanitized, and records must be
kept for each shipment of product. Packaging labels must also include special transport and storage
conditions. A system must also be in place to permit a recall if necessary.
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10.0 Specification Sheets
Primary Seed Media Preparation Tank
(1ST-SEED/V102)

Description and
Function:

130L Tank used to store and mix the primary seed media prior to being pumped
through a sterile filter and used to seed the ampule in 2 L flasks.

Vendor:

Sharpsville Container

Operation:

Batch

Materials Handled:

Input
Glucose Monohydrate
Yeast Extract
Peptone Extract
Total

Characteristics:

Material:

Quantity
1.039 kg
0.260 kg
1.039 kg
2.338 kg
316 L Stainless Steel
Electro-polished
Agitator with Hydrofoil
Impellers
Dimple Style Jacket
104L
130
WIP/CIP

Working Volume:
Total Volume:
Sterilization:

Operating
Conditions

Temp:
Pressure:

Purchase Cost

$19,765

25℃
1 bar
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Secondary Seed Media Preparation Tank
(2ND-TRG/V-103)
Description and
Function:

3250L Tank used to store and mix the primary seed media prior to being
pumped through a sterile filter and into the secondary seed ferment or.

Vendor:

Sharpsville Container

Operation:

Batch

Materials Handled:

Input
Glucose Monohydrate
Yeast Extract
Peptone Extract
PEG
Total

Characteristics:

Material:

Quantity
12.983 kg
3.246 kg
12.983 kg
2.343 kg
31.554 kg
316 L Stainless Steel
Electro-polished
Agitator with Hydrofoil
Impellers
Dimple Style Jacket
2597 L
3250 L
SIP/CIP

Working Volume:
Total Volume:
Sterilization:

Operating
Conditions

Temp:
Pressure:

Purchase Cost

$51,995

25℃
1 bar
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Fermentation Media Preparation Tank
(FERM-STR/V-104)
Description and
Function:

81,150L Tank used to store and mix the Fermentation media prior to being
pumped through a sterile filter and into the 50,000 L Ferment or.

Vendor:

Sharpsville Container

Operation:

Batch

Materials Handled:

Input
Soy flour
Corn Starch
Ammonium Sulfate
Calcium Carbonate
Cobalt Chloride Dihydrate
Ferrous Sulfate Heptahydrate
Alpha Amylase
Soybean Oil
Polyalkylene glycol
Total

Characteristics:

Material:

Quantity (kg)
1217.137
2839.987
81.142
243.427
0.325
3.651
1.623
0.0006
5.193
4392.487

Working Volume:
Total Volume:
Sterilization:

316 L Stainless Steel
Electro-polished
Agitator with Hydrofoil
Impellers
Dimple Style Jacket
64,914 L
81,150 L
SIP/CIP

Operating
Conditions

Temp:
Pressure:

25℃
1 bar

Purchase Cost

$302,765

Reference Page

66

2 L Erlenmeyer Flasks (104)
(52EF-1 SFR-104 & 52EF-2 SFR-101)

Description and
Function:

DURAN Erlenmeyer flask with DIN threads and closed with membrane cap to
allow for gas exchange. Flasks will be used for initial bacterial seeding and placed
on a rotary shaker in an incubator at 37℃.

Vendor:

DURAN Group

Operation:

Batch

Materials
Handled:

Input
Medium
Biomass
Water
Total

Quantity
7.7g
0.42g
250g
258.1g

Characteristics:

Model:
Material:
Flask Type:
Working Volume:
Total Volume:
Sterilization:

2L EF
Glass
Sterile
1L
2L
Autoclave

Operating
Conditions

Temp:
pH:

28℃
6.25-7.75

Purchase Cost

$4,160

(104 flasks)
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1750L Secondary Seed Fermenter (2)
(2ND-SEED1/SFR-105 & 2NDSEED2/SFR-103)
Description and
Function:

1750L Secondary Seed Fermenter. Charged with filtered secondary seed media
and cell solution from the 2L flasks

Vendor:

ABEC

Operation:

Batch

Materials Handled:

Input
Primary Seed with cells
Secondary Seed Media
Total

Characteristics:

Material:

Quantity (kg)
1.341
31.554
32.896

Working Volume:
Total Volume:
Sterilization:

Stainless Steel
Electropolished
1365.9L
1750L
CIP/SIP

Operating
Conditions

Temp:
Pressure:
Speed:
pH:
Aeration:

28℃
7psi backpressure
250 rpm
6.25-7.75
200 slm

Purchase Cost

$925,848.50 each
$1,851,697 for 2 fermenters

(Includes jacketed tank with controls,
agitators, filters, TCM)
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50,000L Fermenter (2)
(FERM1-FR-102 & FERM2/FR-101)
Description and
Function:

50,000L Fermenter.

Vendor:

ABEC

Operation:

Batch

Materials Handled:

Input
Secondary Seed
(incl cells and
product)
Fermentation Media
WFI
Total

Quantity (kg)
32.896
4392.487
5842.259
10267.642

Characteristics:

Working Volume:
Total Volume:
Sterilization:

39664.9L
50,000L
CIP/SIP

Operating Conditions

Temp:
Pressure:
Speed:
pH:
aeration:

28℃
7psi backpressure
180-220 rpm
6.25-7.75
1000-5000 slm

Purchase Cost

$8,461,649.5 each
$16,923,299 for 2
fermenters

(Includes jacketed tank with controls, agitators,
filters, TCM)
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Media Preparation Sterile Filtration
Description and
Function:

Sterilization filters 0.2um to remove bacteria and other impurities from media prior to
feeding the flasks and fermenters. A onetime purchase of the housing unit must be
made and then the filter capsule membranes are disposable and refilled for every use.

Vendor:

Sartorius Stedim Biotech

Operation:

Batch

Characteristics:

Model:
Material:
Size:
Filtration area:
Max. Differential Pressure:
Membrane Unit Sterilization:
Membrane Sterilization:

Sartopore 1 0.2 um
Polyethersulfone (PES)
30’’
1.8m2
5 bar at 20℃
SIP
Disposable

Operating
Conditions

Temp:
Pressure:

25℃
0.5 bar

Purchase Cost

$2,000

Filter Housing (one-time
purchase)
Filter Membrane, onetime use (included in
materials price)

$700
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Surge Tank
(STORAGE`1/V-101)

Description and
Function:

50,000L cooled surge tank to store output of 50,000L fermenter before downstream
processing of geldanamycin. Contents of storage tank cooled to 5℃ with cooling
water running through the tank jacket.

Vendor:

Sharpsville Container

Operation:

Batch

Materials
Handled:

Input
Fermentation Broth
Total

Characteristics:

Material:

Quantity (kg)
10367.939
10367.939

Working Volume:
Total Volume:
Sterilization:

316 L Stainless Steel
Electro-polished
Flat Top and Sloped Bottom
Dimple Style Jacket
39664.9L
50,000L
CIP/SIP

Operating
Conditions

Temp:

5℃ (cooling)

Purchase Cost

$501,431

Jacketed with TCM and spray ball

Reference Page

71

Upstream Pumps
S-8, S-6, S-12, S-10, S-14, S-13, S-11, S-9
Description and
Function:

Pump to transfer fluid. High-flow hygienic pumps that are designed for low-shear
sanitary pumping. They are ideal for viscous or shear sensitive products.

Vendor:

Watson-Marlow

Operation:

Batch

Characteristics:

Model:
Material:
Flow Rate:
Max Pressure:
Tubing

825 Peristaltic Pump
304 Stainless Steel
33.3 L/min
3.5 bar
Bioprene, 25 mm

Operating
Conditions

Temp:
Pressure Change:
Power:

25C
5 psi
1.5-5.0 hp

Purchase Cost

$13,000
$104,000 total

per pump
(8 upstream pumps)
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Rotary Vacuum Filtration
(ROTV-FLT/RVF-102)

Description and
Function:

The rotary vacuum filter will be fed by the surge tank (STORAGE`1/V-101) in
order to separate out the biomass from the fermentation broth.

Vendor:

Komline-Sanderson

Operation:

Continuous

Materials Handled:

Input
Fermentation Media
Biomass
Geldanamycin
Filter Aid
Total

Characteristics:

Material:
Filter area:
Diameter:
Sterilization:

Electro-polished stainless steel
200 sq ft
8ft
SIP/CIP

Operating
Conditions

Temp:

5℃

Purchase Cost

$150,000

Quantity(kg/h)
2874.44
106.33
13.910
386.546
3381.226
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Storage Tank
(STORAGE2/V-102)
Description and
Function:

50,000L cooled storage tank to store output of rotary vacuum filter before further
downstream processing of geldanamycin. Contents of storage tank cooled to 5℃
with cooling water running through the tank jacket.

Vendor:

Sharpsville Container

Operation:

Batch

Materials
Handled:

Input
Fermentation Media
Geldanamycin
Total

Characteristics:

Material:

Quantity (kg)
10060.55
38.948
10099.49

Total Volume:
Sterilization:

316 L Stainless Steel
Electro-polished
Flat Top and Sloped Bottom
Dimple Style Jacket
50,000L
CIP/SIP

Operating
Conditions

Temp:

5℃ (cooled)

Purchase Cost

$501,431

Jacketed with TCM and spray ball
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Cellulose-Based Filter
(CLL-FLT/CL-101)

Description and Function: Cellulose-Based Filter for clarification

Vendor:

Ertel Alsop

Operation:

Batch

Materials Handled:

Input
Quantity (kg)
Fermentation Media
10060.55
Geldanamycin
38.948
Cellulose-Based Filter Media
1352.912
Total
11482.674

Characteristics:

Sterilization:

Purchase Cost

$500,000

SIP/CIP
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Storage Tank
(XTRSTRG1/V-105)

Description and
Function:

8500L cooled storage tank to store output of cellulose based filtration before further
downstream processing of geldanamycin. Contents of storage tank cooled to 5℃
with cooling water running through the tank jacket.

Vendor:

Sharpsville Container

Operation:

Batch

Materials
Handled:

Input
Fermentation Broth
Geldanamycin
Cellulose-based Filter Media
Total

Characteristics:

Material:

Quantity (kg)
2018.163
35.054
1352.912
3406.129

Working Volume:
Total Volume:
Sterilization:

316 L Stainless Steel
Electro-polished
Flat Top and Sloped Bottom
Dimple Style Jacket
39664.9L
50,000L
CIP/SIP

Operating
Conditions

Temp:

5℃

Purchase Cost

$100,000

Jacketed with TCM and spray
ball
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Extraction Vessel
(EXTRCTON/V-103)

Description and
Function:

Liquid extraction with methylene chloride to remove excess media from
cellulose-based filtration.

Vendor:

Sulzer Chemtech

Operation:

Continuous

Materials Handled:

Input
Fermentation Media
Geldanamycin
Methylene Chloride
Cellulose-based Filter Media
Total

Characteristics:

Material:

Quantity (kg/hr)
1006.055
17.527
1732.325
676.456
3432.36

Working Volume:
Total Volume:
Sterilization:

Glass shell; Titanium, zirconium,
PVDF internals
8000L
10000L
SIP/CIP

Operating Conditions

Temp:

25℃

Purchase Cost

$500,000
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Distillation Tank (DISTILL/V-104)

Description and
Function:

The product will be further concentrated by heating off the Methylene
chloride.

Vendor:

Armfield Inc.

Operation:

Continuous

Materials Handled:

Input
Geldanamycin
Methylene Chloride
Total

Characteristics:

Model:
Material:
Working Volume:
Total Volume:
Sterilization:

UOP3CC

Operating Conditions

Temp:

40℃

Purchase Cost

$500,000

Quantity (kg/hr)
3.505
494.00
497.505

2800 L
3500 L
SIP/CIP
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Crystallization/Drying Vessel (CRYST/CR-101)

Description and
Function:

The product will be crystallized in order to be stored and reacted to form the
tanespimycin product further downstream

Vendor:

Conair Group

Operation:

Continuous

Materials Handled:

Input
Geldanamycin
Methylene Chloride
Isooctane
Total

Characteristics:

Model:
Material:
Working Volume:
Total Volume:
Sterilization:

CR135
PET
3823 L
48132 L
CIP/SIP

Operating Conditions

Temp:

35-40℃

Purchase Cost

$500,000

Quantity (kg/hr)
3.505
475.000
246.429
724.934
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Storage Tank
(STORAGE3/V-101)

Description and
Function:

65L cooled storage tank to store crystal slurry from the crystallizer before further
downstream processing of geldanamycin. Contents of storage tank cooled to 5℃
with cooling water running through the tank jacket.

Vendor:

Sharpsville Container

Operation:

Batch

Materials
Handled:

Input
Fermentation Broth
Total

Characteristics:

Material:

Quantity (kg)
10367.939
10367.939

Total Volume:
Sterilization:

316 L Stainless Steel
Electro-polished
Flat Top and Sloped Bottom
Dimple Style Jacket
65L
CIP/SIP

Operating
Conditions

Temp:

5℃

Purchase Cost

$15,000

Jacketed with TCM and spray ball
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Rosenmund Filter
(ROSENMUND/GBX-101)

Description and
Function:

The Rosenmund filter is used to dry 22kg of geldanamycin. The use of the
Rosenmund filter increases efficiency and allows for easy and sterile discharge of
the product with no manual intervention.

Vendor:

De Dietrich Process Systems

Operation:

Continuous

Materials
Handled:

Input
Geldanamycin
Methylene Chloride
Isooctane
Total

Characteristics:

Material:
Filtration area:
Diameter:
Sterilization:

Stainless Steel
.16 sq ft
18”
SIP/CIP

Operating
Conditions

Temp:

5℃

Purchase Cost

$500,000

Quantity (kg)
22.084
33.250
17.250
72.584

Reference Page

81

Downstream Pumps
(S-15, S-16, S-17, S-18, S-20, S-21, S-22, S-23, S-24, S-25, S-26, S-27, S-28, S-29)

Description and
Function:

Pumps to transfer fluid. High-flow hygienic pumps that are designed for low-shear
sanitary pumping. They are ideal for viscous or shear sensitive products.

Vendor:

Watson-Marlow

Operation:

Batch

Characteristics:

Model:
Material:
Flow Rate:
Max Pressure:
Tubing

825 Peristaltic Pump
304 Stainless Steel
33.3 L/min
3.5 bar
Bioprene, 25 mm

Operating
Conditions

Temp:
Pressure Change:
Power:

25C
5 psi
1.5-5.0 hp

Purchase Cost

$13,000
$182,000 total

per pump
(14 downstream pumps)
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60L Reactor (x18)
(REACTOR/PFR-101)

Description and Function: Reaction of geldanamycin and allylamine to produce tanespimycin.

Vendor:

Biomashin

Operation:

Batch

Materials Handled:
(per each reactor)

Input (per reactor)
Geldanamycin
THF
Allylamine in ethanol
Total

Characteristics:

Material:
Working Volume:
Total Volume:
Sterilization:

Stainless steel AISI 316L
48 L
60 L
CIP/SIP

Purchase Cost

$100,000
$1,800,000

per reactor
for 18 reactors

Quantity (kg)
1.217
34.846
1.927
37.990
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Rotary Evaporator
(ROT-AVAP/RVF-101)
Description and Function:

Vendor:

De Dietrich Process Systems

Operation:

Continuous

Materials Handled:

Input
Geldanamycin
THF
Allylamine
Tanespimycin
Total

Characteristics:

Model:
Material:
Working Volume:
Sterilization:

Purchase Cost

$500,000

Quantity (kg/hr)
0.548
313.616
16.002
10.871
341.037
R100
Corrosion-resistant borosilicate 3.3 glass
750 L
SIP-CIP
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Storage Tank
(STORAGE4/V-102)

Description and
Function:

100L cooled storage tank to store product from Rotary Evaporator before further
downstream processing of 17-AAG. Contents of storage tank cooled to 5℃ with
cooling water running through the tank jacket.

Vendor:

Sharpsville Container

Operation:

Batch

Materials Handled:

Input
Geldanamycin
THF
Allylamine
Tanespimycin
Water
Total

Quantity (kg)
0.333
6.68
3.23
43.48
409.35
463.08

Characteristics:

Material:

316 L Stainless Steel
Electro-polished
Flat Top and Sloped
Bottom
Dimple Style Jacket
100L
CIP/SIP

Total Volume:
Sterilization:

Operating
Conditions

Temp:

5℃

Purchase Cost

$12,000

Jacketed with TCM
and spray ball
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Rosenmund Filter
(FLTR-DRY/GBX-101)

Description and
Function:

The Rosenmund filter is used to dry 19.717 kg of Tanespimycin. The use of the
Rosenmund filter increases efficiency and allows for easy and sterile discharge of
the product with no manual intervention.

Vendor:

De Dietrich Process Systems

Operation:

Batch

Materials
Handled:

Input
Geldanamycin
THF
Allylamine
Tanespimycin
WFI
Total

Characteristics:

Material:
Filtration Area:
Diameter:
Working Volume
Sterilization:

Purchase Cost

$500,000

Quantity (kg/batch)
1.095
18.817
32.005
21.742
204.475
289.134
Stainless Steel
5.6 sq ft
32”
250L
SIP/CIP

Reference Page

86

Pumps for 17-AAG Process
(S-32 (x10), S-33, S-34, S-35, S-36)

Description and
Function:

Pumps to transfer fluid. High-flow hygienic pumps that are designed for low-shear
sanitary pumping. They are ideal for viscous or shear sensitive products.

Vendor:

Watson-Marlow

Operation:

Batch

Characteristics:

Model:
Material:
Flow Rate:
Max Pressure:
Tubing

825 Peristaltic Pump
304 Stainless Steel
33.3 L/min
3.5 bar
Bioprene, 25 mm

Operating
Conditions

Temp:
Pressure Change:
Power:

25C
5 psi
1.5-5.0 hp

Purchase Cost

$13,000
$182,000 total

per pump
(14 pumps)
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Spare Pumps (7)
Description and
Function:

Spare pumps in case there is a malfunction. Pumps to transfer fluid. High-flow
hygienic pumps that are designed for low-shear sanitary pumping. They are ideal for
viscous or shear sensitive products.

Vendor:

Watson-Marlow

Operation:

Batch

Characteristics:

Model:
Material:
Flow Rate:
Max Pressure:
Tubing

825 Peristaltic Pump
304 Stainless Steel
33.3 L/min
3.5 bar
Bioprene, 25 mm

Operating
Conditions

Temp:
Pressure Change:
Power:

25C
5 psi
1.5-5.0 hp

Purchase Cost

$13,000
$91,000 total

per pump
7 spare pumps

Reference Page

88

Biowaste Tank
(BIOINACT/LD-101)

Description and Function:

Vendor:

Operation:

Batch

Materials Handled:

Input
Biomass

Characteristics:

Material:

Quantity (kg/batch)
36.612

Working Volume:
Total Volume:
Sterilization:
Operating Conditions

Temp:

Purchase Cost

$125,000
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Neutralization Tank 1
(NEUTRLZ1/LD-102)

Description and
Function:

11,355L Neutralization tank used to store waste exiting the cellulose-based filtration
unit in the geldanamycin production process. All contents of this tank will be
pumped to a neutralization system before being disposed of through the sewage.

Vendor:

Zurn

Operation:

Batch

Materials
Handled:

Input
Fermentation Media
Geldanamycin
Total

Quantity (kg)
8,153.305
3.895
8,157.200

Characteristics:

Model:
Material:
Working Volume:
Total Volume:

Z9A-NT
High density polyethylene
8,150L
11,355L

Operating
Conditions

Temp:
Pressure:

25C
1 bar

Purchase Cost

$90,000
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Neutralization Tank 2
(NEUTRLZ2/LD-101)

Description and
Function:

1040.9L Neutralization tank used to store waste from the rotary evaporation and
filter/drying units in tanespimycin production process. All contents of this tank will
be pumped to a neutralization system before being disposed of through the sewage.

Vendor:

Zurn

Operation:

Batch

Materials
Handled:

Input
Ethanol
Geldanamycin
Allylamine
Tanespimycin
Water

Quantity (kg)
577.422
0.116
1.613
2.025
184.231

Characteristics:

Model:
Material:
Working Volume:
Total Volume:

Z9A-NT
High density polyethylene
920L
1,040.9L

Operating
Conditions

Temp:
Pressure:

25C
1 bar

Purchase Cost

$18,000
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11.0 Equipment Cost Summary
This chapter contains a table with each equipment unit in the process flow diagram (Chapter
6) including the unit number, purchase cost of 1 unit, the number of units, as well as the vendor.
Price estimations were obtained from the individual vendors unless otherwise noted. Vendor sheets
as well as individual quotes are included in the Appendix. Note that additional equipment assumed to
be part of the existing BMS facility are not included here since they are not included in the cost
analysis, but are included in Chapter 9, Equipment list and Unit Descriptions.

11.1 Geldanamycin Upstream Process Equipment
Equipment Description

Unit number

Purchase Cost
(1 unit)

Number of
Units

Vendor

Primary Seed Media Prep
Tank (130L)

1ST-SEED/V-102

$19,765

1

Sharpsville
Container

Secondary Seed Media
Prep Tank (3250L)

2ND-TRG/V-103

$51,995

1

Sharpsville
Container

Fermentation Media Prep
Tank (81,150L)

FERM-STR/V-104

$302,765

1

Sharpsville
Container

2L Erlenmeyer Flasks
(104)

52EF-1 SFR-104 &
52EF-2 SFR-101

$40

104

DURAN

1750 L Secondary
Fermenter

2ND-SEED1/SFR-105 &
2NDSEED2/SFR-103

$925,849

2

ABEC (quote:
consultants)

50000L Fermenter

FERM1-FR-102 &
FERM2/FR-101

$8,461,649

2

ABEC (Quote:
consultants)

Media Filters (6)

S-1, S-2, S-8, S-6, S-12, S-10

$2,000

6

Sartorious Stedim
Biotech

Upstream Pumps (8)

S-8, S-6, S-12, S-10, S-14, S13, S-11, S-9

$13,000

8

Watson-Marlow

50000L Surge Tank

STORAGE`1/V-101

$501,431

1

Sharpsville
Container

11.2 Downstream Process Equipment
Equipment
Description

Unit number

Purchase
Cost (1 unit)

Number of
Units

Vendor

Rotary Vacuum

ROTV-FLT/RVF-102

$150,000

1

Komline-
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Filter

Sanderson

Storage Tank
(50,000L)

STORAGE2/V-102

$501,431

1

Sharpsville
Container

Cellulose-based
filter

CLL-FLT/CL-101

$500,000

1

Ertel Alsop

Storage Tank

XTRSTRG1/V-105

$100,000

1

Sharpsville
Container

Extraction Unit

(EXTRCTON/V-103)

$500,000

1

Sulzer Chemtech

Distillation Unit

DISTILL/V-104

$500,000

1

Armfield, Inc.

Crystallization
Unit

CRYST/CR-101

$500,000

1

Conair Group

Storage Tank
(65L)

STORAGE3/V-101

$15,000

1

Sharpsville
Container

Rosenmund Filter

ROSENMUND/GBX-101

$500,000

1

De Dietrich
Process System

Downstream
Pumps (14)

S-15, -16, -17, -18, -20, -21, -22, 23, -24, -25, -26, -27, -28, -29

$13000

14

Watson-Marlow

Storage Tubs

DRUM/V-101

$20

1

Sharpsville
Container

11.3 Tanespimycin Reaction Process Equipment
Equipment
Description

Unit number

Purchase Cost (1
unit)

Number of
Units

Vendor

60L Reactor (18)

REACTOR/PFR-101

$100,000

18

ABEC

Rotary Evaporator

ROT-EVAP/RVF-101

$500,000

1

De Dietrich Process
Systems

Storage Tank

STORAGE4/V-102

$12,000

1

Sharpsville Container

Rosenmund Filter

FLTR-DRY/GVX-101

$500,000

1

De Dietrich Process
Systems

Pumps (14)

S-32 (x10), S-33, S-34, S35, S-36

$13,000

14

Watson-Marlow
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11.4 Additional Equipment
Equipment
Description

Unit number

Purchase Cost (1
unit)

Number of
Units

Vendor

Spare Pumps (7)

n/a

$13,000

7

Watson-Marlow

Biowaste Tank

BIOINACT/LD-101

$125,000

1

Sharpsville
Container

Neutralization Tank 1

NEUTRLZ1/LD102

$90,000

1

Zurn

Neutralization Tank 2

NEUTRLZ2/LD101

$18,000

1

Zurn
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12.0 Fixed Capital Investment
This chapter will describe the fixed capital investment; including the equipment bare module
costs and the total permanent investment, which accounts for the cost of site preparations, service
facilities, contingencies and contractor fees, and plant start-up. To perform the economic analysis of the
outlined production of tanespimycin, the Profitability Analysis-4.0.xls spreadsheet by Brian K. Downey
(2008) was used. While the inputs are explained in this chapter, the results from the profitability analysis
as well as an input summary are included in Chapter 15.

12.1 Equipment Costs
12.1.1 Unit Purchase Costs and Bare Module Costs
Purchases costs for each unit of equipment were determined either from the respective vendor or
industrial consultants (More information in Chapter 11) and bare module costs were calculated by
multiplying by specific bare module factors, as explained in section 12.1.2. The majority of the equipment
bare module costs is from the geldanamycin upstream process equipment, which amounts to
$116,673,310. The total geldanamycin downstream process equipment bare module cost is $13,604,500,
while the Total 17-AAG reaction process Bare Module Costs is $12,287,120, and the Total Additional
Equipment Bare Module Costs is $1,048,230. The bare module costs by unit are presented in Tables 12.1,
12.2, 12.3, and 12.4. The total bare module cost, $143,613,160, is used to determine the cost of site
preparations, service facilities, contingencies and contractor fees, and plant start-up.
Table 12.1 Geldanamycin Upstream Process Equipment

Equipment
Description

Unit number

Purchase
Cost (1
unit)

Number
of Units

Bare
Module
Factor

Bare Module
Cost (total #
units)

Vendor

Primary Seed
Media Prep
Tank (130L)

1ST-SEED/V-102

$19,765

1

4.16

$82,222

Sharpsville
Container

Secondary Seed

2ND-TRG/V-103

$51,995

1

4.16

$216,299

Sharpsville
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Media Prep
Tank (3250L)

Container

Fermentation
Media Prep
Tank (81,150L)

FERM-STR/V-104

$302,765

1

4.16

$1,259,502

Sharpsville
Container

2L Erlenmeyer
Flasks (104)

52EF-1 SFR-104 &
52EF-2 SFR-101

$40

104

1.1

$8,320

DURAN

1750 L
Secondary
Fermenter

2ND-SEED1/SFR105 &
2NDSEED2/SFR103

$925,849

2

6.00

$11,110,182

ABEC
(quote:
consultants)

50000L
Fermenter

FERM1-FR-102 &
FERM2/FR-101

$8,461,649

2

6.00

$101,539,792

ABEC
(Quote:
consultants)

Media Filters
(6)

S-1, S-2, S-8, S-6, S12, S-10

$2,000

6

2.32

$27,840

Sartorious
Stedim
Biotech

Upstream
Pumps (8)

S-8, S-6, S-12, S-10,
S-14, S-13, S-11, S-9

$13,000

8

3.30

$343,200

WatsonMarlow

50000L Surge
Tank

STORAGE`1/V-101

$501,431

1

4.16

$2,085,953

Sharpsville
Container

Total Geldanamycin Upstream Process Equipment Bare Module Costs: $116,673,310

Table 12.2 Geldanamycin Downstream Process Equipment

Equipment
Description

Unit number

Purchase
Cost (1
unit)

Number
of Units

Bare
Module
Factor

Bare
Module
Cost (total #
units)

Vendor

Rotary
Vacuum Filter

ROTV-FLT/RVF-102

$150,000

1

4.16

$624,000

KomlineSanderson

Storage Tank
(50,000L)

STORAGE2/V-102

$501,431

1

3.21

$1,609,594

Sharpsville
Container

Cellulosebased filter

CLL-FLT/CL-101

$500,000

1

4.16

$2,080,000

Ertel Alsop

Storage Tank

XTRSTRG1/V-105

$100,000

1

3.21

$321,000

Sharpsville
Container

Extraction Unit

(EXTRCTON/V-103)

$500,000

1

4.16

$2,080,000

Sulzer
Chemtech

Distillation

DISTILL/V-104

$500,000

1

4.16

$2,080,000

Armfield,
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Unit

Inc.

Crystallization
Unit

CRYST/CR-101

$500,000

1

4.16

$2,080,000

Conair
Group

Storage Tank
(65L)

STORAGE3/V-101

$15,000

1

3.21

$48,150

Sharpsville
Container

Rosenmund
Filter

ROSENMUND/GBX-101

$500,000

1

4.16

$2,080,000

De Dietrich
Process
System

Downstream
Pumps (14)

S-15, -16, -17, -18, 20, -21, -22, -23, -24, 25, -26, -27, -28, -29

$13000

14

3.3

$600,600

WatsonMarlow

Storage Tubs

DRUM/V-101

$20

1

3.3

$1,156

Sharpsville
Container

Total Geldanamycin Downstream Process Equipment Bare Module Costs: $13,604,500
Table 12.3 Tanespimycin Reaction Process

Equipment
Description

Unit number

Purchase
Cost (1
unit)

Number
of Units

Bare
Module
Factor

Bare Module
Cost (total #
units)

Vendor

60L Reactor
(18)

REACTOR/PFR101

$100,000

18

4.16

$7,488,000

ABEC

Rotary
Evaporator

ROT-EVAP/RVF101

$500,000

1

4.16

$2,080,000

De Dietrich
Process
Systems

Storage Tank

STORAGE4/V-102

$12,000

1

3.21

$38,520

Sharpsville
Container

Rosenmund
Filter

FLTR-DRY/GVX101

$500,000

1

4.16

$2,080,000

De Dietrich
Process
Systems

Pumps (14)

S-32 (x10), S-33, S34, S-35, S-36

$13,000

14

3.3

$600,600

WatsonMarlow

Total Tanespimycin Reaction Process Equipment Bare Module Costs: $12,287,120
Table 12.4 Additional Equipment

Equipment
Description

Unit number

Purchase
Cost (1 unit)

Number
of Units
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Bare
Module
Factor

Bare Module
Cost (total #
units)

Vendor

Spare Pumps (7)

n/a

$13,000

7

3.3

$300,300

WatsonMarlow

Biowaste Tank

BIOINACT/LD101

$125,000

1

3.21

$401,250

Sharpsville
Container

Neutralization
Tank 1

NEUTRLZ1/LD102

$90,000

1

3.21

$288,900

Zurn

Neutralization
Tank 2

NEUTRLZ2/LD101

$18,000

1

3.21

$57,780

Zurn

Total Additional Equipment Bare Module Costs: $1,048,230

12.1.2 Bare Module Factor Assumptions
Bare module factors were chosen as per guidance from the faculty advisors and industrial
consultants. Table 12.3.1 indicates the assumed bar module factors for each type of equipment. The
default in the profitability spreadsheet calculates a bare module factor of 3.21. This calculation is shown
in Table 12.3.2. This value was used for the general storage tanks and neutralization/biowaste tanks. A
bare module factor of 6 was used for the fermenters, as the consultants noted that pharmaceutical grade
products that are involved in cell expansion and growth require additional care for installation and
materials. The other values were selected based on Chapter 22 of Product and Process Design Principles
(Seider, et al.).
Table 12.5 Assumed Bare Module Factors for Equipment Units

Equipment

Assumed Bare
Module Factor

Media Prep Tanks

4.14

Erlenmeyer Flasks

2

Fermenters

6

Surge Tank & Storage Tanks & Waste Tanks

3.21

Pumps

3.3

Sterile Filters

2.32

Downstream Processing Equipment

4.14
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Table 12.6 Bare Module Factor Calculator from profitability Spreadsheet

Bare Module Factor Calculator:
Use the tool below to calculate a particular bare module factor, then input in the required column to the
left:
(Note, if no bare module factor is entered, the default of 3.21 will be used)

Cost of Installation Materials:
Cost of Installation Labor:
Cost for Freight, Insurances, and Taxes:
Cost of Construction Overhead:
Cost of Contractor Engineering Expenses:

71%
54%
9%
57%
30%

of Equipment Purchase Cost
of Equipment Purchase Cost
of Equipment Purchase Cost
of Equipment Purchase Cost
of Equipment Purchase Cost

Total Derived Bare Module Factor:

3.21

of Equipment Purchase Cost

12.2 Permanent Investment Costs
This section includes permanent investment costs related to Site Preparation, Facilities,
Contingencies and Contractor Fees.
As indicated in Table 12.7, the Total Permanent Investment inputs from the profitability
spreadsheet, the cost of site preparations is set to 1.00%, of the total bare module costs, as the equipment
will all be installed in an existing pharmaceutical manufacturing facility. In addition, the cost of service
facilities will be 5.0% of the Total Bare Module cost, the cost of contingencies and contractor fees will be
10.0% of the Total Depreciable Capital. Since this manufacturing facility will be within an existing
manufacturing facility, there are no costs associated with the land or plant start-up. An overall view of the
results from the profitability analysis will be included and analyzed in chapter 15.
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Table 12.7 Total Permanent Investment Table

Total
Permanent
Investment

Year:

2021
2022
2023
2024

% of Total Permanent Investment
100%
0%
0%
0%

(default is first year of Construction, otherwise over-ride this year)

Cost of Site Preparations:
Cost of Service Facilities:
Allocated Costs for utility plants and
related facilities:
Cost of Contingencies and Contractor
Fees:

1.00%
5.00%

10.00%

Cost of Land:

0.00%

Cost of Royalties:

$0

Cost of Plant Start-Up:

0.00%

of Total Bare Module Costs
of Total Bare Module Costs

$0
of Direct Permanent Investment
of Total Depreciable Capital
of Total Depreciable Capital

12.3 The cost of Clinical Trial
An assumed clinical trial sunk cost of $2billion is assumed, as explained further in Chapter 3.
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13.0 Operating Cost- Cost of Manufacture: Input Summary
This chapter will describe the various operating costs involved in the economic analysis of the
outlined production of tanespimycin. To perform the economic analysis of the outlined production of
tanespimycin, the Profitability Analysis-4.0.xls spreadsheet by Brian K. Downey (2008) was used. While
the inputs are explained in this chapter, the results from the profitability analysis as well as an input
summary are included in Chapter 15.

13.1 Raw Materials
The purchase cost of all raw materials was determined by contact with vendors and consultants
(More information in Chapter 5). The cost of raw materials per kg of Tanespimycin is about $43,698.
Table 13.1 Raw Material Costs per kg of Tanespimycin.

Raw Materials

1

Raw Material:

Unit:

Required Ratio:

Cost of Raw Material:

Primary Seed Media

amount per 1kg

1

amount per 1kg per kg of Tanespimycin

$15.318

per amount per 1kg

Secondary Seed
2

Media

amount per 1kg

1

amount per 1kg per kg of Tanespimycin

$199.31

per amount per 1kg

3

Fermentation Media

amount per 1kg

1

amount per 1kg per kg of Tanespimycin

$4,840.59

per amount per 1kg

4

WFI

amount per 1kg

1

amount per 1kg per kg of Tanespimycin

$1.45

per amount per 1kg

5

Filter Aid

amount per 1kg

1

amount per 1kg per kg of Tanespimycin

$1,604.59

per amount per 1kg

6

Methylene Chloride

amount per 1kg

1

amount per 1kg per kg of Tanespimycin

$4,352.78

per amount per 1kg

7

Isooctane

amount per 1kg

1

amount per 1kg per kg of Tanespimycin

$29,587.73

per amount per 1kg

8

Allylamine

amount per 1kg

1

amount per 1kg per kg of Tanespimycin

$437.14

per amount per 1kg

9

THF

amount per 1kg

1

amount per 1kg per kg of Tanespimycin

$2,658.57

per amount per 1kg

Total Weighted
Average:

$43697.478
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per kg of Tanespimycin

13.2 Utilities
The utility requirements can be found in the Utility summary from the profitability
spreadsheet. Utilities demand about $929.346 per kg of 17-AAG produced. This utility calculation
includes high pressure steam, process water, cooling water, electricity, propylene glycol for cooling,
as well as the estimated cost of disposing of specific wastes throughout the process.
Table 13.2: Utility Costs per kg of Tanespimycin

Utilities

1
2
3
4
5
6
7
8
9
10

Utility:
High Pressure
Steam
Low Pressure
Steam
Process Water
Cooling Water
Electricity
Wastes

Unit:

Propylene Glycol

total amount

lb
lb
gal
lb
kWh
total waste

Required
Ratio
711
0
1110
127
2.22E+03
1
1

Utility Cost
lb per kg of Tanespimycin
lb per kg of Tanespimycin
gal per kg of Tanespimycin
lb per kg of Tanespimycin
kWh per kg of Tanespimycin
total waste per kg of Tanespimycin
total amount per kg of
Tanespimycin

Total Weighted Average:

$0.010
$0.000E+00
$2.055E-03
$2.250E-03
$0.080
$657.000

per lb
per gal
per lb
per kWh
per total was

$85.070

per total amo

$929.347

13.3 Fixed Costs
For the upstream and downstream geldanamycin process, a total of 13 employees per shift are
required: 1 employee for fifty-two 2 L fermenters of both trains who will have a break every 5 days to
monitor downstream, 1 employee for secondary fermenter of both trains who will have a break every 5
days to monitor downstream, 1 employee on each of the 50,000 L bioreactors at all times, and 1 employee
at each of the downstream. For the tanespimycin production process, 11 employees per shift are required:
9 total employees for the 18 reactors, 1 employee for downstream and 1 employee for maintenance.
Assuming four 8-hour shifts/day, full time salary is required for 96 employees. Each employee will be
paid $47,000/year (Bureau of Labor Statistics, 2014), for a total employee cost of $4,512,000/year.
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per lb

per kg of Ta

Maintenance and quality control personnel must also be accounted for in order to manage all CIP,
SIP, and waste management procedures. For the facilities, regulatory personnel are also needed. Lastly,
management positions will be needed to manage the engineering, financial, and human resources related
issues.
Since this process is being developed in an existing BMS facility, technical assistance to
manufacturing and a control laboratory are not taken into account in this profitability analysis. Many of
the defaults remain the same in the spreadsheet, as indicated in the fixed cost summary, but property taxes
and insurance were set to zero to the existence of the facility.
Table 13.3 Fixed Costs, Profitability Spreadsheet

Fixed
Costs
Operations
(assumin
g

Operators per Shift:

24

Direct Wages and Benefits:

$40

/operator hour

Direct Salaries and Benefits:
Operating Supplies and
Services:
Technical Assistance to
Manufacturing:

15%

of Direct Wages and Benefits

$0.00

Control Laboratory:

$0.00

Wages and Benefits:

4.50%

Salaries and Benefits:
Materials and Services:

25.00%
100.00
%

Maintenance Overhead:

5.00%

of Total Depreciable Capital
of Maintenance Wages and
Benefits
of Maintenance Wages and
Benefits
of Maintenance Wages and
Benefits

General Plant Overhead:
Mechanical Department
Services:

7.10%

of Maintenance and Operations Wages and Benefits

2.40%

of Maintenance and Operations Wages and Benefits

Employee Relations Department

5.90%

of Maintenance and Operations Wages and Benefits

Business Services

7.40%

of Maintenance and Operations Wages and Benefits

6%

4

shifts)

of Direct Wages and Benefits
per year, for each Operator per
Shift
per year, for each Operator per
Shift

Maintenance

Operating Overhead
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Property Taxes and Insurance
Property Taxes and Insurance:

0.00%

Straight Line Depreciation
Direct
Plant:
8.00% of Total Depreciable Capital, less
Allocated
Plant:

6.00%

of Total Depreciable Capital

1.18

of

1.18

times the Allocated Costs
for Utility Plants and Related
Facilities
times the Allocated Costs for Utility Plants and
Related Facilities

Other Annual Expenses
Rental Fees (Office and
Laboratory Space):

$0

Licensing Fees:

$0

Miscellaneous:

$0

Annual Depletion Allowance:

$0

Depletion Allowance

Moreover, the spreadsheet allows for the specification of the percentages of product sales charged
for selling/transfer expenses, direct research, allocated research, administrative expenses, and
management incentives compensation. It was assumed that about 1.5% of sales would be spent on
selling/transfer expenses with 0.5% of sales allocated to direct research and 4% of sales to allocated
research. It was also assumed that the administrative expenses and management incentive compensation
were both about 1.00% of sales.
The working capital is defined as the sum of the cash reserves, inventory, and accounts
receivable, minus the accounts payable. The cash reserves is set to include 30 days of raw materials,
utilities operation, and maintenance.4 days of product inventory and 2 days of raw material inventory has
also been assumed.
Table 13.4 Other Variable Costs and Working Capital, Profitability Spreadsheet

Other Variable Costs
General Expenses
Selling / Transfer Expenses:
Direct Research:
Allocated Research:
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1.50%
0.50%
4.00%

of Sales
of Sales
of Sales

Administrative Expense:
Management Incentive
Compensation:

1.00%

of Sales

1.00%

of Sales

Working Capital
Accounts Receivable
Cash Reserves (excluding Raw Materials)
Accounts Payable
Tanespimycin (17-AAG)
Inventory











Raw Materials





30
30
30

Days
Days
Days

4

Days

2

Days



14.0 Other Important Considerations
In the designing of an economical production process for tanespimycin, efforts were made to
address environmental concerns and follow good manufacturing practices (GMP) and FDA regulations.
Additionally, an IP expert was consulted to prevent intellectual property infringement due to the preexisting patents.

14.1 Environmental Concerns
Environmental concerns for the process are governed by the biological and non-biological wastes
produced. The biological waste, including the biomass removed from the rotary vacuum filtration, is
considered class II biohazard and must be treated by a biowaste inactivation package. The package heats
the contents to 80C for one minute to inactivate any living cells. After inactivation, the biomass which
was previously mixed with water in order to allow it to be pumped is transferred and combined with the
non-biological waste in the waste neutralization tanks. These tanks neutralize all contained contents to a
pH of 7 and discharges neutralized waste to the sewage system.
Due to their adverse health and environmental effects, special care must be taken when disposing
of methylene chloride and isooctane. In order to eliminate potential human contact with these chemicals,
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methylene chloride and isooctane are directly pumped into 55 gallon drums, followed by removal by
Clean Harbors - the contracted waste management company which will disposes the contents according to
EPA regulated protocols.
No disposable equipment is used in this process; instead large equipment is cleaned using CIP
measures, and small equipment is autoclaved. Additionally, limited landfill waste helps reduce the carbon
footprint of this plant.

14.2 Good Manufacturing Practices
Current good manufacturing practices (cGMP) are a set of principles and procedures that must be
followed by manufactures for therapeutic goods in order to ensure that the final product has the required
quality.
First the plant must be reviewed by a quality management team to approve that the plant complies
with regulations. These standards will be met by accounting for the needs such as WFI, CIP, SIP,
adequate ventilation, and quality materials. Additionally, there must always be an adequate number of
workers and personnel who are versed on the hygiene standards and trained with sufficient experience at
the plant to perform their assigned tasks.
Final quality assurance testing of the product is not sufficient to ensure quality consistent with
FDA regulations. Instead sampling and testing of in-process materials and drug products must be
completed at different checkpoints throughout the process to insure batch uniformity and integrity of drug
products. Checkpoints will be placed at the commencement or completion of all significant phases or
after storage for long periods. Samples will be taken from transfer streams and tested for identity,
strength, quality, and purity as appropriate. In addition, all raw materials will be checked by quality
control personnel before moving to the production floor.
Storage tanks are put in place after each process in the upstream and downstream production.
These tanks can be utilized in the case that the output of a process produces a product that fails quality
control testing resulting in rejected materials. Once the rejected materials are pumped into the tank, the
contents will be disposed of according to FDA regulation and not further processed. These tanks will limit
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the downtime between failed batches and further costs associated with processing an unsatisfactory
product.
A final quality check will be performed at the end of the process before transport to the internal
BMS packaging branch. The packaging branch will also abide by cGMP. The packaging must be nonreactive, clean, and sanitized. Detailed labeling practices must be followed such as all labels must include
details of the contents, strength, and dose form. Shipments with obsolete, insufficient, or outdated labels
shall be destroyed.
All relevant information regarding these procedures as well as detailed descriptions of each
practice are found in the Code of Federal Regulation 21 Part 211 (21 CFR 211) available electronically
through the FDA website.

14.3 Intellectual Property/Patent Considerations
The production process for geldanamycin and tanespimycin presented in this report uses
information and data from a 2003 geldanamycin production application patent and a 2009 tanespimycin
production patent. To better understand the qualifications for infringement of the intellectual property
protected by these patents, Dr. Brandt, a patent agent at Johnson and Johnson was consulted.
This report’s process design for geldanamycin uses information from Upjohn Pharmaceuticals’
2003 patent application from Upjohn Pharmaceuticals. As a patent application is merely a pending
request at the patent office, any aspects of the process described in the application are not protected by
patent law, eliminating concerns of infringement.
This report’s process design for tanespimycin uses a 2009 patent from Conforma. Upon
consultation with Dr. Brandt, it became clear that the extreme specificity of the inventions described in
the patent rendered infringement highly unlikely (unless an exact replica of the described process was
pursued.) Thus, upon scale up modifications, equipment adjustments, and a shift from several batch to
continuous processing steps, we are confident that the proposed design does not bear any infringement
concerns.
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15.0 Profitability Analysis
To determine the profitability of the outlined production of tanespimycin, the Profitability
Analysis-4.0.xls spreadsheet by Brian K. Downey (2008) was used. However, because this costing
estimation does not have the ability to account for the Phase III clinical trial cost of $2 billion, the most
significant expense, additional calculation were conducted in order to account for this cost in year 2020 in
the net present value (NPV) and internal rate of return (IRR).

15.1.0 Profitability Analysis
For the profitability analysis, it is assumed that the plant’s effective tax rate is 37%, and that the
cost of capital for the plant will be 15%. The economic analysis shows that the process for the final case
has a net present value (at 15% and a life of 14 years) of about $3.2 billion and an internal rate of return
(IRR) of 33 percent. The NPV and IRR are greatly dependent upon the cost the Phase III clinical trial
estimate, and selling price of tanespimycin. A sensitivity analysis is performed at the end of this chapter
in order to illustrate their dependency of these costs and values.
While the spreadsheet does not conveniently allow for integration of the Phase III trial cost into
the spreadsheet, the IRR and NPV values were calculated independently and are included in section
15.1.1. Table 15.1 summarizes the end of the year cash flows each year as well as the cumulative net
present value calculated per year. Excel’s IRR function was used to determine the calculated 33 percent
and included each year’s cash flow incorporating the negative $2 billion in year 2020 incurred due to the
Phase III clinical trial cost.

108

15.1.1 Profitability Measures

Profitability Measures
The Internal Rate of Return (IRR) for this project is

33.00%

The Net Present Value (NPV) of this project in 2020 is

$3,172,265,206.53

ROI Analysis (Third Production Year)
Annual Sales

2,200,427,350

Annual Costs

(253,163,493)

Depreciation

(14,686,597)

Income Tax

(715,053,586)

Net Earnings

1,217,523,674

Total Capital Investment

387,535,769

ROI

314.17%

Table 15.1 End of year cash flows in each year and corresponding cumulative net present worth using a discount
rate of 15%.

Year

Cash Flow (Billions)

Cumulative NPV (Billions)

2020

-2.00

-2.00

2021

-0.29

-2.25

2022

0.56

-1.82

2023

0.88

-1.24

2024

1.24

-0.53

2025

1.23

0.08

2026

1.23

0.62

2027

1.23

1.08

2028

1.23

1.48

2029

1.23

1.83

2030

1.23

2.13
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2031

1.23

2.39

2032

1.23

2.62

2033

1.23

2.82

2034

1.23

3.00

2035

1.43

3.17

15.1.2 Price of Tanespimycin
As stated in the Market and Competitive Analysis, the cost of a full course of Herceptin
treatment costs about $70,000 reported by Medical News Daily. Because tanespimycin will be used
in conjunction with this treatment its price must be lower for it is not directly competing with
Herceptin, but rather sharing the patient market. Also the patent on Herceptin expires in 2014 in
Europe and in 2019 in the United States. Normally this would result in the production of a
chemically identical generic version of the drug, which may be sold at a much lower price, for
research and trial costs do not need to be recouped by generic manufacturers. However, Herceptin is
a monoclonal antibody, which is a unique large-molecule drug. The manufacturing is complex and
subject to lack of uniformity by nature (Mulcahy, 2013). Therefore, a chemically identical generic is
impossible to produce, and instead, a biosimilar can be synthesized. This process is much more
difficult and currently only combination therapies are been proposed rather than substitution
therapies for Herceptin. Thus the patent expiration will not have the significant price dropping
implications that usually occur in the pharmaceutical market. Additionally a conservative selling
price is used because breast cancer is a popular field of research. With all the previously mentioned
factors considered, a selling price of $20,000 per treatment will be utilized. Thus tanespimycin will
cost approximately $2,137,000 per kilogram.
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15.1.3 Plant Life
The new facility is expected to have a life of about 14 years. While most of the capital
investment could technically have a longer lifespan, the marketing life of the drug can assumed to be
less. Fourteen years is used as a conservative estimation of the number of years of production, but it
could be more. General patent protection lasts 20 years. With a conservative guess, that the patent
protection begins before the clinical trial begins, and assuming a clinical trial of 5 years and then an
additional year for FDA paperwork and final approval, it is estimated that there will be 14 years that
the drug can be produced under patent protection before generics jump into the market. While this
may be longer (due to method of treatment patents filed during clinical trials or shorter clinical
trials), for the purposes of the economic calculations, it is assumed that the plant will operate for 14
years with 2 additional years for design and construction. Since phase three clinical trials still need to
be performed, the analysis is also based on the premise that installation of the equipment will begin
in 2020, allowing for at least 5 years of the clinical trial to be underway before proceeding. In
addition, it is important to note that the profitability analysis included here takes into account a
$2billion phase III trial accounted for in 2020.
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15.1.4 Input and Cost Summaries
Input and cost summaries generated from the profitability spreadsheet are included below.
Assumptions are explained in Chapter 12 for fixed-capital investment, and chapter 13 for operating costs.
The primary costs are capital investment and variable costs totaling $344 million and $233 million
respectively, and fixed costs only total $31 million.
General Information
Process Title:
Product:
Plant Site Location:
Site Factor:
Operating Hours per
Year:
Operating Days Per
Year:
Operating Factor:

The production of Tanespimycin: Final
Case
Tanespimycin (17-AAG)
Philadelphia
1.10
7919
330
0.9040

Product Information
This Process will Yield

Price

0

kg of Tanespimycin (17-AAG) per hour

3

kg of Tanespimycin (17-AAG) per day

1,084

kg of Tanespimycin (17-AAG) per year

$2,136,752.14

/kg

Chronology
Year

Action

2020

Design

2021

Construction

2022

Distribution of

Production

Depreciation

Permanent Investment

Capacity

5 year MACRS

Product Price

0.0%
100%

0.0%

Production

0%

47.5%

20.00%

$2,136,752.14

2023

Production

0%

71.3%

32.00%

$2,136,752.14

2024

Production

0%

95.0%

19.20%

$2,136,752.14

2025

Production

95.0%

11.52%

$2,136,752.14

2026

Production

95.0%

11.52%

$2,136,752.14

2027

Production

95.0%

5.76%

$2,136,752.14

2028

Production

95.0%

$2,136,752.14

2029

Production

95.0%

$2,136,752.14

2030

Production

95.0%

$2,136,752.14

2031

Production

95.0%

$2,136,752.14
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2032

Production

95.0%

$2,136,752.14

2033

Production

95.0%

$2,136,752.14

2034

Production

95.0%

$2,136,752.14

2035

Production

95.0%

$2,136,752.14

Variable Cost
Summary
Variable Costs at 100% Capacity:
General Expenses
$
34,743,590
$
11,581,197
$
92,649,573
$
23,162,393
$
23,162,393

Selling / Transfer Expenses:
Direct Research:
Allocated Research:
Administrative Expense:
Management Incentive Compensation:

$
185,299,145

Total General Expenses
Raw Materials
Byproducts
Utilities

$43,697.477811

per kg of Tanespimycin (17-AAG)

$47,368,066

$0.000000

per kg of Tanespimycin (17-AAG)

$0

$929.347332

per kg of Tanespimycin (17-AAG)

$1,007,413

Total Variable Costs

$233,674,624

Fixed Cost Summary

Operations
Direct Wages and Benefits

$

7,987,200

Direct Salaries and Benefits

$

1,198,080

Operating Supplies and

$

479,232
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Services
Technical Assistance to Manufacturing

$

-

Control Laboratory

$

-

Total Operations

$

9,664,512

Wages and Benefits

$

7,510,191

Salaries and Benefits

$

1,877,548

Materials and Services

$

7,510,191

Maintenance Overhead

$

375,510

Total Maintenance

$

17,273,440

General Plant Overhead:
Mechanical Department
Services:
Employee Relations
Department:

$

1,318,684

$

445,752

$

1,095,808

Business Services:

$

1,374,403

Total Operating Overhead

$

4,234,648

Maintenance

Operating Overhead

Property Taxes and Insurance
Property Taxes and Insurance:

$

-

Rental Fees (Office and Laboratory Space):
Licensing
Fees:

$

-

$

-

Miscellaneous:

$

-

Total Other Annual Expenses

$

-

Other Annual Expenses

Total Fixed Costs

$

Investment Summary
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31,172,601

Total Bare Module Costs:
Fabricated Equipment

$ 140,474,801

Process Machinery

$

Spares

$

Storage

$

Other Equipment

$

-

Catalysts

$

-

Computers, Software, Etc.

$

-

1,501,500
1,156,756

Total Bare Module Costs:

$

143,133,057

$

151,721,040

$

166,893,144

$

166,893,144

Direct Permanent Investment
Cost of Site Preparations:

$

1,431,331

Cost of Service Facilities:

$

7,156,653

Allocated Costs for utility plants and related facilities:

$

-

Direct Permanent Investment

Total Depreciable Capital
Cost of Contingencies & Contractor Fees

$

15,172,104

Total Depreciable Capital
Total Permanent Investment
Cost of Land:

$

-

Cost of Royalties:

$

-

Cost of Plant Start-Up:

$

-

Total Permanent Investment - Unadjusted
Site Factor

1.10

Total Permanent Investment

$

Working
Capital
2021
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2022

2023

183,582,459

Accounts Receivable

$

90,428,521

$

45,214,261

Cash Reserves

$

1,256,343

$

628,171

Accounts Payable

$

(1,888,632)

$

(944,316)

Tanespimycin (17-AAG) Inventory

$

12,057,136

$

6,028,568

Raw Materials

$

123,287

$

61,643

$
45,214,261
$
628,171
$
(944,316)
$
6,028,568
$
61,643

Total

$ 101,976,655

$

50,988,328

$
50,988,328

Present Value at 15%

$ 88,675,353

$

38,554,501

$
33,525,653

Total Capital
Investment

$

344,337,965

Although these costs are all important to consider ensuring that this process is economical, the
dominating cost is the $2 billion clinical trial cost in 2020. Due to its importance, a sensitivity analysis of
the trial expense is presenting in the following section.

15.2.0 Sensitivity Analysis
A sensitivity analysis must be preformed for critical price parameters and values including the
Phase III clinical trial price estimate and the selling price for tanespimycin treatment. This analysis will
dictate which price estimations and considerations are worth altering based of the desired NPV and IRR.

15.2.1 Phase III Clinical Trial Cost Estimate
As discussed in Chapter 3, a conservative $2 billion Phase III clinical trial cost estimate was used
to include the cost of the treating trial patients and adjust for the associated risk and opportunity cost of
the trial investment. This cost trumps all other expenses involved, for the second largest expense is the
equipment costs, which are on the order of millions. A less conservative Phase III clinical trial cost would
therefore considerably impact both the NPV and IRR. NPV will vary linearly with the trial cost, for this
expense is a present value sunk cost in year zero. Figure 15.1 demonstrates this linear NPV relationship as
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well as the IRR relation to clinical trial cost. This IRR is more sensitive to trial cost when it is less than $1
billion, for once it exceeds $1 billion the trial cost trumps all other expenses and the IRR is less affected
by additional increase.

5.5

200%

5

180%

4.5

160%

4

140%

3.5

120%

3
100%
2.5
80%

2

60%

1.5
1

40%

0.5

20%

0

Internal Rate of Return

Net Present Value (Billions)

Clinical Trial Cost Sensitivy

Net Present Value
Internal Rate of Return

0%
0

1
2
Clinical Trial Cost (Billions)

3

Figure15.1 Sensitivity analysis of the Phase III clinical trial cost on NPV and IRR.

15.2.2 Selling Price of Tanespimycin
As discussed in 15.1.2 the selling price of tanespimycin will be set at $20,000 per treatment after
considering Herceptin pricing and recent patent expiration. This price is also subject to alteration due to
the assumptions and estimations used in its calculation. Figure 15.2, illustrates that the NPV linearly
increases as the selling price of tanespimycin increases. It is critical to note that the break even selling
price per treatment is $7,833, for a negative NPV is achieved if sold below this minimum. The IRR also
increases with the selling price; the IRR is more sensitive to price change below $40,000 and sensitivity
decreases in the higher pricing regime, although this change in sensitivity is not significant.
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Selling Price Sensitivity
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Figure 15.2 Sensitivity analysis of the selling price of tanespimycin on NPV and IRR.
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Net Present Value
Internal Rate of Return

16.0 Conclusions and Recommendations
This report describes an economical, scaled-up process design for the production of
tanespimycin. The proposed facility requires full operation for 293 days/year, with fermentation
yielding 21.9 kg/batch geldanamycin and subsequent reaction with allylamine at 90% yield giving
19.7 kg tanespimycin/ batch. Abiding by the timing and scheduling presented in Chapter 7 and the
Appendix, 55 batches/year should produce 1030 kg of usable tanespimycin per year (95% of total
tanespimycin produced), adequately meeting market demands.
From a financial standpoint, it is highly recommended that BMS move forward with this
process design. Selling tanespimycin at a price of $20,000/kg, corresponding to a price of
_____/treatment, BMS can expect an NPV of ______, an IRR of _____, and a ____% ROI after ____
years. This financial analysis has taken into account the cost of Phase III FDA clinical trials, as well
as a price decrease for the proposed method of treatment with Herceptin, which will be going offpatent in the United States in 2019 (Mulcahy). Thus, these numbers motivate further investigation
and investment in this project by BMS, as a financially feasible design for a cancer therapeutic with
tremendous market potential will prove to be a great asset to the company. However, in order to
adequately carry out the outlined proposal, it is highly recommended that BMS conserve initial
capital by allowing Phase III clinical trials to use drug created by a CMO. Once tanespimycin has
been approved by the FDA, it is recommended that BMS use an existing laboratory, such as the
laboratory in Devens, Massachusetts, to begin production.
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Appendix B – MSDS Sheets

Material Safety Data Sheet
Creation Date 27-Jan-2010

Revision Date 27-Oct-2014

Revision Number 1

1. PRODUCT AND COMPANY IDENTIFICATION
Product Name

Methylene chloride

Cat No. :

D37-1; D37-4; D37-20; D37-200; D37-200LC; D37-500; D37FB-19;
D37FB-50; D37FB-115; D37FB-200; D37POP-19; D37POPB-50;
D37POPB-200; D37RB-19; D37RB-50; D37RB-115; D37RB-200;
D37RS-19; D37RS-28; D37RS-50; D37RS-115; D37RS-200; D37SK-4;
D37SK-4LC; D37SS-28; D37SS-50; D37SS-115; D37SS-200;
D37SS-1350

Synonyms

Dichloromethane; DCM

Recommended Use

Laboratory chemicals

Company
Fisher Scientific
One Reagent Lane
Fair Lawn, NJ 07410
Tel: (201) 796-7100

Emergency Telephone Number
CHEMTREC, Inside the USA: 800-424-9300
CHEMTREC, Outside the USA: 001-703-527-3887

2. HAZARDS IDENTIFICATION
WARNING
Emergency Overview
Possible cancer hazard. May cause cancer based on animal data. Irritating to eyes and skin. May be harmful if
inhaled. May cause irritation of respiratory tract. Inhalation may cause central nervous system effects. WARNING! This
product contains a chemical known in the State of California to cause birth defects or other reproductive harm.
Very toxic: danger of very serious irreversible effects in contact with skin. Flammable. Harmful if swallowed. May
cause allergic respiratory reaction. Toxic to aquatic organisms.
Appearance Colorless
Target Organs

Physical State Liquid

Odor sweet

Skin, Eyes, Central nervous system (CNS), Blood, Liver, Kidney, Central Vascular System
(CVS)

Potential Health Effects
Acute Effects
Principle Routes of Exposure
Eyes

Irritating to eyes. Contact with eyes may cause irritation.
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Methylene chloride
Revision Date 27-Oct-2014
______________________________________________________________________________________________
Irritating to skin. May be harmful in contact with skin. May cause eye/skin irritation.
May be harmful if inhaled. Inhalation may cause central nervous system effects. May cause
irritation of respiratory tract.
May be harmful if swallowed. Ingestion may cause gastrointestinal irritation, nausea,
vomiting and diarrhea. Ingestion may cause irritation to mucous membranes.

Skin
Inhalation
Ingestion

Chronic Effects
Avoid repeated exposure

Aggravated Medical Conditions

Central nervous system disorders. Preexisting eye disorders. Skin disorders. Kidney
disorders. Liver disorders.

3. COMPOSITION/INFORMATION ON INGREDIENTS
Component
Methylene chloride
Methyl alcohol
Cyclohexene
2-Methyl-2-butene

CAS-No
75-09-2
67-56-1
110-83-8
513-35-9

Weight %
>99.5
0 - 0.4
0 - 0.01 0 0.01

4. FIRST AID MEASURES
Eye Contact

Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes. Obtain
medical attention.

Skin Contact

Wash off immediately with plenty of water for at least 15 minutes. Obtain medical attention.

Inhalation

Move to fresh air. If breathing is difficult, give oxygen. Obtain medical attention.

Ingestion

Clean mouth with water and drink afterwards plenty of water.

Notes to Physician

Treat symptomatically

5. FIRE-FIGHTING MEASURES
Flash Point
Method -

No information available No
information available

Autoignition Temperature

556 °C / 1032.8 °F

Explosion Limits
Upper
Lower

23 vol % 13 vol
%

Suitable Extinguishing Media

Use water spray, alcohol-resistant foam, dry chemical or carbon
dioxide.

Unsuitable Extinguishing Media

No information available

Hazardous Combustion Products

No information available.

Sensitivity to Mechanical Impact
Sensitivity to Static Discharge

No information available No
information available

Specific Hazards Arising from the Chemical
Thermal decomposition can lead to release of irritating gases and vapors. Keep product and empty container away from heat and
sources of ignition.
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Protective Equipment and Precautions for Firefighters
As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full
protective gear.
NFPA

Health 2

Flammability 1

Instability 0

Physical hazards N/A

6. ACCIDENTAL RELEASE MEASURES
Personal Precautions

Use personal protective equipment. Ensure adequate ventilation.

Environmental Precautions

Should not be released into the environment. See Section 12 for additional ecological
information.

Methods for Containment and Clean Soak up with inert absorbent material. Keep in suitable, closed containers for disposal.
Up

7. HANDLING AND STORAGE
Handling

Wear personal protective equipment. Ensure adequate ventilation. Do not get in eyes, on
skin, or on clothing. Avoid ingestion and inhalation.

Storage

Keep containers tightly closed in a dry, cool and well-ventilated place.
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8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Engineering Measures

Use only under a chemical fume hood. Ensure adequate ventilation, especially in confined
areas. Ensure that eyewash stations and safety showers are close to the workstation
location.

Exposure Guidelines
Component
Methylene chloride

ACGIH TLV
TWA: 50 ppm

Methyl alcohol

TWA: 200 ppm
STEL: 250 ppm
Skin

Cyclohexene

TWA: 300 ppm

Component

Quebec

Methylene chloride

TWA: 50 ppm
TWA: 174 mg/m3

Methyl alcohol

TWA: 200 ppm
TWA: 262 mg/m3
STEL: 250 ppm
STEL: 328 mg/m3
Skin
TWA: 300 ppm
TWA: 1010 mg/m3

Cyclohexene

OSHA PEL
(Vacated) TWA: 500 ppm
(Vacated) STEL: 2000 ppm
(Vacated) Ceiling: 1000 ppm
TWA: 25 ppm
STEL: 125 ppm
(Vacated) TWA: 200 ppm
(Vacated) TWA: 260 mg/m3
(Vacated) STEL: 250 ppm
(Vacated) STEL: 325 mg/m3
Skin
TWA: 200 ppm
TWA: 260 mg/m3
(Vacated) TWA: 300 ppm
(Vacated) TWA: 1015 mg/m3
TWA: 300 ppm
TWA: 1015 mg/m3
Mexico OEL (TWA)
TWA: 100 ppm
TWA: 330 mg/m3
STEL: 500 ppm
STEL: 1740 mg/m3
TWA: 200 ppm
TWA: 260 mg/m3
STEL: 250 ppm
STEL: 310 mg/m3
TWA: 300 ppm
TWA: 1015 mg/m3

NIOSH IDLH
IDLH: 2300 ppm

IDLH: 6000 ppm
TWA: 200 ppm
TWA: 260 mg/m3
STEL: 250 ppm
STEL: 325 mg/m3

IDLH: 2000 ppm
TWA: 300 ppm
TWA: 1015 mg/m3
Ontario TWAEV
TWA: 50 ppm

TWA: 200 ppm
STEL: 250 ppm
Skin

TWA: 300 ppm

Legend
NIOSH IDLH: The National Institute for Occupational Safety and Health Immediately Dangerous to Life or Health

Personal Protective Equipment
Eye/face Protection
Skin and body protection
Respiratory Protection

Tightly fitting safety goggles. Face-shield. Long
sleeved clothing.
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard
EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if
exposure limits are exceeded or if irritation or other symptoms are experienced.

9. PHYSICAL AND CHEMICAL PROPERTIES
Physical State
Appearance
Odor
Odor Threshold
pH

Liquid
Colorless
sweet
No information available
Not applicable

Vapor Pressure
Vapor Density

20 mmHg @ 3502°C
2.93 (Air = 1.0)
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No information available
39 °C / 102.2 °F
-97 °C / -142.6 °F
No information available No
information available No
information available
1.33
No information available
No data available
84.93
C H2 Cl2

Viscosity
Boiling Point/Range
Melting Point/Range
Decomposition Temperature
Flash Point
Evaporation Rate
Specific Gravity
Solubility
log Pow
Molecular Weight
Molecular Formula

10. STABILITY AND REACTIVITY
Stability

Stable under normal conditions.

Conditions to Avoid

Incompatible products. Excess heat.

Incompatible Materials

Strong oxidizing agents, Strong acids, Amines

Hazardous Decomposition Products

Carbon monoxide (CO), Carbon dioxide (CO2), Hydrogen
chloride gas, Phosgene

Hazardous Polymerization

Hazardous polymerization does not occur.

Hazardous Reactions

None under normal processing.

11. TOXICOLOGICAL INFORMATION
Acute Toxicity
Product Information
Component Information
Component
Methylene chloride
Methyl alcohol
Cyclohexene
2-Methyl-2-butene

LD50 Oral
> 2000 mg/kg ( Rat )
6200 mg/kg ( Rat )
Not listed
700-2600 mg/kg ( Rat )

LD50 Dermal
> 2000 mg/kg ( Rat )
Not listed
>200 mg/kg (Rat)
>2000 mg/kg ( Rat )

Irritation

Irritating to eyes and skin

Toxicologically Synergistic
Products

No information available

LC50 Inhalation
53 mg/L ( Rat ) 6 h
22500 ppm ( Rat ) 8 h
>21.6 mg/L/4h (rat)
61000 ppm ( Rat ) 4 h

Chronic Toxicity
The table below indicates whether each agency has listed any ingredient as a carcinogen.

Carcinogenicity
Component
Methylene chloride

ACGIH
A3

IARC
Group 2B

NTP
Reasonably
Anticipated

OSHA
X

Mexico
A3

ACGIH: (American Conference of Governmental Industrial Hygienists)
A1 - Known Human Carcinogen
A2 - Suspected Human Carcinogen
A3 - Animal Carcinogen
ACGIH: (American Conference of Governmental Industrial Hygienists)
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IARC: (International Agency for Research on Cancer)
IARC: (International Agency for Research on Cancer)
Group 1 - Carcinogenic to Humans
Group 2A - Probably Carcinogenic to Humans Group 2B Possibly Carcinogenic to Humans
NTP: (National Toxicity Program)
NTP: (National Toxicity Program)
Known - Known Carcinogen
Reasonably Anticipated - Reasonably Anticipated to be a Human Carcinogen
Mexico - Occupational Exposure Limits - Carcinogens
Mexico - Occupational Exposure Limits - Carcinogens
A1 - Confirmed Human Carcinogen A2 Suspected Human Carcinogen A3 - Confirmed
Animal Carcinogen
A4 - Not Classifiable as a Human Carcinogen A5 - Not
Suspected as a Human Carcinogen

Sensitization

No information available

Mutagenic Effects

Mutagenic effects have occured in microorganisms.

Reproductive Effects

Experiments have shown reproductive toxicity effects on laboratory animals.

Developmental Effects

Developmental effects have occurred in experimental animals.

Teratogenicity

No information available.

Other Adverse Effects

Tumorigenic effects have been reported in experimental animals. See actual entry in
RTECS for complete information.

Endocrine Disruptor Information

No information available

12. ECOLOGICAL INFORMATION
Ecotoxicity .
Component
Methylene chloride

Freshwater Algae
EC50:>660 mg/L/96h

Methyl alcohol

Not listed

Cyclohexene

Not listed

2-Methyl-2-butene

Not listed

Freshwater Fish
Microtox
Pimephales promelas:
EC50: 1 mg/L/24 h
LC50:193 mg/L/96h
EC50: 2.88 mg/L/15 min
Pimephales promelas: LC50 EC50 = 39000 mg/L 25 min
> 10000 mg/L 96h
EC50 = 40000 mg/L 15 min
EC50 = 43000 mg/L 5 min
Poecillia reticulata: 7.1
Not listed
mg/L/96h
Not listed
Not listed

Persistence and Degradability

.

Bioaccumulation/ Accumulation

No information available.

Mobility

Will likely be mobile in the environment due to its volatility.
Component
Methylene chloride
Methyl alcohol
Cyclohexene

Water Flea
EC50: 140 mg/L/48h
EC50 > 10000 mg/L 24h

Daphnia: EC50: 5.3
mg/L/48h
3 mg/L EC50 = 48 h

log Pow
1.25
-0.74
3.27

13. DISPOSAL CONSIDERATIONS
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Waste Disposal Methods

Chemical waste generators must determine whether a discarded chemical is classified as a
hazardous waste. Chemical waste generators must also consult local, regional, and
national hazardous waste regulations to ensure complete and accurate classification.

Component
Methylene chloride - 75-09-2
Methyl alcohol - 67-56-1

RCRA - U Series Wastes
U080
U154

RCRA - P Series Wastes
-

14. TRANSPORT INFORMATION
DOT
UN-No
Proper Shipping Name
Hazard Class
Packing Group

UN1593
DICHLOROMETHANE
6.1
III

TDG
UN-No
Proper Shipping Name
Hazard Class
Packing Group

UN1593
DICHLOROMETHANE
6.1
III

IATA

UN-No
Proper Shipping Name
Hazard Class
Packing Group

UN1593
Dichloromethane
6.1
III

IMDG/IMO
UN-No
Proper Shipping Name
Hazard Class
Packing Group

UN1593
Dichloromethane
6.1
III

15. REGULATORY INFORMATION
All of the components in the product are on the following Inventory lists: X = listed
International Inventories
Component
Methylene chloride

TSCA
X

DSL
X

Methyl alcohol

X

X

Cyclohexene

X

X

2-Methyl-2-butene

X

X

NDSL EINECS ELINCS NLP
200-8389
200-6596
203-8078
208-1563

PICCS ENCS
X
X

AICS
X

IECSC
X

KECL
X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Legend:
X - Listed
E - Indicates a substance that is the subject of a Section 5(e) Consent order under TSCA.
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F - Indicates a substance that is the subject of a Section 5(f) Rule under TSCA.
N - Indicates a polymeric substance containing no free-radical initiator in its inventory name but is considered to cover the designated polymer
made with any free-radical initiator regardless of the amount used.
P - Indicates a commenced PMN substance
R - Indicates a substance that is the subject of a Section 6 risk management rule under TSCA.
S - Indicates a substance that is identified in a proposed or final Significant New Use Rule
T - Indicates a substance that is the subject of a Section 4 test rule under TSCA.
XU - Indicates a substance exempt from reporting under the Inventory Update Rule, i.e. Partial Updating of the TSCA Inventory Data Base
Production and Site Reports (40 CFR 710(B).
Y1 - Indicates an exempt polymer that has a number-average molecular weight of 1,000 or greater.
Y2 - Indicates an exempt polymer that is a polyester and is made only from reactants included in a specified list of low concern reactants that
comprises one of the eligibility criteria for the exemption rule.

U.S. Federal Regulations
TSCA 12(b)
SARA 313

Component

CAS-No

Weight %

Methylene chloride
Methyl alcohol

75-09-2
67-56-1

>99.5
0 - 0.4

SARA 311/312 Hazardous Categorization
Acute Health Hazard
Chronic Health Hazard
Fire Hazard
Sudden Release of Pressure Hazard
Reactive Hazard

SARA 313 - Threshold
Values %
0.1
1.0

Yes
Yes
No
No
No

Clean Water Act

Component
Methylene chloride
75-09-2 ( >99.5 )

CWA - Hazardous
Substances
-

CWA - Reportable
Quantities
-

CWA - Toxic Pollutants CWA - Priority Pollutants
X

X

Clean Air Act

Component
HAPS Data
Methylene chloride
X
75-09-2 ( >99.5 )
Methyl alcohol
X
67-56-1 ( 0 - 0.4 )
OSHA Occupational Safety and Health Administration
Not applicable
Component

Class 1 Ozone Depletors

Specifically Regulated Chemicals

Class 2 Ozone Depletors
-

Highly Hazardous Chemicals
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Methylene chloride
75-09-2 ( >99.5 )

125 ppm STEL
12.5 ppm Action Level
25 ppm TWA

-

CERCLA
This material, as supplied, contains one or more substances regulated as a hazardous substance under the Comprehensive
Environmental Response Compensation and Liability Act (CERCLA) (40 CFR 302)
Hazardous Substances RQs

Component
Methylene chloride
Methyl alcohol

CERCLA EHS RQs

1000 lb 1 lb

-

5000 lb

-

California Proposition 65
This product contains the following Proposition 65 chemicals:
Component
Methylene chloride

CAS-No
75-09-2

California Prop. 65
Carcinogen

Methyl alcohol

67-56-1

Developmental

Prop 65 NSRL
200 µg/day
50 µg/day
-

Category
Carcinogen
Developmental

State Right-to-Know

Component
Methylene chloride
Methyl alcohol
Cyclohexene
2-Methyl-2-butene

Massachusetts
X
X
X
X

New Jersey
X
X
X
X

Pennsylvania
X
X
X
X

Illinois
X
X
-

Rhode Island
X
X
X
-

U.S. Department of Transportation
Reportable Quantity (RQ):
Marine Pollutant
Severe Marine Pollutant

YDOT
NDOT
N

U.S. Department of Homeland Security
This product does not contain any DHS chemicals.
Other International Regulations
Mexico - Grade

No information available

Canada
This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations (CPR) and
the MSDS contains all the information required by the CPR
WHMIS Hazard Class
D1B Toxic materials
D2A Very toxic materials

16. OTHER INFORMATION
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Prepared By

Regulatory Affairs
Thermo Fisher Scientific
Email: EMSDS.RA@thermofisher.com

Creation Date

27-Jan-2010

Print Date

27-Oct-2014

Revision Summary
(M)SDS sections updated 2
Disclaimer
The information provided on this Safety Data Sheet is correct to the best of our knowledge, information and belief at the
date of its publication. The information given is designed only as a guide for safe handling, use, processing, storage,
transportation, disposal and release and is not to be considered as a warranty or quality specification. The information
relates only to the specific material designated and may not be valid for such material used in combination with any other material
or in any process, unless specified in the text.
End of MSDS
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1. PRODUCT AND COMPANY IDENTIFICATION
Product Name

Isooctane

Cat No.

O296-1; O296-4; O296RS-28; O296RS-115; O296SK-1; O296SK-4;
O296SS-28; O296SS-50; O296SS-115; O296SS-200; O297-4; O299-1;
O299-4; O299FB-50; O299FB-200; O299RS-115; O299SS-28; O299SS-50;
O299SS-115; O299SS-200; O300-1; O300-4; O301-1; O301-4

Synonyms

2,2,4-Trimethylpentane; Isobutyltrimethylmethane (HPLC/Pesticide/Certified
ACS/Spectranalyzed/Optima)

Recommended Use

Laboratory chemicals

Company
Fisher Scientific
One Reagent Lane
Fair Lawn, NJ 07410
Tel: (201) 796-7100

Emergency Telephone Number
CHEMTREC®, Inside the USA: 800424-9300
CHEMTREC®, Outside the USA: 703527-3887

2. HAZARDS IDENTIFICATION

DANGER!
Emergency Overview
Flammable liquid and vapor. Causes eye, skin, and respiratory tract irritation. Vapors may cause drowsiness and
dizziness. Aspiration hazard if swallowed - can enter lungs and cause damage. Very toxic to aquatic organisms, may
cause long-term adverse effects in the aquatic environment.
Appearance Colorless

Target Organs

Physical State Liquid

odor Petroleum distillates

Kidney, Central nervous system (CNS), Eyes, Skin, Respiratory system

Potential Health Effects
Acute Effects
Principle Routes of Exposure
Eyes
Skin
Inhalation

Irritating to eyes.
Irritating to skin. May be harmful in contact with skin.
Irritating to respiratory system. May be harmful if inhaled. Inhalation may cause central nervous
system effects.
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Ingestion

May be harmful if swallowed. Aspiration hazard. Ingestion may cause gastrointestinal irritation,
nausea, vomiting and diarrhea.

Chronic Effects

Mutagenic effects have occurred in experimental animals.. May cause adverse kidney effects.

See Section 11 for additional Toxicological information.
Aggravated Medical Conditions

No information available.

3. COMPOSITION/INFORMATION ON INGREDIENTS

Haz/Non-haz
Component
Isooctane

CAS-No
540-84-1

Weight %
99

4. FIRST AID MEASURES
Eye Contact

Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes. Obtain
medical attention.

Skin Contact

Wash off immediately with plenty of water for at least 15 minutes. Obtain medical attention.

Inhalation

Move to fresh air. If breathing is difficult, give oxygen. Do not use mouth-to-mouth resuscitation
if victim ingested or inhaled the substance; induce artificial respiration with a respiratory
medical device. Obtain medical attention.

Ingestion

Do not induce vomiting. Call a physician or Poison Control Center immediately.

Notes to Physician

Treat symptomatically.

5. FIRE-FIGHTING MEASURES
Flash Point
Method

-12°C / 10.4°F
No information available.

Autoignition Temperature

417°C / 782.6°F

Explosion Limits
Upper
Lower

6.0 vol % 1.1 vol
%

Suitable Extinguishing Media

CO2, dry chemical, dry sand, alcohol-resistant foam. Use water
spray to cool unopened containers.

Unsuitable Extinguishing Media

Water may be ineffective, Do not use a solid water stream as it may
scatter and spread fire

Hazardous Combustion Products

No information available.

Sensitivity to mechanical impact
Sensitivity to static discharge

No information available.
No information available.

Specific Hazards Arising from the Chemical
Flammable. Risk of ignition. Vapors may form explosive mixtures with air. Vapors may travel to source of ignition and flash back.
Containers may explode when heated.
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Protective Equipment and Precautions for Firefighters
As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full protective
gear. Thermal decomposition can lead to release of irritating gases and vapors.
NFPA

Health 1

Flammability 3

Instability 0

Physical hazards N/A

6. ACCIDENTAL RELEASE MEASURES
Personal Precautions

Use personal protective equipment. Remove all sources of ignition. Take precautionary
measures against static discharges. Do not get in eyes, on skin, or on clothing.

Environmental Precautions

Should not be released into the environment.

Methods for Containment and Clean Remove all sources of ignition. Soak up with inert absorbent material. Take precautionary
measures against static discharges. Keep in suitable and closed containers for disposal.
Up

7. HANDLING AND STORAGE
Handling

Use only under a chemical fume hood. Use explosion-proof equipment. Wear personal
protective equipment. Keep away from open flames, hot surfaces and sources of ignition. Take
precautionary measures against static discharges.

Storage

Keep away from open flames, hot surfaces and sources of ignition. Keep containers tightly
closed in a dry, cool and well-ventilated place. Flammables area.

8. EXPOSURE CONTROLS / PERSONAL PROTECTION

Engineering Measures

Use only under a chemical fume hood. Use explosion-proof
electrical/ventilating/lighting/equipment. Ensure that eyewash stations and safety showers are
close to the workstation location.

Exposure Guidelines
Component
Isooctane

ACGIH TLV
TWA: 300 ppm

OSHA PEL

NIOSH IDLH

NIOSH IDLH: Immediately Dangerous to Life or Health

Personal Protective Equipment
Eye/face Protection
Skin and body protection
Respiratory Protection

Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's
eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Wear appropriate protective gloves and clothing to prevent skin exposure.
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN
149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits
are exceeded or if irritation or other symptoms are experienced.

9. PHYSICAL AND CHEMICAL PROPERTIES
Physical State
Appearance
odor
Odor Threshold

Liquid
Colorless
Petroleum distillates
No information available.
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9. PHYSICAL AND CHEMICAL PROPERTIES
Not applicable
51 mbar @ 20 °C
3.94 (Air = 1.0)
0.51 mPa s at 22 °C
98 - 99°C / 208.4 - 210.2°F@ 760 mmHg
-107°C / -160.6°F
No information available.
-12°C / 10.4°F
No information available.
0.690
Insoluble in water No
data available
114.23 C8
H18

pH
Vapor Pressure
Vapor Density
Viscosity
Boiling Point/Range
Melting Point/Range
Decomposition temperature
Flash Point
Evaporation Rate
Specific Gravity
Solubility
log Pow
Molecular Weight
Molecular Formula

10. STABILITY AND REACTIVITY
Stability

Stable under normal conditions.

Conditions to Avoid

Incompatible products. Heat, flames and sparks.

Incompatible Materials

Strong oxidizing agents, Strong acids, Strong bases

Hazardous Decomposition Products

Carbon monoxide (CO), Carbon dioxide (CO2)

Hazardous Polymerization

Hazardous polymerization does not occur.

Hazardous Reactions .

None under normal processing..

11. TOXICOLOGICAL INFORMATION
Acute Toxicity

Component Information
Component
Isooctane

LD50 Oral
2500 mg/kg ( Rat )

LD50 Dermal
Not listed

Irritation

Irritating to eyes, respiratory system and skin

Toxicologically Synergistic
Products

No information available.

LC50 Inhalation
34.7 mg/L ( Rat ) 4 h
47.4 mg/L ( Rat ) 1 h

Chronic Toxicity
Carcinogenicity

There are no known carcinogenic chemicals in this product
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Sensitization

No information available.

Mutagenic Effects

Mutagenic effects have occurred in experimental animals.

Reproductive Effects

No information available.

Developmental Effects

No information available.

Teratogenicity

No information available.

Other Adverse Effects

The toxicological properties have not been fully investigated.. See actual entry in RTECS for
complete information.

Endocrine Disruptor Information

No information available

12. ECOLOGICAL INFORMATION

Ecotoxicity
Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
Persistence and Degradability

No information available

Bioaccumulation/ Accumulation

No information available

Mobility

No information available

13. DISPOSAL CONSIDERATIONS
Waste Disposal Methods

Chemical waste generators must determine whether a discarded chemical is classified as a
hazardous waste. Chemical waste generators must also consult local, regional, and national
hazardous waste regulations to ensure complete and accurate classification

14. TRANSPORT INFORMATION

DOT
UN-No
Proper Shipping Name
Hazard Class
Packing Group
TDG
UN-No
Proper Shipping Name
Hazard Class
Packing Group

UN1262
OCTANES
3II

UN1262
OCTANES
3II

IATA
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14. TRANSPORT INFORMATION
UN-No
Proper Shipping Name
Hazard Class
Packing Group

UN1262
OCTANES
3
II

IMDG/IMO
UN-No
Proper Shipping Name
Hazard Class
Packing Group

UN1262
OCTANES
3II

15. REGULATORY INFORMATION

International Inventories
Component
Isooctane

TSCA
X

DSL
X

NDSL EINECS ELINCS
208-7591

NLP

PICCS
X

ENCS
X

AICS
X

CHINA
X

KECL
KE34634
X

Legend:
X - Listed
E - Indicates a substance that is the subject of a Section 5(e) Consent order under TSCA. F - Indicates
a substance that is the subject of a Section 5(f) Rule under TSCA.
N - Indicates a polymeric substance containing no free-radical initiator in its inventory name but is considered to cover the designated polymer
made with any free-radical initiator regardless of the amount used.
P - Indicates a commenced PMN substance
R - Indicates a substance that is the subject of a Section 6 risk management rule under TSCA.
S - Indicates a substance that is identified in a proposed or final Significant New Use Rule T Indicates a substance that is the subject of a Section 4 test rule under TSCA.
XU - Indicates a substance exempt from reporting under the Inventory Update Rule, i.e. Partial Updating of the TSCA Inventory Data Base
Production and Site Reports (40 CFR 710(B).
Y1 - Indicates an exempt polymer that has a number-average molecular weight of 1,000 or greater.
Y2 - Indicates an exempt polymer that is a polyester and is made only from reactants included in a specified list of low concern reactants that comprises
one of the eligibility criteria for the exemption rule.

U.S. Federal Regulations
TSCA 12(b) Not applicable
SARA 313
Not applicable

SARA 311/312 Hazardous Categorization
Acute Health Hazard
Chronic Health Hazard
Fire Hazard
Sudden Release of Pressure Hazard
Reactive Hazard

Yes
No
Yes No No
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Clean Water Act
Not applicable
Clean Air Act
HAPS Data
X

Component
Isooctane

Class 1 Ozone Depletors

Class 2 Ozone Depletors
-

OSHA
Not applicable
CERCLA
This material, as supplied, contains one or more substances regulated as a hazardous substance under the Comprehensive
Environmental Response Compensation and Liability Act (CERCLA) (40 CFR 302)

Component
Isooctane

Hazardous Substances RQs

CERCLA EHS RQs

1000 lb

-

California Proposition 65
This product does not contain any Proposition 65 chemicals.

State Right-to-Know
Component
I s ooc t ane

Massachusetts
X

New Jersey
X

Pennsylvania
X

Illinois
X

Rhode Island
-

U.S. Department of Transportation
Reportable Quantity (RQ):
Y
DOT Marine Pollutant
NDOT
Severe Marine Pollutant
N
U.S. Department of Homeland Security
This product does not contain any DHS chemicals.
Other International Regulations
Mexico - Grade

Serious risk, Grade 3

Canada
This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations (CPR) and the
MSDS contains all the information required by the CPR.
WHMIS Hazard Class
B2 Flammable liquid
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16. OTHER INFORMATION
Prepared By

Regulatory Affairs
Thermo Fisher Scientific
Tel: (412) 490-8929

Creation Date

22-Jun-2009

Print Date

23-Sep-2009

Revision Summary

"***", and red text indicates revision

Disclaimer
The information provided on this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date
of its publication. The information given is designed only as a guide for safe handling, use, processing, storage,
transportation, disposal and release and is not to be considered as a warranty or quality specification. The information
relates only to the specific material designated and may not be valid for such material used in combination with any other
material or in any process, unless specified in the text.
End of MSDS
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1. PRODUCT AND COMPANY IDENTIFICATION
Product Name

Molecular Biology Grade Ethanol

Cat No. :

BP2818-4, BP2818-100, BP2818-500

Synonyms

Ethyl alcohol; Absolute ethanol

Recommended Use

Laboratory chemicals

Company
Fisher Scientific
One Reagent Lane
Fair Lawn, NJ 07410
Tel: (201) 796-7100

Emergency Telephone Number
CHEMTREC, Inside the USA: 800-424-9300
CHEMTREC, Outside the USA: 001-703-527-3887

2. HAZARDS IDENTIFICATION
WARNING
Emergency Overview
Extremely flammable liquid and vapor. Vapor may cause flash fire. Aspiration hazard if swallowed - can enter lungs
and cause damage. Harmful by inhalation, in contact with skin and if swallowed. Irritating to eyes. Cancer hazard.
This substance has caused adverse reproductive and fetal effects in humans. Hygroscopic.
Appearance Clear, Colorless
Target Organs

Physical State Liquid

Odor sweet, Characteristic

Eyes, Central nervous system (CNS), Reproductive System, Liver, Kidney, Blood

Potential Health Effects
Acute Effects
Principle Routes of Exposure
Eyes
Skin
Inhalation
Ingestion

Irritating to eyes.
May cause irritation. Harmful in contact with skin.
May cause irritation of respiratory tract. Inhalation may cause central nervous system effects.
Harmful by inhalation.
Harmful if swallowed. Aspiration hazard if swallowed - can enter lungs and cause damage.
Ingestion may cause gastrointestinal irritation, nausea, vomiting and diarrhea.

Chronic Effects
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Cancer hazard: This substance has caused adverse reproductive and fetal effects in humans: Substances known to cause
developmental toxicity in humans: Tumorigenic effects have been reported in experimental animals: May cause adverse liver
effects: May cause adverse kidney effects

Aggravated Medical Conditions

Central nervous system disorders. Preexisting eye disorders. Liver disorders. Skin
disorders.

3. COMPOSITION/INFORMATION ON INGREDIENTS
Component
Ethyl alcohol

CAS-No
64-17-5

Weight %
99-100

4. FIRST AID MEASURES
Eye Contact

Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes. Obtain
medical attention.

Skin Contact

Wash off immediately with plenty of water for at least 15 minutes. Get medical attention if
symptoms occur.

Inhalation

Move to fresh air. If breathing is difficult, give oxygen. Get medical attention immediately if
symptoms occur.

Ingestion

Do not induce vomiting. Obtain medical attention.

Notes to Physician

Treat symptomatically

5. FIRE-FIGHTING MEASURES
Flash Point
Method -

12 °C / 53.6 °F
No information available

Autoignition Temperature

363 °C / 685.4 °F

Explosion Limits
Upper
Lower

19 vol % 3.3 vol
%

Suitable Extinguishing Media

Use water spray, alcohol-resistant foam, dry chemical or carbon
dioxide. Use water spray to cool unopened containers. Cool
closed containers exposed to fire with water spray.

Unsuitable Extinguishing Media

Water may be ineffective, Do not use a solid water stream as it
may scatter and spread fire

Hazardous Combustion Products

No information available.

Sensitivity to Mechanical Impact
Sensitivity to Static Discharge

No information available No
information available

Specific Hazards Arising from the Chemical
Flammable. Risk of ignition. Vapors may form explosive mixtures with air. Vapors may travel to source of ignition and flash back.
Containers may explode when heated. Vapors may form explosive mixtures with air.
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Protective Equipment and Precautions for Firefighters
As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full
protective gear. Thermal decomposition can lead to release of irritating gases and vapors.
NFPA

Health 2

Flammability 3

Instability 0

Physical hazards N/A

6. ACCIDENTAL RELEASE MEASURES
Personal Precautions

Use personal protective equipment. Ensure adequate ventilation. Remove all sources of
ignition. Take precautionary measures against static discharges. Do not get in eyes, on skin, or
on clothing.

Environmental Precautions

Should not be released into the environment.

Methods for Containment and Clean Remove all sources of ignition. Soak up with inert absorbent material. Keep in suitable,
closed containers for disposal. Take precautionary measures against static discharges. Use
Up
spark-proof tools and explosion-proof equipment.

7. HANDLING AND STORAGE
Handling

Wear personal protective equipment. Ensure adequate ventilation. Keep away from open
flames, hot surfaces and sources of ignition. Take precautionary measures against static
discharges. Do not breathe vapors or spray mist. Do not get in eyes, on skin, or on clothing. Do not
ingest. Use spark-proof tools and explosion-proof equipment.

Storage

Keep containers tightly closed in a dry, cool and well-ventilated place. Keep away from open
flames, hot surfaces and sources of ignition. Flammables area.
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8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Engineering Measures

Ensure adequate ventilation, especially in confined areas. Use explosion-proof
electrical/ventilating/lighting/equipment. Ensure that eyewash stations and safety showers
are close to the workstation location.

Exposure Guidelines
Component
Ethyl alcohol

ACGIH TLV
STEL: 1000 ppm

Component

Quebec

OSHA PEL
(Vacated) TWA: 1000 ppm
(Vacated) TWA: 1900 mg/m3
TWA: 1000 ppm
TWA: 1900 mg/m3
Mexico OEL (TWA)

Ethyl alcohol

TWA: 1000 ppm
TWA: 1880 mg/m3

TWA: 1000 ppm
TWA: 1900 mg/m3

NIOSH IDLH
IDLH: 3300 ppm
TWA: 1000 ppm
TWA: 1900 mg/m3
Ontario TWAEV
STEL: 1000 ppm

Legend
NIOSH IDLH: The National Institute for Occupational Safety and Health Immediately Dangerous to Life or Health

Personal Protective Equipment
Eye/face Protection

Skin and body protection
Respiratory Protection

Wear appropriate protective eyeglasses or chemical safety goggles as described by
OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Wear appropriate protective gloves and clothing to prevent skin exposure.
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard
EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if
exposure limits are exceeded or if irritation or other symptoms are experienced.

9. PHYSICAL AND CHEMICAL PROPERTIES
Physical State
Appearance
Odor
Odor Threshold
pH
Vapor Pressure
Vapor Density
Viscosity
Boiling Point/Range
Melting Point/Range
Decomposition Temperature
Flash Point
Evaporation Rate
Specific Gravity
Solubility
log Pow
Molecular Weight
Molecular Formula

Liquid
Clear, Colorless
sweet, Characteristic
No information available No
information available
No information available No
information available No
information available
78 °C / 172.4 °F
-114 °C / -173.2 °F
No information available
12 °C / 53.6 °F
No information available No
information available No
information available
No data available
46.07
C2 H6 O

10. STABILITY AND REACTIVITY
Hygroscopic.
Stability
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Conditions to Avoid

Incompatible products. Heat, flames and sparks. Keep away from
open flames, hot surfaces and sources of ignition.

Incompatible Materials

Strong oxidizing agents, Strong acids, Acid anhydrides, Acid
chlorides

Hazardous Decomposition Products

Carbon monoxide (CO), Carbon dioxide (CO2)

Hazardous Polymerization

Hazardous polymerization does not occur.

Hazardous Reactions

None under normal processing.

11. TOXICOLOGICAL INFORMATION
Acute Toxicity
Product Information
Component Information
Component
Ethyl alcohol

LD50 Oral
3450 mg/kg ( Mouse )

LD50 Dermal
Not listed

Irritation

Irritating to eyes

Toxicologically Synergistic
Products

No information available

LC50 Inhalation
20000 ppm/10H ( Rat )

Chronic Toxicity
Carcinogenicity

The table below indicates whether each agency has listed any ingredient as a carcinogen.

Component
ACGIH
IARC
Ethyl alcohol
A3
Group 1
ACGIH: (American Conference of Governmental Industrial Hygienists)
A1 - Known Human Carcinogen
A2 - Suspected Human Carcinogen
A3 - Animal Carcinogen
ACGIH: (American Conference of Governmental Industrial Hygienists)
OSHA: (Occupational Safety & Health Administration)
OSHA: (Occupational Safety & Health Administration)
X - Present
Mexico - Occupational Exposure Limits - Carcinogens
Mexico - Occupational Exposure Limits - Carcinogens
A1 - Confirmed Human Carcinogen A2 Suspected Human Carcinogen A3 - Confirmed
Animal Carcinogen
A4 - Not Classifiable as a Human Carcinogen A5 - Not
Suspected as a Human Carcinogen

NTP
Not listed

OSHA
X Not listed

Mexico

Sensitization

No information available

Mutagenic Effects

Mutagenic effects have occurred in humans.

Reproductive Effects

Adverse reproductive effects have occurred in humans.

Developmental Effects

Substances known to cause developmental toxicity in humans.

Teratogenicity

Teratogenic effects have occurred in humans.

Other Adverse Effects

Tumorigenic effects have been reported in experimental animals. See actual entry in
RTECS for complete information.

______________________________________________________________________________________________
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Endocrine Disruptor Information

No information available

12. ECOLOGICAL INFORMATION
Ecotoxicity .
Component
Ethyl alcohol

Freshwater Algae
EC50 (72h) = 275 mg/l
(Chlorella vulgaris)

Freshwater Fish
Fathead minnow
(Pimephales promelas)
LC50 = 14200 mg/l/96h

Microtox
Photobacterium
phosphoreum:EC50 = 34634
mg/L/30 min
Photobacterium
phosphoreum:EC50 = 35470
mg/L/5 min

Persistence and Degradability

Readily biodegradable.

Bioaccumulation/ Accumulation

No information available.

Mobility

Will likely be mobile in the environment due to its water solubility.

Water Flea
EC50 = 9268 mg/L/48h
EC50 = 10800 mg/L/24h

log Pow
-0.32

Component
Ethyl alcohol

13. DISPOSAL CONSIDERATIONS
Waste Disposal Methods

Chemical waste generators must determine whether a discarded chemical is classified as a
hazardous waste. Chemical waste generators must also consult local, regional, and
national hazardous waste regulations to ensure complete and accurate classification.

14. TRANSPORT INFORMATION
DOT
UN-No
Proper Shipping Name
Hazard Class
Packing Group

UN1170
ETHANOL
3
II

TDG
UN-No
Proper Shipping Name
Hazard Class
Packing Group

UN1170
ETHANOL
3
II

IATA

UN-No
Proper Shipping Name
Hazard Class
Packing Group

UN1170
ETHANOL
3II

IMDG/IMO
UN-No
Proper Shipping Name
Hazard Class
Packing Group

UN1170
ETHANOL
3II

______________________________________________________________________________________________
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15. REGULATORY INFORMATION
International Inventories
Component
Ethyl alcohol

TSCA
X

DSL
X

NDSL EINECS ELINCS NLP
200-5786

PICCS ENCS
X
X

AICS
X

IECSC
X

KECL
X

Legend:
X - Listed
E - Indicates a substance that is the subject of a Section 5(e) Consent order under TSCA.
F - Indicates a substance that is the subject of a Section 5(f) Rule under TSCA.
N - Indicates a polymeric substance containing no free-radical initiator in its inventory name but is considered to cover the designated polymer
made with any free-radical initiator regardless of the amount used.
P - Indicates a commenced PMN substance
R - Indicates a substance that is the subject of a Section 6 risk management rule under TSCA.
S - Indicates a substance that is identified in a proposed or final Significant New Use Rule
T - Indicates a substance that is the subject of a Section 4 test rule under TSCA.
XU - Indicates a substance exempt from reporting under the Inventory Update Rule, i.e. Partial Updating of the TSCA Inventory Data Base
Production and Site Reports (40 CFR 710(B).
Y1 - Indicates an exempt polymer that has a number-average molecular weight of 1,000 or greater.
Y2 - Indicates an exempt polymer that is a polyester and is made only from reactants included in a specified list of low concern reactants that
comprises one of the eligibility criteria for the exemption rule.

U.S. Federal Regulations
TSCA 12(b) Not applicable
SARA 313
Not applicable
SARA 311/312 Hazardous Categorization
Acute Health Hazard
Chronic Health Hazard
Fire Hazard
Sudden Release of Pressure Hazard
Reactive Hazard

Yes
Yes Yes No
No

Clean Water Act
Not applicable
Clean Air Act Not
applicable
OSHA Occupational Safety and Health Administration
Not applicable
CERCLA
Not applicable
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California Proposition 65
This product contains the following Proposition 65 chemicals: Ethyl alcohol is only a considered a Proposition 65 developmental
hazard when it is ingested as an alcoholic beverage
Component
Ethyl alcohol

CAS-No
64-17-5

California Prop. 65
Developmental

Prop 65 NSRL
-

Category
Developmental
Carcinogen

State Right-to-Know

Component
Ethyl alcohol

Massachusetts
X

New Jersey
X

Pennsylvania
X

Illinois
X

Rhode Island
X

U.S. Department of Transportation
Reportable Quantity (RQ):
Marine Pollutant
Severe Marine Pollutant

NDOT
NDOT
N

U.S. Department of Homeland Security
This product does not contain any DHS chemicals.
Other International Regulations
Mexico - Grade

Serious risk, Grade 3

Canada
This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations (CPR) and
the MSDS contains all the information required by the CPR
WHMIS Hazard Class
B2 Flammable liquid
D2A Very toxic materials
D2B Toxic materials

16. OTHER INFORMATION
Prepared By

Regulatory Affairs
Thermo Fisher Scientific
Email: EMSDS.RA@thermofisher.com

Creation Date

24-Apr-2009

Print Date

23-Oct-2014

Revision Summary
(M)SDS sections updated 2 3
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Disclaimer
The information provided on this Safety Data Sheet is correct to the best of our knowledge, information and belief at the
date of its publication. The information given is designed only as a guide for safe handling, use, processing, storage,
transportation, disposal and release and is not to be considered as a warranty or quality specification. The information
relates only to the specific material designated and may not be valid for such material used in combination with any other material
or in any process, unless specified in the text.
End of MSDS
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Material Safety Data Sheet
Allylamine, 97%
MSDS# 87403
Section 1 - Chemical Product and Company Identification
MSDS Name:
Catalog Numbers:
Synonyms:

Allylamine, 97%
AC220730000, AC220730010, AC220730500, AC220732500
3-Amino-1-propene;3-aminopropylene;2-propen-1-amine
Acros Organics BVBA
Janssen Pharmaceuticalaan 3a
2440 Geel, Belgium
Acros Organics
One Reagent Lane
Fair Lawn, NJ 07410
800-ACROS-01 +32
14 57 52 11 +32 14
57 52 99
201-796-7100
800-424-9300
703-527-3887

Company Identification:

Company Identification: (USA)
For information in the US, call:
For information in Europe, call:
Emergency Number, Europe:
Emergency Number US:
CHEMTREC Phone Number, US:
CHEMTREC Phone Number, Europe:

Section 2 - Composition, Information on Ingredients
---------------------------------------CAS#:
Chemical Name:
%:
EINECS#:
----------------------------------------

107-11-9
Allylamine
97.0
203-463-9

Hazard Symbols:

TF

Risk Phrases:

11 23/24/25
Section 3 - Hazards Identification

EMERGENCY OVERVIEW
Danger! May be fatal if absorbed through the skin. Causes severe eye and skin burns. Harmful if inhaled or swallowed.
Causes digestive and respiratory tract irritation with possible burns. Extremely flammable liquid and vapor. Vapor may
cause flash fire. Target Organs: Eyes, skin, mucous membranes.
Potential Health Effects
Eye:

Causes severe eye burns. Vapor or mist may cause irritation and severe burns. May cause conjunctivitis.
Lachrymator (substance which increases the flow of tears).
May be fatal if absorbed through the skin. Causes severe burns.

Skin:
Ingestion: Harmful if swallowed. May cause irritation of the digestive tract.
May be fatal if inhaled. Exposure to high concentrations may produce narcosis, nausea and loss of
Inhalation: consciousness. Causes respiratory tract irritation with possible burns. May cause severe tearing, conjunctivitis,
corneal edema, coughing, nausea, and pulmonary edema.
Chronic: No information found.

Eyes:
Skin:
Ingestion:
Inhalation:

Section 4 - First Aid Measures
Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower
eyelids. Get medical aid immediately. Do NOT allow victim to rub eyes or keep eyes closed.
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while
removing contaminated clothing and shoes. Remove contaminated clothing and shoes.
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give
anything by mouth to an unconscious person. Get medical aid immediately.
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing,
give artificial respiration. If breathing is difficult, give oxygen.

Notes to
Physician:

General
Information:

Extinguishing
Media:

Section 5 - Fire Fighting Measures
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved
or equivalent), and full protective gear. Vapors may form an explosive mixture with air. Vapors can travel to
a source of ignition and flash back. Combustion generates toxic fumes. Use water spray to keep fireexposed containers cool. Extremely flammable liquid and vapor. Vapors may be heavier than air. They can
spread along the ground and collect in low or confined areas. Will be easily ignited by heat, sparks or flame.
Containers may explode when heated.
For small fires, use dry chemical, carbon dioxide, water spray or alcohol-resistant foam. Use water spray to
cool fire-exposed containers. Water may be ineffective. For large fires, use water spray, fog or alcoholresistant foam. Do NOT use straight streams of water. Cool containers with flooding quantities of water
until well after fire is out.

Autoignition 705 deg F ( 373.89 deg C)
Temperature:
Flash Point: -20 deg C ( -4.00 deg F)
Explosion 2.0 vol %
Limits: Lower:
Explosion
Limits: Upper: 22.00 vol %
NFPA Rating: health: 3; flammability: 3; instability: 0;
Section 6 - Accidental Release Measures
General
Information:
Spills/Leaks:

Use proper personal protective equipment as indicated in Section 8.
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Remove all
sources of ignition. A vapor suppressing foam may be used to reduce vapors. Water spray may reduce
vapor but may not prevent ignition in closed spaces.
Section 7 - Handling and Storage

Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Ground and bond
containers when transferring material. Do not get in eyes, on skin, or on clothing. Empty containers retain product
Handling: residue, (liquid and/or vapor), and can be dangerous. Keep container tightly closed. Keep away from heat,
sparks and flame. Do not ingest or inhale. Use only in a chemical fume hood. Do not pressurize, cut, weld, braze,
solder, drill, grind, or expose empty containers to heat, sparks or open flames.
Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a tightly closed container.
Storage: Keep from contact with oxidizing materials. Store in a cool, dry, well-ventilated area away from incompatible
substances. Keep away from acids.
Section 8 - Exposure Controls, Personal Protection
+-------------------- +------------------- +------------------- +----------------- +
|
Chemical Name
|
ACGIH
|
NIOSH
|OSHA - Final PELs|
|-------------------- |------------------- |------------------- |----------------- |
| Allylamine
|none listed
|none listed
|none listed
|
+-------------------- +------------------- +------------------- +----------------- +

OSHA Vacated PELs: Allylamine: None listed
Engineering Controls:
Use only under a chemical fume hood.

Exposure Limits
Personal Protective Equipment
Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face
Eyes:
protection regulations in 29 CFR 1910.133 or European Standard EN166.
Wear appropriate protective gloves to prevent skin exposure.
Skin:
Clothing: Wear appropriate protective clothing to prevent skin exposure.
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a
Respirators: NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
Section 9 - Physical and Chemical Properties
Physical State: Liquid
Color: clear light yellow
Odor: Strong ammoniacal odor
pH: Not available
Vapor Pressure: 242 mm Hg @25C
Vapor Density: 1.97
Evaporation Rate: Not available
Viscosity: 0.44 cP 25 deg C
Boiling Point: 55-58C
Freezing/Melting Point: -123 deg C ( -189.40 F)
Decomposition Temperature: Not available
Solubility in water: soluble
Specific Gravity/Density: .7610g/cm3
Molecular Formula: C3H7N
Molecular Weight: 57.09
Section 10 - Stability and Reactivity
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
High temperatures, incompatible materials, ignition sources.
Incompatibilities with Other
Metals, oxidizing agents, acids, amines, halogenated agents, alkalies, chlorine,
Materials
hypochlorite.
Hazardous Decomposition Products Carbon monoxide, oxides of nitrogen, carbon dioxide.
Hazardous Polymerization
May occur.
Section 11 - Toxicological Information
RTECS#:

LD50/LC50:

Carcinogenicity:
Other:

CAS# 107-11-9: BA5425000
RTECS:
CAS# 107-11-9: Draize test, rabbit, skin: 500 mg/24H Severe;
Inhalation, rat: LC50 = 177 ppm/8H;
Oral, mouse: LD50 = 57 mg/kg;
Oral, rat: LD50 = 102 mg/kg;
Skin, rabbit: LD50 = 35 mg/kg; .
Allylamine - Not listed as a carcinogen by ACGIH, IARC, NTP, or CA Prop 65. See
actual entry in RTECS for complete information.
Section 12 - Ecological Information

Ecotoxicity: Bacteria: Phytobacterium phosphoreum: EC50 = 16 mg/L; 5, 15 minutes; Microtox test; 14.9-15.1 degrees C
Section 13 - Disposal Considerations
Dispose of in a manner consistent with federal, state, and local regulations.
Section 14 - Transport Information
US DOT
Shipping Name: ALLYLAMINE

Hazard Class: 6.1
UN Number: UN2334
Packing Group: I
Canada TDG
Shipping Name: Not available
Hazard Class: UN
Number:
Packing Group:

Section 15 - Regulatory Information
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T F
Risk Phrases:
R 11 Highly flammable.
R 23/24/25 Toxic by inhalation, in contact with skin and if swallowed.
Safety Phrases:
S 9 Keep container in a well-ventilated place.
S 16 Keep away from sources of ignition - No smoking. S
24/25 Avoid contact with skin and eyes.
S 45 In case of accident or if you feel unwell, seek medical advice immediately (show the label where
possible).
S 61 Avoid release to the environment. Refer to special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 107-11-9: 2
Canada
CAS# 107-11-9 is listed on Canada's DSL List
Canadian WHMIS Classifications: B2
This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations
and the MSDS contains all of the information required by those regulations.
CAS# 107-11-9 is listed on Canada's Ingredient Disclosure List
US Federal
TSCA
CAS# 107-11-9 is listed on the TSCA
Inventory.
Section 16 - Other Information
MSDS Creation Date: 5/10/1999
Revision #5 Date 7/20/2009
The information above is believed to be accurate and represents the best information currently available
to us. However, we make no warranty of merchantibility or any other warranty, express or implied,
with respect to such information, and we assume no liability resulting from its use. Users should make
their own investigations to determine the suitability of the information for their particular purposes. In no
event shall the company be liable for any claims, losses, or damages of any third party or for lost profits or
any special, indirect, incidental, consequential, or exemplary damages howsoever arising, even if the
company has been advised of the possibility of such damages.
--------------------------------------------------------------------------------
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1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING
Pfizer Inc
Pfizer Pharmaceuticals Group
235 East 42nd Street
New York, New York 10017
1-212-573-2222

Pfizer Ltd
Ramsgate Road
Sandwich, Kent
CT13 9NJ
United Kingdom
+00 44 (0)1304 616161
Emergency telephone number:
International CHEMTREC (24 hours): +1-703-527-3887

Emergency telephone number:
CHEMTREC (24 hours): 1-800-424-9300
Contact E-Mail:
pfizer-MSDS@pfizer.com

Material Name: Water for injection, USP
Trade Name:
Chemical Family:
Intended Use:

Not established
Not applicable
Pharmaceutical product

2. HAZARDS IDENTIFICATION
Appearance:

Clear, colorless liquid

Statement of Hazard:

Non-hazardous in accordance with international standards for workplace safety.

EU Indication of danger:

Not classified

Australian Hazard Classification
(NOHSC):

Non-Hazardous Substance. Non-Dangerous Goods.

Note:

This document has been prepared in accordance with standards for workplace safety, which
require the inclusion of all known hazards of the active substance or its intermediates
regardless of the potential risk. The precautionary statements and warnings included may not
apply in all cases. Your needs may vary depending upon the potential for exposure in your
workplace.

3. COMPOSITION/INFORMATION ON INGREDIENTS

Ingredient
Water for injection
Additional Information:

CAS Number
7732-18-5

EU EINECS/ELINCS List EU Classification
231-791-2
Not Listed

%
100

Ingredient(s) indicated as hazardous have been assessed under standards for workplace
safety.

4. FIRST AID MEASURES
Eye Contact:
Due to the nature of this material first aid is not normally required.
_______________________________________________________________________________________________________
EX02902

MATERIAL SAFETY DATA SHEET
Material Name: Water for injection, USP
Page 2 of 4
Revision date: 29-Nov-2012
Version: 1.1
_______________________________________________________________________________________________________

Skin Contact:

Due to the nature of this material first aid is not normally required.

Ingestion:

Due to the nature of this material first aid is not normally required.

Inhalation:

Not an expected route of exposure.

5. FIRE FIGHTING MEASURES
Extinguishing Media:

As for primary cause of fire.

Hazardous Combustion Products:

Not applicable

Fire Fighting Procedures:

Not applicable

Fire / Explosion Hazards:

Not applicable

6. ACCIDENTAL RELEASE MEASURES
Health and Safety Precautions:

Not applicable

Measures for Cleaning / Collecting:

Wipe up with a damp cloth and place in container for disposal.

Measures for Environmental
Protections:

None

Additional Consideration for Large
Spills:

None

Additional Information:

No special measures are required.

7. HANDLING AND STORAGE
General Handling:
Storage Conditions:

No special handling requirements for normal use of this material.
Store as directed by product packaging.

8. EXPOSURE CONTROLS / PERSONAL PROTECTION
No Occupational Exposure Limit (OEL) or Short Term Exposure Limit (STEL) has been identified.
Engineering Controls:
Environmental Exposure Controls:
Personal Protective Equipment:

Hands:
Eyes:
Skin:
Respiratory protection:

Engineering controls should be used as the primary means to control exposures.
Refer to specific Member State legislation for requirements under Community environmental
legislation.
Refer to applicable national standards and regulations in the selection and use of personal
protective equipment (PPE).
Not required for the normal use of this product. Not
required under normal conditions of use.
Not required for the normal use of this product. None
required under normal conditions of use.
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9. PHYSICAL AND CHEMICAL PROPERTIES
Physical State:
Odor:
Molecular Weight:

Liquid
None
18.02

pH:
Melting/Freezing Point (°C):
Boiling Point (°C):

7
0
100

Color:
Molecular Formula:

Colorless
H2O

10. STABILITY AND REACTIVITY
Chemical Stability:
Conditions to Avoid:
Incompatible Materials:

Stable
None
None

11. TOXICOLOGICAL INFORMATION

12. ECOLOGICAL INFORMATION
Environmental Overview:

No harmful effects to aquatic organisms are expected.

13. DISPOSAL CONSIDERATIONS
Waste Treatment Methods:

Dispose of waste in accordance with all applicable laws and regulations. Member State
specific and Community specific provisions must be considered. Considering the relevant
known environmental and human health hazards of the material, review and implement
appropriate technical and procedural waste water and waste disposal measures to prevent
occupational exposure and environmental release. It is recommended that waste minimization
be practiced. The best available technology should be utilized to prevent environmental
releases. This may include destructive techniques for waste and wastewater.

14. TRANSPORT INFORMATION
The following refers to all modes of transportation unless specified below.
Not regulated for transport under USDOT, EUADR, IATA, or IMDG regulations.

15. REGULATORY INFORMATION
EU Indication of danger:
Not classified
_______________________________________________________________________________________________________
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15. REGULATORY INFORMATION

OSHA Label:
Non-hazardous in accordance with international standards for workplace safety.

Canada - WHMIS: Classifications
WHMIS hazard class:
None required

Water for injection
Inventory - United States TSCA - Sect. 8(b)
Australia (AICS):
REACH - Annex IV - Exemptions from the
obligations of Register:
EU EINECS/ELINCS List

Present
Present
Present
231-791-2

16. OTHER INFORMATION
Data Sources:

Publicly available toxicity information.

Reasons for Revision:

Updated Section 1 - Identification of the Substance/Preparation and the Company/Undertaking.

Prepared by:

Product Stewardship Hazard Communication
Pfizer Global Environment, Health, and Safety Operations

Pfizer Inc believes that the information contained in this Material Safety Data Sheet is accurate, and while it is provided in good faith, it
is without warranty of any kind, expressed or implied. If data for a hazard are not included in this document there is no known
information at this time.
End of Safety Data Sheet

_______________________________________________________________________________________________________
EX02902

Material Safety Data Sheet
Catalog Number: 960024
Revision date: 26-Apr-2006

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND COMPANY INFORMATION
Catalog Number: 960024
Product name: SOY FLOUR
Supplier:
MP Biomedicals, LLC
29525 Fountain Parkway
Solon, OH 44139 tel: 440337-1200
Emergency telephone number: CHEMTREC: 1-800-424-9300 (1-703-527-3887)

2. COMPOSITION/INFORMATION ON INGREDIENTS

Components
SOY FLOUR

CAS Number
N/A

Weight %
90 - 100%

ACGIH Exposure Limits:
None

OSHA Exposure Limits:
None

3. HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW: May cause skin irritation and/or dermatitis

Principle routes of exposure: Skin
Inhalation: May cause irritation of respiratory tract
Ingestion: May be harmful if swallowed.
Skin contact: May cause allergic skin reaction
Eye contact: Avoid contact with eyes
Statements of hazard MAY CAUSE ALLERGIC SKIN REACTION.
Statement of Spill or Leak - ANSI Label Eliminate all ignition sources. Absorb and/or contain spill with inert materials
(e.g., sand, vermiculite). Then place in appropriate container. For large spills, use water spray to disperse vapors, flush
spill area. Prevent runoff from entering waterways or sewers.

4. FIRST AID MEASURES
General advice: In the case of accident or if you feel unwell, seek medical advice immediately (show the label where
possible).
Inhalation: Move to fresh air. Call a physician immediately.
Skin contact: Rinse immediately with plenty of water and seek medical advice
Ingestion: Do not induce vomiting without medical advice.
Eye contact: In the case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
Protection of first-aiders: No information available
Medical conditions aggravated by exposure: None known

Catalog Number: 960024

Product name: SOY FLOUR
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MP Biomedicals, LLC

www.mpbio.com

5. FIRE FIGHTING MEASURES
Suitable extinguishing media:
Specific hazards:
Unusual hazards:
Special protective equipment for firefighters:

Specific methods:
Flash point:
Autoignition temperature:
NFPA rating:
NFPA Health:
NFPA Flammability:
NFPA Reactivity:

Use dry chemical, CO2, water spray or "alcohol" foam
Burning produces irritant fumes.
None known
As in any fire, wear self-contained breathing apparatus
pressure-demand, MSHA/NIOSH (approved or equivalent)
and full protective gear
Water mist may be used to cool closed containers.
Not determined Not
determined

0
00

6. ACCIDENTAL RELEASE MEASURES
Use personal protective equipment.
Prevent product from entering drains.
Sweep up and shovel into suitable containers for disposal.

Personal precautions:
Environmental precautions:
Methods for cleaning up:

7. HANDLING AND STORAGE
Storage:
ROOM TEMPERATURE COOL & DRY
Handling:
Safe handling advice:
Incompatible products:

Use only in area provided with appropriate exhaust
ventilation.
Wear personal protective equipment.
Oxidising and spontaneously flammable products

8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Engineering measures: Ensure adequate ventilation.
PERSONAL PROTECTIVE EQUIPMENT
Respiratory protection: Breathing apparatus only if aerosol or dust is formed.
Hand protection: Pvc or other plastic material gloves
Skin and body protection: Usual safety precautions while handling the product will provide adequate protection against
this potential effect.
Eye protection: Safety glasses with side-shields
Hygiene measures: Handle in accordance with good industrial hygiene and safety practice.

9. PHYSICAL AND CHEMICAL PROPERTIES
Physical state:
Formula:
Melting point/range:
Boiling point/range:
Density:
Vapor pressure:
Evaporation rate:
Vapor density:
Catalog Number: 960024

Powder
Not applicable
No data available at this time.
No Data available at this time.
No data available
No data available
No data available
No data available
Product name: SOY FLOUR
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Solubility (in water):
Flash point:
Autoignition temperature:

No data available
Not determined
Not determined

10. STABILITY AND REACTIVITY
Stability:
Polymerization:
Hazardous decomposition products:

Stable under recommended storage conditions.
None under normal processing.
Thermal decomposition can lead to release of irritating
gases and vapours such as carbon oxides.
Strong oxidising agents
Exposure to air or moisture over prolonged periods.

Materials to avoid:
Conditions to avoid:

11. TOXICOLOGICAL INFORMATION
Product Information
Acute toxicity
Components
SOY FLOUR

Chronic toxicity:
Local effects:
Specific effects:
Primary irritation:
Carcinogenic effects:
Mutagenic effects:
Reproductive toxicity:

RTECS Number:
Not Available

Selected LD50s and LC50s
Not Determined

Chronic exposure may cause nausea and vomiting, higher exposure causes
unconsciousness.
Symptoms of overexposure may be headache, dizziness, tiredness, nausea and
vomiting.
May include moderate to severe erythema (redness) and moderate edema (raised
skin), nausea, vomiting, headache.
No data is available on the product itself. No
data is available on the product itself. No data
is available on the product itself. No data is
available on the product itself.

12. ECOLOGICAL INFORMATION
Mobility:
Bioaccumulation:
Ecotoxicity effects:
Aquatic toxicity:

No data available No
data available No data
available
May cause long-term adverse effects in the aquatic
environment.

SOY FLOUR

U.S. DOT - Appendix B Marine Pollutan
Not Listed

U.S. DOT - Appendix B Severe Marine Pollutants
Not Listed

Components

Germany VCI (WGK)

SOY FLOUR

Not Listed

World Health Organization Ecotoxicity - Fish Species
(WHO) - Drinking Water
Data
Not Listed
Not Listed

Components
SOY FLOUR

Ecotoxicity - Freshwater
Algae Data
Not Listed

Ecotoxicity - Microtox Data Ecotoxicity - Water Flea
Data
Not Listed
Not Listed

Components

EPA - ATSDR Priority List

SOY FLOUR

Not Listed

EPA - HPV Challenge
Program Chemical List
Not Listed

Components

Catalog Number: 960024

Product name: SOY FLOUR

United Kingdom - The Red
List:
Not Listed

California - Priority Toxic
Pollutants
Not Listed

Page 3 of 5

MP Biomedicals, LLC
Components
SOY FLOUR

www.mpbio.com
California - Priority Toxic Pollutants
Not Listed

California - Priority Toxic Pollutants
Not Listed

13. DISPOSAL CONSIDERATIONS
Waste from residues / unused products:

Contaminated packaging:

Waste disposal must be in accordance with appropriate
Federal, State, and local regulations. This product, if
unaltered by use, may be disposed of by treatment at a
permitted facility or as advised by your local hazardous
waste regulatory authority. Residue from fires extinguished
with this material may be hazardous.
Do not re-use empty containers

14. TRANSPORT INFORMATION
UN/Id No:

Not regulated

Proper shipping name:

Not Regulated

DOT:

Components
SOY FLOUR

U.S. DOT - Appendix A Table 1 - Reportable Quantities
Not Listed

TDG (Canada):
WHMIS hazard class:

Non-controlled

IMDG/IMO
IMDG - Hazard Classifications
Components
SOY FLOUR

Not Applicable

U.S. DOT - Appendix B - Marine Pollutan U.S. DOT - Appendix B - Severe Marine
Pollutants
Not Listed
Not Listed

IMO-labels:

15. REGULATORY INFORMATION
International Inventories
Components
SOY FLOUR
Inventory - United States TSCA - Sect. 8(b)
Canada DSL Inventory List U.S. regulations:
Components
SOY FLOUR
Catalog Number: 960024

Not Listed
Not Listed

California Proposition 65 Massachusetts Right to New Jersey Right to
Know List:
Know List:
Not Listed
Not Listed
Not Listed

Product name: SOY FLOUR

Pennsylvania Right to Know
List:
Not Listed

Page 4 of 5

MP Biomedicals, LLC

www.mpbio.com
Rhode Island Right to
Know List:
Not Listed

Illinois - Toxic Air
Contaminants
Not Listed

Components

Florida substance List:

SOY FLOUR

Not Listed

Components

SARA 313 Emission
CERCLA/SARA - Section NTP:
reporting/Toxic Release 302 Extremely Haz
of Chemicals
Not Listed
Not Listed
None

SOY FLOUR
SARA 313 Notification:

Connecticut - Hazardous Air
Pollutants
Not Listed

IARC:

None

The above is your notification as to the SARA 313 listing for this product(s) pursuant
to Section 313 of Title III of the Superfund Ammendments and Reauthorization Act of
1986 and 40 CFR Part 372.
If you are unsure if you are subject to the reporting requirements of Section 313, or
need more information, please call the EPA Emergency Planning and Community
Right-To-Know Information Hotline: (800) 535-0202 or (202) 479-2499 (in
Washington, DC or Alaska).

State Notification:

The above information is your notice as to the Right-to-Know listings of the stated
product(s). Individual states will list chemicals for a variety of reasons including, but
not limited to, the compounds toxicity; carcinogenic, tumorigenic and/or reproductive
hazards; and the compounds environmental impact if accidentally released.

16. OTHER INFORMATION
Prepared by: Health & Safety
Disclaimer: The information and recommendations contained herein are based upon tests believed to be reliable.
However, MP Biomedicals does not guarantee the accuracy or completeness NOR SHALL ANY OF THIS
INFORMATION CONSTITUTE A WARRANTY, WHETHER EXPRESSED OR IMPLIED, AS TO THE SAFETY OF THE
GOODS, THE MERCHANTABILITY OF THE GOODS, OR THE FITNESS OF THE GOODS FOR A PARTICULAR
PURPOSE. Adjustment to conform to actual conditions of usage maybe required. MP Biomedicals assumes no
responsibility for results obtained or for incidental or consequential damages, including lost profits arising from the use of
these data. No warranty against infringement of any patent, copyright or trademark is made or implied.
End of Safety Data Sheet

Catalog Number: 960024

Product name: SOY FLOUR
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Safety Data Sheet
acc. to OSHA HCS
Printing date 01/16/2013

Reviewed on 01/16/2013

1 Identification of the substance/mixture and of the company/undertaking

• Product identifier
• Trade name: Soybean Oil
• Article number: 104687
• CAS Number:
80 01-22-7

• EC number:
23 2-274-4

• Details of the supplier of the safety data sheet
• Manufacturer/Supplier:
MP Biomedicals, LLC
29525 Fountain Parkway
Solon, OH 44139
United States
www.mpbio.com

• Information department: Product safety department
• Emergency telephone number: CHEMTREC: 1-800-424-9300 (1-703-527-3887)
2 Hazards identification

• Classification of the substance or mixture
The substance is not classified according to the Globally Harmonized System (GHS).

• Classification according to Directive 67/548/EEC or Directive 1999/45/EC Not applicable.
• Information concerning particular hazards for human and environment: Not applicable.
• Label elements
• GHS label elements Void • Hazard
pictograms Void
• Signal word Void
• Hazard statements Void
• Additional information: Void
• Classification system:
• NFPA ratings (scale 0 - 4)
Health = 0
Fire = 1
Reactivity = 0

010

• HMIS-ratings (scale 0 - 4)
HEALTH

0

FIRE

1

REACTIVITY 0

Health = 0
Fire = 1
Reactivity = 0

• Other hazards
• Results of PBT and vPvB assessment • PBT:
Not applicable. • vPvB: Not applicable.
3 Composition/information on ingredients

• Chemical characterization: Substances
• CAS No. Description
8001-22-7 Soybean Oil
(Contd. on page 2)
USA
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Safety Data Sheet
acc. to OSHA HCS
Printing date 01/16/2013

Reviewed on 01/16/2013

Trade name: Soybean Oil

• Identification number(s)
• EC number: 232-274-4

(Contd. of page 1)

4 First aid measures

• Description of first aid measures
• General information: No special measures required.
• After inhalation: Supply fresh air; consult doctor in case of complaints. • After
skin contact: Generally the product does not irritate the skin.
• After eye contact: Rinse opened eye for several minutes under running water. • After
swallowing: If symptoms persist consult doctor.
• Information for doctor:
• Most important symptoms and effects, both acute and delayed No further relevant information available.
• Indication of any immediate medical attention and special treatment needed
No further relevant information available.

5 Firefighting measures

• Extinguishing media
• Suitable extinguishing agents: Use fire fighting measures that suit the environment.
• Special hazards arising from the substance or mixture No further relevant information available.
• Advice for firefighters
• Protective equipment: No special measures required.
6 Accidental release measures

• Personal precautions, protective equipment and emergency procedures Not required. •
Environmental precautions: No special measures required.
• Methods and material for containment and cleaning up:
Absorb with liquid-binding material (sand, diatomite, acid binders, universal binders, sawdust).
• Reference to other sections
No dangerous substances are released.
See Section 7 for information on safe handling.
See Section 8 for information on personal protection equipment. See
Section 13 for disposal information.

7 H an dl i n g an d s t or age

• Handling:
• Precautions for safe handling No special measures required.
• Information about protection against explosions and fires: No special measures required.
• Conditions for safe storage, including any incompatibilities
• Storage: 15-30 °C
• Requirements to be met by storerooms and receptacles: No special requirements. •
Information about storage in one common storage facility: Not required. • Further
information about storage conditions: None.
• Specific end use(s) No further relevant information available.
USA

(Contd. on page 3)
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Safety Data Sheet
acc. to OSHA HCS
Printing date 01/16/2013

Reviewed on 01/16/2013

Trade name: Soybean Oil
(Contd. of page 2)

8 Exposure controls/personal protection

• Additional information about design of technical systems: No further data; see item 7.
• Control parameters
• Components with limit values that require monitoring at the workplace: Not required.
• Additional information: The lists that were valid during the creation were used as basis.
• Exposure controls
• Personal protective equipment:
• General protective and hygienic measures:
The usual precautionary measures for handling chemicals should be followed.

• Breathing equipment: Not required.
• Protection of hands:

The glove material has to be impermeable and resistant to the product/ the substance/ the preparation.
Due to missing tests no recommendation to the glove material can be given for the product/ the preparation/ the
chemical mixture.
Selection of the glove material on consideration of the penetration times, rates of diffusion and the degradation
• Material of gloves
The selection of the suitable gloves does not only depend on the material, but also on further marks of quality and
varies from manufacturer to manufacturer.
• Penetration time of glove material
T h e e x a c t b re a k t h r o u g h t im e h a s t o b e f o u n d o u t b y t h e m a n u f a c tu re r o f t h e p ro t e c ti v e g lo v e s a n d h a s to b e
observed.
• Eye protection: Goggles recommended during refilling.

9 Physical and chemical properties

• Information on basic physical and chemical properties
• General Information
• Appearance:
Form:
Color:
• Odor:
• Odour threshold:

• pH-value:
• Change in condition
Melting point/Melting range:
Boiling point/Boiling range:

• Flash point:
• Flammability (solid, gaseous):
• Ignition temperature:
Decomposition temperature:

• Auto igniting:
• Danger of explosion:
• Explosion limits:
Lower:
Upper:

Fluid
Not determined.
Characteristic
Not determined.
Not determined.
Undetermined.
Undetermined.
282 °C (540 °F) Not
applicable.

Not determined.
Not determined.
Product does not present an explosion hazard.
Not determined. Not
determined.
(Contd. on page 4)
USA
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Safety Data Sheet
acc. to OSHA HCS
Printing date 01/16/2013

Reviewed on 01/16/2013

Trade name: Soybean Oil
(Contd. of page 3)

• Vapor pressure:
• Density at 20 °C (68 °F):
• Relative density •
Vapour density
• Evaporation rate

Not determined.
0.917 g/cm³ (7.652 lbs/gal)
Not determined.
Not determined.
Not determined.

• Solubility in / Miscibility with
Water:

Not miscible or difficult to mix.

• Partition coefficient (n-octanol/water): Not determined.
• Viscosity:
Dynamic:
Kinematic:
Organic solvents:
• Other information

Not determined.
Not determined.
0 .0 %
No further relevant information available.

10 Stability and reactivity

• Reactivity
• Chemical stability
• Thermal decomposition / conditions to be avoided: No decomposition if used according to specifications. •
Possibility of hazardous reactions No dangerous reactions known. • Conditions to avoid No further relevant
information available.
• Incompatible materials: No further relevant information available.
• Hazardous decomposition products: No dangerous decomposition products known.

11 Toxicological information

• Information on toxicological effects
• Acute toxicity:
• Primary irritant effect:
• on the skin: No irritant effect. • on the
eye: No irritating effect.
• Sensitization: No sensitizing effects known.
• Additional toxicological information:
When used and handled according to specifications, the product does not have any harmful effects according to
our experience and the information provided to us. The
substance is not subject to classification.

• Carcinogenic categories
• IARC (International Agency for Research on Cancer)
Substance is not listed.

• NTP (National Toxicology Program)
Substance is not listed.

12 Ecological information

• Toxicity
• Aquatic toxicity: No further relevant information available.
(Contd. on page 5)
USA
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Printing date 01/16/2013

Reviewed on 01/16/2013

Trade name: Soybean Oil

• Persistence and degradability No further relevant information available.
• Behavior in environmental systems:
• Bioaccumulative potential No further relevant information available. •

(Contd. of page 4)

Mobility in soil No further relevant information available.
• Additional ecological information:
• General notes: Generally not hazardous for water
• Results of PBT and vPvB assessment • PBT:
Not applicable. • vPvB: Not applicable.
• Other adverse effects No further relevant information available.

13 Disposal considerations

• Waste treatment methods
• Recommendation: Smaller quantities can be disposed of with household waste.
• Uncleaned packagings:
• Recommendation: Disposal must be made according to official regulations.
14 Transport information

• UN-Number
• DOT, ADR, IMDG, IATA
• UN proper shipping name
• DOT, ADR, IMDG, IATA
• Transport hazard class(es) •
DOT, ADR, IMDG, IATA
• Class

• Packing group
• DOT, ADR, IMDG, IATA
• Environmental hazards:
• Marine pollutant:
• Special precautions for user
• Transport in bulk according to Annex II of
MARPOL73/78 and the IBC Code

• UN "Model Regulation":

Void
Void

Void
Void
No
Not applicable.
Not applicable.
-

15 Regulatory information

• Safety, health and environmental regulations/legislation specific for the substance or mixture
• Sara
• Section 355 (extremely hazardous substances):
Substance is not listed.

• Section 313 (Specific toxic chemical listings):
Substance is not listed.
(Contd. on page 6)
USA
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Printing date 01/16/2013

Reviewed on 01/16/2013

Trade name: Soybean Oil

• TSCA (Toxic Substances Control Act):

(Contd. of page 5)

Substance is listed.

• Proposition 65
• Chemicals known to cause cancer:
Substance is not listed.

• Chemicals known to cause reproductive toxicity for females:
Substance is not listed.

• Chemicals known to cause reproductive toxicity for males:
Substance is not listed.

• Chemicals known to cause developmental toxicity:
Substance is not listed.

• Carcinogenic categories
• EPA (Environmental Protection Agency)
Substance is not listed.

• TLV (Threshold Limit Value established by ACGIH)
Substance is not listed.

• NIOSH-Ca (National Institute for Occupational Safety and Health)
Substance is not listed.

• OSHA-Ca (Occupational Safety & Health Administration)
Substance is not listed.
• GHS label elements Void
• Hazard pictograms Void
• Signal word Void
• Hazard statements Void
• Chemical safety assessment: A Chemical Safety Assessment has not been carried out.

16 Other information
T h i s i n fo r m a t i o n i s b a s e d o n o u r p r e se n t k n o w l e d g e . H o w e v e r , t h is s h a l l n o t c o n s t i t u t e a g u a ra n t e e f o r a n y
specific product features and shall not establish a legally valid contractual relationship.

• Department issuing MSDS: Product safety department
• Abbreviations and acronyms:
A D R : A c c o r d e u r o p é e n s u r l e t r a n s p o r t d e s ma r c h a n d i s e s d a n g e r e u s e s p a r R o u t e ( E u r o p e a n A g r e e m e n t c o n c e r n i n g t h e In t e r n a t i o n a l
Carriage of Dangerous Goods by Road)
ACGIH: American Conference of Governmental Industrial Hygienists
EINECS: European Inventory of Existing Commercial Chemical Substances
CAS: Chemical Abstracts Service (division of the American Chemical Society)
NFPA: National Fire Protection Association (USA)
HMIS: Hazardous Materials Identification System (USA)
USA
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SAFETY DATA SHEET
Version 5.3
Revision Date 12/22/2014
Print Date 03/30/2015

1. PRODUCT AND COMPANY IDENTIFICATION
1.1

Product identifiers
Product name

:

Poly(ethylene glycol)

Product Number
Brand

:
:

81280 Fluka

CAS-No.

:

25322-68-3
1.2

Relevant identified uses of the substance or mixture and uses advised against
Identified uses

1.3

1.4

:

Laboratory chemicals, Manufacture of substances

Details of the supplier of the safety data sheet
Company

:

Sigma-Aldrich
3050 Spruce Street
SAINT LOUIS MO 63103
USA

Telephone
Fax

:
:

+1 800-325-5832
+1 800-325-5052

Emergency telephone number
Emergency Phone #

:

(314) 776-6555

2. HAZARDS IDENTIFICATION
2.1

Classification of the substance or mixture
Not a hazardous substance or mixture.

2.2

GHS Label elements, including precautionary statements
Not a hazardous substance or mixture.

2.3

Hazards not otherwise classified (HNOC) or not covered by GHS - none

3. COMPOSITION/INFORMATION ON INGREDIENTS
3.1

Substances
Synonyms
Formula

:

PEG

:
:
:

(C2H4O)nH2O CAS-No.
25322-68-3 EC-No.
500-038-2

Component

Classification

Concentration

PEG 10000
<= 100 %
4. FIRST AID MEASURES
4.1

Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.

Fluka - 81280
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In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
4.2

Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11

4.3

Indication of any immediate medical attention and special treatment needed
No data available

5. FIREFIGHTING MEASURES
5.1

Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.

5.2

Special hazards arising from the substance or mixture
Carbon oxides
Nature of decomposition products not known.
Carbon oxides

5.3

Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.

5.4

Further information
No data available

6. ACCIDENTAL RELEASE MEASURES
6.1

Personal precautions, protective equipment and emergency procedures
Avoid dust formation. Avoid breathing vapours, mist or gas. For
personal protection see section 8.

6.2

Environmental precautions
Do not let product enter drains.

6.3

Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.

6.4

Reference to other sections
For disposal see section 13.

7. HANDLING AND STORAGE
7.1

Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.

7.2

Conditions for safe storage, including any incompatibilities
Keep container tightly closed in a dry and well-ventilated place.

7.3

Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

8. EXPOSURE CONTROLS/PERSONAL PROTECTION
8.1

Control parameters
Components with workplace control parameters

Fluka - 81280
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Component

CAS-No.

Value

PEG 10000

25322-68-3

TWA
TWA

8.2

Control
parameters
10.000000
mg/m3
10.000000
mg/m3

Basis
USA. Workplace Environmental
Exposure Levels (WEEL)
USA. Workplace Environmental
Exposure Levels (WEEL)

Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards such as
NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without
touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in
accordance with applicable laws and good laboratory practices. Wash and dry hands.
Full contact
Material: Nitrile rubber
Minimum layer thickness: 0.11 mm
Break through time: 480 min
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M)
Splash contact
Material: Nitrile rubber
Minimum layer thickness: 0.11 mm
Break through time: 480 min
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M)
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, e-mail sales@kcl.de, test method:
EN374
If used in solution, or mixed with other substances, and under conditions which differ from EN 374, contact the
supplier of the CE approved gloves. This recommendation is advisory only and must be evaluated by an
industrial hygienist and safety officer familiar with the specific situation of anticipated use by our customers. It should
not be construed as offering an approval for any specific use scenario.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous substances, and
to the specific work-place., The type of protective equipment must be selected according to the concentration and
amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired, use type
N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and approved under
appropriate government standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

9. PHYSICAL AND CHEMICAL PROPERTIES
9.1

Information on basic physical and chemical properties
a)

Appearance

Form: solid

b)

Odour

No data available No

c)

Odour Threshold

data available No

d)

pH

data available

e)

Melting point/freezing
point

Melting point/range: 62 - 65 °C (144 - 149 °F)

Fluka - 81280
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9.2

f)

Initial boiling point and
boiling range

No data available

g)

Flash point

No data available h)

Evaporation rate

No data available

i)

Flammability (solid, gas) No data available

j)

Upper/lower
flammability or
explosive limits

No data available

k)

Vapour pressure

No data available

l)

Vapour density

No data available

m) Relative density

No data available

n)

Water solubility

No data available No data

o)

Partition coefficient: noctanol/water

available

p)

Auto-ignition
temperature

No data available

q)

Decomposition
temperature

No data available

r)

Viscosity

No data available

s)

Explosive properties

No data available No data

t)

Oxidizing properties

available

Other safety information
No data available

10. STABILITY AND REACTIVITY
10.1

Reactivity
No data available

10.2

Chemical stability
Stable under recommended storage conditions.

10.3

Possibility of hazardous reactions
No data available

10.4

Conditions to avoid
No data available

10.5

Incompatible materials
Strong oxidizing agents

10.6

Hazardous decomposition products
Other decomposition products - No data available
In the event of fire: see section 5

11. TOXICOLOGICAL INFORMATION
11.1

Information on toxicological effects
Acute toxicity
LD50 Oral - Rat - 50,000 mg/kg
Remarks: Kidney, Ureter, Bladder:Other changes.
Inhalation: No data available
Dermal: No data available
No data available

Fluka - 81280
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Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitisation
No data available
Germ cell mutagenicity
No data available
Carcinogenicity
IARC:

No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.

ACGIH:

No component of this product present at levels greater than or equal to 0.1% is identified as a
carcinogen or potential carcinogen by ACGIH.

NTP:

No component of this product present at levels greater than or equal to 0.1% is identified as a
known or anticipated carcinogen by NTP.

OSHA:

No component of this product present at levels greater than or equal to 0.1% is identified as a
carcinogen or potential carcinogen by OSHA.

Reproductive toxicity
No data available
No data available
Specific target organ toxicity - single exposure
No data available
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
RTECS: Not available
12. ECOLOGICAL INFORMATION
12.1

Toxicity
No data available

12.2

Persistence and degradability
No data available

12.3

Bioaccumulative potential
No data available

12.4

Mobility in soil
No data available

12.5

Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted

12.6

Other adverse effects
No data available

13. DISPOSAL CONSIDERATIONS
13.1

Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.

Fluka - 81280
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Contaminated packaging
Dispose of as unused product.
14. TRANSPORT INFORMATION
DOT (US)
Not dangerous goods
IMDG
Not dangerous goods
IATA
Not dangerous goods
15. REGULATORY INFORMATION
SARA 302 Components
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 313 Components
This material does not contain any chemical components with known CAS numbers that exceed the threshold (De
Minimis) reporting levels established by SARA Title III, Section 313.
SARA 311/312 Hazards
No SARA Hazards
Massachusetts Right To Know Components
No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right To Know Components
PEG 10000

CAS-No.
25322-68-3

Revision Date

CAS-No.
25322-68-3

Revision Date

New Jersey Right To Know Components
PEG 10000

California Prop. 65 Components
This product does not contain any chemicals known to State of California to cause cancer, birth defects, or any other
reproductive harm.

16. OTHER INFORMATION
HMIS Rating
Health hazard:
Chronic Health Hazard:
Flammability:
Hazard
NFPA Rating
Health hazard:
Hazard:
Hazard:

0
0Physical
0
0Fire
0Reactivity
0

Further information
Copyright 2014 Sigma-Aldrich Co. LLC. License granted to make unlimited paper copies for internal use only.
The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a
guide. The information in this document is based on the present state of our knowledge and is applicable to the
product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the
product. Sigma-Aldrich Corporation and its Affiliates shall not be held liable for any damage resulting from handling
or from contact with the above product. See www.sigma-aldrich.com and/or the reverse side of invoice or packing slip for
additional terms and conditions of sale.

Fluka - 81280
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Preparation Information
Sigma-Aldrich Corporation
Product Safety - Americas Region
1-800-521-8956
Version: 5.3
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Safety Data Sheet
acc. to OSHA HCS
Printing date 04/04/2013

Reviewed on 04/04/2013

1 Identification of the substance/mixture and of the company/undertaking

• Product identifier
• Trade name: Polyethylene Glycol, MW 8000
• Article number: 195445
• CAS Number:
25 322-68-3

• NLP Number:
50 0-038-2

• Details of the supplier of the safety data sheet
• Manufacturer/Supplier:
MP Biomedicals, LLC
29525 Fountain Parkway
Solon, OH 44139
United States
www.mpbio.com

• Information department: Product safety department
• Emergency telephone number: CHEMTREC: 1-800-424-9300 (1-703-527-3887)
2 Hazards identification

• Classification of the substance or mixture
The substance is not classified according to the Globally Harmonized System (GHS).

• Classification according to Directive 67/548/EEC or Directive 1999/45/EC Not applicable.
• Information concerning particular hazards for human and environment: Not applicable.
• Label elements
• GHS label elements Void • Hazard
pictograms Void
• Signal word Void
• Hazard statements Void
• Classification system:
• NFPA ratings (scale 0 - 4)
Health = 0
Fire = 1
Reactivity = 0

010

• HMIS-ratings (scale 0 - 4)
HEALTH

0

FIRE

1

REACTIVITY 0

Health = 0
Fire = 1
Reactivity = 0

• Other hazards
• Results of PBT and vPvB assessment • PBT:
Not applicable. • vPvB: Not applicable.
3 Composition/information on ingredients

• Chemical characterization: Substances
• CAS No. Description
25322-68-3 Polyethylene glycol
(Contd. on page 2)
USA
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Trade name: Polyethylene Glycol, MW 8000

• Identification number(s) •

(Contd. of page 1)

NLP Number: 500-038-2

4 First aid measures

• Description of first aid measures
• General information: No special measures required.
• After inhalation: Supply fresh air; consult doctor in case of complaints. • After
skin contact: Generally the product does not irritate the skin.
• After eye contact: Rinse opened eye for several minutes under running water. • After
swallowing: If symptoms persist consult doctor.
• Information for doctor:
• Most important symptoms and effects, both acute and delayed No further relevant information available.
• Indication of any immediate medical attention and special treatment needed
No further relevant information available.

5 Firefighting measures

• Extinguishing media
• Suitable extinguishing agents: Use fire fighting measures that suit the environment.
• Special hazards arising from the substance or mixture No further relevant information available.
• Advice for firefighters
• Protective equipment: No special measures required.
6 Accidental release measures

• Personal precautions, protective equipment and emergency procedures Not required.
• Environmental precautions: Do not allow to enter sewers/ surface or ground water. •
Methods and material for containment and cleaning up: Pick up mechanically.
• Reference to other sections
No dangerous substances are released.
See Section 7 for information on safe handling.
See Section 8 for information on personal protection equipment. See
Section 13 for disposal information.

7 H an dl i n g an d s t or age

• Handling:
• Precautions for safe handling No special measures required.
• Information about protection against explosions and fires: No special measures required.
• Conditions for safe storage, including any incompatibilities
• Storage: 15-30 °C
• Requirements to be met by storerooms and receptacles: No special requirements. •
Information about storage in one common storage facility: Not required. • Further
information about storage conditions: None.
• Specific end use(s) No further relevant information available.
USA

(Contd. on page 3)
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Trade name: Polyethylene Glycol, MW 8000
(Contd. of page 2)

8 Exposure controls/personal protection

• Additional information about design of technical systems: No further data; see item 7.
• Control parameters
• Components with limit values that require monitoring at the workplace:
25322-68-3 Polyethylene glycol
WEEL 10 mg/m³
(H); MW>200
• Additional information: The lists that were valid during the creation were used as basis.

• Exposure controls
• Personal protective equipment:
• General protective and hygienic measures:
The usual precautionary measures for handling chemicals should be followed.

• Breathing equipment: Not required.
• Protection of hands:

The glove material has to be impermeable and resistant to the product/ the substance/ the preparation.
Due to missing tests no recommendation to the glove material can be given for the product/ the preparation/ the
chemical mixture.
Selection of the glove material on consideration of the penetration times, rates of diffusion and the degradation
• Material of gloves
The selection of the suitable gloves does not only depend on the material, but also on further marks of quality and
varies from manufacturer to manufacturer.
• Penetration time of glove material
T h e e x a c t b re a k t h r o u g h t im e h a s t o b e f o u n d o u t b y t h e m a n u f a c tu re r o f t h e p ro t e c ti v e g lo v e s a n d h a s to b e
observed.
• Eye protection: Not required.

9 Physical and chemical properties

• Information on basic physical and chemical properties
• General Information
• Appearance:
Form:
Color:
• Odor:
• Odour threshold:

• pH-value:
• Change in condition
Melting point/Melting range:
Boiling point/Boiling range:

• Flash point:
• Flammability (solid, gaseous):
• Ignition temperature:
Decomposition temperature:

• Auto igniting:

Solid
Not determined.
Characteristic
Not determined.
Not applicable.
Undetermined.
Undetermined.
199 °C (390 °F)
Product is not flammable.

Not determined.
Not determined.
(Contd. on page 4)
USA
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Trade name: Polyethylene Glycol, MW 8000
(Contd. of page 3)

• Danger of explosion:
• Explosion limits:
Lower:
Upper:

• Vapor pressure:
• Density:
• Relative density •
Vapour density
• Evaporation rate

Product does not present an explosion hazard.
Not determined. Not
determined.
Not applicable. Not
determined.
Not determined. Not
applicable. Not
applicable.

• Solubility in / Miscibility with
Water:

Soluble.

• Partition coefficient (n-octanol/water): Not determined.
• Viscosity:
Dynamic:
Kinematic:
Organic solvents:

Not applicable.
Not applicable.
0 .0 %

Solids content:

1 0 0 .0 %
No further relevant information available.

• Other information
10 Stability and reactivity

• Reactivity
• Chemical stability
• Thermal decomposition / conditions to be avoided: No decomposition if used according to specifications. •
Possibility of hazardous reactions No dangerous reactions known. • Conditions to avoid No further relevant
information available.
• Incompatible materials: No further relevant information available.
• Hazardous decomposition products: No dangerous decomposition products known.

11 Toxicological information

• Information on toxicological effects
• Acute toxicity:
• Primary irritant effect:
• on the skin: No irritant effect. • on the
eye: No irritating effect.
• Sensitization: No sensitizing effects known.
• Additional toxicological information:
When used and handled according to specifications, the product does not have any harmful effects according to
our experience and the information provided to us. The
substance is not subject to classification.

• Carcinogenic categories
• IARC (International Agency for Research on Cancer)
Substance is not listed.
(Contd. on page 5)
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• NTP (National Toxicology Program)
Substance is not listed.

12 Ecological information

• Toxicity
• Aquatic toxicity: No further relevant information available.
• Persistence and degradability No further relevant information available.
• Behavior in environmental systems:
• Bioaccumulative potential No further relevant information available. •
Mobility in soil No further relevant information available.
• Additional ecological information:
• General notes:
Water hazard class 1 (Self-assessment): slightly hazardous for water
Do not allow undiluted product or large quantities of it to reach ground water, water course or sewage system.
• Results of PBT and vPvB assessment
• PBT: Not applicable. • vPvB:
Not applicable.
• Other adverse effects No further relevant information available.

13 Disposal considerations

• Waste treatment methods
• Recommendation: Smaller quantities can be disposed of with household waste.
• Uncleaned packagings:
• Recommendation: Disposal must be made according to official regulations.
14 Transport information

• UN-Number
• DOT, ADR, ADN, IMDG, IATA
• UN proper shipping name
• DOT, ADR, ADN, IMDG, IATA
• Transport hazard class(es)
• DOT, ADR, ADN, IMDG, IATA
• Class
• Packing group
• DOT, ADR, IMDG, IATA
• Environmental hazards:
• Marine pollutant:
• Special precautions for user
• Transport in bulk according to Annex II of
MARPOL73/78 and the IBC Code

Void
Void

Void
Void
No
Not applicable.
Not applicable.
(Contd. on page 6)
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• UN "Model Regulation":

-

15 Regulatory information

• Safety, health and environmental regulations/legislation specific for the substance or mixture
• Sara
• Section 355 (extremely hazardous substances):
Substance is not listed.

• Section 313 (Specific toxic chemical listings):
Substance is not listed.

• TSCA (Toxic Substances Control Act):
Substance is listed.
• Proposition 65
• Chemicals known to cause cancer:
Substance is not listed.

• Chemicals known to cause reproductive toxicity for females:
Substance is not listed.

• Chemicals known to cause reproductive toxicity for males:
Substance is not listed.

• Chemicals known to cause developmental toxicity:
Substance is not listed.

• Carcinogenic categories
• EPA (Environmental Protection Agency)
Substance is not listed.

• TLV (Threshold Limit Value established by ACGIH)
Substance is not listed.

• NIOSH-Ca (National Institute for Occupational Safety and Health)
Substance is not listed.

• OSHA-Ca (Occupational Safety & Health Administration)
Substance is not listed.

• GHS label elements Void
• Hazard pictograms Void
• Signal word Void
• Hazard statements Void
• Chemical safety assessment: A Chemical Safety Assessment has not been carried out.
16 Other information
T h i s i n fo r m a t i o n i s b a s e d o n o u r p r e se n t k n o w l e d g e . H o w e v e r , t h is s h a l l n o t c o n s t i t u t e a g u a ra n t e e f o r a n y
specific product features and shall not establish a legally valid contractual relationship.

• Department issuing MSDS: Product safety department
• Abbreviations and acronyms:
A D R : A c c o r d e u r o p é e n s u r l e t r a n s p o r t d e s ma r c h a n d i s e s d a n g e r e u s e s p a r R o u t e ( E u r o p e a n A g r e e m e n t c o n c e r n i n g t h e In t e r n a t i o n a l
Carriage of Dangerous Goods by Road)
IMDG: International Maritime Code for Dangerous Goods
(Contd. on page 7)
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DOT: US Department of Transportation
IATA: International Air Transport Association
ACGIH: American Conference of Governmental Industrial Hygienists
EINECS: European Inventory of Existing Commercial Chemical Substances
CAS: Chemical Abstracts Service (division of the American Chemical Society)
NFPA: National Fire Protection Association (USA)
HMIS: Hazardous Materials Identification System (USA)
USA

SAFETY DATA SHEET
according to the (US) Hazard Communication Standard (29 CFR 1910.1200)
Revision Date 06/05/2014

Version 1.2

SECTION 1. Identification
Product identifier
Product number

103965

Product name

Iron(II) sulfate heptahydrate for analysis EMSURE® ACS,ISO,Reag.
Ph Eur

CAS-No.

7782-63-0

Relevant identified uses of the substance or mixture and uses advised against
Identified uses

Reagent for analysis

Details of the supplier of the safety data sheet
Company

Emergency telephone

EMD Millipore Corporation | 290 Concord Road, Billerica, MA 01821,
United States of America | General Inquiries: +1-978-715-4321 |
Monday to Friday, 9:00 AM to 4:00 PM Eastern Time (GMT-5)

800-424-9300 CHEMTREC (USA)
+1-703-527-3887 CHEMTREC (International)
24 Hours/day; 7 Days/week

SECTION 2. Hazards identification
GHS Classification
Acute toxicity, Category 4, Oral, H302
Skin irritation, Category 2, H315 Eye
irritation, Category 2, H319
For the full text of the H-Statements mentioned in this Section, see Section 16.
GHS-Labeling

Hazard pictograms

Signal Word
Warning
Hazard Statements
H302 Harmful if swallowed. H315
Causes skin irritation.
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SAFETY DATA SHEET
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Product number
Product name

103965
Version 1.2
Iron(II) sulfate heptahydrate for analysis EMSURE® ACS,ISO,Reag. Ph Eur

H319 Causes serious eye irritation.

Precautionary Statements
P302 + P352 IF ON SKIN: Wash with plenty of soap and water.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact
lenses, if present and easy to do. Continue rinsing.
OSHA Hazards
This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR
1910.1200). This information is based on 29 CFR 1910.1200 criteria prior to adoption of the GHS and may
deviate from the GHS information.
Other hazards
None known.

SECTION 3. Composition/information on ingredients
Formula

FeSO₄ * 7H₂O

Molar mass

278.02 g/mol

FeO₄S * 7H₂O (Hill)

Hazardous ingredients

Chemical Name ( Concentration)
CAS-No.
Iron(II) sulphate heptahydrate ( >= 90 % - <= 100 % )
7782-63-0
Exact percentages are being withheld as a trade secret.
SECTION 4. First aid measures
Description of first-aid measures

Inhalation
After inhalation: fresh air.
Skin contact
After skin contact: wash off with plenty of water. Remove contaminated clothing.
Eye contact
After eye contact: rinse out with plenty of water. Call in ophthalmologist.
Ingestion
After swallowing: immediately make victim drink water (two glasses at most). Consult a
physician.
Never give anything by mouth to an unconscious person.
Most important symptoms and effects, both acute and delayed
Diarrhea, Bloody vomiting, irritant effects
The following applies to soluble iron compounds: nausea and vomiting after swallowing. The
absorption of large quantities is followed by cardiovascular disorders. Toxic effect on liver and
kidneys.
Indication of any immediate medical attention and special treatment needed
No information available.
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Product number
Product name

103965
Version 1.2
Iron(II) sulfate heptahydrate for analysis EMSURE® ACS,ISO,Reag. Ph Eur

SECTION 5. Fire-fighting measures
Extinguishing media

Suitable extinguishing media
Use extinguishing measures that are appropriate to local circumstances and the surrounding
environment.
Unsuitable extinguishing media
For this substance/mixture no limitations of extinguishing agents are given.
Special hazards arising from the substance or mixture
Not combustible.
Ambient fire may liberate hazardous vapors.
Fire may cause evolution of:
Sulfur oxides
Advice for firefighters

Special protective equipment for fire-fighters
Stay in danger area only with self-contained breathing apparatus. Prevent skin contact by
keeping a safe distance or by wearing suitable protective clothing.
Further information
Suppress (knock down) gases/vapors/mists with a water spray jet. Prevent fire extinguishing
water from contaminating surface water or the ground water system.
SECTION 6. Accidental release measures
Personal precautions, protective equipment and emergency procedures
Advice for non-emergency personnel: Avoid inhalation of dusts. Avoid substance contact.
Ensure adequate ventilation. Evacuate the danger area, observe emergency procedures, consult an
expert.
Advice for emergency responders: Protective equipment see section 8.
Environmental precautions
Do not empty into drains.
Methods and materials for containment and cleaning up
Cover drains. Collect, bind, and pump off spills.
Observe possible material restrictions (see sections 7 and 10).
Take up dry. Dispose of properly. Clean up affected area. Avoid generation of dusts.
SECTION 7. Handling and storage
Precautions for safe handling
Observe label precautions.
Conditions for safe storage, including any incompatibilities
Tightly closed. Dry. Protected from light.
Store at +15°C to +25°C (+59°F to +77°F).
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Product number
Product name

103965
Version 1.2
Iron(II) sulfate heptahydrate for analysis EMSURE® ACS,ISO,Reag. Ph Eur

SECTION 8. Exposure controls/personal protection
Exposure limit(s)

Ingredients
Basis

Value

Threshold
limits

Remarks

Iron(II) sulphate heptahydrate 7782-63-0
ACGIH
NIOSH/GUIDE
Z1A

Time Weighted Average
(TWA):
Recommended
exposure limit (REL):
Time Weighted Average
(TWA):

1 mg/m³

Expressed as: as Fe

1 mg/m³

Expressed as: as Fe

1 mg/m³

Expressed as: as Fe

Engineering measures
Technical measures and appropriate working operations should be given priority over the use of personal
protective equipment.
Individual protection measures
Protective clothing should be selected specifically for the workplace, depending on concentration and quantity of
the hazardous substances handled. The chemical resistance of the protective equipment should be inquired at
the respective supplier.

Hygiene measures
Immediately change contaminated clothing. Apply skin- protective barrier cream. Wash hands
and face after working with substance.
Eye/face protection
Safety glasses
Hand protection
Chemical-resistant, impervious gloves complying with an approved standard should be worn at
all times when handling chemical products if a risk assessment indicates this is necessary.
Other protective equipment:
protective clothing
Respiratory protection
required when dusts are generated.
Use a properly fitted, air-purifying or air-fed respirator complying with an approved standard if a risk assessment
indicates this is necessary. Respirator selection must be based on known or anticipated exposure levels, the
hazards of the product and the safe working limits of the selected respirator.
SECTION 9. Physical and chemical properties
Physical state

solid

Color

blue green

Odor

odorless

Odor Threshold

not applicable
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pH

3-4
at 50 g/l
68 °F ( 20 °C)

Melting point

> 60 °C
Elimination of water of crystallization

Boiling point

No information available.

Flash point

does not flash

Evaporation rate

No information available.

Flammability (solid, gas)

No information available.

Lower explosion limit

not applicable

Upper explosion limit

not applicable

Vapor pressure

No information available.

Relative vapor density

No information available.

Density

1.89 g/cm³
at 68 °F ( 20 °C)

Relative density

No information available.

Water solubility

ca. 400 g/l
at 68 °F ( 20 °C)

Partition coefficient: noctanol/water
Autoignition temperature

No information available.
No information available.

Decomposition temperature

> 572 °F ( > 300 °C)

Viscosity, dynamic

not applicable

Explosive properties

Not classified as explosive.

Oxidizing properties

none

Ignition temperature

not combustible

Bulk density

ca. 600 kg/m³

SECTION 10. Stability and reactivity
Reactivity
See below
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Iron(II) sulfate heptahydrate for analysis EMSURE® ACS,ISO,Reag. Ph Eur

Chemical stability
Sensitivity to light
releases water of crystallization when heated.
Possibility of hazardous reactions
increased reactivity with:
Bases, Oxidizing agents
Conditions to avoid
Exposure to moisture.
Incompatible materials
no information available
Hazardous decomposition products
in the event of fire: See section 5.
SECTION 11. Toxicological information
Information on toxicological effects

Likely route of exposure
Eye contact, Skin contact, Ingestion
Acute oral toxicity
LD50 rat: 319 mg/kg (anhydrous substance) (Lit.)
absorption

Acute inhalation toxicity
Symptoms: Possible damages:, mucosal irritations

Skin irritation
Causes skin irritation.
Eye irritation
Causes serious eye irritation.
Sensitization
In animal experiments:
Result: negative
(IUCLID)
Genotoxicity in vitro
Ames test
Result: negative
(Lit.)
Specific target organ systemic toxicity - single exposure
The substance or mixture is not classified as specific target organ toxicant, single exposure.
Specific target organ systemic toxicity - repeated exposure
The substance or mixture is not classified as specific target organ toxicant, repeated exposure.
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Product name
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Aspiration hazard
Regarding the available data the classification criteria are not fulfilled.
Carcinogenicity
IARC

No ingredient of this product present at levels greater than or
equal to 0.1% is identified as probable, possible or confirmed
human carcinogen by IARC.

OSHA

No ingredient of this product present at levels greater than or
equal to 0.1% is identified as a carcinogen or potential
carcinogen by OSHA.

NTP

No ingredient of this product present at levels greater than or
equal to 0.1% is identified as a known or anticipated carcinogen by
NTP.

ACGIH

No ingredient of this product present at levels greater than or
equal to 0.1% is identified as a carcinogen or potential
carcinogen by ACGIH.

Further information
Systemic effects:
After swallowing of large amounts:
Bloody vomiting, Diarrhea, drop in blood pressure
The following applies to soluble iron compounds: nausea and vomiting after swallowing. The
absorption of large quantities is followed by cardiovascular disorders. Toxic effect on liver and
kidneys.
Other dangerous properties can not be excluded.
Handle in accordance with good industrial hygiene and safety practice.
SECTION 12. Ecological information
Ecotoxicity

Toxicity to fish
LC50 Poecilia retiaculata (guppy): 925 mg/l; 96 h (IUCLID)
Toxicity to daphnia and other aquatic invertebrates
EC50 Daphnia magna (Water flea): 152 mg/l; 48 h (anhydrous substance) (IUCLID)
Toxicity to bacteria
EC0 Pseudomonas fluorescens: 100 mg/l; 24 h (anhydrous substance) (IUCLID)
Persistence and degradability
No information available.
Bioaccumulative potential
No information available.
Mobility in soil
No information available.
Additional ecological information
Discharge into the environment must be avoided.
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SECTION 13. Disposal considerations
The information presented only applies to the material as supplied. The identification based on characteristic(s)
or listing may not apply if the material has been used or otherwise contaminated. It is the responsibility of the
waste generator to determine the toxicity and physical properties of the material generated to determine the
proper waste identification and disposal methods in compliance with applicable regulations. Disposal should be
in accordance with applicable regional, national and local laws and regulations.
SECTION 14. Transport information
Land transport (DOT)
Not classified as dangerous in the meaning of transport regulations.
Air transport (IATA)
Not classified as dangerous in the meaning of transport regulations.
Sea transport (IMDG)
Not classified as dangerous in the meaning of transport regulations.
SECTION 15. Regulatory information
United States of America
OSHA Hazards
Toxic by ingestion
Skin irritant Eye irritant
This information is based on 29 CFR 1910.1200 criteria prior to adoption of the GHS, and may
deviate from the GHS information on the label and in section 2.
SARA 311/312 Hazards
Acute Health Hazard
SARA 313
SARA 313: This material does not contain any chemical components with known CAS numbers
that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.
SARA 302
SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title
III, Section 302.
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Clean Water Act
The following Hazardous Substances are listed under the U.S. CleanWater Act, Section 311, Table 116.4A:

Ingredients
Iron(II) sulphate heptahydrate
The following Hazardous Chemicals are listed under the U.S. CleanWater Act, Section 311, Table 117.3:

Ingredients
Iron(II) sulphate heptahydrate
DEA List I
Not listed
DEA List II
Not listed
US State Regulations
Massachusetts Right To Know

Ingredients
Iron(II) sulphate heptahydrate
Pennsylvania Right To Know

Ingredients
Iron(II) sulphate heptahydrate
New Jersey Right To Know

Ingredients
Iron(II) sulphate heptahydrate
California Prop 65 Components
This product does not contain any chemicals known to the State of California to cause cancer,
birth, or any other reproductive defects.
Notification status
TSCA:
DSL:

All components of the product are listed in the TSCA-inventory.
All components of this product are on the Canadian DSL.

SECTION 16. Other information
Training advice
Provide adequate information, instruction and training for operators.
Full text of H-Statements referred to under sections 2 and 3.
H302
H315
H319

Harmful if swallowed.
Causes skin irritation.
Causes serious eye irritation.

Key or legend to abbreviations and acronyms used in the safety data sheet
Used abbreviations and acronyms can be looked up at www.wikipedia.org.
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Revision Date06/05/2014

The information contained herein is based on the present state of our knowledge. It characterizes the product with regard to
appropriate safety precautions. It does not represent a warranty of any product properties and we assume no liability for any
loss or injury which may result from the use of this information. Users should conduct their own investigations to determine
the suitability of the information.

All rights reserved. Millipore and the "M" Mark are registered trademarks of Merck KGaA, Darmstadt, Germany.
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MATERIAL SAFETY DATA SHEET
according to the Hazard Communication Standard (29 CFR 1910.1200)
Date of issue: 09/17/2012

Version 1.0

SECTION 1. Identification
Product identifier
Product number

108342

Product name

D(+)-Glucose monohydrate for microbiology

Relevant identified uses of the substance or mixture and uses advised against
Identified uses

Reagent for analysis

Details of the supplier of the safety data sheet
Company

EMD Millipore Corporation | 290 Concord Road, Billerica, MA 01821,
United States of America | SDS Phone Support: +1-978-715-1335 |
General Inquiries: +1-978-751-4321 | Monday to Friday, 9:00 AM to
4:00 PM Eastern Time (GMT-5)
e-mail: mm_sds@merckgroup.com

Emergency telephone

800-424-9300 CHEMTREC (USA)
+1-703-527-3887 CHEMTREC (International)
24 Hours/day; 7 Days/week

SECTION 2. Hazards identification
GHS-Labeling
Not a dangerous substance according to GHS.
OSHA Hazards
While this material is not considered hazardous by the OSHA Hazard Communication Standard (29
CFR 1910.1200), this MSDS contains valuable information critical to the safe handling and proper use
of the product. This MSDS should be retained and available for employees and other users of this
product.
Other hazards
None known.

SECTION 3. Composition/information on ingredients
Formula

C₆H₁₂O₆ * H₂O (Hill) CAS-

No.

14431-43-7

Molar mass

198.17 g/mol
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Version 1.0

No hazardous ingredients according to the OSHA Hazard
Communication Standard 29 CFR 1910.1200.

SECTION 4. First aid measures
Description of first-aid measures

Inhalation
After inhalation: fresh air.
Skin contact
After skin contact (particles, dusts): Rinse with water.
Eye contact
After eye contact: rinse out with plenty of water.
Ingestion
After swallowing (large amounts): consult doctor if feeling unwell.
Never give anything by mouth to an unconscious person.
Most important symptoms and effects, both acute and delayed
We have no description of any toxic symptoms.
Indication of any immediate medical attention and special treatment needed
No information available.
SECTION 5. Fire-fighting measures
Extinguishing media

Suitable extinguishing media
Water, Carbon dioxide (CO2), Foam, Dry powder
Unsuitable extinguishing media
For this substance/mixture no limitations of extinguishing agents are given.
Special hazards arising from the substance or mixture
Combustible material
Advice for firefighters

Special protective equipment for fire-fighters
In the event of fire, wear self-contained breathing apparatus.
SECTION 6. Accidental release measures
Personal precautions, protective equipment and emergency procedures
Advice for non-emergency personnel: Avoid inhalation of dusts. Evacuate the danger area,
observe emergency procedures, consult an expert.
Advice for emergency responders: Protective equipment see section 8.
Environmental precautions
No special precautionary measures necessary.
Methods and materials for containment and cleaning up
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Observe possible material restrictions (see sections 7 and 10).
Take up dry. Dispose of properly. Clean up affected area. Avoid generation of dusts.
SECTION 7. Handling and storage
Precautions for safe handling
Observe label precautions.
Conditions for safe storage, including any incompatibilities
Tightly closed. Dry.
Store at +15°C to +25°C (+59°F to +77°F).
SECTION 8. Exposure controls/personal protection
Exposure limit(s)
Contains no substances with occupational exposure limit values.
Engineering measures
Technical measures and appropriate working operations should be given priority over the use of personal
protective equipment.
Individual protection measures
Protective clothing should be selected specifically for the workplace, depending on concentration and quantity of
the hazardous substances handled. The chemical resistance of the protective equipment should be inquired at the
respective supplier.

Hygiene measures
Change contaminated clothing. Wash hands after working with substance.
Eye/face protection
Safety glasses
Hand protection
Chemical-resistant, impervious gloves complying with an approved standard should be worn at all times when
handling chemical products if a risk assessment indicates this is necessary.
Recommended:
full contact:
Glove material:
Glove thickness:
Break through time:

Nitrile rubber
0.11 mm
> 480 min

Glove material:
Glove thickness:
Break through time:

Nitrile rubber
0.11 mm
> 480 min

splash contact:

Respiratory protection
required when dusts are generated.
Use a properly fitted, air-purifying or air-fed respirator complying with an approved standard if a risk assessment
indicates this is necessary. Respirator selection must be based on known or anticipated exposure levels, the
hazards of the product and the safe working limits of the selected respirator.
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SECTION 9. Physical and chemical properties
Physical state

solid

Color

colorless

Odor

odorless

Odor Threshold

No information available.

pH

6-7
at 100 g/l
68 °F ( 20 °C)

Melting point

ca. 181 °F ( 83 °C)

Boiling point

No information available.

Flash point

No information available.

Evaporation rate

No information available.

Flammability (solid, gas)

No information available.

Lower explosion limit

No information available.

Upper explosion limit

No information available.

Vapor pressure

No information available.

Relative vapor density

No information available.

Relative density

No information available.

Water solubility

1,000 g/l
at 68 °F ( 20 °C)

Partition coefficient: noctanol/water

log Pow: -3.29
(anhydrous substance) Bioaccumulation is not expected (log
Pow <1).

Autoignition temperature

No information available.

Decomposition temperature

No information available.

Viscosity, dynamic

No information available.

Ignition temperature

ca. 932 °F ( 500 °C)

Bulk density

ca. 630 kg/m³
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SECTION 10. Stability and reactivity
Reactivity
Risk of dust explosion.
Chemical stability
releases water of crystallization when heated.
Possibility of hazardous reactions
Strong oxidizing agents
Conditions to avoid
no information available
Incompatible materials
no information available
Hazardous decomposition products
no information available
SECTION 11. Toxicological information
Information on toxicological effects

Likely route of exposure
Eye contact, Skin contact, Ingestion
Acute oral toxicity
LD50 rat: 25,800 mg/kg (anhydrous substance) (RTECS)
Specific target organ systemic toxicity - single exposure
The substance or mixture is not classified as specific target organ toxicant, single exposure.
Specific target organ systemic toxicity - repeated exposure
The substance or mixture is not classified as specific target organ toxicant, repeated exposure.
Aspiration hazard
Regarding the available data the classification criteria are not fulfilled.
Carcinogenicity
IARC

No ingredient of this product present at levels greater than or
equal to 0.1% is identified as probable, possible or confirmed
human carcinogen by IARC.

OSHA

No ingredient of this product present at levels greater than or
equal to 0.1% is identified as a carcinogen or potential
carcinogen by OSHA.

NTP

No ingredient of this product present at levels greater than or
equal to 0.1% is identified as a known or anticipated carcinogen by
NTP.

ACGIH

No ingredient of this product present at levels greater than or
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equal to 0.1% is identified as a carcinogen or potential
carcinogen by ACGIH.
Further information
Our own experience has provided no indication of any hazardous potential.
Further data:
Substances which occur in nature
Handle in accordance with good industrial hygiene and safety practice.
Substance which occurs in the human body under physiological conditions.
SECTION 12. Ecological information
Ecotoxicity

Toxicity to fish
LC0 fish: 60,000 mg/l (anhydrous substance) (External MSDS)
Persistence and degradability
Biodegradability
48 %; 5 d
OECD Test Guideline 301D
(External MSDS)
Readily biodegradable.
Bioaccumulative potential

Partition coefficient: n-octanol/water
log Pow: -3.29
(anhydrous substance) Bioaccumulation is not expected (log Pow <1).
Mobility in soil
No information available.
Other adverse effects

Additional ecological information
No ecological problems are to be expected when the product is handled and used with due care
and attention.
SECTION 13. Disposal considerations
The information presented only applies to the material as supplied. The identification based on characteristic(s)
or listing may not apply if the material has been used or otherwise contaminated. It is the responsibility of the
waste generator to determine the toxicity and physical properties of the material generated to determine the
proper waste identification and disposal methods in compliance with applicable regulations. Disposal should be in
accordance with applicable regional, national and local laws and regulations.
SECTION 14. Transport information
Land transport (DOT)
Not classified as dangerous in the meaning of transport regulations.

Air transport (IATA)
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Not classified as dangerous in the meaning of transport regulations.

Sea transport (IMDG)
Not classified as dangerous in the meaning of transport regulations.

SECTION 15. Regulatory information
United States of America
OSHA Hazards
No OSHA Hazards
This information is based on 29 CFR 1910.1200 criteria prior to adoption of the GHS, and may
deviate from the GHS information on the label and in section 2.
SARA 311/312 Hazards
No SARA Hazards
Clean Water Act
This product does not contain any Hazardous Substances listed under the U.S. CleanWater Act, Section 311,
Table 116.4A.
This product does not contain any Hazardous Chemicals listed under the U.S. CleanWater Act, Section 311,
Table 117.3.
Massachusetts Right To Know
Remarks
No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right To Know

Ingredients
D-(+)-glucose
water of crystallization
New Jersey Right To Know

Ingredients
D-(+)-glucose
water of crystallization
California Prop 65 Components
This product does not contain any chemicals known to the State of California to cause cancer,
birth, or any other reproductive defects.
Notification status
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TSCA:

On TSCA Inventory

DSL:

All components of this product are on the Canadian DSL.

Version 1.0

SECTION 16. Other information
National Fire Protection Association (U.S.A)
Flammability

0

0

Reactivity

Health

0

Specific Hazard

Training advice
Provide adequate information, instruction and training for operators.
Key or legend to abbreviations and acronyms used in the safety data sheet
Used abbreviations and acronyms can be looked up at www.wikipedia.org.

The information contained herein is based on the present state of our knowledge. It characterizes the product with regard to
appropriate safety precautions. It does not represent a warranty of any product properties and we assume no liability for any
loss or injury which may result from the use of this information. Users should conduct their own investigations to determine the
suitability of the information.

All rights reserved. Millipore and the "M" Mark are registered trademarks of Merck KGaA, Darmstadt, Germany.
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Safety Data
Rev

Product Name

1. PRODUCT AND COMPANY IDENTIFICATION

Cat No.
Synonyms

Calcium carbonate

Recommended Use

C63-10, C63-3

Company
Fisher Scientific
One Reagent Lane
Fair Lawn, NJ 07410
Tel: (201) 796-7100

Precipitated chalk; Aragonite; Agricultural limestone
Laboratory chemicals
Emergency Telephone Number
CHEMTREC®, Inside the USA: 800424-9300
CHEMTREC®, Outside the USA: 001703-527-3887

WARNING!

Appearance Off-white

2. HAZARDS IDENTIFICATION

Emergency Overview
Irritating to eyes and skin. May cause irritation of respiratory tract.

Target Organs

odor odorless

Physical State Solid

Potential Health Effects
Acute Effects
Principle Routes of Exposure

Skin, Eyes

Eyes
Skin
Inhalation

Ingestion
Chronic Effects

Irritating to eyes.
Irritating to skin. May be harmful in contact with skin.
May cause irritation of respiratory tract. May be harmful if inhaled.
May be harmful if swallowed. Ingestion may cause gastrointestinal irritation, nausea, vomiting
and diarrhea.
None known.

See Section 11 for additional Toxicological information.
Aggravated Medical Conditions

Preexisting eye disorders. Skin disorders.

_____________________________________________________________________________________________
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3. COMPOSITION/INFORMATION ON INGREDIENTS

Haz/Non-haz
Component
Calcium carbonate

CAS-No
471-34-1

Weight %
>95

4. FIRST AID MEASURES
Eye Contact

Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes. Obtain
medical attention.

Skin Contact

Wash off immediately with plenty of water for at least 15 minutes. Obtain medical attention.

Inhalation

Move to fresh air. If breathing is difficult, give oxygen. Get medical attention immediately if
symptoms occur.

Ingestion

Do not induce vomiting. Obtain medical attention.

Notes to Physician

Treat symptomatically.

5. FIRE-FIGHTING MEASURES
Flash Point
Method

Not applicable
No information available.

Autoignition Temperature
Explosion Limits
Upper
Lower

No information available.

Suitable Extinguishing Media

Substance is nonflammable; use agent most appropriate to
extinguish surrounding fire..

Unsuitable Extinguishing Media

No information available.

Hazardous Combustion Products

No information available.

No data available No
data available

Sensitivity to mechanical impact
Sensitivity to static discharge

No information available.
No information available.

Specific Hazards Arising from the Chemical
Thermal decomposition can lead to release of irritating gases and vapors.
Protective Equipment and Precautions for Firefighters
As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full protective
gear.
NFPA

Health 1

Flammability 0

Instability 0

Physical hazards N/A

6. ACCIDENTAL RELEASE MEASURES
Personal Precautions

Ensure adequate ventilation. Use personal protective equipment. Avoid dust formation.

Environmental Precautions

Should not be released into the environment.

_____________________________________________________________________________________________
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Methods for Containment and Clean Sweep up or vacuum up spillage and collect in suitable container for disposal. Avoid dust
formation.
Up

7. HANDLING AND STORAGE
Handling

Wear personal protective equipment. Ensure adequate ventilation. Do not get in eyes, on skin,
or on clothing. Avoid ingestion and inhalation. Avoid dust formation.

Storage

Keep containers tightly closed in a dry, cool and well-ventilated place.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION

Engineering Measures

Ensure that eyewash stations and safety showers are close to the workstation location. Ensure
adequate ventilation, especially in confined areas.

Exposure Guidelines
Component
Calcium carbonate

Component
Calcium carbonate

ACGIH TLV

OSHA PEL

NIOSH IDLH
TWA: 10 mg/m3
TWA: 5 mg/m3

Quebec

Mexico OEL (TWA)

Ontario TWAEV

TWA: 10 mg/m3

NIOSH IDLH: Immediately Dangerous to Life or Health

Personal Protective Equipment
Eye/face Protection
Skin and body protection
Respiratory Protection

Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's
eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Wear appropriate protective gloves and clothing to prevent skin exposure.
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN
149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits
are exceeded or if irritation or other symptoms are experienced.

9. PHYSICAL AND CHEMICAL PROPERTIES
Physical State
Appearance
odor
Odor Threshold
pH
Vapor Pressure
Vapor Density
Viscosity
Boiling Point/Range
Melting Point/Range
Decomposition temperature
Flash Point
Evaporation Rate
Specific Gravity
Solubility
log Pow
Molecular Weight

Solid
Off-white
odorless
No information available.
8-9
No information available. No
information available. No
information available. No
information available.
825°C / 1517°F
825 °C
Not applicable
No information available. No
information available.
Slightly soluble in water
No data available
100.09
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9. PHYSICAL AND CHEMICAL PROPERTIES
C Ca O3

Molecular Formula

10. STABILITY AND REACTIVITY
Stability

Stable under normal conditions.

Conditions to Avoid

Incompatible products. Excess heat. Avoid dust formation.

Incompatible Materials

Strong oxidizing agents, Acids

Hazardous Decomposition Products

Carbon monoxide (CO), Carbon dioxide (CO2), Calcium oxides

Hazardous Polymerization

Hazardous polymerization does not occur.

Hazardous Reactions .

None under normal processing..

11. TOXICOLOGICAL INFORMATION
Acute Toxicity

Component Information
Component
Calcium carbonate

LD50 Oral
6450 mg/kg ( Rat )

LD50 Dermal
Not listed

Irritation

Irritating to eyes and skin

Toxicologically Synergistic
Products

No information available.

LC50 Inhalation (Dust)
Not listed

Chronic Toxicity
Carcinogenicity

There are no known carcinogenic chemicals in this product

Sensitization

No information available.

Mutagenic Effects

No information available.

Reproductive Effects

No information available.

Developmental Effects

No information available.

Teratogenicity

No information available.

Other Adverse Effects

The toxicological properties have not been fully investigated.. See actual entry in RTECS for
complete information.

Endocrine Disruptor Information

No information available

_____________________________________________________________________________________________
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12. ECOLOGICAL INFORMATION

Ecotoxicity
Do not empty into drains
Persistence and Degradability

No information available

Bioaccumulation/ Accumulation

No information available

Mobility

No information available

13. DISPOSAL CONSIDERATIONS
Chemical waste generators must determine whether a discarded chemical is classified as a
hazardous waste. Chemical waste generators must also consult local, regional, and national
hazardous waste regulations to ensure complete and accurate classification.

Waste Disposal Methods

14. TRANSPORT INFORMATION

DOT

Not regulated

TDG

Not regulated

IATA

Not regulated

IMDG/IMO

Not regulated

15. REGULATORY INFORMATION
International Inventories
Component
Calcium carbonate

TSCA
X

DSL
X

NDSL EINECS ELINCS
207-4399

NLP

PICCS
X

ENCS
X

AICS
X

CHINA
X

Legend:
X - Listed
E - Indicates a substance that is the subject of a Section 5(e) Consent order under TSCA. F - Indicates
a substance that is the subject of a Section 5(f) Rule under TSCA.
N - Indicates a polymeric substance containing no free-radical initiator in its inventory name but is considered to cover the designated polymer
made with any free-radical initiator regardless of the amount used.
P - Indicates a commenced PMN substance
R - Indicates a substance that is the subject of a Section 6 risk management rule under TSCA.
S - Indicates a substance that is identified in a proposed or final Significant New Use Rule T Indicates a substance that is the subject of a Section 4 test rule under TSCA.

_____________________________________________________________________________________________
Page 5 / 7

KECL
X

Thermo Fisher Scientific - Calcium carbonate

Revision Date 08-Nov-2012

_____________________________________________________________________________________________
XU - Indicates a substance exempt from reporting under the Inventory Update Rule, i.e. Partial Updating of the TSCA Inventory Data Base
Production and Site Reports (40 CFR 710(B).
Y1 - Indicates an exempt polymer that has a number-average molecular weight of 1,000 or greater.
Y2 - Indicates an exempt polymer that is a polyester and is made only from reactants included in a specified list of low concern reactants that comprises
one of the eligibility criteria for the exemption rule.

U.S. Federal Regulations
TSCA 12(b) Not applicable
SARA 313
Not applicable

SARA 311/312 Hazardous Categorization
Acute Health Hazard
Chronic Health Hazard
Fire Hazard
Sudden Release of Pressure Hazard
Reactive Hazard

Yes
No
No
No
No

Clean Water Act
Not applicable
Clean Air Act Not
applicable
OSHA
Not applicable
CERCLA
Not Applicable
California Proposition 65
This product does not contain any Proposition 65 chemicals.

State Right-to-Know
Not applicable

U.S. Department of Transportation
Reportable Quantity (RQ):
N
DOT Marine Pollutant
NDOT
Severe Marine Pollutant
N
U.S. Department of Homeland Security
This product does not contain any DHS chemicals.
Other International Regulations
Mexico - Grade

No information available

Canada
This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations (CPR) and the
MSDS contains all the information required by the CPR.
WHMIS Hazard Class
Non-controlled
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16. OTHER INFORMATION
Prepared By

Regulatory Affairs
Thermo Fisher Scientific
Email: EMSDS.RA@thermofisher.com

Creation Date

02-Feb-2010

Print Date

08-Nov-2012

Revision Summary

(M)SDS sections updated 2

Disclaimer
The information provided on this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date
of its publication. The information given is designed only as a guide for safe handling, use, processing, storage,
transportation, disposal and release and is not to be considered as a warranty or quality specification. The information
relates only to the specific material designated and may not be valid for such material used in combination with any other
material or in any process, unless specified in the text.
End of MSDS

_____________________________________________________________________________________________
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SECTION 1. Identification
Product identifier
Product number

101217

Product name

Ammonium sulfate for analysis EMSURE® ACS,ISO,Reag. Ph Eur CAS-

No.

7783-20-2

Relevant identified uses of the substance or mixture and uses advised against
Identified uses

Reagent for analysis

Details of the supplier of the safety data sheet
Company

Emergency telephone

EMD Millipore Corporation | 290 Concord Road, Billerica, MA 01821,
United States of America | General Inquiries: +1-978-715-4321 |
Monday to Friday, 9:00 AM to 4:00 PM Eastern Time (GMT-5)

800-424-9300 CHEMTREC (USA)
+1-703-527-3887 CHEMTREC (International)
24 Hours/day; 7 Days/week

SECTION 2. Hazards identification
GHS-Labeling
Not a dangerous substance according to GHS.
Other hazards
None known.

SECTION 3. Composition/information on ingredients
Formula

(NH₄)₂SO₄

H₈N₂O₄S (Hill)

Molar mass

132.14 g/mol

Remarks

No hazardous ingredients according to the OSHA Hazard
Communication Standard 29 CFR 1910.1200.

SECTION 4. First aid measures
Description of first-aid measures

Inhalation
After inhalation: fresh air.
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Skin contact
In case of skin contact: Take off immediately all contaminated clothing. Rinse skin with water/
shower.
Eye contact
After eye contact: rinse out with plenty of water.
Ingestion
After swallowing: make victim drink water (two glasses at most). Consult doctor if feeling unwell.
Never give anything by mouth to an unconscious person.
Most important symptoms and effects, both acute and delayed
The following applies to ammonium salts in general: after swallowing: local irritation symptoms,
nausea, vomiting, diarrhea. Systemic effect: after the uptake of very large qantities: drop in blood
pressure, collapse, CNS disorders, spasms, narcotic conditions, respiratory paralysis, hemolysis.
Indication of any immediate medical attention and special treatment needed
No information available.
SECTION 5. Fire-fighting measures
Extinguishing media

Suitable extinguishing media
Use extinguishing measures that are appropriate to local circumstances and the surrounding
environment.
Unsuitable extinguishing media
For this substance/mixture no limitations of extinguishing agents are given.
Special hazards arising from the substance or mixture
Not combustible.
Ambient fire may liberate hazardous vapors.
Fire may cause evolution of:
nitrogen oxides, Sulfur oxides
Advice for firefighters

Special protective equipment for fire-fighters
In the event of fire, wear self-contained breathing apparatus.
Further information
Suppress (knock down) gases/vapors/mists with a water spray jet. Prevent fire extinguishing
water from contaminating surface water or the ground water system.
SECTION 6. Accidental release measures
Personal precautions, protective equipment and emergency procedures
Advice for non-emergency personnel: Avoid inhalation of dusts. Evacuate the danger area,
observe emergency procedures, consult an expert.
Advice for emergency responders: Protective equipment see section 8.
Environmental precautions
Do not empty into drains.
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Methods and materials for containment and cleaning up
Cover drains. Collect, bind, and pump off spills.
Observe possible material restrictions (see sections 7 and 10).
Take up dry. Dispose of properly. Clean up affected area. Avoid generation of dusts.
SECTION 7. Handling and storage
Precautions for safe handling
Observe label precautions.
Conditions for safe storage, including any incompatibilities
Tightly closed. Dry.
Store at +5°C to +30°C (+41°F to +86°F).

SECTION 8. Exposure controls/personal protection
Exposure limit(s)
Contains no substances with occupational exposure limit values.
Engineering measures
Technical measures and appropriate working operations should be given priority over the use of personal
protective equipment.
Individual protection measures
Protective clothing should be selected specifically for the workplace, depending on concentration and quantity of
the hazardous substances handled. The chemical resistance of the protective equipment should be inquired at the
respective supplier.

Hygiene measures
Change contaminated clothing. Wash hands after working with substance.
Eye/face protection
Safety glasses
Hand protection
Chemical-resistant, impervious gloves complying with an approved standard should be worn at
all times when handling chemical products if a risk assessment indicates this is necessary.
Respiratory protection
required when dusts are generated.
Use a properly fitted, air-purifying or air-fed respirator complying with an approved standard if a risk assessment
indicates this is necessary. Respirator selection must be based on known or anticipated exposure levels, the
hazards of the product and the safe working limits of the selected respirator.
SECTION 9. Physical and chemical properties
Physical state

solid

Color

colorless

Odor

odorless

Odor Threshold

Not applicable

Page 3 of 8

SAFETY DATA SHEET
according to the (US) Hazard Communication Standard (29 CFR 1910.1200)
Product number
Product name

101217
Ammonium sulfate for analysis EMSURE® ACS,ISO,Reag. Ph Eur

pH

ca. 5
at 100 g/l

Melting point

(decomposition), Not applicable

Boiling point/boiling range

Not applicable

Flash point

does not flash

Evaporation rate

No information available.

Flammability (solid, gas)

No information available.

Lower explosion limit

Not applicable

Upper explosion limit

Not applicable

Vapor pressure

No information available.

Relative vapor density

Not applicable

Density

1.77 g/cm³
at 68 °F ( 20 °C)

Relative density

No information available.

Water solubility

754 g/l
at 68 °F ( 20 °C)

Partition coefficient: noctanol/water
Autoignition temperature

No information available.

Decomposition temperature

> 455 °F ( > 235 °C)

Viscosity, dynamic

No information available.

Explosive properties

Not classified as explosive.

Oxidizing properties

none

Ignition temperature

Not applicable

Bulk density

ca. 850 kg/m³

Version 1.3

No information available.

SECTION 10. Stability and reactivity
Reactivity
See below
Chemical stability
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hygroscopic
Possibility of hazardous reactions
Exothermic reaction with:
chlorates, with, heat nitrates,
with, Heat.
Risk of explosion with:
chlorates, with, Acids
nitrates, with, Potassium
nitrates, with, Acids
nitrites, sodium hypochlorite
Generates dangerous gases or fumes in contact with:
alkalines, Possible formation of:, Ammonia
Conditions to avoid
Strong heating (decomposition).
Incompatible materials
no information available
Hazardous decomposition products
in the event of fire: See section 5.
SECTION 11. Toxicological information
Information on toxicological effects

Likely route of exposure
Eye contact, Skin contact, Ingestion
Acute oral toxicity
LD50 Rat: 2,840 mg/kg (IUCLID)
Skin irritation
Rabbit
Result: No irritation
(IUCLID)
Eye irritation
Rabbit
Result: No eye irritation
(IUCLID)
Genotoxicity in vitro
Ames test
Result: negative
Method: OECD Test Guideline 471
Mutagenicity (mammal cell test): chromosome aberration.
Result: negative
(IUCLID)
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Specific target organ systemic toxicity - single exposure
The substance or mixture is not classified as specific target organ toxicant, single exposure.
Specific target organ systemic toxicity - repeated exposure
The substance or mixture is not classified as specific target organ toxicant, repeated exposure.
Aspiration hazard
Regarding the available data the classification criteria are not fulfilled.
Carcinogenicity
IARC

No ingredient of this product present at levels greater than or equal
to 0.1% is identified as probable, possible or confirmed human
carcinogen by IARC.

OSHA

No ingredient of this product present at levels greater than or
equal to 0.1% is identified as a carcinogen or potential
carcinogen by OSHA.

NTP

No ingredient of this product present at levels greater than or
equal to 0.1% is identified as a known or anticipated carcinogen by
NTP.

ACGIH

No ingredient of this product present at levels greater than or
equal to 0.1% is identified as a carcinogen or potential
carcinogen by ACGIH.

Further information
The following applies to ammonium salts in general: after swallowing: local irritation symptoms,
nausea, vomiting, diarrhea. Systemic effect: after the uptake of very large qantities: drop in blood
pressure, collapse, CNS disorders, spasms, narcotic conditions, respiratory paralysis, hemolysis.
Further hazardous properties cannot be excluded but unlikely when the product is handled
appropriately.
Handle in accordance with good industrial hygiene and safety practice.
SECTION 12. Ecological information
Ecotoxicity

Toxicity to fish
LC50 Danio rerio (zebra fish): 420 mg/l; 96 h (IUCLID)
Toxicity to daphnia and other aquatic invertebrates
EC50 Daphnia magna (Water flea): 129 mg/l; 48 h (IUCLID)
Persistence and degradability
No information available.
Bioaccumulative potential
No information available.
Mobility in soil
No information available.

Additional ecological information
Biological effects:
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Fertilizing effect possible.
Discharge into the environment must be avoided.
SECTION 13. Disposal considerations
The information presented only applies to the material as supplied. The identification based on characteristic(s)
or listing may not apply if the material has been used or otherwise contaminated. It is the responsibility of the waste
generator to determine the toxicity and physical properties of the material generated to determine the
proper waste identification and disposal methods in compliance with applicable regulations. Disposal should be in
accordance with applicable regional, national and local laws and regulations.
SECTION 14. Transport information
Land transport (DOT)
Not classified as dangerous in the meaning of transport regulations.
Air transport (IATA)
Not classified as dangerous in the meaning of transport regulations.
Sea transport (IMDG)
Not classified as dangerous in the meaning of transport regulations.

SECTION 15. Regulatory information
United States of America
SARA 313
The following components are subject to reporting levels established by SARA Title III, Section
313:

Ingredients
ammonium sulphate

7783-20-2

100 %

SARA 302
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302.
Clean Water Act
This product does not contain any Hazardous Substances listed under the U.S. CleanWater Act, Section 311,
Table 116.4A.
This product does not contain any Hazardous Chemicals listed under the U.S. CleanWater Act, Section 311, Table
117.3.
DEA List I
Not listed
DEA List II
Not listed
US State Regulations
Massachusetts Right To Know

Ingredients
ammonium sulphate
Page 7 of 8

SAFETY DATA SHEET
according to the (US) Hazard Communication Standard (29 CFR 1910.1200)
Product number
Product name

101217
Ammonium sulfate for analysis EMSURE® ACS,ISO,Reag. Ph Eur

Version 1.3

Pennsylvania Right To Know

Ingredients
ammonium sulphate
New Jersey Right To Know

Ingredients
ammonium sulphate
California Prop 65 Components
This product does not contain any chemicals known to the State of California to cause cancer,
birth, or any other reproductive defects.
Notification status
TSCA:
DSL:

All components of the product are listed in the TSCA-inventory.
All components of this product are on the Canadian DSL.

SECTION 16. Other information
Training advice
Provide adequate information, instruction and training for operators.
Key or legend to abbreviations and acronyms used in the safety data sheet
Used abbreviations and acronyms can be looked up at www.wikipedia.org.

Revision Date10/14/2014

The information contained herein is based on the present state of our knowledge. It characterizes the product with regard to
appropriate safety precautions. It does not represent a warranty of any product properties and we assume no liability for any
loss or injury which may result from the use of this information. Users should conduct their own investigations to determine the
suitability of the information.
All rights reserved. Millipore and the "M" Mark are registered trademarks of Merck KGaA, Darmstadt, Germany.
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Reviewed on 03/10/2014

1 Identification

• Product identifier
• Trade name: alpha-Amylase
• Article number: 100447
• CAS Number:
90 00-90-2

• EC number:
23 2-565-6

• Index number:
6 4 7 -0 1 5 -0 0 -4

• Details of the supplier of the safety data sheet
• Manufacturer/Supplier:
MP Biomedicals, LLC
29525 Fountain Parkway
Solon, OH 44139
United States
www.mpbio.com

• Information department: Product safety department
• Emergency telephone number: CHEMTREC: 1-800-424-9300 (1-703-527-3887)
2 Hazard(s) identification

• Classification of the substance or mixture
GHS08 Health hazard
Resp. Sens. 1 H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.

• Classification according to Directive 67/548/EEC or Directive 1999/45/EC
Harmful
May cause sensitisation by inhalation.

• Information concerning particular hazards for human and environment: Not applicable.
• Label elements
• GHS label elements The substance is classified and labeled according to the Globally Harmonized System (GHS).
• Hazard pictograms

GHS08

• Signal word Danger
• Hazard-determining components of labeling:
Amylase, alpha-

• Hazard statements
May cause allergy or asthma symptoms or breathing difficulties if inhaled.

• Precautionary statements

If medical advice is needed, have product container or label at hand.
Keep out of reach of children. Read label
before use.
In case of inadequate ventilation wear respiratory protection. Avoid
breathing dust/fume/gas/mist/vapours/spray.
(Contd. on page 2)
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Trade name: alpha-Amylase
(Contd. of page 1)

If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.
IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
Dispose of contents/container in accordance with local/regional/national/international regulations.
• Classification system:
• NFPA ratings (scale 0 - 4)
Health = 0
Fire = 0
Reactivity = 0

000

• HMIS-ratings (scale 0 - 4)
HEALTH

*0

FIRE

0

REACTIVITY 0

Health = *0
Fire = 0
Reactivity = 0

• Other hazards
• Results of PBT and vPvB assessment • PBT:
Not applicable. • vPvB: Not applicable.
3 Composition/information on ingredients

• Chemical characterization: Substances
• CAS No. Description
9000-90-2 Amylase, alpha-

• Identification number(s)
• EC number: 232-565-6
• Index number: 647-015-00-4
4 First-aid measures

• Description of first aid measures
• After inhalation: Supply fresh air; consult doctor in case of complaints. • After
skin contact: Generally the product does not irritate the skin.
• After eye contact: Rinse opened eye for several minutes under running water. • After
swallowing: If symptoms persist consult doctor.
• Information for doctor:
• Most important symptoms and effects, both acute and delayed No further relevant information available.
• Indication of any immediate medical attention and special treatment needed
No further relevant information available.

5 Fire-fighting measures

• Extinguishing media
• Suitable extinguishing agents:
CO2, extinguishing powder or water spray. Fight larger fires with water spray or alcohol resistant foam.

• Special hazards arising from the substance or mixture No further relevant information available.

(Contd. on page 3)
USA
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Trade name: alpha-Amylase

• Advice for firefighters
• Protective equipment: No special measures required.

(Contd. of page 2)

6 Accidental release measures

• Personal precautions, protective equipment and emergency procedures Not required.
• Environmental precautions: Do not allow to enter sewers/ surface or ground water.
• Methods and material for containment and cleaning up:
Dispose contaminated material as waste according to item 13.

• Reference to other sections

See Section 7 for information on safe handling.
See Section 8 for information on personal protection equipment. See
Section 13 for disposal information.

7 H an dl i n g an d s t or age

• Handling:
• Precautions for safe handling
Ensure good ventilation/exhaustion at the workplace.
Prevent formation of dust.
• Information about protection against explosions and fires: No special measures required.

• Conditions for safe storage, including any incompatibilities
• Storage: 2-8 °C
• Requirements to be met by storerooms and receptacles: No special requirements. •
Information about storage in one common storage facility: Not required.
• Further information about storage conditions:
Store in dry conditions.
Protect from humidity and water.
• Specific end use(s) No further relevant information available.

8 Exposure controls/personal protection

• Additional information about design of technical systems: No further data; see item 7.
• Control parameters
• Components with limit values that require monitoring at the workplace: Not required.
• Additional information: The lists that were valid during the creation were used as basis.
• Exposure controls
• Personal protective equipment:
• General protective and hygienic measures:
Keep away from foodstuffs, beverages and feed.
Wash hands before breaks and at the end of work.
• Breathing equipment:
In case of brief exposure or low pollution use respiratory filter device. In case of intensive or longer exposure use
respiratory protective device that is independent of circulating air.
• Protection of hands:
Protective gloves
(Contd. on page 4)
USA
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Trade name: alpha-Amylase
(Contd. of page 3)

The glove material has to be impermeable and resistant to the product/ the substance/ the preparation.
Due to missing tests no recommendation to the glove material can be given for the product/ the preparation/ the
chemical mixture.
Selection of the glove material on consideration of the penetration times, rates of diffusion and the degradation
• Material of gloves
The selection of the suitable gloves does not only depend on the material, but also on further marks of quality and
varies from manufacturer to manufacturer.
• Penetration time of glove material
T h e e x a c t b re a k t h r o u g h t im e h a s t o b e f o u n d o u t b y t h e m a n u f a c tu re r o f t h e p ro t e c ti v e g lo v e s a n d h a s to b e
observed.
• Eye protection: Not required.

9 Physical and chemical properties

• Information on basic physical and chemical properties
• General Information
• Appearance:
Form:
Color:
• Odor:
• Odour threshold:

• pH-value:
• Change in condition
Melting point/Melting range:
Boiling point/Boiling range:

• Flash point:
• Flammability (solid, gaseous):
• Ignition temperature:
Decomposition temperature:

• Auto igniting:
• Danger of explosion:
• Explosion limits:
Lower:
Upper:

• Vapor pressure:
• Density:
• Relative density •
Vapour density
• Evaporation rate

Solid
Not determined.
Characteristic
Not determined.
Not applicable.
Undetermined.
Undetermined.
Not applicable.
Product is not flammable.

Not determined.
Not determined.
Product does not present an explosion hazard.
Not determined. Not
determined.
Not applicable. Not
determined.
Not determined. Not
applicable. Not
applicable.

• Solubility in / Miscibility with
Water:

Soluble.

• Partition coefficient (n-octanol/water): Not determined.
• Viscosity:
Dynamic:
Kinematic:

Not applicable.
Not applicable.
(Contd. on page 5)
USA
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Trade name: alpha-Amylase
(Contd. of page 4)

Organic solvents:

0 .0 %

Solids content:

1 0 0 .0 %
No further relevant information available.

• Other information
10 Stability and reactivity

• Reactivity
• Chemical stability
• Thermal decomposition / conditions to be avoided: No decomposition if used according to specifications. •
Possibility of hazardous reactions No dangerous reactions known. • Conditions to avoid No further relevant
information available.
• Incompatible materials: No further relevant information available.
• Hazardous decomposition products: No dangerous decomposition products known.

11 Toxicological information

• Information on toxicological effects
• Acute toxicity:
• Primary irritant effect:
• on the skin: No irritant effect. • on the
eye: No irritating effect.
• Sensitization: Sensitization possible through inhalation.
• Additional toxicological information:

• Carcinogenic categories
• IARC (International Agency for Research on Cancer)
Substance is not listed.

• NTP (National Toxicology Program)
Substance is not listed.

12 Ecological information

• Toxicity
• Aquatic toxicity: No further relevant information available.
• Persistence and degradability No further relevant information available.
• Behavior in environmental systems:
• Bioaccumulative potential No further relevant information available. •
Mobility in soil No further relevant information available.
• Additional ecological information:
• General notes:
Water hazard class 1 (Self-assessment): slightly hazardous for water
Do not allow undiluted product or large quantities of it to reach ground water, water course or sewage system.
• Results of PBT and vPvB assessment
• PBT: Not applicable. • vPvB:
Not applicable.
• Other adverse effects No further relevant information available.
USA

(Contd. on page 6)
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Trade name: alpha-Amylase
(Contd. of page 5)

13 Disposal considerations

• Waste treatment methods
• Recommendation:
Must not be disposed of together with household garbage. Do not allow product to reach sewage system.

• Uncleaned packagings:
• Recommendation: Disposal must be made according to official regulations. •
Recommended cleansing agent: Water, if necessary with cleansing agents.

14 Transport information

• UN-Number
• DOT, ADR, ADN, IMDG, IATA
• UN proper shipping name
• DOT, ADR, ADN, IMDG, IATA
• Transport hazard class(es)
• DOT, ADR, ADN, IMDG, IATA
• Class
• Packing group
• DOT, ADR, IMDG, IATA
• Environmental hazards:
• Marine pollutant:
• Special precautions for user
• Transport in bulk according to Annex II of
MARPOL73/78 and the IBC Code

• UN "Model Regulation":

Void
Void

Void
Void
No
Not applicable.
Not applicable.
-

15 Regulatory information

• Safety, health and environmental regulations/legislation specific for the substance or mixture
• Sara
• Section 355 (extremely hazardous substances):
Substance is not listed.

• Section 313 (Specific toxic chemical listings):
Substance is not listed.

• TSCA (Toxic Substances Control Act):
Substance is listed.
• Proposition 65
• Chemicals known to cause cancer:
Substance is not listed.

• Chemicals known to cause reproductive toxicity for females:
Substance is not listed.
(Contd. on page 7)
USA
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Trade name: alpha-Amylase

• Chemicals known to cause reproductive toxicity for males:

(Contd. of page 6)

Substance is not listed.

• Chemicals known to cause developmental toxicity:
Substance is not listed.

• Carcinogenic categories
• EPA (Environmental Protection Agency)
Substance is not listed.

• TLV (Threshold Limit Value established by ACGIH)
Substance is not listed.

• NIOSH-Ca (National Institute for Occupational Safety and Health)
Substance is not listed.

• OSHA-Ca (Occupational Safety & Health Administration)
Substance is not listed.
• GHS label elements The substance is classified and labeled according to the Globally Harmonized System (GHS).
• Hazard pictograms

GHS08

• Signal word Danger
• Hazard-determining components of labeling:
Amylase, alpha-

• Hazard statements
May cause allergy or asthma symptoms or breathing difficulties if inhaled.

• Precautionary statements

If medical advice is needed, have product container or label at hand.
Keep out of reach of children. Read label
before use.
In case of inadequate ventilation wear respiratory protection. Avoid
breathing dust/fume/gas/mist/vapours/spray.
If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.
IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
Dispose of contents/container in accordance with local/regional/national/international regulations.
• Chemical safety assessment: A Chemical Safety Assessment has not been carried out.

16 Other information
T h i s i n fo r m a t i o n i s b a s e d o n o u r p r e se n t k n o w l e d g e . H o w e v e r , t h is s h a l l n o t c o n s t i t u t e a g u a ra n t e e f o r a n y
specific product features and shall not establish a legally valid contractual relationship.

• Department issuing MSDS: Product safety department
• Date of preparation / last revision 03/10/2014 / • Abbreviations and acronyms:
A D R : A c c o r d e u r o p é e n s u r l e t r a n s p o r t d e s ma r c h a n d i s e s d a n g e r e u s e s p a r R o u t e ( E u r o p e a n A g r e e m e n t c o n c e r n i n g t h e In t e r n a t i o n a l
Carriage of Dangerous Goods by Road)
ACGIH: American Conference of Governmental Industrial Hygienists
EINECS: European Inventory of Existing Commercial Chemical Substances
CAS: Chemical Abstracts Service (division of the American Chemical Society)
(Contd. on page 8)
USA
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Trade name: alpha-Amylase
(Contd. of page 7)
NFPA: National Fire Protection Association (USA)
HMIS: Hazardous Materials Identification System (USA)
Resp. Sens. 1: Sensitisation - Respirat., Hazard Category 1
USA

SAFETY DATA SHEET
17-AAG

Page: 1
Revision: 06/06/2013
Supersedes Revision: 10/15/2012

Cayman Chemical Company 1180 E.
Ellsworth Rd. Ann Arbor, MI 48108

Section 1. Identification of the Substance/Mixture and of the
1.1

1.2

Product Code:

11039

Product Name:

17-AAG

Synonyms:

17-demethoxy-17-(2-propenylamino)-geldanamycin; BMS 722782; CP 127374; KOS 953; NSC
330507; Tanespimycin;

Relevant identified uses of the substance or mixture and uses advised against

Relevant identified uses:
1.3

For research use only, not for human or veterinary use.

Details of the Supplier of the Safety Data Sheet
Company Name:

Cayman Chemical Company

Emergency Contact:

CHEMTREC Within USA and Canada:

+1 (800)424-9300

Alternate Emergency Contact:

CHEMTREC Outside USA and Canada:

+1 (703)527-3887

Information:

Cayman Chemical Company

Web site address:

www.caymanchem.com

+1 (734)971-3335

Section 2. Hazards Identification
GHS Classification

Key word

GHS hazard phrase

Flammable Liquids, Category 2

Flame

Placard

Danger

Highly flammable liquid and vapor

Acute Toxicity: Inhalation, Category 3

Skull and

Danger

Toxic if inhaled

Danger

Toxic if swallowed

Danger

Toxic in contact with skin

Danger

Causes damage to organs {eyes}.

crossbones
Acute Toxicity: Oral, Category 3

Skull and
crossbones

Acute Toxicity: Skin, Category 3

Skull and
crossbones

Target Organ Systemic Toxicity (single
exposure), Category 1

Health hazard

GHS Hazard Phrases:

H225: Highly flammable liquid and vapor.
H331: Toxic if inhaled.
H301: Toxic if swallowed.
H311: Toxic in contact with skin.
H370: Causes damage to organs {eyes}.

GHS Precaution Phrases:

P210: Keep away from {heat/sparks/open flames/hot surfaces}. - No smoking.
P280: Wear {protective gloves/protective clothing/eye protection/face protection}.
P261: Avoid breathing {dust/fume/gas/mist/vapours/spray}. P264: Wash {hands}
thoroughly after handling.
P361+364: Take off immediately all contaminated clothing and wash it before reuse.
P260: Do not breathe {dust/fume/gas/mist/vapours/spray}.

GHS Response Phrases:

P303+361+353: IF ON SKIN (or hair): Remove/take off immediately all contaminated clothing.
Rinse skin with water/shower.
P304+340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable
for breathing.
P311: Call a {POISON CENTER/doctor/...}.
P301+310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P330: Rinse mouth.
P302+352: IF ON SKIN: Wash with plenty of soap and water.
P312: Call a {POISON CENTER/doctor/...} if you feel unwell.
P321: Specific treatment {see ... on this label}.
P307+311: IF exposed: Call a POISON CENTER or doctor/physician.
Multi-region format
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GHS Storage and Disposal Phrases:

Please refer to Section 7 for Storage and Section 13 for Disposal information.

2.3

Cannot be made nonpoisonous.

Adverse Human Health Effects and

Symptoms:

Harmful vapors.
Material may be irritating to the mucous membranes and upper respiratory tract.
May be fatal or cause blindness if swallowed.
May cause eye, skin, or respiratory system irritation.
Toxic if swallowed, inhaled, or absorbed through the skin.
Toxic: danger of very serious irreversible effects through inhalation, in contact with skin and if
swallowed.
To the best of our knowledge, the toxicological properties have not been thoroughly investigated.

Target Organs:

Central nervous system, Eyes, Gastrointestinal System, Respiratory system, Skin.

LD 50 / LC 50:

Please refer to Section 11.

Medical Conditions Generally Aggravated By No data available.
Exposure:

Section 3. Composition/Information on Ingredients
Hazardous Components (Chemical Name)
1.

17-AAG

2.

Methanol

CAS #
75747-14-7
67-56-1

Concentration

EC#

Risk Phrases

RTECS #

0.1 %

NA

No phrases apply.

LX8932000

99.9 %

200-659-6

R11-23/24/25-39/23 PC1400000
/24/25

Section 4. First Aid Measures
4.1

Description of First Aid Measures:

4.1.1

In Case of Inhalation:

Overexposure may cause: confusion, dermatitis, headache, drowsiness, dizziness, gastrointestinal
disturbance, optic nerve damage (blindness), nausea, unconsciousness, vomiting, visual
disturbance, weakness. May cause convulsions.
Once methanol is absorbed into the body, it is very slowly eliminated.
Remove to fresh air. If not breathing, give artificial respiration or give oxygen by trained
personnel. Get immediate medical attention.
Immediately wash skin with soap and plenty of water for at least 20 minutes. Remove

4.1.2

In Case of Skin Contact:

4.1.3

In Case of Eye Contact:

4.1.4

In Case of Ingestion:

contaminated clothing. Get medical attention if symptoms occur. Wash clothing before reuse.
Hold eyelids apart and flush eyes with plenty of water for at least 20 minutes. Have eyes
examined and tested by medical personnel.
Wash out mouth with water provided person is conscious. Never give anything by mouth to an
unconscious person. Get medical attention. Do NOT induce vomiting unless directed to do so by
medical personnel.
No data available.

4.2
Important Symptoms and Effects,
Both Acute and Delayed:
4.3

Indication of any immediate medical

No data available.

attention and special treatment needed:

Section 5. Fire Fighting Measures
5.1

5.2

Suitable Extinguishing Media:

Use alcohol-resistant foam, carbon dioxide, water, or dry chemical spray.
Use water spray to cool fire-exposed containers.

Unsuitable Extinguishing Media:

A solid water stream may be inefficient.

Flammable Properties and Hazards:

Can release vapors that form explosive mixtures at temperatures at or above the flashpoint.
Container explosion may occur under fire conditions.
Emits toxic fumes under fire conditions. Sensitive to static
discharge.
Vapors can travel to a source of ignition and flash back.

Multi-region format
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Flash Pt:

11.00 C

Method Used: Closed Cup

Autoignition Pt:

385.00 C

Explosive Limits:

LEL:

Hazardous Combustion Products:

No data available.

Fire Fighting Instructions:

As in any fire, wear self-contained breathing apparatus pressure-demand (NIOSH approved or

6.0%

at 25.0 C

UEL:

36.0

at 25.0 C

equivalent), and full protective gear to prevent contact with skin and eyes.
Note: Flammable as diluted in methanol.

Section 6. Accidental Release Measures
Equipment and Emergency Procedures:

Avoid breathing vapors and provide adequate ventilation.
As conditions warrant, wear a NIOSH approved self-contained breathing apparatus, or respirator,
and appropriate personal protection (rubber boots, safety goggles, and heavy rubber gloves).

6.2

Environmental Precautions:

Take steps to avoid release into the environment, if safe to do so.

6.3

Methods and Material For

Contain spill and collect, as appropriate.

6.1

Protective Precautions, Protective

Transfer to a chemical waste container for disposal in accordance with local regulations.

Containment and Cleaning Up:

Section 7. Handling and Storage
7.1

Precautions To Be Taken in Handling:

Avoid breathing dust/fume/gas/mist/vapours/spray.
Avoid prolonged or repeated exposure. Keep
away from sources of ignition.
Take precautionary measures against static discharge.

7.2

Precautions To Be Taken in Storing:

Keep away from heat, sparks, and flame.
Keep container tightly closed.
Store in accordance with information listed on the product insert.
Avoid contact with skin and eyes.

Hazard Label Information:

Do not reuse this container.

Use with adequate ventilation.

Wash thoroughly after handling.

Section 8. Exposure Controls/Personal Protection
Hazardous Components (Chemical Name)
1.

17-AAG

2.

Methanol

CAS #
75747-14-7
67-56-1

OSHA PEL

ACGIH TWA

Other Limits

No data.

No data.

No data.

TLV: 200 ppm

No data.

PEL: 200 ppm

STEL: 250 ppm
Hazardous Components (Chemical Name)
1.

17-AAG

2.

Methanol

CAS #
75747-14-7
67-56-1

Britain EH40

France VL

Europe

No data.

No data.

No data.

TWA: 266 mg/m3 (200 ppm)

TWA: 260 mg/m3 (200 ppm)

TWA: 260

STEL: 333 mg/m3 (250 ppm)

STEL: 1300 mg/m3 (1000

mg/m3

ppm)

Label Information:

Compatible chemical-resistant gloves
glasses Safety shower in work area

8.2.1

Use process enclosures, local exhaust ventilation, or other engineering controls to control airborne

Protective Equipment Summary - Hazard

Engineering Controls (Ventilation

Eye wash station in work area
Vent Hood

etc.):

levels below recommended exposure limits.

8.2.2.1 Eye Protection:

Safety glasses

8.2.2.2 Protective Gloves:

Compatible chemical-resistant gloves

Other Protective Clothing:

Lab coat

Safety

Lab coat

8.2.2.3 Respiratory Equipment (Specify
Type):

NIOSH approved respirator, as conditions warrant.

Work/Hygienic/Maintenance Practices:

Do not take internally.
Facilities storing or utilizing this material should be equipped with an eyewash and a safety
shower.
Wash thoroughly after handling.

Multi-region format
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No data available.

Environmental Exposure Controls:

Section 9. Physical and Chemical Properties
9.1

Information on Basic Physical and Chemical Properties

Physical States:

[ ] Gas

Appearance and Odor:

Solution

Melting Point:

No data.

Boiling Point:

No data.

[ X ] Liquid

11.00 C

Flash Pt:

[ ] Solid

Method Used: Closed Cup

No data.

Evaporation Rate:

LEL:

Explosive Limits:

6.0%

at 25.0 C

Vapor Pressure (vs. Air or mm Hg):

96 MM_HG at 20.0 C No data.

Vapor Density (vs. Air = 1):

No data. No data. 385.00 C

Specific Gravity (Water = 1):

No data available. No data

Solubility in Water:

available.

UEL:

36.0

at 25.0 C

Autoignition Pt:
Explosive Properties:
Oxidizing Properties:
9.2

Other Information

Percent Volatile:

No data.

Formula:

C31H43N3O8

Molecular Weight:

585.70

Section 10. Stability and Reactivity
10.1

Reactivity:

No data available.

10.2

Stability:

Unstable [

10.3

Stability Note(s):

Stable if stored in accordance with information listed on the product insert.

10.4

Conditions To Avoid:

heat, flames and sparks

10.3

Polymerization:

Will occur [

10.5

Incompatibility - Materials To Avoid:

acids

]

Stable [ X ]

]

Will not occur [ X ]

acid anhydrides
acid chlorides alkali
metals
oxidizing agents reducing
agents
10.6

carbon dioxide

Hazardous Decomposition Or

carbon monoxide

Byproducts:

Section 11. Toxicological Information
11.1

Information on Toxicological Effects:

The toxicological effects of this product have not been thoroughly studied.
Methanol - Toxicity Data: Oral LD50 (rat): 5,600 mg/kg; Oral LD50 (rabbit): 14,200 mg/kg;
Inhalation LC50 (rat): 64,000 ppm (4h); Inhalation LC50 (mouse): 61,100 ppm (134 m); Skin
LD50 (rabbit): 15,800 mg/kg; Oral LDLO (human): 143 mg/kg;
Methanol - Irritation Data: Skin (rabbit): 20 mg (24h) moderate; Eyes (rabbit): 40 mg moderate;
Eyes (rabbit): 100 mg (24h) moderate;

Multi-region format
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Methanol - Investigated as a mutagen and reproductive effector.
Only select Registry of Toxic Effects of Chemical Substances (RTECS) data is presented here.
See actual entry in RTECS for complete information.
Methanol RTECS Number: PC1400000

Chronic Toxicological Effects:

Hazardous Components (Chemical Name)
1.

17-AAG

2.

Methanol

Revision: 06/06/2013
Supersedes Revision: 10/15/2012

NTP

IARC

ACGIH

OSHA

75747-14-7

CAS #

n.a.

n.a.

n.a.

n.a.

67-56-1

n.a.

n.a.

n.a.

n.a.

Section 12. Ecological Information
12.1

Avoid release into the environment.
Runoff from fire control or dilution water may cause pollution.

Toxicity:

Section 13. Disposal Considerations
13.1

Dispose in accordance with local, state, and federal regulations.

Waste Disposal Method:

Section 14. Transport Information
14.1

LAND TRANSPORT (US DOT)

DOT Proper Shipping Name

Methanol Solution

DOT Hazard Class:

3 (6.1)

DOT Hazard Label:

COMBUSTIBLE LIQUID, POISON

UN/NA Number:

1230

Packing Group:

II

14.1

LAND TRANSPORT (European ADR/RID)

ADR/RID Shipping Name

Methanol Solution

UN Number:

1230

Hazard Class:

3 (6.1) - COMBUSTIBLE LIQUID, POISON

Packing Group:

II

14.3

AIR TRANSPORT (ICAO/IATA)

ICAO/IATA Shipping Name

Methanol Solution

UN Number:

1230

Hazard Class:

3 (6.1) - COMBUSTIBLE LIQUID, POISON

Packing Group:

II

IATA Classification:

3, 6.1
Transport in accordance with local, state, and federal regulations.

Additional Transport Information:

Section 15. Regulatory Information
European Community Hazard Symbol codes

F: Highly Flammable; T: Toxic

European Community Risk and Safety Phrases
R11

- Highly flammable.

R39/23/24/25 - Toxic: danger of very serious irreversible effects through inhalation, in contact with skin and if swallowed.
S7
- Keep container tightly closed.
S16
- Keep away from sources of ignition.
S24/25
- Avoid contact with skin and eyes.
S33
- Take precautionary measures against static discharges.
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.
S45
- In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
US EPA SARA Title III
Hazardous Components (Chemical Name)
1.

17-AAG

CAS #
75747-14-7

Sec.302 (EHS)

Sec.304 RQ

Sec.313 (TRI)

Sec.110

No

No

No

No

Multi-region format

SAFETY DATA SHEET
17-AAG
Hazardous Components (Chemical Name)
2.

Methanol

CAS #
67-56-1

Page: 6
Revision: 06/06/2013
Supersedes Revision: 10/15/2012

Sec.302 (EHS)

Sec.304 RQ

Sec.313 (TRI)

Sec.110

No

Yes 5000 LB

Yes

No

CAA HAP,ODC

CWA NPDES

TSCA

CA PROP.65

No

No

No

No

HAP

No

Inventory

Yes

Other US EPA or State Lists
Hazardous Components (Chemical Name)
1.

17-AAG

2.

Methanol

Regulatory Information Statement:

CAS #
75747-14-7
67-56-1

This SDS was prepared in accordance with Regulation (EC) No.1272/2008 and European
Directive 67/548/EEC as amended.

Section 16. Other Information
Revision Date:

06/06/2013

Company Policy or Disclaimer
DISCLAIMER: This information is believed to be accurate and represents the best information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their
own investigations to determine the suitability of the information for their particular purposes.
N.A.=Not available, N.P.=Not applicable, N.D.=Not determined, N.E.=Not established, N.R.=Not required
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Material Safety Data Sheet
Ethyl alcohol 200 Proof MSDS
Section 1: Chemical Product and Company Identification
Product Name: Ethyl alcohol 200 Proof

Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396

Catalog Codes: SLE2248, SLE1357
CAS#: 64-17-5
RTECS: KQ6300000
TSCA: TSCA 8(b) inventory: Ethyl alcohol 200 Proof
CI#: Not applicable.
Synonym: Ethanol; Absolute Ethanol; Alcohol; Ethanol
200 proof; Ethyl Alcohol, Anhydrous; Ethanol, undenatured;
Dehydrated Alcohol; Alcohol

US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400

Chemical Name: Ethyl Alcohol
Chemical Formula: CH3CH2OH

Section 2: Composition and Information on Ingredients
Composition:
Name

CAS #

% by Weight

Ethyl alcohol 200 Proof

64-17-5

100

Toxicological Data on Ingredients: Ethyl alcohol 200 Proof: ORAL (LD50): Acute: 7060 mg/kg [Rat]. 3450 mg/kg [Mouse].
VAPOR (LC50): Acute: 20000 ppm 8 hours [Rat]. 39000 mg/m 4 hours [Mouse].

Section 3: Hazards Identification
Potential Acute Health Effects:
Hazardous in case of skin contact (irritant), of eye contact (irritant), of inhalation. Slightly hazardous in case of skin contact
(permeator), of ingestion.
Potential Chronic Health Effects:
Slightly hazardous in case of skin contact (sensitizer). CARCINOGENIC EFFECTS: A4 (Not classifiable for human or
animal.) by ACGIH. MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for bacteria and/or yeast.
TERATOGENIC EFFECTS: Classified PROVEN for human. DEVELOPMENTAL TOXICITY: Classified Development toxin
[PROVEN]. Classified Reproductive system/toxin/female, Reproductive system/toxin/male [POSSIBLE]. The substance is toxic
to blood, the reproductive system, liver, upper respiratory tract, skin, central nervous system (CNS). Repeated or prolonged
exposure to the substance can produce target organs damage.
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Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. Immediately flush eyes with running water for at least 15 minutes, keeping eyelids
open. Cold water may be used. Get medical attention.
Skin Contact:
In case of contact, immediately flush skin with plenty of water. Cover the irritated skin with an emollient. Remove contaminated
clothing and shoes. Cold water may be used.Wash clothing before reuse. Thoroughly clean shoes before reuse. Get medical
attention.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek medical attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention if symptoms appear.
Serious Inhalation:
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or waistband. If
breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth resuscitation. Seek medical
attention.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.

Section 5: Fire and Explosion Data
Flammability of the Product: Flammable.
Auto-Ignition Temperature: 363°C (685.4°F)
Flash Points: CLOSED CUP: 12.78°C (55°F). OPEN CUP: 17.78°C (64°F) (Cleveland).
Flammable Limits: LOWER: 3.3% UPPER: 19%
Products of Combustion: These products are carbon oxides (CO, CO2).
Fire Hazards in Presence of Various Substances:
Highly flammable in presence of open flames and sparks, of heat. Slightly flammable to flammable in presence of oxidizing
materials.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Slightly explosive in presence of open
flames and sparks, of heat, of oxidizing materials, of acids.
Fire Fighting Media and Instructions:
Flammable liquid, soluble or dispersed in water. SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use alcohol foam,
water spray or fog.
Special Remarks on Fire Hazards:
Containers should be grounded. CAUTION: MAY BURN WITH NEAR INVISIBLE FLAME Vapor may travel considerable
distance to source of ignition and flash back. May form explosive mixtures with air. Contact with Bromine pentafluoride is likely to
cause fire or explosion. Ethanol ignites on contact with chromyl chloride. Ethanol ignites on contact with iodine heptafluoride gas.
It ignites than explodes upon contact with nitrosyl perchlorate. Additon of platinum black catalyst caused ignition.
Special Remarks on Explosion Hazards:
Ethanol has an explosive reaction with the oxidized coating around potassium metal. Ethanol ignites and then explodes on
contact with acetic anhydride + sodium hydrosulfate (ignites and may explode), disulfuric acid + nitric acid, phosphorous(III)
oxide platinum, potassium-tert-butoxide+ acids. Ethanol forms explosive products in reaction with the following compound :
p. 2

ammonia + silver nitrate (forms silver nitride and silver fulminate), iodine + phosphorus (forms ethane iodide), magnesium
perchlorate (forms ethyl perchlorate), mercuric nitrate, nitric acid + silver (forms silver fulminate) silver nitrate (forms ethyl
nitrate) silver(I) oxide + ammonia or hydrazine (forms silver nitride and silver fulminate), sodium (evolves hydrogen gas).
Sodium Hydrazide + alcohol can produce an explosion. Alcohols should not be mixed with mercuric nitrate, as explosive
mercuric fulminate may be formed. May form explosive mixture with manganese perchlorate + 2,2-dimethoxypropane. Addition of
alcohols to highly concentrate hydrogen peroxide forms powerful explosives. Explodes on contact with calcium hypochlorite

Section 6: Accidental Release Measures
Small Spill:
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal container.
Large Spill:
Flammable liquid. Keep away from heat. Keep away from sources of ignition. Stop leak if without risk. Absorb with DRY earth,
sand or other non-combustible material. Do not touch spilled material. Prevent entry into sewers, basements or confined
areas; dike if needed. Be careful that the product is not present at a concentration level above TLV. Check TLV on the MSDS
and with local authorities.

Section 7: Handling and Storage
Precautions:
Keep locked up.. Keep away from heat. Keep away from sources of ignition. Ground all equipment containing material. Do
not ingest. Do not breathe gas/fumes/ vapor/spray. Wear suitable protective clothing. In case of insufficient ventilation, wear
suitable respiratory equipment. If ingested, seek medical advice immediately and show the container or the label. Avoid
contact with skin and eyes. Keep away from incompatibles such as oxidizing agents, acids, alkalis, moisture.
Storage:
Store in a segregated and approved area. Keep container in a cool, well-ventilated area. Keep container tightly closed and
sealed until ready for use. Avoid all possible sources of ignition (spark or flame). Do not store above 23°C (73.4°F).

Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their respective
threshold limit value. Ensure that eyewash stations and safety showers are proximal to the work-station location.
Personal Protection:
Splash goggles. Lab coat. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Gloves. Use a
respirator if the exposure limit is exceeded.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits:
TWA: 1900 (mg/m3) from OSHA (PEL) [United States] TWA: 1000 (ppm) from OSHA (PEL) [United States] TWA: 1900 (mg/
m3) from NIOSH [United States] TWA: 1000 (ppm) from NIOSH [United States] TWA: 1000 (ppm) [United Kingdom (UK)]
TWA: 1920 (mg/m3) [United Kingdom (UK)] TWA: 1000 STEL: 1250 (ppm) [Canada]Consult local authorities for acceptable
exposure limits.

Section 9: Physical and Chemical Properties
Physical state and appearance: Liquid. (Liquid.)
Odor:
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Mild to strong, rather pleasant; like wine or whiskey. Alcohol-like; Ethereal, vinous.
Taste: Pungent. Burning.
Molecular Weight: 46.07 g/mole
Color: Colorless. Clear
pH (1% soln/water): Not available.
Boiling Point: 78.5°C (173.3°F)
Melting Point: -114.1°C (-173.4°F)
Critical Temperature: 243°C (469.4°F)
Specific Gravity: 0.789 (Water = 1) Vapor
Pressure: 5.7 kPa (@ 20°C)
Vapor Density: 1.59 (Air = 1) Volatility:
Not available.
Odor Threshold: 100 ppm
Water/Oil Dist. Coeff.: The product is more soluble in water; log(oil/water) = -0.3
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water, methanol, diethyl ether, acetone.
Solubility:
Easily soluble in cold water, hot water. Soluble in methanol, diethyl ether, acetone.

Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, heat, sources of ignition.
Incompatibility with various substances: Reactive with oxidizing agents, acids, alkalis.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Ethanol rapidly absorbs moisture from the air. Can react vigorously with oxiders. The following oxidants have been
demonstrated to undergo vigorous/explosive reaction with ethanol: barium perchlorate, bromine pentafluoride, calcium
hypochlorite, chloryl perchlorate, chromium trioxide, chromyl chloride, dioxygen difluoride, disulfuryl difluoride, fluorine nitrate,
hydrogen peroxide, iodine heptafluoride, nitric acid nitrosyl perchlorate, perchloric acid permanganic acid, peroxodisulfuric
acid, potassium dioxide, potassium perchlorate, potassium permanganate, ruthenium(VIII) oxide, silver perchlorate, silver
peroxide, uranium hexafluoride, uranyl perchlorate. Ethanol reacts violently/expodes with the following compounds: acetyl
bromide (evolves hydrogen bromide) acetyl chloride, aluminum, sesquibromide ethylate, ammonium hydroxide & silver
oxide, chlorate, chromic anhydride, cyanuric acid + water, dichloromethane + sulfuric acid + nitrate (or) nitrite, hydrogen
peroxide + sulfuric acid, iodine + methanol + mercuric oxide, manganese perchlorate + 2,2-dimethoxy propane, perchlorates,
permanganates + sulfuric acid, potassium superoxide, potassium tert-butoxide, silver & nitric acid, silver perchlorate, sodium
hydrazide, sulfuric acid + sodium dichromate, tetrachlorisilane + water. Ethanol is also incompatible with platinium, and
sodium. No really safe conditions exist under which ethyl alcohol and chlorine oxides can be handled. Reacts vigorously with
acetyl chloride
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.

Section 11: Toxicological Information
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Routes of Entry: Absorbed through skin. Dermal contact. Eye contact. Inhalation. Ingestion.
Toxicity to Animals:
WARNING: THE LC50 VALUES HEREUNDER ARE ESTIMATED ON THE BASIS OF A 4-HOUR EXPOSURE. Acute oral
toxicity (LD50): 3450 mg/kg [Mouse]. Acute toxicity of the vapor (LC50): 39000 mg/m3 4 hours [Mouse].
Chronic Effects on Humans:
CARCINOGENIC EFFECTS: A4 (Not classifiable for human or animal.) by ACGIH. MUTAGENIC EFFECTS: Mutagenic for
mammalian somatic cells. Mutagenic for bacteria and/or yeast. TERATOGENIC EFFECTS: Classified PROVEN for human.
DEVELOPMENTAL TOXICITY: Classified Development toxin [PROVEN]. Classified Reproductive system/toxin/female,
Reproductive system/toxin/male [POSSIBLE]. Causes damage to the following organs: blood, the reproductive system, liver,
upper respiratory tract, skin, central nervous system (CNS).
Other Toxic Effects on Humans:
Hazardous in case of skin contact (irritant), of inhalation. Slightly hazardous in case of skin contact (permeator), of ingestion.
Special Remarks on Toxicity to Animals:
Lowest Published Dose/Conc: LDL[Human] - Route: Oral; Dose: 1400 mg/kg LDL[Human child] - Route: Oral; Dose: 2000 mg/
kg LDL[Rabbit] - Route: Skin; Dose: 20000 mg/kg
Special Remarks on Chronic Effects on Humans:
May affect genetic material (mutagenic) Causes adverse reproductive effects and birth defects (teratogenic) , based on
moderate to heavy consumption. May cause cancer based on animal data. Human: passes through the placenta, excreted in
maternal milk.
Special Remarks on other Toxic Effects on Humans:
Acute potential health effects: Skin: causes skin irritation Eyes: causes eye irritation Ingestion: May cause gastrointestinal tract
irritation with nausea, vomiting, diarrhea, and alterations in gastric secretions. May affect behavior/central nervous system
(central nervous system depression - amnesia, headache, muscular incoordination, excitation, mild euphoria, slurred speech,
drowsiness, staggaring gait, fatigue, changes in mood/personality, excessive talking, dizziness, ataxia, somnolence, coma/
narcosis, hallucinations, distorted perceptions, general anesthetic), peripherial nervous system (spastic paralysis)vision
(diplopia). Moderately toxic and narcotic in high concentrations. May also affect metabolism, blood, liver, respiration (dyspnea),
and endocrine system. May affect respiratory tract, cardiovascular(cardiac arrhythmias, hypotension), and urinary systems.
Inhalation: May cause irritation of the respiratory tract and affect behavior/central nervous system with symptoms similar to
ingestion. Chronic Potential Health Effects: Skin: Prolonged or repeated skin contact may casue dermatitis, an allergic
reaction. Ingestion: Prolonged or repeated ingestion will have similiar effects as acute ingestion. It may also affect the brain.

Section 12: Ecological Information
Ecotoxicity: Ecotoxicity in water (LC50): 14000 mg/l 96 hours [Rainbow trout]. 11200 mg/l 24 hours [fingerling trout].
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.

Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.

Section 14: Transport Information
DOT Classification: CLASS 3: Flammable liquid.
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Identification: : Ethanol UNNA: 1170 PG: II
Special Provisions for Transport: Not available.

Section 15: Other Regulatory Information
Federal and State Regulations:
California prop. 65: This product contains the following ingredients for which the State of California has found to cause cancer,
birth defects or other reproductive harm, which would require a warning under the statute: Ethyl alcohol 200 Proof (in alcoholic
beverages) California prop. 65: This product contains the following ingredients for which the State of California has found
to cause birth defects which would require a warning under the statute: Ethyl alcohol 200 Proof (in alcoholic beverages)
Connecticut hazardous material survey.: Ethyl alcohol 200 Proof Illinois toxic substances disclosure to employee act: Ethyl
alcohol 200 Proof Rhode Island RTK hazardous substances: Ethyl alcohol 200 Proof Pennsylvania RTK: Ethyl alcohol 200
Proof Florida: Ethyl alcohol 200 Proof Minnesota: Ethyl alcohol 200 Proof Massachusetts RTK: Ethyl alcohol 200 Proof
Massachusetts spill list: Ethyl alcohol 200 Proof New Jersey: Ethyl alcohol 200 Proof Tennessee: Ethyl alcohol 200 Proof
California - Directors List of Hazardous Substances (8 CCR 339): Ethyl alcohol 200 Proof TSCA 8(b) inventory: Ethyl alcohol
200 Proof
Other Regulations:
OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200). EINECS: This product is on the
European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada):
CLASS B-2: Flammable liquid with a flash point lower than 37.8°C (100°F). CLASS D-2A: Material causing other toxic effects
(VERY TOXIC).
DSCL (EEC):
R11- Highly flammable. S7- Keep container tightly closed. S16- Keep away from sources of ignition - No smoking.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 3
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 3
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Wear appropriate respirator
when ventilation is inadequate. Splash goggles.

Section 16: Other Information
References:
-SAX, N.I. Dangerous Properties of Indutrial Materials. Toronto, Van Nostrand Reinold, 6e ed. 1984. -Material safety data
sheet emitted by: la Commission de la Santé et de la Sécurité du Travail du Québec. -Hawley, G.G.. The Condensed
Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987. -The Sigma-Aldrich Library of Chemical Safety
Data, Edition II. HSDB, RTECS, and LOLI databases.
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Other Special Considerations: Not available.
Created: 10/09/2005 05:28 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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MATERIAL SAFETY DATA SHEET
Cat# 1564-1, -5, Geldanamycin

MSDS DATE: Feb 21, 2012

SECTION 1: PRODUCT AND COMPANY IDENTIFICATION
PRODUCT NAME:

Geldanamycin

PRODUCT CODES:

Cat# 1564-1, -5

MANUFACTURER:
ADDRESS:

BioVision, Inc.
155 S. Milpitas Boulevard, Milpitas, CA 95035

EMERGENCY PHONE: 858-373-8066
CHEMTREC PHONE:
OTHER CALLS:
408-493-1800
FAX PHONE:
408-493-1801
SECTION 2: COMPOSITION/INFORMATION ON INGREDIENTS
Component

Description

Geldanamycin

Solid

Volume
1564-1: 1 mg
1564-5: 5 mg

Safety Information
See below

SECTION 3: HAZARDS IDENTIFICATION
Product Name/Chemical Name

CAS Number

EC-No.

MW

Chemical Formula

Geldanamycin

30562-34-6

--

560.64

C29H40N2O9

Geldanamycin:
Emergency Overview
OSHA Hazards: Target organ effect, Carcinogen, Teratogen
Target Organs: Liver, Pancreas, Kidney, Gastrointestinal tract, Skeletal muscle
GHS Classification: Acute toxicity, Oral (Category 5)
GHS Label elements, including precautionary statements
Pictogram:

Signal word:
Warning
Hazard statement(s):
H303 May be harmful if swallowed.
Precautionary statement(s): none
HMIS Classification
Health hazard: 1
Chronic Health Hazard: *
Flammability: 0
Physical hazards: 0
NFPA Rating
Health Hazard: 1
Fire: 0
Reactivity Hazard: 0
Potential Health Effects
Inhalation: May be harmful if inhaled. May cause respiratory tract irritation. Skin:
May be harmful if absorbed through skin. May cause skin irritation. Eyes: May
cause eye irritation.
Ingestion: May be harmful if swallowed.
SECTION 4: FIRST AID MEASURES
General advice: Consult a physician. Show this safety data sheet to the doctor in attendance. Move out of dangerous area.
If inhaled: If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. In
case of skin contact: Wash off with soap and plenty of water. Consult a physician. In case of eye contact: Flush
eyes with water as a precaution.
If swallowed: Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
5: FIRE-FIGHTING MEASURES
Condition of flammability: Not flammable or combustible.
Suitable extinguishing media: Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special protective equipment for fire-fighters: Wear self-contained breathing apparatus for firefighting if necessary.
Hazardous combustion products: Hazardous decomposition products formed under fire conditions— carbon oxides, nitrogen oxides.
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MATERIAL SAFETY DATA SHEET
Cat# 1564-1, -5, Geldanamycin

MSDS DATE: Feb 21, 2012

SECTION 6: ACCIDENTAL RELEASE MEASURES
Personal precautions: Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist, gas, or dust. Ensure
adequate ventilation. Evacuate personnel to safe areas.
Environmental precautions: Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
Methods for cleaning up: Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for
disposal.
SECTION 7: HANDLING AND STORAGE
Precautions for safe handling
Avoid formation of dust and aerosols. Provide appropriate exhaust ventilation at places where dust is formed.
Conditions for safe storage
Keep container tightly closed in a dry and well-ventilated place.
Recommended storage temperature: -20 °C
SECTION 8: EXPOSURE CONTROLS/PERSONAL PROTECTION
Contains no substances with occupational exposure limit values.
Personal protective equipment
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired, use type N95 (US) or type P1
(EN 143) dust masks. Use respirators and components tested and approved under appropriate government standards such as
NIOSH (US) or CEN (EU).
Hand protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer
surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and
good laboratory practices. Wash and dry hands.
Eye protection
Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN
166(EU).
Skin and body protection
Choose body protection in relation to its type, to the concentration and amount of dangerous substances, and to the specific workplace. The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at
the specific workplace.
Hygiene measures
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of the workday.
SECTION 9: PHYSICAL AND CHEMICAL PROPERTIES
Property
Appearance:
pH:
Water Solubility:
Specific Gravity (g/ml):
Boiling Point (°C):
Melting Point (°C):
Flash Point (°C):
Ignition Temperature (°C):
Density

Geldanamycin
Yellow to orange solid
No data available No
data available No data
available No data
available No data
available No data
available No data
available No data
available

SECTION 10: STABILITY AND REACTIVITY
Property
Chemical stability
Conditions to avoid:
Materials to avoid:
Hazardous decomposition products:

Geldanamycin
Stable under recommended storage conditions
No data available
Strong oxidizing agents
Carbon oxides, nitrogen oxides

SECTION 11: TOXICOLOGICAL INFORMATION
Geldanamycin:
Acute toxicity: LD50 Oral - rat - 2,500 mg/kg
Skin corrosion/irritation: no data available
Serious eye damage/eye irritation: no data available
Respiratory or skin sensitization: no data available
Germ cell mutagenicity: Genotoxicity in vitro - mouse - lymphocyte: DNA inhibition
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MATERIAL SAFETY DATA SHEET
Cat# 1564-1, -5, Geldanamycin

MSDS DATE: Feb 21, 2012

Carcinogenicity:
This is or contains a component that has been reported to be carcinogenic based on its IARC, OSHA, ACGIH, NTP, or EPA classification.
IARC:
No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or
confirmed human carcinogen by IARC.
No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential
ACGIH:
carcinogen by ACGIH.
No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated
NTP:
carcinogen by NTP.
No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential
OSHA:
carcinogen by OSHA.
Reproductive toxicity: no data available
Teratogenicity: Possible risk of congenital malformation in the fetus.
Specific target organ toxicity - single exposure (GHS): no data available
Specific target organ toxicity - repeated exposure (GHS): no data available
Aspiration hazard: no data available
Potential Health Effects
Inhalation: May be harmful if inhaled. May cause respiratory tract irritation. Skin:
May be harmful if absorbed through skin. May cause skin irritation. Eyes: May
cause eye irritation.
Ingestion: May be harmful if swallowed.
Signs and Symptoms of Exposure: Effects may be delayed. Pulmonary edema, irregular breathing, stomach/intestinal disorders, nausea,
vomiting, dizziness, drowsiness, increased liver enzymes, and/or weakness. Heavy or prolonged skin exposure may result in the absorption of
harmful amounts of material.
Synergistic effects: no data available
Additional information: RTECS: LX8920000
SECTION 12: ECOLOGICAL INFORMATION
Geldanamycin:
Persistence and degradability: no data available
Toxicity: no data available
Bioaccumulative potential: no data available
Mobility in soil: no data available
PBT and vPvB assessment: no data available
Other adverse effects: no data available
SECTION 13: DISPOSAL CONSIDERATIONS
Product: Offer surplus and non-recyclable solutions to a licensed disposal company. Contact licensed professional waste disposal service to
dispose of this material. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an
afterburner and scrubber.
Contaminated packaging: Dispose of as unused product.
SECTION 14: TRANSPORT INFORMATION
Geldanamycin:
DOT (US): Not dangerous goods. IMDG: Not
dangerous goods. IATA: Not dangerous
goods.
SECTION 15: REGULATORY INFORMATION
Geldanamycin:
OSHA Hazards: Target organ effect, Carcinogen, Teratogen
SARA 302 Components: SARA 302: No chemical in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 313 Components: SARA 313: This material does not contain any chemical components with known CAS numbers that exceed the
threshold (De Minimis) reporting levels established by SARA Title II, Section 313.
SARA 311/312 Hazards: Chronic Health Hazard
Massachusetts Right To Know Components: No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right To Know Components: Geldanamycin, CAS-No. 30562-34-6
New Jersey Right To Know Components: Geldanamycin, CAS-No. 30562-34-6
California Prop. 65 Components: This product does not contain any chemicals known to State of California to cause cancer, birth defects, or
any other reproductive harm.
EU regulations
Component
Geldanamycin

Risk Phrases
R22, R68
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Safety Phrases
S22, S24/25, S36/37/39

MATERIAL SAFETY DATA SHEET
Cat# 1564-1, -5, Geldanamycin

MSDS DATE: Feb 21, 2012

SECTION 16: OTHER INFORMATION
OTHER INFORMATION:
PREPARATION INFORMATION:
DISCLAIMER:
The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a
guide. The information in this document is based on the present state of our knowledge and is applicable to the
product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the
product. BioVision, Inc., shall not be held liable for any damage resulting from handling or from contact with the
above product. See reverse side of invoice or packing slip for additional terms and conditions of sale.
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Material Safety Data Sheet
Yeast extract MSDS
Section 1: Chemical Product and Company Identification
Product Name: Yeast extract

Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396

Catalog Codes: SLY1108
CAS#: 8013-01-2

US Sales: 1-800-901-7247
International Sales: 1-281-441-4400

RTECS: ZF6610000
TSCA: TSCA 8(b) inventory: Yeast extract

Order Online: ScienceLab.com

CI#: Not available.
Synonym:

CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300

Chemical Name: Not available.

International CHEMTREC, call: 1-703-527-3887

Chemical Formula: Not available.

For non-emergency assistance, call: 1-281-441-4400

Section 2: Composition and Information on Ingredients
Composition:
Name

CAS #

% by Weight

Yeast extract

8013-01-2

100

Toxicological Data on Ingredients: Not applicable.

Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of
inhalation.
Potential Chronic Health Effects:
Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation. CARCINOGENIC
EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.

Section 4: First Aid Measures
Eye Contact: Immediately flush eyes with running water for at least 15 minutes, keeping eyelids open. Cold water may be
used.
Skin Contact:
p. 1

After contact with skin, wash immediately with plenty of water. Gently and thoroughly wash the contaminated skin with running
water and non-abrasive soap. Be particularly careful to clean folds, crevices, creases and groin. Cold water may be used.
Cover the irritated skin with an emollient. If irritation persists, seek medical attention. Wash contaminated clothing before
reusing.
Serious Skin Contact: Not available.
Inhalation: Allow the victim to rest in a well ventilated area. Seek immediate medical attention.
Serious Inhalation: Not available.
Ingestion:
Do not induce vomiting. Loosen tight clothing such as a collar, tie, belt or waistband. If the victim is not breathing, perform
mouth-to-mouth resuscitation. Seek immediate medical attention.
Serious Ingestion: Not available.

Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available. Flash
Points: Not available.
Flammable Limits: Not available.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not available.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.

Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the
contaminated surface and allow to evacuate through the sanitary system.

Section 7: Handling and Storage
Precautions:
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the residue under a
fume hood. Ground all equipment containing material. Do not breathe dust.
Storage:
Keep container dry. Keep in a cool place. Ground all equipment containing material. Keep container tightly closed. Keep in a
cool, well-ventilated place. Combustible materials should be stored away from extreme heat and away from strong oxidizing
agents.

p. 2

Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection: Safety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.

Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Granular solid.)
Odor: Characteristic. Taste: Not
available.
Molecular Weight: Not available. Color:
Yellowish.
pH (1% soln/water): Not available. Boiling
Point: Not available. Melting Point:
Decomposes.
Critical Temperature: Not available. Specific
Gravity: Not available. Vapor Pressure: Not
applicable. Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available. Ionicity
(in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility: Easily soluble in cold water.

Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Not available.
Incompatibility with various substances: Not available.
Corrosivity: Non-corrosive in presence of glass.
p. 3

Special Remarks on Reactivity: Not available.
Special Remarks on Corrosivity: Not available.
Polymerization: No.

Section 11: Toxicological Information
Routes of Entry: Not available.
Toxicity to Animals:
LD50: Not available. LC50: Not available.
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans: Nuisance dust.

Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The products of degradation are more toxic.
Special Remarks on the Products of Biodegradation: Not available.

Section 13: Disposal Considerations
Waste Disposal:

Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.

Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Yeast extract
Other Regulations: Not available..
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
p. 4

This product is not classified according to
the EU regulations.
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Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or
equivalent. Safety glasses.

Section 16:
Other Information
References
: Not
available.
Other Special
Considerations: Not
available.
Created:
10/10/2005
08:33 PM
Last Updated:
05/21/2013 12:00 PM

The information above is believed to be accurate and represents the best information currently
available to us. However, we make no warranty of merchantability or any other warranty, express or
implied, with respect to such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the information for their particular
purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third
party or for lost profits or any special, indirect, incidental, consequential or exemplary damages,
howsoever arising, even if ScienceLab.com has been advised of the possibility of such damages.

Appendix C – Vendor Sheets

600 Main Street, Sharpsville PA 16150
T

Specific Equpiment Specifications & Pricing:

130L, Dished Top and Bottom Heads, 316L Stainless Steel, 10-15 Ra ID,
Electropolished, welds ground smooth and flush. 32 Ra AVG OD with welds ground
smooth and flush. Top head has (2) 2” Tri-Clamp Ferrules, (1) 1” Ferrule, and (1) 6”

Hand Hole. Agitator Flange is (1) 6” 150# RFSO Flange for LIGHTNIN XP650
Agitator with Hydrofoil Impellers. Vessel is ASME Rated for 30 psig @ 250F, Jacket is
Dimple Style and rated for 150 psig @ 250°F
$19,765.00……lead time is 10-12 weeks ARAD
3250L, Dished Top and Bottom Heads, 316L Stainless Steel, 10-15 Ra ID,
Electropolished, welds ground smooth and flush. 32 Ra AVG OD with welds ground
smooth and flush. Top head has (2) 2” Tri-Clamp Ferrules, (1) 1” Ferrule, and (1) 18”
Manway. Agitator Flange is (1) 8” 150# RFSO Flange for LIGHTNIN XP650 Agitator
with Hydrofoil Impellers. Vessel is ASME Rated for 30 psig @ 250F, Jacket is Dimple
Style and rated for 150 psig @ 250°F
$51,995.00……lead time is 18-20 weeks ARAD
Add Bottom Entry STERIDOSE Magnetic Drive Mixer………………..$16,795.00
80,000L Dished Top and Bottom Heads, 316L Stainless Steel, 10-15 Ra ID,
Electropolished, welds ground smooth and flush. 32 Ra AVG OD with welds ground
smooth and flush. Top head has (8) 2” Tri-Clamp Ferrules, (7) 1” Ferrule, and (1) 24”
Manway. Agitator Flange is (1) 12” 150# RFSO Flange for LIGHTNIN XP Agitator
with Hydrofoil Impellers. Vessel is ASME Rated for 30 psig @ 250F, Jacket is Dimple
Style and rated for 150 psig @ 250°F
$302,765.00……lead time is 24-26 weeks ARAD
80,000L (Storage Vessel) Flat Top and Sloped Bottom, 316L Stainless Steel, 32 Ra
AVG ID, welds ground smooth and flush. 32 Ra AVG OD with welds ground smooth
and flush. Top head has (8) 2” Tri-Clamp Ferrules, (10) 1” Ferrule, and (1) 24”
Manway
$79,650.00……lead time is 16-18 weeks ARAD
Harris E. Rogner- Sales Engineering Manager
Sharpsville Container Corporation |hrogner@scacon.com
600 Main St. Sharpsville, PA 16150 | (C) 330.647.8205 (P) 724.962.1100 x 105 | (F) 724.962.1169

Media Filters
http://www.sartorius.us/us/product/product-detail/5442507i2/

TPDX028-0811

CONVERT
AMORPHOUS PET
TO USABLE
CRYSTALLINE
MATERIAL

CR Series

RELIABLE, HIGH-QUALITY MATERIAL OUTPUT

TPDX028-0811

S P E C I F I C AT I O N S
Model CR4 and CR10

Model CR21 - CR135

Blower

E

D

A

A

FRONT VIEW

*

B

C

B

FRONT VIEW

SIDE VIEW

FRONT VIEW

MODELS
Performance characteristics
Throughput ft3/hr {l/hr}
Heater energy source
Air circuit
Dimensions inches {mm}
A - Overall crystallizer height
B - Overall crystallizer width
- Overall crystallizer depth
D - Blower height†

Approximate weight lbs {kg}
Crystallizer installed
Surge bin installed
Blower installed
Voltage total amps
230V/3 phase/60 Hz
400V/3 phase/50 Hz
460V/3 phase/60 Hz
575V/3 phase/60 Hz
Discharge type (via rotary air lock)
Surge bin 10 ft3{281 l/hr}
Surge bin 17 ft3 {481 l/hr}
Blower noise level

CR4†

CR10†

4 {113}

10 {283}

electric or natural gas electric or natural gas

F

C
SIDE VIEW

CR21†

CR42†

21 {595}

42 {1189}

electric or natural gas electric or natural gas

SIDE VIEW
CR85†

CR135†

85 {2407}

135 {3823}

electric or natural gas electric or natural gas

open or closed loop

open or closed loop

open or closed loop

open or closed loop

open or closed loop

open or closed loop

159.2 {4043.7}
66.0 {1676.4}
70.5 {1790.7}
NA NA
NA NA
NA NA

169.0 {4292.6}
66.0 {1676.4}
75.0 {1905.0}
37.8 {960.1}
32.5 {825.5}
68.4 {1734.4}

192.5 {4889.5}
69.0 {1752.6}
70.1 {1780.5}
37.8 {960.1}
32.5 {825.5}
70.4 {1788.2}

226.8 {5760.7}
79.1 {2009.1}
81.4 {2067.6}
37.8 {960.1}
32.5 {825.5}
77.5 {1968.5}

261.8 {6649.7} 281.1 {7139.9}
86.3 {2192.0}
98.3 {2496.8} C
94.2 {2392.7}
106.3 {2700.0}
45.8 {1163.3} E - Blower width†
37.5 {952.5} F - Blower depth†
80.6 {2047.2}

2863 {1299}
270 {122}
NA NA

3130 {1420}
270 {122}
700 {318}

3315 {1504}
650 {295}
800 {363}

4422 {2006}
650 {295}
900 {408}

6590 {2989}
650 {295}
1100 {499}

7754 {3517}
650 {295}

38.8
22.3
19.3
15.5

NA
55.6
48.4
38.7

NA
107.5
93.5
74.8

NA
159.1
138.4
110.7

NA
292.5
254.4
203.5

NA
305.3
265.5
212.4

standard
NA

standard
NA

standard
NA

NA
standard

NA
standard

NA
standard

<90 dbA @5 ft.

OPTIONS

SPECIFICATION NOTES:

■

* Shown with optional cyclone mounted on stand this applies to model CR4 only.

■
■
■

†

The blowers on models CR4 and CR10 are located on the stand. Blowers on
models CR21, CR42, CR85 and CR135 are independent of the stand, adequate
space will need to be planned for positioning of the blower on these models.

Specifications may change without notice. Consult a Conair representative for the
most current information.

■
200 West Kensinger Drive ● Cranberry Township, PA 16066 ● 724-584-5500 ● fax 724-584-5299 ● www.conairgroup.com
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Distillation Columns - uOP3

NEW & IMPROVED UOP3CC + UOP3BM
New: LabVIEW™ software options
Unique* eight point sample & feed sieve plate column sections
S a m p l e & f e e d p o i n t s a t eve r y t r a y
C o l u m n c a n u s e f l a m m a b l e s o l ve n t s
C o l u m n s e c t i o n s a v a i l a b l e a s a r e t r o f i t t o ex i s t i n g U O P 3 u n i t s

Considerable advances in the instrumentation and
control of distillation columns have been made in
recent years, prompted by the advent of computerlinked systems supported by software packages
for handling plant operating data. To reflect these
advances, Armfield has developed two new stateof-the-art laboratory-based distillation columns
that enable safe hands-on practical training for
student engineers and plant operators:© Armfield Ltd. 2012

> A continuous or batch operation, computercompatible column (model reference UOP3CC),
which enables a full range of demonstrations
from the introductory stages of a process
engineering course through to the more
complex demonstrations of modern control
strategies.
> A batch-only operated version (model reference
UOP3BM) manually controlled, permits
comprehensive study of the basic principles of
distillation.
> Both units are designed for safe options
using flammable solvents.
The Armfield UOP3CC and UOP3BM have been significantly
improved with the addition of sampling ports on each of
the trays.
Previously, the thermocouple was
removed in order to take a sample.
The new sampling ports enable vapour
or liquid samples to be drawn from each
of the sieve plates by simply inserting a
hypodermic needle into the septum seal
whilst the distillation is in full, continuous
operation. In addition, sample ports can
be utilised as additional feed positions on
each sieve plate.

en vir™ o

The ports are now fitted as standard, and
are available as a retrospective install
to existing UOP3CC & UOP3BM units.

PRODUCT
S

<E X T E N D E D >
2-YR
WA
R
R

2years

A TYO

Contact Armfield for more details.
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Above: Computer interfaced distillation column UOP3CC shown with safe area console

This data sheet is available online at:

w.armfield.co.uk/uop3

issue8

Fig. 1: Column pressure drop as a function of
boil-up rate

Fig. 2: Column overall efficiency as a function of
boil-up rate

Fig. 3: McCabe-Thiele construction for batch
distillation at total reflux (methylcyclohexane-toluene
mixture, atmospheric pressure, boiler power 1.0kW)

LABORATORY WORK ASSIGNMENT CAPABILITIES
For Batch Distillation Column UOP3BM under manual control:
n pressure drop across the column as a function of
boil-up rate (Fig. 1)
n column efficiency as a function of boil-up rate, at
total reflux (Fig. 2)
n plate-to-plate temperature profiles along the column
n McCabe-Thiele construction of operating line (Fig. 3) n
distillation at constant reflux ratio: variation of top
product composition with time (Fig. 4)
n mass balance across the system
n manual control of reflux ratio, for example to achieve
a top product of specified composition
n comparison of packed column with sieve plate
column performance
Note: These capabilities can also be performed with UOP3CC.

Fig. 7: Reflux separator during azeotropic distillation of a water/organics mixture

© Armfield Ltd.
2012

Training on the UOP3CC.
One-to-one and group training is available at Armfield or at point of installation.

Close-up of new column section

Fig. 4: Batch distillation:
variation of composition with time at fixed reflux ratio of 5:1 (methylcyclohexane-toluene mixture, atmospheric pressure, boiler power 1.1kW)

For Computer-Interfaced Distillation Column UOP3CC only
- continuous operation, manual or computer operation:
n includes all demonstrations listed for UOP3BM
under 'Batch Distillation Column'
n continuous, steady state distillation including
temperature profiles and McCabe-Thiele analysis
n distillation under reduced pressure conditions
(Fig. 5 - page 6)

n comparison of packed and plate column
continuous operation (Table 1)
n effect of feed pre-heat (Fig. 6)
n effect of feed position (Table 2)
n demonstration of azeotropic distillation (Fig. 7)
n computer control assignments:
- the on-line use of mimic diagrams (Fig. 8)
- setting up data logging and subsequent analyses of
captured data, including use of spreadsheets (Fig. 9)
- batch distillation at constant reflux ratio
(Fig. 10 - page 6) or varying with time
- batch distillation with reflux ratio control from a
column temperature (Fig. 11 - page 6)
- continuous distillation with three-term control of
reboiler heater from a column temperature
- continuous distillation with top temperature
controlling reflux ratio
- continuous distillation with temperature control of
reboiler heater and reflux ratio (two- loop control system)
- optimum controller settings for changes in feed rate,
composition or temperature
- alternative, user-originated control algorithms
- process dynamics e.g. monitoring and controlling plant
start-up/shut down for continuous operation

UOP3CC Safe area console

n proprietary controller demonstrations:
- PLC control of reboiler heater and/or reflux ratio and
alarm functioning (requires Armfield PCT19BR unit
incorporating an industry-standard PLC) (Figs. 13 & 14)
- demonstration of PC supervision of PLC and PID
controllers - an introduction to distributed control
systems
- PID analog control of reboiler heater from column
temperature (requires Armfield PCT20H unit
incorporating an industry-standard controller

Fig. 8: On-line mimic diagram during batch distillation at constant reflux ratio
[Table]

Acknowledgements:
Figs 1, 2, 3 and 4 and Table 2: Results taken from Armfield UOP3CC Distillation
Column in the Process Laboratories of the Department of Chemical Engineering,
University of Aston, U.K. courtesy of Dr. J. D. Jenkins

Fig. 9: Typical results displayed in tabular format

DESCRIPTION
Batch Distillation Column (Manual) UOP3BM
The unit is a self-contained and fully instrumented
distillation facility, suitable for practical laboratory
work relevant to the teaching of unit operations.
The equipment employs galvanically isolated intrinsically
safe circuits and flameproof devices as appropriate, to
enable safe distillation of standard test mixtures such as
methylcyclohexane-toluene, methyl alcohol-water etc.
The equipment consists of two interconnected units:
a floor standing process unit and a bench-mounted
control console.
The following features are included:
Process Unit
n a 50mm diameter plate distillation column containing
eight sieve plates and downcomers. Every plate includes
a temperature sensor positioned to measure accurately
the temperature of the liquid on each plate. The sheaths
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of each plate temperature sensor are not more than
1.5mm diameter, to ensure rapid dynamic response.
n a 50mm packed column supplied as a separate item,
but readily interchangeable with the plate column by
the user, for comparative studies of the two types of
distillation column.
n electrically heated reboiler of sufficient capacity for up
to two hours of batch operation. The reboiler heater is
protected against overheating and by a low level alarm.
n an overhead condenser with cooling water flow
measurement and adjustment.
n a condensate collecting vessel, equipped with double
overflow weirs and exit pipes to enable separation of
immiscible liquids.
n a reflux return valve, solenoid operated, to provide for
0%-100% reflux, adjustable by electrical signal.
n a differential manometer connected to the top and
bottom of the column, to monitor column pressure drop.
n a vacuum system with gauge to enable distillation
studies at reduced pressures down to 200mbar(abs).
n sampling points throughout the system for
composition analyses.
n materials of construction for surfaces in contact with the
process fluids are; glass, stainless steel, PTFE or similar
solvent-resistant materials.
n overall height of the process unit does not exceed 2.5
metres (8.2ft).
n lagging is provided, although it is possible to see at least
one plate in operation with distillation in progress.
n maximum operating temperature inside the column
operation is at least 130 ˚C.

Reboiler
Heater

Heat
exchanger

Vent

Feedpump
Bottom product
receiver

Temp sensor
UOP3CC Only
Schematic diagram of Armfield distillation columns

Control Console
n monitoring and selectable display of at least 13 system
temperatures, including those of the liquid on each tray,
the reboiler and across the condenser.
n monitoring, display and manual adjustment of:
i) the electrical power to the reboiler heater.
ii) the reflux ratio setting.
n front panel connections to enable the user to connect
0-5 Volt industry-standard analog or programmable
logic controllers, to provide on-line control of the boilup rate or reflux ratio from chosen column temperature
measurements. The connection points also permit
the use of standard laboratory chart recorders and
data loggers. (Up to two temperature measurements
simultaneously).
n mains power connection (single phase 3kW max. supply)
protected by Residual Current Device. No-volt protection
safety circuits to prevent unintentional start-up.
n individual circuits protected against excess current with
resetable circuit breakers.

DESCRIPTION
Computer-Interfaced Distillation Column UOP3CC
This unit incorporates all the features of the manually
operated batch column described on opposite page
(UOP3BM) but includes the following additional items:
Process Unit
n two 5 litre feed vessels, with rapid changeover to permit
step changes in feed composition to be made.
n peristaltic feed pump, range 0-0.25 litres/minute
adjustable by voltage input variation to the pump
motor controller.
n electrically heated reboiler of sufficient capacity for onetwo hours of batch operation, but equipped with an
internal overflow when continuous operation is required.
n a bottoms product heat exchanger which may either be
water cooled or used as a (variable) feed pre-heater.
n alternative column feed points and the ability to vary the
inlet feed temperature to the column.
n dosing feed vessel, connected to the column for the
continuous addition of a third liquid component, which,
together with the condensate phase separator vessel,
enables the study of azeotropic distillation.
n temperature sensors in each flow stream entering and
leaving the condenser and of the feed, product system
and reboiler temperatures.
Control Console
n monitoring and selectable display of at least 14 system
temperatures, including those of the liquid on each tray,
the reboiler, across the condenser, and of the feed and
product streams.
n monitoring, display and manual adjustment of:
i) the electrical power to the reboiler heater.
ii) the reflux ratio setting. iii) the feed rate
setting.
n ribbon cable connector at rear of the console allows
the use of standard laboratory chart recorders and data
loggers (all measurements simultaneously).
n USB connector at the rear of the unit allows connection
to a user supplied PC, via the integral USB interface.
n remote/manual switch is provided on the front panel of
the console to enable simple changeover from PC to front
panel control to be made by the operator.
n power and motor control circuits shut down automatically
with loss of computer control signals (when in computer
control mode).

SOfTWARE

PID controller screen from Armfield software

Armsoft 306 software included as standard
n bespoke Armsoft-306 Windows based software, enables
real time data acquisition via USB port, mimic diagram
of process tabular and graphical display of results, and
export to external spreadsheet.
n fully configurable, multiple loop control strategies.
control options include:
i) manual control of feed rate, reboiler power and
reflux ratio.
ii) alarm setting.
iii) adjustable PID control of the power to the
reboiler heater from a temperature sensor.
iv) alternative algorithms for controlling the
reflux ratio, in particular by programmed
variation with time and from a column
temperature.
v) 'two point' temperature control of reboiler
power and reflux ratio simultaneously.
n full help facilities including presentation screen to provide
a brief overview of the equipment, and detailed texts
giving all the information required to run the experiments.
LabVIEW software
n as an alternative to the Armsoft-306 software, the
software to control the UOP3CC can be supplied in the
LabVIEW™ format. Two versions are available:
- UOP3CC-LV-RT is a run time version of the
software. It does not require that LabVIEW™ is
installed on the computer and requires no further
license to run the software.
- UOP3CC-LV-SC is aimed at experienced LabVIEW™
developers. It includes all the source files so that
users can amend the software and optimise it to
their own requirements. To use UOP3CC-LV-SC,
the National Instruments LabView development
program must be installed on the computer
(i.e.. NI Developer Suite 2012), complete with all
appropriate licenses. (Armfield do not supply the
National Instruments software).

Fig. 14: Hard copy of results

Distillation column control using an Armfield PCT19BR Industrial PLC Unit
Comparison of batch distillation for different
reflux ratio control strategies

Effect of operating parameters on column temperature profile

(Feed rate of 60ml/min, 60% trichlorethylene/40% methylene
chloride, boiler power 0.75kW, reflux ratio 2:1)

Fig. 10: Constant reflux ratio
Fig. 5: Effect of reduced pressure

Fig. 11: Reflux ratio controlled by top plate
temperature

Measurements in

Temp. of
top plate

Fig. 6: Effect of feed pre-heat

feed to top of column

Temp. of
boiler
Time

Packed column

48.4˚C

82.5 ˚C

Plate column

48.0˚C

85.0 ˚C

Conditions:
Feed: 60ml/min of 60:40 trichlorethylene/methylene
chloride
Reboiler power: 0.75kW
Reflux ratio: 2:1
Ambient feed temperature: 17˚C
Atmospheric pressure.

Table 1: Comparison of temperatures across packed and
plate columns

Compositions, m.f. MCH
Feed Overheads
Bottoms

Power Reflux
Input, kW
Ratio

Temperatures, ˚C
Reboiler
O/H Line Top Plate

13.40 0.293
15.00
15.15
15.20

0.472

0.088

15.35

0.464

0.097

15.50

0.481

0.107

15.30

0.79
0.77

2:1
2:1

108.8
108.4

103.4
103.0

103.5
102.7

0.79

2:1

107.1

102.9

103.6

0.75

2:1

107.4

103.0

103.6

Table 2: Results for an alternative feed position

PCT19BR Industrial PLC controller

PCT20H Industrial PID controller

INSTALLATION REQUIREMENTS
Solvent resistant level floor.
Either a flameproofed room or in an area where a 2 metre
clear and uninterrupted space on each and every side
and above the unit can be maintained and into which no
potentially spark producing equipment should be allowed
to enter.
Electrical supply:
UOP3BM-A:
UOP3BM-B:
UOP3BM-G:
UOP3CC-A:
UOP3CC-B:
UOP3CC-G:

220-240V/1ph/50Hz @ 13A
120V/1ph/60Hz @ 25A
220V/1ph/60Hz @ 13A
220-240V/1ph/50Hz @ 13A
120V/1ph/60Hz @ 25A
220V/1ph/60Hz @ 13A

Cold water supply:
15 litres/min at 2.0bar pressure (min.)
Venting:
exhaust line to fume cupboard or to safe discharge area
outside of laboratory.
NB: The distillation unit is floor mounted and is supplied
already connected to the bench- mounting control
console by sufficient armoured cable to allow the 2m
clear space to be maintained around the column.

ESSENTIAL ACCESSORIES
Analytical equipment, suitable for composition
analyses of any particular liquid mixture selected by
the user (e.g. refractometer).
For UOP3CC only:Windows PC with USB port. (not supplied by Armfield)
Note: It is not possible to upgrade a UOP3BM unit
to a UOP3CC unit, owing to the complexity of the
flameproof barriers within the UOP3CC control console.

PCT19BR:
PLC unit incorporating Allen Bradley SLC500 complete
with proprietary ladder logic set-up program (requiring
user-supplied PC). This program is initially configured
by Armfield for two analogue input/output control loops
suited to the UOP3 Distillation Column unit (either BM
or CC versions), but may be re-configured by users via
their PC.
PCT20H:
PID controller, incorporating a Honeywell UDC3300
series unit, with voltage/mA input and output for
single loop control and alarm configurations. Suitable
for both UOP3BM and CC versions. A software
package is supplied on disk to demonstrate the basic
principles of SCADA whereby a user-supplied PC can
address the PID controller on-line.

DISCOVER

WITH

ORDERING SPECIfICATION - UOP3BM
Batch Distillation Column (manual):
• Self-contained sieve plate distillation column unit including
reboiler, condenser and reflux tank, suitable for use with
flammable solvents and fully instrumented for batch operation
• Eight feed and sample points

ORDERING SPECIfICATION - UOP3CC
Computer-interfaced Distillation Column:
• Self-contained sieve plate distillation column unit including
feed vessels and pump, reboiler, condenser, reflux separator,
product collecting tanks, bottoms product cooler/feed preheater, suitable for use with flammable solvents and fully
instrumented for both batch and continuous operation
• Eight feed and sample points

• Temperatures throughout the process including those on each
and every sieve plate are monitored and displayed on a bench
mounted control console, via a selector switch. The console
also houses controls for the power supplied to the reboiler
heater and for reflux ratio settings between 0 and 100%
• The console front panel connections enable the use of
standard laboratory recorders and data loggers and of
industry-standard PID and PLC controllers (not supplied)
• A U-tube manometer is incorporated to measure
pressure drop over the distillation column
• The 50mm diameter sieve plate column may be readily
interchanged with a packed column supplied as an alternative
• A vacuum system enables operation at reduced
pressures down to 200mbar(abs)
• The unit is supplied completely assembled including
lagging, and a comprehensive instruction manual describes
commissioning, maintenance and instructional assignments

• Temperatures throughout the process including those on each
and every sieve plate are monitored and displayed on a bench
mounted control console, via a selector switch. The console
also houses controls for the power supplied to the reboiler
heater and for reflux ratio settings between 0 and 100%
• The console front panel connections enable the use of
standard laboratory recorders and data loggers and of
industry-standard PID and PLC controllers (not supplied)
• The console is designed to be connected to a PC
(not supplied), and software is provided to enable
on-line data logging, real time trend monitoring and
PID control loops to be set up, monitored and
configured by the user via a mimic diagram
• A U-tube manometer is incorporated to measure
pressure drop over the distillation column
• A vacuum system enables operation at reduced
pressures down to 200mbar(abs)
• A third feed vessel is supplied such that, with the reflux
phase separator, azeotropic distillation may be demonstrated

OVERALL DIMENSIONS
Process Unit:
Control Console:
Height: 2.25m
Height: 0.30m
Width: 0.85m
Width:
0.52m
Depth: 0.80m
Depth: 0.40m

• The 50mm diameter sieve plate column may be readily

interchanged with a packed column supplied as an alternative

• The unit is supplied completely assembled including

lagging, and a comprehensive instruction manual describes
commissioning, maintenance and instructional assignments

SHIPPING SPECIfICATION
Packed Volume:
Gross Weight:

3.4m³
425kg

OVERALL DIMENSIONS
Process Unit:
Height: 2.25m
Width: 0.85m
Depth: 0.80m
306

Control Console:
Height: 0.42m
Width:
0.52m
Depth: 0.40m

SHIPPING SPECIfICATION

64/32 BIT CompaT l

Packed Volume:
Gross Weight:

3.5m³
450 kg

Ar-mSofIBte™
Armsoft 306 - 64/32-bit Windows compatible software
FOR FURTHER INFORMATION ON THE ADVANCED FEATURES
OF THE SOPHISTICATED ARMFIELD SOFTWARE VISIT:
D
PRO
DP
RO DUDCC
UTSTS
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ArmSoft™
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*Armfield UOP3CC and UOP3BM are the the only units on the market with this
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Pharmaceutical
industry equipment

Reactor
The processes in the pharmaceutical industry
have the highest and most precise requirements in terms of quality. In result, suppliers
of pharmaceutical equipment should comply
with the highest requirements in accordance
with GMP. Biomashin produces and supplies
pharmaceutical equipment in accordance
with Good manufacturing Practice (GMP) and
accompanied by validating documentation IQ,
OQ, FAT, SAT inclusively. For reactors with maximum allowable working pressure > 0.5 bar we
offer product certification in accordance with
PED 97/23/EC.
Reactors are used for heat treatment, stirring,
mixing and treatment of liquid and creamy
components, living organisms inclusively, as
well as active biochemical ingredients. Leading producers in the pharmaceutical industry
use our reactors to produce infusion solutions,
gels, etc.

Reactor, basic design
n

Made of stainless steel AISI 316L/AISI316Ti

n

Wide range of volumes

n

Surfaces in contact with the product Ra
1.6÷0.4 µm

The pharmaceutical and cosmetic industry
requires complex process tanks and solutions

n

Ability to work under pressure and vacuum

consisting of different aggregated systems

n

Heat-exchanging device - inner or outer
serpentine

n

Agitator/Stirring mechanism in accordance with the application of the reactor,
viscosity and density of the product

n

Insulation with mineral wool or PU-foam,
covered with fully welded insulation cladding

n

Safety armature and electro-sensors for
control of the process

with various configurations.
Biomashinostroene AD has a wide product
range of tanks and apparatuses for the pharmaceutical industry. We use the latest inventions in terms of engineering and production
of such equipment.
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The application of the mixing & melting tanks
is for heat treatment, mixing and treatment of

Mixing & Melting Tanks

Tanks - Homogenizer

Mixing and melting tanks, basic design

The term "homogenization" means a process of emulsification of the
fluid in another or uniform dispersion of solids in a liquid to increase

liquid and creamy products.

n

Made of stainless steel AISI 316L/AISI304

density, stability, durability, aroma and other qualities of the products.

Melting tanks are used in the cosmetics industry to melt aqueous and oil phase when pro-

n

Volumes from 100l to 1000l

n

Surfaces in contact with the product Ra 1.6÷0.4 µm

Biomashin offers tanks for homogenizers for cosmetic emulsions used
for production of creams, gels, tooth paste, cleansing milk, etc.

n

Ability to work under pressure and vacuum

n

Heat-exchanging device - dimple jacket or outer serpentine

ducing cosmetic products.

Tanks - Homogenizer, basic design

made of half pipe
n

Agitator/Stirring mechanism in accordance with the product

n

Insulation with mineral wool or PU-foam, covered with fully
welded insulation cladding

n

4

n

Made of stainless steel AISI 316L/AISI316Ti

n

Surface in contact with the product Ra 1.6÷0.4 µm

n

Volume from 100 to 1000l

n

Ability to work under pressure and vacuum

n

Heat-exchanging device - outer serpentine

n

Insulation with mineral wool or PU-foam,
covered with fully welded insulation cladding

Armature and electro-sensors for control of the process
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Containers

S&T heat-exchangers

The containers that Biomashin offers and produces have various applications - servicing, storage, stirring/mixing, and transportation of

S&T heat-exchangers are widely spread. Their simplified design makes
them a perfect solution when it comes to heating or cooling processes

pharmaceutical products. They could be used for powdered products,

for wide application.

granules, capsules, or tablets.
We offer a variety of types and volumes that correspond to the different needs. Our containers are designed in such a way, so that they

Biomashinostroene AD is equipped with up-to-date machines suitable
for the production of S&T heat-exchangers made of stainless steel. We
have highly efficient equipment for the production of plates. To fix the

could be serviced by pallets or forklifts with maximum solidity, preci-

tubes to the plates, we use specialized instruments as well as auto-

sion and durability.

matic orbital welding heads.

Biomashin produces and supplies pharmaceutical containers in accordance with Good Manufacturing Practice (GMP) and accompanied by

Biomashin's equipment and technologies, as well as experience, allow
us to cover all hygiene standards for heat-exchangers used in the phar-

validating documentation IQ, OQ, FAT, SAT inclusively.

maceutical and food industries.
For heat-exchangers working under pressure we offer product certification in accordance with PED 97/23/EC. During their construction we
apply the European norm for design EN 13445 or AD -2000 Merkblaet-

Containers, basic design
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n

Made of stainless steel AISI 316L/AISI 304

n

Surfaces in contact with the product Ra 1.6÷0.4 µm

n

Ability of insulation with mineral wool and fully
welded insulation cladding

ter.
Biomashinostroene AD covers the highest levels of quality of welded
joints with the support and supervision of our welding control and
quality control.
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Quality and Environment
The management of Biomashin builds a corporate culture aimed at creating quality products and mentality towards meeting customers' needs and bringing satisfaction.
Consequently, the following certificates are implemented
in the company:
n

System for Quality Control ISO 9001:2008 which is permanently and precisely controlled and upgraded

n

Product certification in accordance to the Pressure
Equipment Directive EC 97/23/EG - PED

n

A system for Occupational Health & Safety Advisory
Services: BS OHSAS 18001:2007

n

GOST-R - a quality certificate in accordance to the
requirements of the Russian Federation

n

RTN (Russian Technonadzor) for producing vessels under pressure in accordance to the requirements of the
Russian Federation

These certificates allow Biomashin to export and legitimate its products on the territory of the European Union,
Switzerland, Russia and the countries from the former Soviet
Union, as well as many others.

Excellent performance.
Biomashinostroene AD
Bulgaria - 4003 Plovdiv 160
Vassil Aprilov Blvd. tel.
+359 (32) 951 603 tel.
+359 (32) 961 634
office@biomashin.com
www.biomashin.com
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1. Filling

2. Filtering

3. Displacement washing

Process steps
Filters and Filter/Dryers

4. Reslurry washing

5. Smoothing

6. Drying/cooling

7. Discharging

Products and
services
A closely linked system of
innovative products and effective services
is the guarantee for complete success.
For customers as well as for Rosenmund!

Rosenmund offers a comprehensive range of innovative
products that meet the highest standards of quality for the
pharmaceutical and chemical industry: from separators
for solid and liquid materials to high-performance filter
systems and dryers to engineered systems.

In addition, Rosenmund offers a
complete range of control systems
for all products: manual,
Filter/Dryers
semi-automatic or fully
Universal Dryers
automatic systems
Pan Dryers
Filters
via PLC/DCS. This wide
Spherical Dryers
range of products is
Engineered
Systems
perfectly supplemented
by
a comprehensive
Gas circulation
Evaporation and
range
of services,
concentration
systems
for which highly motivated
and qualified specialists are
available
around the globe.
Rosenmund divisions

Range of services:
Testing
Process assistance
Installation
Commissioning
Qualification
Training
After-sales services

Range of products:
Engineered systems
Separation & drying of liquid and solid material:
Filters · Filter/Dryers · Dryers
The following materials are available for manufacturing:
Stainless steel · Hastelloy · Alloy · Glass-Lined
Heating/Cooling systems
Vacuum systems
Gas recirculation systems
Control systems
Product discharge and containment systems
Pilot Plant Facility
Rosenmund spherical dryer 1000 l

All electrical and mechanical Rosenmund
devices are in conformance with ATEX 95
(European directive 94/9/EC).
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Spare parts and rental program:
A wide range of rental machines
Recycling & range of used products
On-site service & maintenance program
Spare parts service
World-wide service centres local to customers

Progress by
tradition
Advanced technologies
have a long tradition at
Rosenmund.
For almost 200 years, Rosenmund has been known for
innovative products that are accompanied by first-rate
performance in service and customer support.
The company was founded in Liestal/Switzerland in 1810, and
today it is an extremely successful technology leader in the
global market.

Rosenmund VTA AG
Liestal, Switzerland

Rosenmund S.A.S.
Semur-en-Auxois, France

1971

First vacuum filter 1965

Rosenmund has acquired an excellent reputation with
pioneering developments such as the very first Filter/Dryer,
and it has consistently increased its technological lead
since then. Today, Rosenmund is one of the world's best
known manufacturers of mechanical separators, filters,
dryers, and engineered systems for the pharmaceutical and
chemical industry. And this committed company puts all
its effort into extending this lead even further
in the future!

Milestones
1810 Foundation of the company
1965 First vacuum filter
with mechanical discharge
1969 First automatic pressure filter
with mechanical discharge
1970 First pilot plant 1976
First Filter/Dryer
1981 First Nutrex reactor/Filter/Dryer
1981 First sterile Filter/Dryer
1984 First paddle filter, Filter/Dryer
with contact drying
1985 Basel innovation prize for Nutrex system
1994 ISO 9001 certification
1994 1,000th machine produced
1995 Acquisition of the
Guedu company (France)
1995 First Spherical Dryer 1999
Rosenmund becomes
a subsidiary of
De Dietrich (France)
2001 Acquisition of Glatt Inox
dryer technology
Rosenmund is active worldwide

a
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ahead
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Filters and Filter/
Dryers
The elementary advantages
of the innovative Rosenmund filter
and Filter/Dryer technology:
• Optimum efficiency
• Professional high performance
• Total flexibility • Easy cleaning
(CIP/WIP and SIP).

Whether in the chemical, pharmaceutical or food
industry - Rosenmund filters and Filter/Dryers
prove themselves through a very high efficiency in
washing and isolating solids, even in the most
difficult production processes. The high-performance
Rosenmund filters can also be converted to
Filter/Dryers simply and quickly, by the addition of
upgraded features.

Side discharge.
The ideal application spectrum for side discharge:
Multi-purpose production with frequent product changes.
Processes with stringent
requirements for lowparticle and
sterile production.
Limited building heights.
Special design features:
Side discharge valve with
metal-to-metal seal.
Side discharge valve for pressure-tight closure
after each product discharge - without prior
cleaning of the sealing areas! Ideal for automatic
process control and contamination-free production.
Rosenmund Easiclean side discharge valve for
manual cleaning in the case of difficult products.
Two- or three-blade agitator for an efficient agitation
and discharge process.
Quick-lock bayonet or C-clamp main flange closure.

Rosenmund
Filter/Dryer 0,4 m2

Side discharge valve

Total discharge with the
Gas Knife system.
The Rosenmund Gas Knife
is a unique and innovative
solution that enables
a total product
discharge without
manual intervention.

Gas Knife System

Rosenmund Filter/Dryer 2 m2 sterile version

Glass-Lined Filter/Dryer.
The great demand for non-corrosive Filter/Dryers
led to this joint development between De Dietrich and
Rosenmund. The innovative Glass-Lined/Hastelloy
construction guarantees maximum resistance to
chemical solutions and aggressive solvents.

Rosenmund Filter/Dryer 0.4 m2
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Rosenmund Filter/Dryer 0,4 m2

F

Cleaning and Decontamination
(CIP/WIP and SIP).
CIP/WIP and SIP systems are an integral part of
Rosenmund's process equipment range, including steam
sterilisation and aseptic use. The application of specialised
spray systems and sterilisation methods validation of the vessel
preparation process.

Special applications: microwave drying.
The use of microwaves for chemical processes
provides clear advantages:
Improved heat transfer to the product.
Volumetric and selective heating. No harmful
substances.
Gentle and fast drying of difficult products. Low
energy consumption.
Reduced drying times, especially in the case of
temperature-sensitive products and when conventional heat
transfer methods are difficult to apply.

2-blade agitator

D

Nominal
area m2
F
F/D
0,03
0,06
0,1
0,1
0,2
0,2
0,3
0,3
0,4
0,4
0,6
0,6
1
1
1,5
1,5
2
2
2,5
2,5
3
4
5
6
8
10
10
12
12

Used
volume l/m3
F
F/D
17
35
80
80
145
145
185
185
350
350
490
490
1,05
1,05
1,4
1,4
1,8
1,8
2,3
2,3
2,9
2,9
3,7
3,7
5,2
5,2
6,4
6,4
7,9
9,9
10,2
12,5
13,9
15,4

16
16
16,8
18,7
F = Filter
F/D = Filter/Dryer

Max. cake
volume l/m3
F
F/D
6
12
30
30
55
55
75
75
130
130
185
185
0,44 0,44
0,6
0,6
0,8
0,8
1
1
1,2
1,2
1,6
1,6
2,4
2,4
3
3
4
4
5,3
5,3
6,2
6,2

7,85 7,85

Drive
power kW
F
F/D
1,5
3
4
4
4
5,5
4
5,5
5,5
7,5
5,5
7,5
7,5
11
11
11
11
11
11
15
15
18,5
15
18,5
18,5 22
18,5 22
22
37
22
37
25
37

30

45

Rosenmund Filter/Dryer 0.4 m2

Empty weight
approx. kg
F
F/D
320
600
1000 1000
1500 1500
2000 2000
2500 2500
3000 3000
3500 3500
4500 4500
5000 5000
6000 6000
8000 8000
9000 9000
10000 10000
12000 12000
14000 14000
18000 18000
22000 22000

Container
D mm
F
F/D
203
288
400
400
550
550
630
630
750
750
900
900
1200 1200
1400 1400
1600 1600
1800 1800
2000 2000
2300 2300
2500 2500
2800 2800
3200 3200
3700 3700
4000 4000

H mm
F
F/D
1960
2670
1910 2240
2320 2560
2420 2660
2420 2660
2710 2940
3450 3850
3450 3850
3450 3850
3450 4150
3850 4200
3900 4250
4250 4750
4250 4750
4400 5450
4500 5100
5100 5250

S mm
F F/D
200
200
250 250
250 250
250 250
250 250
300 300
400 400
400 400
400 400
400 400 3
400 400 4
400 400 5
500 500 6
500 500 8
500 500
500 500
500 500

26000 26000

4500 4500

5100 5250

500 500
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Universal Dryer
The innovation: agitator
and chopper in one system.
The horizontal construction
with an integrated agitator/chopper
system and full-area heating
allows an unequalled application
spectrum and extremely short drying
times with the highest possible
fill volume.

The better the mixing, the more efficient the drying.
To achieve a maximum drying performance,
Rosenmund has integrated a high-speed rotating
chopper in one of the two agitator arms of the
horizontal dryer. This chopper moves through the
product with the agitator, efficiently breaking up
lumps of agglomerates (wet or dry) but also providing
additional mixing capability.

Fast drying through fullarea heating.
Maximum heat transfer input to the product is achieved
by heating the total vessel area and the agitator.
A further advantage is the formation of an especially
fine product powder in the dryer, which accelerates the heat
transfer and thus the drying. The particle size of
the product can be decrease further by the addition of a
fixed stator to the agitator system.

Wet or dry chopping.
Wet or dry chopping with the chopper/stator
combination can make further milling or sieving
steps unnecessary. The wet milling reduces the thermal
strain on the product. In addition, a good milling
effect is often achieved with an appropriate grain
size distribution. For products that are sensitive to
high-shear agitation, the chopper can be removed
quickly and easily.

Assembly:
Rosenmund Standard Dryer 4000 l

Huge flexible degree of filling
due to a high torque and a
very good mixing effect of the
agitator/chopper system.
Rosenmund
Universal Dryer 8000 l

Hydraulic drives for the agitator and chopper ensure
a consistently high torque, even with low rotational
speeds. Therefore the dryer can be filled between
20-90% of total capacity whilst retaining optimal
agitation, mixing and drying performance. This huge
degree of flexibility makes it possible to dry batch
sizes that have greatly varying volumes and products
that have greatly varying physical characteristics.
Regardless of whether you have suspensions, solutions
or filter-moist products - lumpy transition phases in
which the agitator and chopper require more power
can be easily overcome.

Agitator with chopper

F
Agitator with chopper
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Agitator to wall clearance
prevents crust formation and
product overheating.

Important advantages summarised:

The special construction of the agitator (results in a
typical wall clearance of 2-5 mm) therefore the entire
interior surface of the dryer is evenly coated. Crust
formation is therefore absolutely minimised and heat
is applied evenly to the product during the entire drying
process. Since the agitator is supported at both ends
of the shaft, it results smaller wall clearances than those
in spherical and pan dryers can be achieved whilst
maintaining the very high agitator torque!

• Chopper integrated in the agitator arm.
• Reliable lumpbreaking.
• Small particle / grain size.
• Wet and dry milling.
• Drying independent of the initial product consistency.
• Small agitator to wall clearance.
• Hinged door for easy inspection.
• Full-surface heating of the agitator and vessel.
• High torque means maximum filling volume.
• Complete encasing of the drive system.
• Single-nozzle device on the agitator for applying
nitrogen (N2) or liquids for granulation.

Special version.

• Pilot scale trials can be conducted in the

Standard Dryer with three-arm agitator instead
of chopper.

Rosenmund technical centre.

Easy inspection
through the front door.
The hinged front door, which can be quickly and
easily opened for inspection, provides access to the entire
diameter of the cylinder. The agitator is held in place
by the main bearing.

H1

H

Chopper

L

B

Rosenmund Universal Dryer 8000 l

D

Nominal
volume l

Used
volume l

Drive
power kW

Empty weight
approx. kg

H mm

L mm

B mm

H1 mm

50
100
200
400
600
800
1000
1500
2000
3000
4000
6000
8000

50
100
200
400
600
800
1000
1500
2000
3000
4000
6000
8000

11
11
15
30
37
37
45
75
75
75
75
90
110

1400
2700
3500
4000
4800
5500
7200
8000
8500
10000
11000
12000
14000

3450
3650
3850
4250
4600
4600
5500
5800
5800
5900
6000
7100
7300

2000
2300
2700
2800
2900
3100
3400
3800
4100
4100
5000
5400
5700

750
950
1100
1300
1450
1450
1700
1950
1950
2400
2400
2600
2800

950
950
950
950
950
950
1400
1400
1400
1400
1400
1400
1400
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Spherical Dryers
Cleaned in a flash. Emptied completely.
The trendsetting spherical dryer
range with top or bottom drive
is the latest development of the proven
Rosenmund dryers that achieve the highest
performance standards. A versatile solution
for drying, mixing and granulating.

The easy cleaning and simple emptying are the most
convincing features of the Rosenmund spherical dryer.
Its simple structure, the spherical vessel and the slide
ring seal above the product area make CIP/WIP cleaning
and SIP sterilisation possible with a few spray balls or
ARD nozzles. Cleaning fluids and dissolved product
residues run out through the drain fittings at the lowest
point of the vessel. Along with the slope in the direction
of the outlet valve, this enables a complete and fast
product discharge. The product outlet is a special ball
valve that seals the vessel with minimum volume.

Maximum mixing
with the three-arm agitator.

Rosenmund Spherical Dryer
with top drive 1000 l

The spherical dryer achieves a high degree of mixing
via a three-arm agitator with a high rational speed.
By heating the agitator, the heat-exchange area can be
increased further, thus improving heat transfer and
preventing wet goods from being baked onto the hub
and blades. These are the ideal prerequisites for short
drying times and a reproducible drying results.

High speed chopper
reduces agglomerate formation.
To prevent the formation of agglomerates that avoid
moisture from being removed from the product, an
additional chopper will improve results in many cases.
The vertically arranged chopper brings two decisive
advantages: First of all, it helps to achieve consistent
results that are practically independent of the filling
volume. Secondly, no wet product is sprayed on parts
of the walls that the agitator does not reach.
Rosenmund Spherical Dryer
with bottom drive 100 l

Rosenmund Spherical Dryer
with top drive 1000 l

Everything in view during inspection!
To allow quick inspection at any time, the top driven
spherical dryer can be opened easily, by swivelling
up the lower half of the sphere. This simple operation is
achieved by a hydraulic part-turn actuator driving
open a bayonet quicklock main flange, all at the
touch of button! The dryer can be fixed to the ceiling,
ideal for cleaning-room installations for product
offloading.

Rosenmund Spherical Dryer
with top drive 1000 l

Rosenmund Spherical Dryer
with top drive 100 l

F
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Explosion pressure surges?
No problem at all!

Important advantages at a glance:

Since dryers are usually designed for vacuum operation,
the risk of thermal decomposition or dust explosion requires
them to be designed for higher pressures in many cases.
The spherical shape with maximum volume and minimum
surface is the ideal geometry for an explosion containing
vessel. The ball valve will remain in the sealed position
even if a power failure occurs, and it is a reliable component
in this fail-safe principle. A construction that is resistant to
explosion pressure surges is therefore easily accomplished!

• Drying, mixing and granulating.
• Fast and easy cleaning (CIP/WIP and SIP).
• Total product discharge.
• Short drying times.
• Reproducible drying result.
• Heatable agitator.
• Vertical chopper/lumpbreaker.
• Easy to inspect.
• Assembly in ceiling.
• Containment of explosion pressure surges.

Rosenmund Spherical Dryer
with bottom drive 100 l

H1

H1

H

H

Rosenmund Spherical Dryer with top drive 100 l

L

Nominal
volume l
t. d. b. d.
25
50
50
100
100
200
200
300
300
400
400
600
600
1000 1000
2000 2000
4000
6000

D

t. d. = top drive

Used
volume l
t. d. b. d.
25
47
58
131
155
204
230
283
320
427
457
675
722
1009 1079
1804 1929
3733
5598

Drive
power kW
t. d. b. d.
4
10
7,5
15
11
20
18,5
22
22
30
37
33
45
45
55
55
75
90
110

L

Empty weight
approx. kg
t. d. b. d.
500
1200 800
1500 1300
1800 1600
1800 1800
3000 2800
4000 3500
6000 4400
8500 7500
9500
12500

Container
D mm
t. d. b. d.
400
495
495
695
695
805
805
898
898
1030 1030
1200 1200
1372 1372
1665 1665
2075
2375

H mm
t. d. b. d.
2500
2600 2000
2700 2455
2800 3050
2900 3150
3450 3610
3850 3890
4900 4165
5900 4595
5640
6435

L mm
t. d. b. d.
1200
1350 1285
1500 1700
1650 1860
1950 2020
2000 2115
2225 2222
2700 2330
3250 2790
3230
3760

H1 mm
t. d. b. d.
900
900
300
900
895
900 1115
900 1225
900 1390
1050 1425
1400 1460
1700 1535
1900
2265

b. d. = bottom drive

1
1

Pan Dryers
Field-proven and reliable: the
Filter/Dryer design.
Heated agitator
with adjustable speed.
The pan dryer is based on
the well established and proven
Filter/Dryer technology; here, however,
the porous filter bottom is replaced
with a heated flat bottom.

The simple change in the design of the heated flat
bottom enlarges the heating area considerably.
The agitator of the pan dryer is also normally heated
and is equipped with speed control. Many elements
such as the metallically sealed side discharge valve have
been taken from the proven Filter/Dryer range.

Fast agitator
replaces the chopper.
The top driven pan dryer (alternatively with bottom
drive as well) relies on rotational velocity. A particularly
fast agitator with a circumferential speed of up to
3 m/s (spherical dryer only around 1.5 m/s) ensures
optimum mixing. The lifting and lowering agitator also
provides mixing on the vertical axis. At the same time,
the minimal agitator to wall clearance keeps the wall
free from product crust. The rotational high speed of the
agitator combined with its vertical translation does not
require the use of a chopper.

Slide ring seal
without product contact.

Rosenmund Pan Dryer
Final assembly

Rosenmund Pan Dryer
Final assembly

As with the spherical dryer, the mechanical seal of the
pan dryer is also advantageously located outside of
the product area. Depending on the application, it can
either be lubricated with gas or liquid. The axial motion
of the agitator is sealed by metal bellows, as with the
Filter/Dryer.

Rosenmund Pan Dryer

F
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Easy internal inspection.
Inspection is easily possible when the pan bottom is lowered,
as with the spherical dryer. In the case of frequent cleaning
and opening cycles, the pan dryer is also ideally equipped
with a time-saving main flange bayonet quick-lock fitting
instead of C-clamps.

Important advantages at a glance:

• Proven Filter/Dryer technology.
• Agitator speed-controlled and heated.
• Fast cleaning (CIP/WIP and SIP).
• Simple emptying.
• Short drying times.
• Easy to inspect.

H

S

Rosenmund Pan Dryer agitator

Rosenmund Pan Dryer, Final assembly
D

D

Nominal
volume l
100
200
400
1000
1600
2300
3000
3700
5000
6000
7500

Used
volume l
100
200
400
1000
1600
2300
3000
3700
5000
6000
7500

Drive
power kW
6
8,8
12
15
16
23
29
35
43
59
70

Empty weight
approx. kg
1500
2500
3000
3500
4500
5000
6000
8000
9000
10000
12000

Container
D mm
550
750
900
1200
1400
1600
1800
2000
2300
2500
2800

H mm
2350
2500
2500
3750
3750
4400
4400
4400
4500
5000
5000

S mm
250
300
300
500
500
600
600
600
600
600
600
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De Dietrich
Double conical
dryer SR
The glass lined double conical dryer Field-proven and reliable: type
SR is a device that was designed the Dryer principle.
for drying easily flowing products.
The rotation of the double cone A proven concept.
allows the product to be mixed without an internal agitator. The design of the double conical dryer combines the

drying and mixing function in one simple and stable
device. The operation and maintenance costs are very low.
The drying times are reduced to an acceptable level.
As a result, this concept provides a simple solution for
many drying requirements.

Double Conical Dryer SR 1600 clean room design:
reverse mechanical sealing and vacuum tube on the same side
in order to reduce dead zones and improve the cleanability.

The advantages of a glass lined coating.
The characteristics of the glass lined coating provide
special solutions for numerous processes:
Anti-corrosion, when the dry solution is
not chemically neutral.
Fire polishing and anti-sticking, the dry mass
does not stick.
Anti-contamination for products that
require a 100% metal-free contact. Easy
cleaning for API.

F
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Various options:
Adjustable lump breakers (choppers) for materials
that tend to become lumpy.
Insulation and special coating.
Heated cover to prevent condensation.
"Clean room" version with minimised dead zones
and remote control for filling, emptying and
cleaning functions.
Stainless steel design available.

Important advantages at a glance:

• Functional design.
• Simple operation.
• Problem-free cleaning.
• Low operating costs.
• Wide range of options.

A De Dietrich product.
The double conical dryer is part of the De Dietrich
product range. Like Rosenmund, this company
is a member of the French group De Dietrich Process
Systems with its long tradition, innovation and
expertise.

Double Conical Dryer SR

d1

A

h3

Double Conical Dryer SR 1000:
Stainless steel design with ruffled cover

h1

h2

B

d

axb

D

Type Container Heating Drive
SR
volume area
power
l
m2
kW
120
1.15
1.5
100
400
475
2.8
2.2
4.0
34
1000
1040
1600
6.7
1625
5.5
2500
2550
9.5
11
4000
4300
15
13.1
6300
6500
17.9

Empty
weight
appr. kg
1900
2100
3300
4300
5800
8300
11000

a x b mm
1795 x 900
2355 x 1200
2705 x 1500
3084 x 1700
3384 x 2000
3937 x 2300
4301 x 2600

Dimensions in mm
h1 mm h2 mm h3 mm A mm B mm
676
1300
520
300
150
1950
785
450
160
1288
2150
935
450
200
1327
1494
2450
450
200
1070
1490
2600
1225
450
200
1502
2850
1465
500
250
1581
1640
3100
500
250

d mm
600
1000
1300
1500
1800
2100
2400

d1 mm
700
1100
1400
1600
1900
2250
2550
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Pilot Plant Facility
Experiments and process optimisation
in the new pilot plant in
Liestal/Switzerland.
Made-to-measure solutions
for all customers.
The decisive step from theory
to practice. In the recently built
technical centre pilot plant,
customers can perform practical
experiments and test process
optimisation steps with experienced
experts from Rosenmund.

No two customers are alike. No two problems are the
same. From years of experience, we know that every
equipment is unique. Every customer has his own
products, which are manufactured on different premises
by individual employees - based on different ideas. For this
reason, we offer comprehensive services to
individually optimise our product range of delivery - at
our new technical centre.

A completely new technical centre.
The fully equipped Rosenmund technical centre
opened in November 2002. This international test
centre provides Rosenmund customers from the
pharmaceutical and chemical industry with a complete
range of services. The technical centre is designed for
carrying out industrial experiments with products from
the chemical and pharmaceutical industry. The recognised
core competence lies in the area of the concentration
and drying of API (Active Pharmaceutical Ingredients)
that contain solvents.

Plant and know-how
from one supplier.

Rosenmund technical centre, Universal Dryer 100 l

Rosenmund technical centre, Universal Dryer 100 l
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The Liestal technical centre provides Rosenmund
customers with comprehensive competence that
significantly simplify the decision-making involved
in selecting plants and machines. Do you want to change
or optimise your process? For this purpose, you will want to
compare systems - for example, between a horizontal,
vertical or spherical dryer. No problem at the new technical
centre; our experimental units are at your disposal.
Since we provide all the systems, we can guarantee you
objective advice.

Direct advantages
for Rosenmund customers:

• Shorter equipment commissioning times through

determination of product suitability correct system
selection and process sequence specification.
• Optimisation of processing times through precise
scale-up and / or estimation of vessel residence
times throughout the process route.
• Determination of effective cleaning processes
(CIP/WIP and SIP).
• Determination of the selection criteria according
to customer evaluation, e.g. drying time,
quality (crystal shape, activity etc.), emptying,
CIP-capability, price.
Rosenmund technical centre, Evapor CEP-1

Dr. Rainer Laible, manager of the Rosenmund technical centre

Summary of
Rosenmund Tech Centre
Pilot Plant Capability:
Due to their special design,
which fulfils all GMP standards,
Rosenmund equipment allows
complete GMP and FDA
validation.

Data acquisition and analysis.
Scale-up experiments as a basis for projection to
production sizes in respect to filtration and drying time,
fill volume, recrystallisation and particle size distribution.
Optimisation of the process sequence. Machine
optimisation.
Product trials for equipment selection and to
establish suitability.
17

Rosenmund technical centre, Spherical Dryer with top drive 100 l

Spherical Dryer 100 l

Test product

Technical centre equipment

Universal
Dryer
100 l

Spherical
Dryer
100 l

Evapor
evaporator
CEP-1

Pan
Dryer

Test report

Estimation
Production size
Scale-up
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High-Tech
Solution
Engineering.
Profit from the We not only perform the planning and integration of
superior competence of our product in your buildings, we also partner with our
high-tech solutions! customers to provide fully engineered solutions from

concept stage to performance qualification.

Product handling.
We provide almost everything to do with the filter and
vacuum dryer: screens/sieves, lifting columns, containers,
container mixers, insulation valves, weighing systems
and many other pieces of equipment.

Training and courses.
Should your personnel already be trained on the new
control system when the plant is delivered? Or does your
process first have to be optimised on the new plant?
We will be happy to support you with
help and advice.

a

solution

ahead
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Addresses
Switzerland
ROSENMUND VTA AG
DDPSSWITZERLAND
Headquarters
Liestal

Rosenmund is a subsidiary of the
French De Dietrich technology group.
Rosenmund customers therefore
have quick access to the technology,
the know-how and the global service of an
international company at all times.
You benefit from this!
Service without limitation or borders.
Whether you need advice or troubleshooting,
information or services - we provide you
with a quick and direct connection
worldwide through our global sales and
service network. This guarantees short
reaction times and excellent service.
The addresses of our factories and sales
representatives are found here.

Phone +41 61 925 11 11
Fax +41 61 921 48 93
info@rosenmund.org
France
DE DIETRICH
PROCESS SYSTEMS S.A.S.
Headquarters
BP 8 -F 67110 Zinswiller
Phone +33 3 88 53 23 00
Fax +33 3 88 53 23 99
sales@dedietrich.com
DE DIETRICH
PROCESS SYSTEMS S.A.S.
Courcouronnes Site (EIVS)
Phone +33 1 69 47 04 00
Fax +33 1 67 47 04 10
eivs@eivs.fr
ROSENMUND S.A.S.
Semur en Auxois
Phone +33 3 80 97 12 23
Fax +33 3 80 97 07 58
rog@rosenmund.fr

©ROSENMUND VTA AG Liestal, Switzerland-June 2005-NEUBERGER.DESIGN-ColorOffset2000 EN

Germany
QVF EGINEERING
Mainz
Phone +49 61 31 97 04 0
Fax +49 61 31 97 04 500
mail@qvf.de
Belgium
IVIA N.V.
Heverlee-Leuven
Phone +32 16 40 5000
Fax +32 16 40 5500
info@ivia.be
Holland
IVIA B.V.
GMBreda
Phone +31 765 42 15 44
Fax +31 765 42 15 76
info@ivia.nl

a
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solution

Great Britain
QV
F
PROCESS SYSTEMS Ltd.
Stafford
Phone +44 1785 609 900
Fax +44 1785 609 899
sales@qvf.co.uk

Brazil
DE DIETRICH
DO BRAZIL
São Paulo
Phone +55 11 6703 73 80

Ireland
DE DIETRICH PROCESS
SYSTEMS IRELAND Ltd.
Shannon
Phone +353 61 366 925
Fax +353 61 366 854
bobmulqueen@eircom.net

Singapore
DE DIETRICH
SINGAPORE (PTE) Ltd.
Phone +65 6 861 12 32
Fax +65 6 861 61 12
dedietrichdds@pacific.net.sg

Japan
License
TANABE WILLTEC Inc.
Osaka
Phone +81 6 6356 11 55
Fax +81 6 6321 58 26
tw-nifty@mxl.alpha-web.ne.jp
Spain
DE DIETRICH EQUIPOS
QUIMICOS S.L.
Barcelona
Phone +34 93 21 88 613
Fax +34 93 21 84 709
comercial@dedietrichbcn.com
South Africa
DE DIETRICH SOUTH
AFRICA (PTY) Ltd.
Dunswart
Phone +27 11 918 41 31
Fax +27 11 918 41 33
ddsa@iafrica.com
USA
DE DIETRICH
PROCESS SYSTEMS Inc.
Union, NJ
Phone +1 908 686 49 00
Fax +1 908 686 83 40
sales@ddpsinc.com
Charlotte, NC
Phone +1 704 587 04 40
Fax +1 704 588 68 66
rosenmund@ddpsinc.com

ahead

Fax +55 11 6702 42 84
ddbrazil@uol.com.br

China
DE DIETRICH PROCESS
SYSTEMS
Shanghai
Phone +86 21 5261 0128/5261 0097
Fax +86 21 5261 014
florian.bordier@dedietrich.com
India
DE DIETRICH PROCESS
SYSTEMS
Andheri (East), Mumbai 72
Phone +91 22 2850 5794/2850 5731
Fax +91 22 2850 5731
Russia
DE DIETRICH PROCESS
SYSTEMS
Sergey Grabovski
Phone +7 916 270 5399
ddps.russia@dedietrich.com
Thailand
DE DIETRICH
SINGAPORE (PTE) Ltd.
(Thailand Office)
Bangkok
Phone +66 91 29 55 92
Fax +66 27 51 87 35
ddps.thailand@dedietrich.com

The pump
of choice
for industry

Recognised expertise

Watson-Marlow Pumps Group
is acknowledged as the world's
leading manufacturer of positive
displacement pumps.
Founded on over 50 years of
supplying trusted engineering
and process expertise across a
wide range of industries and with
over one million pumps installed
worldwide, our products and
solutions are tried, tested and
proven to deliver.

Our vision
At Watson-Marlow our vision is
to deliver products, services and
knowledge of such excellence
that Watson-Marlow Pumps
Group will be the first choice for
pump technology and process
solutions in the market.

The revolutionary Qdos 30
no-valve metering pump

Mor e t ha n on e m illion p u m ps
installed worldwide
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Unparalleled experience

Watson-Marlow Pumps Group
consistent, year-on-year growth,
revenue over the last 5 years

No other company shares our
level of experience and knowledge

£124.5m

of positive displacement pump
technology.

£118.4m
£103.0m
£83.8m
£75.4m

2008

2009

2010

2011

2012

Watson-Marlow is committed
to continuous investment in
innovation, technology leadership
and advanced manufacturing
techniques.
We have grown significantly in
recent years through selective
acquisitions and strategic
investment.
Watson-Marlow is now comprised
of six distinct businesses and six
world-class manufacturing facilities.
This has strengthened our portfolio,
expanded our accessible markets
and significantly increased our
market share.

As a wholly-owned subsidiary of
Spirax Sarco Engineering Group
plc, (LSE:SPX) we are part of
a global organisation which
employs over 4,500 people
worldwide, enjoys consistent
and profitable growth, and has
been quoted on the London
Stock Exchange for more than
40 years.

2

Our business

Our roots lie in positive
displacement pump
technology. As the
acknowledged leader in
our field, Watson-Marlow
products are the pumps
of choice for applications
requiring accuracy,
hygiene and reliability.

Watson-Marlow Pumps Group is comprised
of six established brands, each with their own
areas of expertise:
peristaltic tube pumps

precision tubing
aseptic filling and
capping systems
heavy-duty hose pumps
sinusoidal pumps
solutions for OEM customers
equipment and machinery
manufacturers

3

No other company shares the same
experience and knowledge of positive
displacement pump technology as
Watson-Marlow Pumps Group

Watson-Marlow is also the only pump
company in the world to
manufacture and supply its own
precision tubing.
Watson-Marlow Tubing offers
accurate, long-term performance.
Our tubing complements our
peristaltic pumps and enables
our customers to deploy end-toend solutions for their pumping
requirements from a single reliable and
innovative source.

4

Peristaltic pumps have
become the first choice
of pump for chemical
and industrial metering
applications.
Watson-Marlow peristaltic
pumps are simple to install,
operate and maintain.

5

As nothing but the tube touches the fluid, the
risk of contamination in the pump is eliminated.
Pump action is created by compressing the tube
between rotating rollers and a track. Between each
roller pass, the tube recovers to create a vacuum
and draws in fluid. Complete tube closure provides
the pump with its action, preventing backflow
and siphoning, and eliminating the need for
check-valves when the pump is not running.
Widely accepted as the world's fastest growing
pump type, peristaltic pumps have no valves, seals
or glands. Peristaltic pumps have a number of
advantages over other pump types: they provide
superior flow rate stability and metering accuracy;
have extensive chemical compatibility; and are
inherently hygienic.

Flexicon Liquid Filling
equipment facilitates high
accuracy aseptic filling
(±0.5%) and easy product
changeover without issues
of cross-contamination or
cleaning validation.

The liquid being filled only contacts the FDA
approved pump tubing and the filling nozzle.
Modular bottle handling including conveying, filling,
capping and sealing, with users able to choose
from simple manual filling to semi-automatic filling
or fully automated systems designed to deliver
volumes ranging from 0.1ml to 100ml with a
filling accuracy of ±0.5% which is check-weighed
throughout the filling batch, with adjustments made
automatically if required. Accusil™ tubing fulfils
biopharmaceutical requirements and is ideal for
single-use filling.
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MasoSine sinusoidal
process pumps offer a
highly reliable, economic
method of fluid transfer
ideally suited to high
pressure, hygienic
operations in sectors such
as food manufacture.
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The pump's exclusive sinusoidal rotor overcomes
the limitations of conventional rotary lobe pumps
to produce powerful suction with low shear, low
pulsation and gentle handling.
MasoSine pumps can be dismantled, cleaned,
and running again in 20 minutes. No special
skills or tools are required and the task can be
completed by production line operatives rather
than maintenance engineers. They offer a flow
capacity up to 91.2 m³/hr and pressures up to
15 bar. They can safely pump high viscosity
products, while their innovative yet simple
design allows economical in-line maintenance.

Bredel is the world's largest
manufacturer of hose
pumps and hose element
materials. Our positive
displacement pumps are
working non-stop around
the world.

With operating pressures to 16 bar and flow rates
to 80 m³/hr, our pumps save time and money by
successfully handling the toughest applications.
Bredel hose pumps are the ideal pump for a vast
range of industry applications, including chemical,
ceramics, water and waste treatment, food and
beverage, print and packaging. Our positive
displacement pumps have no valves, seals or
glands, and the fluid contacts only the bore of the
hose. They are simple to install and operate, and
easy to maintain.
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H ig h q u a l i t y t u b i ng i s
precisely why increasing
numbers of customers are
turning to Watson-Marlow,
a major global player in
tubing design, manufacture
and supply, specifically
for the biopharmaceutical
industry.

9

The company's tubing product range has been
developed in-line with key market drivers such
as derivative-free, low leachable materials, high
reliability, security of supply and - where
required - single-use technology. The product
range on offer is vast - 10 different materials
and 50 different sizes, from 0.13 to 40mm.
In Watson-Marlow's state-of-the-art cleanrooms
the company manufactures Pumpsil premium
quality platinum-cured (and post cured) silicone
tube, Bioprene, a unique thermoplastic elastomer
(TPE) tube, and, most recently PureWeld XL,
which is a thermoplastic elastomer tubing
designed to deliver purity and performance in
single-use bio-processing applications.

Zero contamination and
virtually maintenance-free
pumping are just two of the
reasons Alitea OEM pumps
are specified for medical
devices and environmental
analysers.

Peristaltic pumps have clear advantages when
handling fluids containing small particles such as
those in endoscopy or dental surgery equipment.
Compact in size, the pumps function as their
own check valve so avoiding the need for further
expense or system complication in equipment
often severely restricted by space.
With over 300 drive speeds and voltages, 130
pumphead variants and 60 tubing sizes, we are
confident we can offer medical and diagnostic
equipment designers and manufacturers the best
solution to their pumping needs.
All pumps have a long and predictable service
life, with minimal downtime and spares inventory,
providing the lowest whole life cost of any OEM
pump type.
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Product innovation

At Watson-Marlow, we
have always been one step
ahead of the competition.
Product innovation is
the foundation of our
growth strategy.

Our smallest pump, operating at its lowest speed,
would take nearly 13,000 years to pump what our
l a r g e s t p u m p, a t i t s h i g h e s t s p e e d , c a n p u m p i n
just one minute.
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Our strong connections with the market means we
understand customer needs, and we continuously
research to identify new product opportunities.
Our current products aim to be best-in-class, and
our new products are winning market share from
other positive displacement pump types, such as
diaphragm, lobe and progressive cavity.
We are committed to investing in technology
to fully integrate our products and systems
with customers' processes. This allows them
to increase plant efficiency and reduce their
maintenance costs.

Optimised performance

Our goal is to help our customers
maximise their throughput and
achieve cost reductions.
As part of our commitment to continual
improvement, our design teams encourage
customer feedback throughout the product
development process. This enables us to
ensure we are designing products that meet our
customers needs, now and in the future.
Our approach concept, CASE (Consult, Audit,
Specify and Ensure) means we work closely with
our customers to identify the potential for even
better product performance and then specify the
exact solution to deliver that improvement.

•
•
•
•

Minimising downtime
Improving end-product quality
Minimising wastage
Implementing process efficiencies

Consult

Ensure

Audit

Specify
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Global presence - local expertise

Watson-Marlow is a global
business, but we deliver
local solutions.
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With direct sales operations in 24 countries and
distributors in a further 50, we are better placed
than any other pump manufacturer to respond to
the needs of our customers.
Customer support is provided through a network
of industry specialists and technical support
teams. This ensures our customers always benefit
from local knowledge and sector expertise.
No matter where your business operates,
Watson-Marlow is never far away.

Knowledge and development

Direct sales operations in 24 countries and
distributors in 50 other countries.

We recognise that our people are equally
important as our technology. Ongoing investment
in training and development for all our staff lies at
the core of Watson-Marlow's corporate philosophy.
Our people understand the importance of
providing the highest standard of service to our
customers, at every level. We work with them
to develop their understanding of our customers,
their applications and the pressures which affect
their business.

At every level, our team is committed
to helping customers:

•
•
•

increase productivity
improve their processes
deliver cost reductions
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Safeguarding our environment

At Watson-Marlow, we continually work
to improve our environmental performance
in the design, development and manufacture of
our products.
As an ISO14001 certified company, we have
implemented a range of measures to safeguard
and minimise our impact on the environment.
These include eliminating use of chemical
substances, using recyclable materials where
possible and reducing energy consumption
during manufacture.
We have incorporated specific design features
into our products to reduce energy consumption
when in use and always keep product 'end of life' in
mind.
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A key requirement for customers selecting our
products is environmental improvement. Waste
water treatment, for example, where our pumps
are ideally suited to chemical dosing.
Our technical expertise and knowledge regarding
the application of our products is a key factor in
maximising the production and process benefits
that can be achieved; all of which have a significant
and positive effect on the environment.

Our on-going commitment

Our "Value for Life"
promise means that
everything we design is
built to last.
Watson-Marlow equipment has an unrivalled
reputation for quality and dependability. We combine
this with our "Value for Life" promise, meaning that
everything we design and manufacture is built to last.
We apply our technical expertise to the application
of our products, services and engineered solutions.
This maximises the benefits of the products we
supply, ensuring customers always get the right
solution for their application.
In selecting Watson-Marlow, you can be confident
that you will also receive the reliability, quality and
performance that sets Watson-Marlow apart as the
world's leading manufacturer of positive displacement pumps
and tubing.
16

Serving a host of industries
Where our one million
pumps keep industry
productive.
Watson-Marlow pumps save time and
money worldwide by successfully handling the
toughest applications in a broad range
of industries including:
Biopharmaceutical:
fully automatic aseptic filling, plugging and
capping systems.
Food and beverage:
clean-in-place applications, dairy, bakery,
flavourings and additives.
Mining:
reagents, polymers and floccullants.
Water and waste:
sodium hypochlorite, hydrofluorosilic acid and
ferric chloride.
OEM applications:
medical devices and environmental analysis.
Chemical:
safe containment of acids, alkalis and bases.
Engineering:
spray coating and waste recovery.
Ceramics:
eliminating pinholes, contamination and pulsing.
Paint and pigments:
dispersion mill feed, pigment and latex transfer.
Print and packaging:
varnishes, inks, coatings and adhesives, with no
colour cross-contamination or aeration.
Pulp and paper:
dyes, brighteners, sizing agents, retention aids
and titanium dioxide.
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A Spirax-Sarco Engineering Company

Watson-Marlow Pumps Group has six world-class
factories supported by direct sales operations in 24
countries and distributors in more than 50 countries.
For contact details visit our website:

www.wmpg.com
Watson-Marlow

Bredel

Flexicon

MasoSine

Watson-Marlow online
Our engineers around the world can help you choose
the perfect pump and tubing for your needs.

Copyright © 2013 Watson-Marlow Pumps Group

Design: abgdesign.uk.com

HB0410/2

More information? Our brochures are on our website
- www.wmpg.com

Watson-Marlow Innovation in
Full Flow
Tel: +44 (0) 1326 370370

Watson-Marlow Pumps Group
Falmouth,Cornwall TR114RU,UK
The information in this document is believed to be correct, but
Watson-Marlow
Pumps Group accepts no liability for any errors it contains, and
reserves the right to alter specifications without notice. WARNING:
These products are not designed for use in, and should not be used
for, patient-connected applications. Watson-Marlow,

info@wmpg.com

w w w. w m p g . c o m

Pumpsil, PureWeld, LoadSure, LaserTraceability, Bioprene and Marprene are
registered trademarks of Watson-Marlow Limited. STA-PURE PCS and STA-PURE
PFL and Style 400 are trademarks of WL Gore and Associates Inc.

BIO-PHARM

An Efficient CIP in
Compact, Portable Design

The patented Sani-Matic ULTRAFLOW is a self-contained,
compact, and portable system programmed to accommodate a
variety of single-use, recirculated CIP applications. Designed for
critical cleaning, the ULTRAFLOW meets cGMP and ASME-BPE
standards.

Advantages

• Small Footprint. Space-saving design for installations with limited
floor space. Fits through standard doorways with ease.

• Wide Operating Range. The systems range from 2-45 GPM and
5-110 GPM and are able to clean small and large applications.

• Self-Cleaning. Self-cleans without extra step, and eliminates crosscontamination.

• Portable. Positioned on low-friction casters for easy movement
between process suites. No expensive supply and return line
installation required.

• Water & Chemical Savings. The high-turbulence flow rate and low
water requirements for operation reduce the amount of water and
chemicals needed for a complete clean.

• Low Outlets? No Problem. Returns solutions with entrained air to
accommodate vessels with low and restricted outlets.

ULTRAFLOW 110

ULTRAFLOW 45

• 74"L x 33"W x 80"H
• Operating range of 5-110 GPM @ 60 psig
• Electric or steam heat available
• For process tank diameters up to 10' •

• 62"L x 24"W x 73"H
• Operating range of 2-45 GPM @ 55 psig
• Electric or steam heat available
• For process tank diameters up to 4.5'
• For process line diameters up to 2"

For process line diameters up to 3"
OPERATING REQUIREMENTS

OPERATING REQUIREMENTS

Instrument Air

Instrument Air

1/ " NPT, 10 scfm @ 90 psig 2

Water Supply

Two 1" tri-clamps, WFI, DI, potable
< 2 GPM @ 25 psig, 20˚- 80˚C
2" tri-clamp (programmable to meet app)

1/ "

NPT, 10 scfm @ 90 psig

2

Water Supply
Drain
Dry Weight
Electrical Power
(electric heater)
Electrical Power
(steam heat)
Plant Steam

Two 1" tri-clamps, WFI, DI, potable
< 2 GPM @ 25 psig, 20˚- 80˚C
2" tri-clamp (programmable to meet app)
1,000 lbs (approximate)

• 15 kW, 50 amps @ 460 VAC, 3 Ph, 60 Hz
• 30 kW, 68 amps @ 460 VAC, 3 Ph, 60 Hz
27 amps @ 460 VAC, 3 Ph, 60 Hz
1 /2" flange, 540 lbs/hr @ 50 psig 1

Drain
Dry Weight
Electrical Power
(electric heater)
Electrical Power
(steam heat)
Plant Steam

900 lbs (approximate)

• 12kW, 27 amps @ 460 VAC, 3 Ph, 60 Hz
• 24kW, 43 amps @ 460 VAC, 3 Ph, 60 Hz
11 amps @ 460 VAC, 3 Ph, 60 Hz
1/ "

flange, 195 lbs/hr @ 50 psig

2

1" flange

Plant Condensate

1/

CIP Supply

2" tri-clamp, 5-110 GPM @ 60 psig

CIP Supply

11/2" tri-clamp, 2-45 GPM @ 55 psig

CIP Return

2" or 3 tri-clamp,
5-110 GPM @ 11' of head @ 80˚C

CIP Return

2" tri-clamp, 2-45 GPM @ 8.5' of head @ 80° C

Plant Condensate

(p) 800-356-3300

(f) 608-222-5348

www.sanimatic.com

" flange 2

1915 S. Stoughton Rd., Madison, WI 53716

BIO-PHARM

Eductor Return System

How it
Works

Water Flow
Air Flow

D

A

Motive solution is pumped to the eductor through this nozzle.

B

Vacuum is created within the eductor through a series of velocity
changes. The velocity of the solution exiting the nozzle is reduced in the wide
body and then increased again as solution exits the top of the eductor.

C

A mixture of air and solution (in the return line) rushes in to satisfy the vacuum
within the eductor. The volume of both air and liquid is greater than that being
supplied to the vessel.

D

Returned air and solution enter the chamber through the top port.

E

Centrifugal action spins the solution around the walls of the chamber, forcing
air through the center of the vortex and out of the vent.

F

Solution exits back to the pump from the bottom port.

E
B

C

F
A

Air Separation Chamber

Eductor

1

1
Plant
Water
Supply

Plant
Water
Supply

FE

FE

PI

CIP
Supply

LE
Chemical

PI

Plant
Water
Supply

FE

CIP
Supply

LE
Chemical

PI

CIP
Supply

LE
Chemical
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Rinse

3

4
CE

5

TE

CIP
Return

Optional Documentation

•
•
•
•
•
•
•
•
•

CIP
Return

2

2

Functional Specifications (FS)
Configuration Specification (CS)
Factory Acceptance Test (FAT)
Site Acceptance Test (SAT)
Installation and Operation Qualification (IQ/OQ)
Traceability matrix
ISA Data Sheets
Cleaning and passivation report
Digital weld video record (Borescope)

Drain Step
The discharge control valve (4) is closed
and solution from the separator tank (3)
is pumped through the eductor (5) and
back into the separator tank (3) inlet,
which creates a vacuum at the CIP return
connection. Returning solutions create a
high-level condition in the separator tank (3)
causing the drain control valve (6) to bleed
solution to drain at a set flow rate until the
process and separator tank (3) are empty.

TE

LE

6

Rinse Step
The separator tank (3) is filled through one
of the two separator tank water fill valves (1).
The supply pump (2) draws the water from the
separator tank (3) and delivers the solution
to the process through the discharge control
valve (4) at a programmed flow rate. At the
same time, solution is pumped through the
eductor (5) and back into the separator tank
(3) inlet, thereby creating a vacuum at the
CIP return connection. The high turbulence
created within the ULTRAFLOW prevents
the settling of any solids and self-cleans the
system. The rinse step is followed by a drain
step. Typically, a series of 3 to 4 rinse/drain
steps are utilized for the final rinse.

CE

CE

TE

LE

5

4

3

CE

CE

TE

TE

Wash

5

4

CE

CIP
Return

LE

TE

Drain

3

7

Wash Step
The separator tank (3) is filled through one
of the two separator tank water fill valves (1)
The supply pump (2) draws the water from the
separator tank (3) and delivers the solution to
the process through the discharge control valve
(4) at a programmed flow rate. At the same
time, solution is pumped through the eductor
(5) and back into the separator tank (3) inlet,
thereby creating a vacuum at the CIP return
connection. The high turbulence created within
the ULTRAFLOW prevents the settling of any
solids and self-cleans the system. CIP solution
temperatures are elevated utilizing a heater (7)
in the recirculation loop. Chemical solutions (8)
are injected into the highly turbulent separator
tank (3) and controlled through conductivity.

Controls/Programming

• Allen-Bradley CompactLogix (standard)
• Allen-Bradley PanelView HMI
• Ethernet communication
• 40 customizable cleaning cycle programs
• Report ticket printer available
• UL listed, 304SS, NEMA 4X enc

(p) 800-356-3300
Madison, WI 53716 BP-UF 0414

(f) 608-222-5348

www.sanimatic.com

1915 S. Stoughton Rd.,

QVF® PHARMA REACTOR
Series

Function

Reaction units are of considerable
importance to the chemical and
pharmaceutical industry in production
and development. Particularly where
small volumes are concerned batchwise
reaction and distillation processes are

The QVF® PHARMA REACTOR is
specially designed for the two process
stages of reaction and distillation. The
reaction stage operates under total reflux,
whereupon the solvent can be distilled
off as effectively as possible in the
concentration phase. Both stages can be
carried out under either positive pressure
(+0.6 barg) or vacuum. The materials of
construction used are borosilicate glass
3.3, glass-lined steel and PTFE.

¾ 16 to 63 litre compact version
¾ Innovative vessel design
¾ Matching GMP requirements

Distillation overhead ASSEMBLY Reaction vessel

economic solutions.
Pharmaceutical applications provided
the user requirements for the design of
the QVF® PHARMA REACTOR. The
development goals were maximum purity
and optimized heat and mass transfer
combined with suitability for GMP use.
To suit the availability of space in the
majority of laboratories the QVF® PHARMA
REACTOR is designed in a compact layout
with reduced headroom requirements for
reaction vessel capacities from 16 to 63
liters.

B1
l

vessel

heating
area m²

W1
m²

W2
m²

16

0,25

1,0

0,2

5

5

25

0,37

1,0

0,2

10

10

40

0,53

2x0,7

0,3

20

20

63

0,75

2x1

0,3

20

20

B2/B3
l

Tab. 1: Technical daten - QVF® Pharma Reactor

Fig. 1: QVF® Pharma Reaktor 16-63 l

addition to the temperature of the vessel
content and the distillate, the pressure is
indicated by a tantalum membrane
manometer. A bursting disk provides
protection against excess pressure. The
rotation speed of the glass lined impeller
stirrer can be adjusted by means of the
handwheel on the drive.
All the valves are located close to the
vessel involved, thus enabling direct
and correct operation. Valve V8 controls
the adjustment of the integral reflux
separator.

The distillation overhead assembly is
made of components from the QVF ®
SUPRA-Line meeting the requirements
of the Pressure Equipment Directive and
the equipment safety regulations. The
components made of borosilicate glass
3.3 larger than DN25 are accordingly CEmarked. With its buttress glass flanges
the QVF® SUPRA-Line not only provides
a GMP-compliant connection but also a
wide variety of well thought-out individual
solutions.
To ensure that the equipment drains
completely the horizontal product piping
is largely installed at an angle of 5°. The
inclined condenser has a rinsing neck
and the receiver vessel can be emptied
and rinsed during the process by means
of valve V3.
The integral sampling valve V9 is used to
take samples from the actual distillate flow,
even when operating under vacuum. In the
basic version of the QVF® PHARMA
REACTOR the instrumentation is equipped
with all basic functions. In

The enamelled reaction vessel developed
by De Dietrich Process Systems for
the QVF® PHARMA REACTOR has the
following special features:
• Block flange for connection to the
glass cover (1)

Fig. 2: QVF® Pharma Reactor

Fig. 3: Special reaction vessel developed dy DDPS

•
•
•
•
•

Heating jacket up to the flange (2)
Support brackets without thermal
bridge (3)
Block flange with minimal dead space
bottom outlet valve (4)
Polished insulating jacket with foam
glass, stainless steel, tightly welded (5)
White enamel to improve visual control (6)

Flat buttress ends with GMP gasket

In addition to the basic benefits of the
flat glass buttress end the QVF® SUPRA- flange
has two special features which make it the
obvious choice for GMP- compliant plant. All
nominal bores up to DN 300 have fire-polished
sealing faces and a groove. The groove stabilises
and ensures positive location of the PTFE gasket
seated on the extremely smooth sealing face.
Together with the GMP compliant gasket, which,
via centering in the groove and on the outer
edge, effects a seal on the inside diameter of the
flange, the flat buttress end provides a coupling
with minimal dead space fully draining in pipelines
laid out at an angle of at least 5°.

Modular construction
Because of its modular construction the
basic version of the QVF® PHARMA REACTOR
can be expanded to handle various special
functions. The following
options are, therefore, available:

•

Hydraulic lifting device for the
reaction vessel
Phase separator

•

Electronic speed indicator

•

Version for increased pressure

•

Coated glass components

•
•
•
•

Weighing cells for reactor, feed and
distillate vessel
Double-acting mechanical seal
Anchor, turbine and propeller
type stirrers
Process control systems

De Dietrich Process Systems GmbH
Hattenbergstraße 36 Tel.: +49 (0) 61 31/97 04-0
55122 Mainz
Fax: +49 (0) 61 31/97 04-500

PP138e.4, Technical data are subject to change. All rights reserved. Copyright © De Dietrich Process Systems GmbH
07/2013.
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ErtelAlsop
The First Name in Liquid Filtration

Micro-Media®
FielRtgerCMieedoaCritical Processing i
Th

i ht ho c f r

Composition
ErtelAlsop Micro-Media® filter sheets are composed of
cellulose pulp, Diatomaceous Earth and/or Perlite, or
C e l P u re ® f o r t h e X L S e r i e s ™ , a n d a w e t s t re n g t h re s i n ,
which charge modifies the media to exhibit a net positive
charge referred to as Zeta Potential. This allows for the
highly efficient removal of particles smaller than the filter's
nominal rating.

Pilot Testing - Rentals
F o r i n - p l a n t t e s t i n g a n d s c a l e - u p p ro c e d u re s , E r t e l A l s o p
offers a variety of lab filters for rent. A portion of rental fees can
be applied to the purchase of your full production filter.

The Format to Fit Your Needs
A l l E r t e l A l s o p m e d i a f o r m u l a t i o n s c a n b e m a n u f a c t u re d i n f o r m a t s

Applications:

• Blood Fractions
• Sera
• C e l l C u l t u re M e d i a
• A c t i v e P h a r m a c e u t ic a l I n g re d i e n t
•s
• Large Volume Parenterals

to fit your application. Filter sheets, discs and Pak® Lenticular
C a r t r i d g e s a re a l l a v a i l a b l e t o p ro v i d e y o u w i t h p ro d u c t t o o p t i m i z e
y o u r a p p l i c a t i o n . E r t e l A l s o p a l s o m a n u f a c t u re s a c o m p l e t e l i n e o f
filter machinery, from Small Batch and Pilot Scale Lab Filters to
Plate and Frame Filters, Sealed Disc Filters and Pak® Lenticular
Cartridge Housings.

Small Volume Parenterals

Product Testing
Product testing is always available either at your facility,
t h ro u g h o u r n e t w o r k o f d i s t r i b u t o r s , o r a t o u r i n - h o u s e
laboratory.

Micro-Media

Cellulose/Perlite

F o r o v e r 8 0 y e a r s , E r t e l A l s o p h a s b e e n p ro a c t i v e l y s o l v i n g t h e d e p t h
filtration problems of industry. We originated and patented the Pak®
Lenticular Cartridge concept. We created the BioClean™ Sanitary
Filter Plate Assembly to accommodate the stringent cleaning
standards of the pharmaceutical industry.

XL Series

Cellulose/DE

Cellulose/DE**
Retention

P-Grade Micro-Media®

M-05P

M-054P

M-053P

15 µm

M-10P

M-104P

M-103P

10 µm

M-40P

M-404P

M-403P

5.0 µm

M-45P

M-454P

M-453P

2.5 µm

M-50P

M-504P

M-503P

1.0 µm

M-50TP

M-504TP

M-503TP

0.8 µm

T h e m o s t a c c u r a t e w a y t o o p t i m i z e y o u r p ro c e s s i s t h
ro u g h l a b o r a t o r y s c a l e t e s t i n g . S a m p l e s o f P - G r a d e M i c
ro - M e d i a ® , M i c ro - M e d i a ® X L S e r i e s ™ , o r M i c ro Clear™ Media are available at no charge. Authorized E r t e l
A l s o p re p re s e n t a t i v e s a re e q u i p p e d t o r u n t r i a l s o n - s i t e , o
r p ro d u c t s a m p l e s m a y b e s e n t d i re c t l y t o E r t e l A l s o p f o r t e s
t i n g w i t h p r i o r a p p ro v a l .

M-70P

M-704P

M-703P

0.45 µm

Table to the left is for reference only.

M-85P*

M-854P

M-853P

0.3 µm

M-954P

M-953P

0.25 µm

* Contains Cellulose, Perlite, and DE **
Contains Cellulose, High Purity DE

ErtelAlsop • PO Box 3358 • Kingston • NY • 12402 • ErtelAlsop.com • 845.331.4552 • Fax 845.339.1063

Filter Media

P h a r m a c e u t i c a l G r a d e M i c ro - M e d i a ® S e r i e s D e p t h F i l t e
r M e d i a , f o r m u l a t e d w i t h c e l l u l o s e , w e t s t re n g t h re s i n a n d
diatomite and/or perlite is specifically designed for use in
critical pharmaceutical and biotech applications. All
c o m p o n e n t s a re l i s t e d i n t h e C F R a s g e n e r a l l y re c o g n i z e d
as safe for contact with food as dictated by 21CFR 176.170.
P h a r m a c e u t i c a l G r a d e M i c ro - M e d i a ® S e r i e s D e p t h F i l t e
r
M e d i a i s m a n u f a c t u re d i n a c c o rd a n c e w i t h E r t e l A l s o p D r u g
Master File located at the United States Food and Drug
A d m i n i s t r a t i o n C e n t e r f o r D r u g E v a l u a t i o n a n d R e s e a rc h .

Flow Rates

M954P

M854P

M85P

M704P

M70P

M-504TP

M-50TP

M504P

M50P

M454P

M45P

M404P

M40P

M104P

M10P

M054P

M05P

Chart shows flow characteristics of
E r t e l A l s o p M i c ro - M e d i a ® a t 1 0 p s i
with clean water at 70°F

Filter Media
ErtelAlsop filter media is available for any application and/or operating condition, and is chosen based on your specific
operating conditions, the performance required by the filtering media, and criteria given to us by you and/or by sample p ro c e s
singwedoinourlab.
ErtelAlsop offers the widest varieties of filter media including 100% cellulose pads, cellulose and diatomaceous earth pads,
c e l l u l o s e a n d C e l p u re ® d i a t o m a c e o u s e a r t h p a d s , c e l l u l o s e a n d p e r l i t e p a d s , a n d c e l l u l o s e a n d a c t i v a t e d c a r b o n p a d s .
All filter pads are manufactured to very high standards for a wide range of applications in the pharmaceutical, chemical,
cosmetic, electric utility and food and beverage markets. ErtelAlsop also offers a Validation Guide to assist in the validation
of its filter pads in your process. The Validation Guide contains information regarding raw materials, extractables, and
general information about the product. The combination of ErtelAlsop "P" grade filter pads and ErtelAlsop's BioClean™ plate
and frame filter press design, can help to simplify your depth filtration validation now more than ever.

For additional
product information visit
ErtelAlsop.com
Technical Bulletin MMP-11

Your Local Distributor

ErtelAlsop
PO Box 3358
Kingston, NY 12402 US
ErtelAlsop.com
800.553.7835 Telephone
845.339.1063 Fax

Keep in touch.
Join our Newsletter to learn
about the latest filter best
practices and more!
Visit us at ErtelAlsop.com

Integritest 4
Series

®

Automated Filter Integrity
Test Instruments and Central
Instrument Management
Tool Software
Portable, easy to use

Easy-to-use, portable, networkable,* and fully-automated

Reliable, accurate measurements integrity test systems that offer reliable, repeatable
Fast testing improves productivity

measurements fast

Network model is 21 CFR Part 11
compliance ready
Centralized administration with
IMT software
Available in multiple languages

The networked configuration enables users to quickly
perform an integrity test, print the results on a shared
network printer and automatically store test reports on
a network data repository.

Data Sheet

The Integritest 4 instrument is an easy-to-use,
portable, fully-automated integrity test system.
Available in either a standalone or networkable
configuration, the Integritest 4 instrument offers
reliable and repeatable integrity test data.
The intuitive touch screen user interface streamlines
the test while the accelerated testing capability
provides users with more time for processing.
On-site calibration support and diagnostic
capability minimizes downtime, saving time
and money. Leveraging a proven test algorithm,
the Integritest 4 instrument performs bubble point,
diffusion, enhanced bubble point, and HydroCorrSM
(Millipore water-based test for hydrophobic filters)
tests on a wide range of filters including disks,
cartridges and TFF filters, virus, and asymmetric
membrane filters.
The rugged, ergonomic design of the system
enables users to easily carry the Integritest 4
instrument to any site. The standalone
configuration enables users to print the results
on the onboard printer.

*Integritest 4N only

The Integritest 4N networkable configuration
enables users to print results directly to any
networked printer via Ethernet connection.
The Integritest 4N instrument is 21 CFR Part 11
compliance ready for electronic records and
electronic signatures, improving productivity and
facilitating record keeping.

Easy to Use
The Integritest 4 instrument features a graphical
user interface with touch-screen menus and intuitive
icons for faster testing, enabling more effective use
of production equipment and resources. Millipore
and customer specific filter testing information can
be easily entered on-site. Test results can be printed
using the built-in printer. Printed test results can be
customized to include operator, batch, or other
desired data.
• Intuitive, multilingual graphical user interface
• 10-inch touch-screen color SVGA display
with active matrix
• Pivoting base for easy adjustment of
display angle
• Bar code input for easy filter identification
and data entry*
• Utilizes market-leading Windows XP®
embedded operating system
• Customized interface based on operational roles
• Context-based online help

Accurate, Reliable Results
The instrument has been designed and qualified to
achieve high test accuracy. To ensure correct
performance, the software automatically checks the
functionality of the computer and pneumatic
manifold components prior to each test. User
programmable test parameters allow for more case
specific testing when needed for analysis.

*Requires external bar code reader
2

Rugged Industrial Design
The exterior surfaces can be easily wiped clean
with alcohol or bleach. Instrument-grade inlet and
outlet connections on the pneumatic manifold
assembly minimize leaks, providing accurate results.
• Compact industrial design with quick-connect
ports for easy set up
• External valve array prevents back flow of fluids
into the instrument
• Modular hardware design allows for easy
servicing on location
• Durable, onboard printer produces a printout
that does not fade, even when wet
• Easily field calibrated for routine maintenance
and record keeping

Sound Algorithm
The Integritest 4 instrument uses a software algorithm
to determine the bubble point of a filter. The
accuracy of this algorithm is key to proving that
your filter is integral. Our algorithm is based on a
mathematically proven tangent method. Unlike other
solutions on the market today, it extrapolates the
accurate portion of a flow curve while avoiding
dependencies on the volatile portions. This, in
combination with an event-based capture of the
flow curve, gives you the most reliable, sustainable
method of bubble point testing.
• Supports all traditional tests such as bubble point
and diffusion
• Optional accelerated test allows you to quickly
obtain accurate, repeatable results
• Accurate, reliable testing for asymmetric
bubble point
• Programmable prepressurization for properly
testing multilayer virus removal filters
• New pressure hold test to test vessels, valves,
equipment and pipework

Networkable Configuration
Leveraging the built-in networking capability of the
Integritest 4N instrument together with the Windows
XP® tool kit, users can share a networked printer for
central printout of test reports. The software also
enables electronic signatures for sign-off of test
reports, which can be transferred to a central data
repository for the backup of all Integritest 4N
instrument test reports. The Integritest 4N instrument
can also support wireless Ethernet communication
eliminating the need to physically plug the unit into
the network.

21 CFR Part 11 Compliance Ready
The Integritest 4N software meets the technical
requirements of FDA regulation 21 CFR Part 11
for electronic records and electronic signatures.

Increase Process Speed
When integrated into a network, final filter integrity
test results are uploaded into the main control system
enabling an immediate stop/go decision, improving the pharmaceutical production process without
compromising quality control.

Central Instrument Management
Tool Software
Centralized instrument management and
automated electronic recordkeeping

The Integritest 4N Central Instrument Management Tool (Central IMT) software allows centralized
management of all Integritest 4N instruments
integrated to a network domain, improving manufacturing and system administrator productivity .
The Integritest 4N Central IMT software enables
system administrators to:
• Manage Users
- Assign users to instruments
- Define user roles
- No need to create user IDs or assign
passwords*
- Track password* changes
• Manage Integritest 4N Instruments
- Add or change test definitions
- Define report formats
- Track the addition and deletion of users*
• Manage Filter Test Reports
- Define data repository location
• Automatically download setups when Integritest
4N instruments are logged onto the network
• Organize instrument groups
• Automatically generate remote backups
- Periodically
- Information for instrument recovery and
event logs
• Security
- Domain controller assigned user names

Assign Instruments and Users to
Logical Groups
• Users are selected from the domain of users
provided by the domain controller

• Tests are assigned to defined instruments in the
group

• An instrument tab lists all the instruments added
to the Central IMT software. All checked
instruments are part of the group.
• Report transfer, remote backup and electronic
signature parameters are assigned to a group of
instruments

The ability to manage remote instruments via a
networked PC, streamlines operations as well as
optimizing integrity testing consistency and reliability
throughout manufacturing.
*The central IMT software uses the same ID and password
used to log onto a company's network domain.
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Consistent, Effective and Reliable Integrity
Tester Instrument Management

Available Expedited Instrument
Validation Service

Centralized user and instrument management of all

The Integritest 4 instrument was developed and
validated according to the GAMP Guide for
Validation of Automated Systems. Validation reports
are available for review during an on-site audit.
The Integritest 4 instrument can be validated on-site
using a validation protocol customized for you and
executed by a Millipore Access® Services team.

Integritest 4N test systems enhances testing consistency and repeatability. Central IMT allows a user
in one location to access and configure multiple
instruments in several locations. A test can be
entered on one PC and added to a group of
Integritest 4N instruments without having to access
each instrument individually. A password change
on one instrument automatically propagates to all
instruments on the same network when a domain
controller is used.

Comprehensive Services and Support

Access Services is available to conduct installation,
calibration and validation on-site. Millipore offers a
proven validation protocol that tests the range of
filters and tests used in a facility.
Millipore Service Representatives
F i g u r e 1 . The Integritest 4N systems can be connected
offer factory or on-site mainteto a network printer and a central data repository.
nance and repair services.

The Requirement of
Integrity Testing
Regulatory agencies require
integrity testing of sterilizing
grade filters as well as the
integrity of process critical filters,
such as bioburden reduction

Hub

Printer

Networked Attached
Storage (NAS) or
PC File Server

F i g u r e 2 . The Integritest 4N systems can also be
networked to a domain-controlled Local Area Network
(LAN).
PC with Central
IMT Software
Domain
Controller

Corporate Network

Print Server and Central
Data Repository File Server

Hub
Printer
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filters, which directly affect
product quality. For production
operators, supervisors, and
validation managers who need
to perform on-site filter integrity
tests, the Integritest 4 instrument
is a solution that is easy to
learn
and gives you the confidence
and assurance you need for your
test results. Users can conduct
bubble point, diffusion, enhanced bubble point, HydroCorr
and pressure hold tests on disk,
cartridge and TFF filters, virus,
and asymmetric membrane
filters.

Specifications
Test Accuracy (at standard, stable conditions)
Test Type

Range

Accuracy

Diffusion (Standard
and Accelerated)

Flow rates < 20 mL/min
Flow rates  20 mL/min (water)
Flow rates  20 mL/min (alcohol)

 1mL/min
 5%
 10%

30 Second Diffusion*

Flow rates < 20 mL/min
Flow rates  20 mL/min

 2 mL/min
 15% /-10%

Bubble Point (BP) Standard

345-6205 mbar (5-90 psig)

 68.9 mbar (1 psig) <

Bubble Point Asymmetric

345-6205 mbar (5-90 psig)

344.7 mbar (5 psig)

Accelerated BP Hydrophilic PVDF 345-6205 mbar (5-90 psig)

 137.9 mbar (2 psig)

Accelerated BP Hydrophobic PTFE 345-6205 mbar (5-90 psig)

 206.8 mbar (3 psig)

HydroCorr

Flow rates < 0.4 mL/min
Flow rates  0.4 mL/min

 0.02 mL/min
 5%

Virus Diffusion

Flow rates < 20 mL/min
Flow rates  20 mL/min

 2 mL/mi
 10%

Pressure Hold

Pressure drops < 68.9 mbar (1 psig) 3.5 mbar (0.05 psi)
Pressure drops  68.9 mbar (1 psig)  5%

*Used in accelerated enhanced bubble point and asymmetric enhanced bubble point tests.

Test Reproducibility (at standard, stable conditions)
Coefficient of variation (CV) or standard deviation (sn-1)
Test Type

Range

Reproducibility

Diffusion*

Flow rates < 20 mL/min
Flow rates  20 mL/min

sn-1 2 mL/min
CV  10%

All Bubble Point Tests
HydroCorr

345-6205 mbar (5-90 psig)

CV 10%

Flow rates < 0.4 mL/min
Flow rates  0.4 mL/min

sn-1 0.04 mL/min
CV  10%

Virus Diffusion

Flow rates < 20 mL/min
Flow rates  20 mL/min

sn-1 2 mL/min
CV  10%

Pressure Hold

Pressure drops < 68.9 mbar (1 psi)
Pressure drops  68.9 mbar (1 psi)

sn-1 6.9 mbar
(0.1 psi) CV  10%

*Diffusion reproducibility is not specified for the 30 second diffusion test.

Test Specifications
Test Type

Configuration Range

Operating Range

Diffusion*

47 mm disks Diffusion rate: 1 - 750 mL/min
12 round x 30 in. systems Test pressure: 345-6550 mbar (5-95 psig)
Capsules to TFF systems

Bubble Point (All Except
47 mm disks Accelerated Hydrophobic) 3 round x 30 in. systems

Test pressure: 345-6205 mbar
(5-90 psig)

Accelerated Hydrophobic 47 mm disks Bubble Point
1 round x 30 in. systems

Test pressure: 345-6205 mbar
(5-90 psig)

HydroCorr

47 mm disks (Aervent-50) - Test pressure: 345-6205 mbar (5-90 psig)
3 round x 30 in. systems
Flow rate: 0.01 - 10 mL/min

Virus Diffusion

25 mm disks 3 round x 30 in. systems

Diffusion rate: 1 - 600 mL/min
Test pressure: 345-6550 mbar (5-95 psig)

Pressure Hold

Up to 12 round x
30 in. systems

Test pressure: 345-6550 mbar
(5-95 psig)

* Pneumatic flow rate is at least 2500 mL/min at 5516 mbar (80 psi). The operating range claim of 750 mL/min is based upon the
qualification testing of a 12 x 30-inch filter configuration. However, the maximum physical capacity of the pneumatic module is
2500 mL/min, which enables integrity testing of large TFF systems.
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Specifications (continued)
Power Requirements
Voltage

90 -264 volts AC, 50/60 Hz

Current rating

3.5 amps

Compressed Gas
Inlet pressure

Clean, dry air or nitrogen source of 2.4 - 8.2 bar
(35 -120 psi) at least 1.03 bar (15 psi) greater
than the highest test pressure

Operating pressure range

0.34 - 7.03 bar (5 -102 psig)

Environmental
Storage temperature

-20 to 80 °C

Operating temperature

1 to 40 °C

Humidity

5 to 95%, non-condensing

Nominal Dimensions
Height

37.2 cm (14.6 in.)

Width

41.6 cm (16.4 in.)

Depth

25.4 cm (10.0 in.)

Weight

< 15 kg (32 lb)

Computer
Software operating system

Windows XP embedded

Port 1

5-pin DIN connector for service access

Port 2

PS/2 Bar code reader input

Port 3*

RJ45 for Ethernet connection

*Integritest 4N only
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System Attributes
Comprehensive library of integrity testing modes
that include diffusion (standard, accelerated/virus);
bubble point (standard/asymmetric/accelerated;
enhanced BP; HydroCorr test; pressure hold
Intuitive, multilingual, easy to use 10.4 in. SVGA
touch user interface
Rugged, por table industrial design
Developed according to GAMP 4 Guidelines
Network Ready
Ethernet printer support
Remote Integritest 4N database backup with
Networked Attached Storage (NAS) or networked
server PC
Automatic filter test report transfer and storage on
a central repository with a NAS or networked PC
when electronic signature requirements are met
Meets the technical requirements of 21 CFR Part 11

Integritest 4*
Instrument

Integritest 4N
Instrument

•
•
•

•
•
•
•
•
•

•

•

•
•

From a networked PC:
- Add or change network definitions Define users and user permissions
- Track additiom and deletions of users
- Track changing of passwords
- Organize instruments into groups

Integritest 4N Used with
PC Central IMT Software

•

•
•
•
••
•
•
•
•
••
••

* The Integritest 4 can be upgraded to an Integritest 4N instrument. Contact Millipore for details.

Ordering Information
Description

Catalogue No.

Integritest 4 Standalone Instrument**

XIT4 S00 01

Integritest 4N Instrument**

XIT4 N00 01

Integritest 4 External Valve Array

XIT4S PEVA 01

Integritest 4 Field Calibration Kit

XIT4SP FCA 01

Integritest 4 Printer Paper (3 pack)
Integritest 4 Printer Ribbon Cartridge (3 pack)
Integritest 4N Central IMT Software
Integritest 4 Inlet Tubing with Dessicant Air Filter

P83071
P83075
XIT4N CIMT 01
P83076

** Includes power cord, external valve array and operators manual
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To Place an Order or Receive Technical Assistance
In the U.S. and Canada, call toll-free
1-800-MILLIPORE (1-800-645-5476)
In the U.S., Canada and Puerto Rico, fax orders
to 1-800-MILLIFX (1-800-645-5439)
Outside of North America contact your local office.
To find the office nearest you visit www.millipore.com/offices
Internet: www.millipore.com
Technical Service: www.millipore.com/techservice

Millipore, Integritest and Access are registered trademarks of Millipore Corporation.
HydroCorr is a service mark of Millipore Corporation.
Windows XP is a registered trademark of Microsoft Corporation.
Lit. No. DS1675EN00 Rev. C 08/07 Printed in U.S.A. 07-237
© 2007 Millipore Corporation, Billerica, MA 01821 U.S.A. All rights reserved.

BIOLOGICAL SAFETY CABINETS
Class II, Type A2 Biological Safety Cabinet
PART 1 - GENERAL
1.1

REFERENCES
The publications listed below form a part of this section to the extent referenced. The
publications are referred to within the text by the basic designation only.
NATIONAL ASSOCIATION OF ARCHITECTURAL METAL MANUFACTURERS (NAAMM)
NAAMM MFM (1988) Metal Finishes Manual
NSF INTERNATIONAL (NSF)
NSF 49 (2007) Class II (Laminar Flow) Biosafety Cabinetry
UNDERWRITER'S LABORATORY (UL)
UL Standard 61010-1

1.2

DESIGN AND PERFORMANCE CRITERIA
A. Provide biological safety cabinets with workspace for testing and experimentation of
low to moderate risk agents in the Classes and Types indicated, as defined by NSF
International NSF/ANSI 49. Class II cabinets shall provide protection of experiment from
ambient environment and protection of ambient environment from experiment.
B. Biological safety cabinets shall operate in an efficient and sustainable manner.
Electrical consumption of new units shall be no greater than: 170 watts for nominal
width 3 foot unit; 200 watts nominal width 4 ft unit; 310 watts for nominal width 5 foot unit;
and 400 watts for nominal width 6 foot unit.

1.3

SUBMITTALS
Product Data - Biological safety cabinets
Biological safety cabinets - Compliance with NSF/ANSI 49
Biological safety cabinets - Operating and Service Manuals
Biological safety cabinets - Demonstration
Factory Test Reports

1.4

QUALITY ASSURANCE
A. Each cabinet will be certified by UL for electrical safety and integrity.
B. Each cabinet will be NSF listed and approved for design, construction and
performance.
C. A factory test for each cabinet validating proper performance including:
1. Cabinet integrity test with pressure decay or soap bubble leak
2. HEPA Filter leak test of downflow and exhaust filters
3. Downflow air velocity and uniformity
4. Inflow air velocity
5. Airflow smoke patterns

1.5

QUALIFICATIONS
A. Manufacturer
Company with minimum ten years documented experience in the construction of NSF Listed
and Approved Class II biological safety cabinets.
B. Cabinet
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1.6

Cabinet shall be an NSF Listed and Approved Class II biological safety cabinet.
WARRANTY
a.
Manufacturer's warranty against defects in material or workmanship covering parts
and labor must be available for a period of five years. Standard exceptions for
filters, lamps and glass shall apply.

PART 2 - PRODUCTS
2.1

MANUFACTURERS
A. Thermo Scientific

2.2

CLASS II TYPE A2 BIOLOGICAL SAFETY CABINETS
1. Exterior dimensions
a. Nominal 3 ft width - 61.8"H x 39.4"W x 31.5"D (1568mm H x 1000mm W x
800mm D)
b. Nominal 4 ft width - 61.8"H x 51.2"W x 31.5"D (1568mm H x 1300mm W x
800mm D)
c. Nominal 5 ft width - 61.8"H x 63"W x 31.5"D (1568mm H x 1600mm W x
800mm D)
d. Nominal 6 ft width - 61.8"H x 74.8"W x 31.5"D (1568mm H x 1900mm W x
800mm D)
2. Additional Height Range with Stand
a. Adjustable Height Stand - Work surface heights from 30 to 38" (750 to 950
mm) adjustable in 2" increments, overall cabinet height from 88.5" to 95.4"
(2248 to 2448 mm) [stand is 26.8" to 34.7", 680 to 880 mm]
b. Motorized Stand - Work surface heights from 30 to 38" (750 to 950 mm),
overall cabinet height from 88.6" to 96.5" (2249 to 2449 mm) [stand is 26.8" to
34.6", 680 to 880 mm]
c. Castor Stand - Work surface heights at 30" (760 mm), overall cabinet height is
88.6" (2350 mm) [stand is 680 mm]
3. Interior dimensions
a. Nominal 3 ft width - 30.7"H x 35.4"W x 24.8"D (780mm H x 900mm W x
630mm D)
b. Nominal 4 ft width - 30.7"H x 47.2"W x 24.8"D (780mm H x 1200mm W x
630mm D)
c. Nominal 5 ft width - 30.7"H x 59.1"W x 24.8"D (780mm H x 1500mm W x
630mm D)
d. Nominal 6 ft width - 30.7"H x 70.9"W x 24.8"D (780mm H x 1800mm W x
630mm D)

2.3

CONSTRUCTION
A. Cabinet shell shall use steel no less than 19 gauge (0.0394" thick) and validated to
meet the NSF performance specification where top front edge shall not move forward
more than 0.063 inches (1.6 mm) from the static position when a 250 lb (110 kg) lateral
force is applied to the top rear edge and the top of the sides shall not move forward
more than the same amount when the same force is applied to the top of the opposite side.
B. Unit shall have all metal plenums designed for easy removal at filter change. (Nonmetal, fabric type plenums are not acceptable.)
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C. To facilitate cleaning, the interior sides and rear wall of the work area shall be of one
piece no less than 19 gauge (0.0394" thick) Type 304 stainless steel construction with
No. 4 finish. The joins between the side and rear interior walls shall have coved corners of no
smaller than 0.406" radii.
D. An efficient means of adjusting the downflow and inflow separately shall be provided.
Additional penetrations of the shell of the cabinet should be avoided.
E. Corrosion resistant ball valve for drain from trough beneath the work surface. F.
Externally mounted fluorescent lighting fixture.
G. One supply and one exhaust, scan-tested, zero-probe HEPA filter, 99.995% percent
efficient on most penetrating particle size (H14 per EN 1822), serviceable and
removable from front of unit.
H. Two duplex receptacles, GFI protected with total load capacity of at least 5 amps. I.
Single power cord 12 ft in length with a NEMA plug 5-15P. J. Corrosion resistant diffuser
below the downflow filter.
K. Protective screen to prevent foreign objects from being drawn into fans.
L. A minimum of six media valves (at least three on each side, for vacuum or other)
available on the cabinet.
M. A minimum of two replaceable 3 inch cable/tubing ports (at least one on each side)
2.4

PERFORMANCE REQUIREMENTS
A. Work access opening inflow velocity: Acceptable operating range 100 - 110 fpm.
B. Inflow compensation controlling inflow velocity with 3% of set value with 100% increase
in filter loading.
C. Visual indicator on the front panel for the following features:
1. Compensation reserve capability.
2. Hours of operation
3. Inflow velocity display (feet per minute)
4. Downflow velocity display (feet per minute)
5. Night Set-Back mode
6. UV on
7. Receptacles on
8. Operating speed airflow
9. Front window position
D. No HEPA filter leakage  0.01% of upstream concentration.
E. Downflow velocity ± 5 fpm of NSF/ANSI validated nominal value.
F. All downflow measurements within 20% of average.
G. Separate downflow and inflow velocity flow alarms to signal overall variation greater
than 20% from set values.
H. Airflow smoke patterns test acceptable
1. Downflow is smooth with no dead spots or upward flow.
2. Smoke released behind view screen moves smoothly down and does not escape
from the cabinet.
3. Smoke released outside the cabinet will not escape from the cabinet once drawn in
or billow over the work surface or penetrate onto it.
4. No smoke released in the work area 2 inches from the window side or top edges
will escape from the cabinet.
I. Power consumption: Not to exceed 170 watts for nominal 3 ft width, 200 watts for
nominal 4 ft width or 400 watts for nominal 6 ft width.
J. Reduced flow or Night Set-Back mode allowing reduction in airflow and energy
consumption while maintaining cleanliness and containment when not in operation.
Power consumption during reduced flow or Night Set-Back not to exceed 70 watts for
nominal 3 ft or 4 ft widths, and 120 watts for nominal 5 ft and 6 ft widths.

2.5

ERGONOMIC OPERATION REQUIREMENTS
A. 10° sloped front (the top of the cabinet is slanted away from the operator) to provide
operator the space to change position forward and back while working.
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B.
C.
D.
E.
F.

2.6

Work area illumination: No less than 120 footcandles at the worksurface
Noise: No greater than 65 dB(A)
Front and back of window easily cleanable without special tools.
Armrests must sit above front air intake grill and be easily removable
Available UV disinfection cycle
1. adjustable UV exposure time saved in memory to facilitate consistent operation
2. safety interlock to prevent UV illumination when window is open

ACCESSORIES
A. Thimble connections for external exhaust allowing external exhaust variation of 30%:
Nominal 3 ft width with 8 inch opening - 269 cfm
Nominal 3 ft width with 10 inch opening - 336 cfm
Nominal 4 ft width with 8 inch opening - 360 cfm
Nominal 4 ft width with 10 inch opening - 450 cfm
Nominal 5 ft width with 8 inch opening -448 cfm
Nominal 5 ft width with 10 inch opening - 560 cfm
Nominal 6 ft width with 8 inch opening - 540 cfm
Nominal 6 ft width with 10 inch opening - 670 cfm
B.
C.
D.
E.
F.
G.
H.
I.

External exhaust alarm (as required by NSF 2012)
Universal Piping to top, side and bottom, up to two pre-plumbed penetrations per side
Floor anchoring brackets
Service valve taps
Adjustable footrest
Ergolign saddle stool
IV bag holder
Hanging shelf for base stand
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Recycling Services
Solvents for Recycling Fact Sheet
Typical Solvents Recycled

Clean Harbors Recycling Services offer a full range of
solvent recycling options from traditional recycling to
tolling, or a combination of the two. Recovered
products, which are not returned to customers, are
available for sale.
Our flexible operations, combined with chemical
knowledge and engineering expertise, bring advanced
solutions to the challenges of separation and purification.
During the recovery process, components of the
solvent/chemical streams are isolated and purified to
high-quality product specifications.
Clean Harbors Recycling Services employees are experts
in recycling and tolling. All processing meets strict

local, state, federal regulations, and customer
requirements.
Recycling - We provide recycling services, where the
product is recycled to our high quality specifications and
sold on the secondary market.
Customized Solutions - Customized solutions that
utilize traditional recycling with tolling to meet
customers' unique requirements are also available.

Chemical Name

CAS #

Methylene Chloride
Tetrachloroethylene
1,1,1 Trichloroethane
Trichloroethylene
Trichlorotrifluoroethane
Perchloroethylene (Dry Cleaning Filters)
N-Methyl-2-Pyrrolidone
N-Propyl Bromide
Ethanol Solutions*
*Excluding Specially Denatured Alcohols
Methanol
Isopropyl Alcohol
Isopropyl Alcohol (High Water)
Toluene
Xylenes (ortho-, meta-, para-)
Tetrahydrofuran
Acetone
Methyl Ethyl Ketone
Ethyl Acetate
Petroleum Distillates
Petroleum Distillates (Dry Cleaning Filters)
Naptha
Naptha (Dry Cleaning Filters)

75-09-2
127-18-4
71-55-6
79-01-6
76-13-1
127-18-4
872-50-4
106-94-5
64-17-5
67-56-1
67-63-0
67-63-0
108-88-3
1330-207 109-990
67-64-1
78-93-3
141-78-6
8052-413 805241-3
8032-324 803232-4

Tolling - Our tolling programs provide a closed loop
cycle in which the customer's spent solvents are
recycled to their precise specifications and returned
directly to them.
Examples of Solvents for Tolling

•
•
•
•
•

Decalin (Decahydronaphthalene)
N,N-Dimethyl Acetamide
Dimethyl Sulfoxide
1-Ethyl-2-Pyrrolidone
Isoamyl Alcohol

Recycled Materials for Sale - High quality recycled
materials are sold through Service Chemical, LLC a full
service distributor of specialty and commodity
chemicals.
Clean Harbors Recycling Services • 221 Sutton Street • North Andover, MA 01845 • 978.685.2121 • www.cleanharbors.com

MVE CryoSystem Series

The MVE CryoSystem Series combines the benefits of low nitrogen consumption with mid-range vial capacity to meet the diverse
needs of today's professionals worldwide. The lightweight and low-space demands of these containers make them the most economi- cal
units in their class.

Features Include:

• Designed for large capacity storage
• Low liquid nitrogen consumption
• Convenient lightweight package
18

ML111001 E

A Durable, tamper-proof lid design
B High strength neck tube reduces liquid nitrogen
loss
C Canisters
D Strong, lightweight aluminum construction
E Advanced chemical vacuum retention system
F Spider design on platform for easy retrieval and
insertion of product canisters
G Liquid Nitrogen Reservoir
CryoSystem
750

CryoSystem
2000

CryoSystem
4000

CryoSystem
6000

Number of Canisters

6

4

4

6

Number of 1.2 & 2.0 ml vials 100/box

-

2,000

4,000

6,000

750

-

--Boxes per Rack

5

10

10

Maximum Storage Capacity

Number of 1.2 & 2.0ml via 25/box

5

Performance
LN2 Capacity L

47.4

61.0

121.0

175.0

Static Evaporation Rate* L/day

0.39

0.85

0.99

0.99

Working Volume L

47

51

111

165

Normal Working Duration**, Full Days

76

38

70

104

Neck Opening in. (mm)

5.0 (127)

8.5 (216)

8.5 (216)

8.5 (216)

Overall Height in. (mm)

26.50 (673)

27.25 (692)

38.00 (965)

37.75 (959)

Outer Diameter in. (mm)

20 (508)

22 (559)

22 (559)

26 (665)

Weight Empty lb. (kg)

42 (19.0)

58 (26.3)

81 (36.7)

103 (46.7)

Weight Full lb. (kg)

126 (57)

182 (82.5)

300 (136)

425 (193)

Unit Dimensions

* Static evaporation rate and static holding time are nominal. Actual rate and holding time will be affected by the nature of container use, atmospheric conditions, and manufacturing tolerances.
** Normal Working Duration is an arbitrary reference, to estimate container performance under normal operating conditions. Actual working time may vary due to current atmospheric conditions, container
history, manufacturing tolerances and any individual patterns of use.

TWO Year Standard Warranty • THREE Year Vacuum Warranty
Conforms to MDD 93/42/EEC, the Medical Device Directive for the
EU

MVE CryoSystem

Tank Features

